0001575872-23-000353.txt : 20230314 0001575872-23-000353.hdr.sgml : 20230314 20230314160058 ACCESSION NUMBER: 0001575872-23-000353 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 61 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230314 DATE AS OF CHANGE: 20230314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TradeUP Acquisition Corp. CENTRAL INDEX KEY: 0001844417 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40608 FILM NUMBER: 23730647 BUSINESS ADDRESS: STREET 1: 437 MADISON AVENUE, 27TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (732) 910-9692 MAIL ADDRESS: STREET 1: 437 MADISON AVENUE, 27TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 10-K 1 uptd-20221231.htm FORM 10-K TradeUP Acquisition Corp
3P10DNY0001844417FYfalsetruetruetrue 0001844417 2021-12-31 0001844417 2022-12-31 0001844417 2021-01-06 2021-12-31 0001844417 2022-01-01 2022-12-31 0001844417 2021-07-31 0001844417 2021-07-19 2021-12-31 0001844417 2021-01-01 2021-12-31 0001844417 2023-03-14 0001844417 2022-07-25 0001844417 2022-08-16 2022-08-16 0001844417 2022-06-30 0001844417 2021-07-19 0001844417 2021-01-05 0001844417 uptd:CommonStockSubjectToRedemptionMember 2022-12-31 0001844417 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryBondSecuritiesMember 2022-12-31 0001844417 uptd:RelatedPartyLoansMember uptd:WorkingCapitalLoansWarrantMember 2022-12-31 0001844417 us-gaap:IPOMember uptd:PublicWarrantsMember 2022-12-31 0001844417 us-gaap:OverAllotmentOptionMember uptd:FounderSharesMember 2022-12-31 0001844417 us-gaap:IPOMember 2022-12-31 0001844417 uptd:PublicWarrantsMember 2022-12-31 0001844417 uptd:SponsorMember 2022-12-31 0001844417 us-gaap:CommercialLoanMember 2022-12-31 0001844417 us-gaap:CommonClassAMember 2022-12-31 0001844417 uptd:MergerAgreementMember uptd:ShareholdersOfEstrellaMember 2022-12-31 0001844417 uptd:CommonStockSubjectToRedemptionMember 2021-12-31 0001844417 us-gaap:USTreasuryBondSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001844417 uptd:FounderSharesMember us-gaap:OverAllotmentOptionMember 2021-12-31 0001844417 us-gaap:CommercialLoanMember 2021-12-31 0001844417 uptd:RedeemableCommonStockMember 2022-01-01 2022-12-31 0001844417 uptd:NonRedeemableCommonStockMember 2022-01-01 2022-12-31 0001844417 uptd:BusinessCombinationMarketingAgreementMember 2022-01-01 2022-12-31 0001844417 us-gaap:OverAllotmentOptionMember 2022-01-01 2022-12-31 0001844417 us-gaap:IPOMember 2022-01-01 2022-12-31 0001844417 us-gaap:OverAllotmentOptionMember uptd:FounderSharesMember 2022-01-01 2022-12-31 0001844417 us-gaap:PrivatePlacementMember 2022-01-01 2022-12-31 0001844417 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001844417 uptd:CommonStockSubjectToPossibleRedemptionMember 2022-01-01 2022-12-31 0001844417 us-gaap:ParentMember 2022-01-01 2022-12-31 0001844417 uptd:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds16.50Member us-gaap:WarrantMember 2022-01-01 2022-12-31 0001844417 uptd:FounderSharesMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001844417 uptd:FounderSharesMember 2022-01-01 2022-12-31 0001844417 uptd:SponsorMember uptd:FounderSharesMember 2022-01-01 2022-12-31 0001844417 uptd:FounderSharesMember us-gaap:OverAllotmentOptionMember 2022-01-01 2022-12-31 0001844417 uptd:PublicWarrantsMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001844417 us-gaap:IPOMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001844417 uptd:UnitsEachConsistingOfOneShareOfClassCommonStockAndOneHalfOfOneWarrantMember 2022-01-01 2022-12-31 0001844417 us-gaap:CommonClassAMember 2022-01-01 2022-12-31 0001844417 uptd:WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember 2022-01-01 2022-12-31 0001844417 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001844417 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001844417 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001844417 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001844417 uptd:SponsorMember 2022-01-01 2022-12-31 0001844417 uptd:FriedmanLlpMember 2022-01-01 2022-12-31 0001844417 uptd:FounderSharesMember 2021-01-06 2021-09-30 0001844417 us-gaap:IPOMember 2021-07-19 2021-07-19 0001844417 uptd:SponsorMember us-gaap:PrivatePlacementMember 2021-07-19 2021-07-19 0001844417 us-gaap:PrivatePlacementMember 2021-07-19 2021-07-19 0001844417 us-gaap:OverAllotmentOptionMember 2021-07-19 2021-07-19 0001844417 us-gaap:PrivatePlacementMember uptd:TradeUpIncMember 2021-07-19 2021-07-19 0001844417 us-gaap:PrivatePlacementMember 2021-07-19 0001844417 us-gaap:OverAllotmentOptionMember 2021-07-19 0001844417 us-gaap:IPOMember 2021-07-19 0001844417 uptd:SponsorMember us-gaap:PrivatePlacementMember 2021-07-19 0001844417 us-gaap:PrivatePlacementMember uptd:TradeUpIncMember 2021-07-19 0001844417 us-gaap:OverAllotmentOptionMember 2021-07-21 2021-07-21 0001844417 uptd:SponsorMember us-gaap:PrivatePlacementMember 2021-07-21 2021-07-21 0001844417 us-gaap:PrivatePlacementMember 2021-07-21 2021-07-21 0001844417 us-gaap:IPOMember 2021-07-21 2021-07-21 0001844417 uptd:FounderSharesMember us-gaap:PrivatePlacementMember 2021-07-21 2021-07-21 0001844417 us-gaap:PrivatePlacementMember 2021-07-21 0001844417 us-gaap:PrivatePlacementMember uptd:SponsorMember 2021-07-21 0001844417 us-gaap:OverAllotmentOptionMember 2021-07-21 0001844417 us-gaap:IPOMember 2021-07-21 0001844417 uptd:TradeUpIncMember us-gaap:PrivatePlacementMember 2021-07-21 0001844417 uptd:RedeemableCommonStockMember 2021-01-06 2021-12-31 0001844417 uptd:NonRedeemableCommonStockMember 2021-01-06 2021-12-31 0001844417 us-gaap:RetainedEarningsMember 2021-01-06 2021-12-31 0001844417 us-gaap:AdditionalPaidInCapitalMember 2021-01-06 2021-12-31 0001844417 us-gaap:CommonStockMember 2021-01-06 2021-12-31 0001844417 us-gaap:PreferredStockMember 2021-01-06 2021-12-31 0001844417 uptd:CommonStockSubjectToPossibleRedemptionMember 2021-01-06 2021-12-31 0001844417 us-gaap:ParentMember 2021-01-06 2021-12-31 0001844417 us-gaap:IPOMember us-gaap:PreferredStockMember 2021-01-06 2021-12-31 0001844417 us-gaap:CommonStockMember us-gaap:IPOMember 2021-01-06 2021-12-31 0001844417 us-gaap:IPOMember us-gaap:AdditionalPaidInCapitalMember 2021-01-06 2021-12-31 0001844417 us-gaap:RetainedEarningsMember us-gaap:IPOMember 2021-01-06 2021-12-31 0001844417 us-gaap:IPOMember 2021-01-06 2021-12-31 0001844417 us-gaap:PreferredStockMember us-gaap:PrivatePlacementMember 2021-01-06 2021-12-31 0001844417 us-gaap:PrivatePlacementMember us-gaap:CommonStockMember 2021-01-06 2021-12-31 0001844417 us-gaap:AdditionalPaidInCapitalMember us-gaap:PrivatePlacementMember 2021-01-06 2021-12-31 0001844417 us-gaap:RetainedEarningsMember us-gaap:PrivatePlacementMember 2021-01-06 2021-12-31 0001844417 us-gaap:PrivatePlacementMember 2021-01-06 2021-12-31 0001844417 us-gaap:OverAllotmentOptionMember 2021-09-01 2021-09-01 0001844417 uptd:PromissoryNoteWithRelatedPartyMember 2021-01-19 0001844417 us-gaap:PrivatePlacementMember uptd:TradeUpIncMember 2021-01-19 0001844417 uptd:FounderSharesMember uptd:SponsorMember 2021-01-20 2021-01-20 0001844417 uptd:SponsorMember uptd:FounderSharesMember 2021-02-11 2021-02-11 0001844417 uptd:FounderSharesMember uptd:SponsorMember 2021-02-11 0001844417 uptd:SponsorMember uptd:FounderSharesMember 2021-02-12 2021-02-12 0001844417 uptd:FounderSharesMember 2021-02-12 2021-02-12 0001844417 uptd:RunningLionHoldingsMember 2022-07-25 0001844417 uptd:TradeUpIncMember 2022-07-25 0001844417 us-gaap:IPOMember 2021-07-31 0001844417 us-gaap:WarrantMember 2021-07-31 0001844417 uptd:PromissoryNoteWithRelatedPartyMember us-gaap:SubsequentEventMember 2023-03-19 0001844417 uptd:EstrellaBiopharmaIncMember us-gaap:SubsequentEventMember 2023-03-19 0001844417 uptd:SponsorMember us-gaap:SubsequentEventMember 2023-01-19 0001844417 uptd:TradeUpIncMember uptd:PromissoryNoteWithRelatedPartyMember us-gaap:SubsequentEventMember 2023-03-03 0001844417 us-gaap:RetainedEarningsMember 2022-12-31 0001844417 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001844417 us-gaap:CommonStockMember 2022-12-31 0001844417 us-gaap:PreferredStockMember 2022-12-31 0001844417 us-gaap:RetainedEarningsMember 2021-01-05 0001844417 us-gaap:AdditionalPaidInCapitalMember 2021-01-05 0001844417 us-gaap:CommonStockMember 2021-01-05 0001844417 us-gaap:PreferredStockMember 2021-01-05 0001844417 us-gaap:RetainedEarningsMember 2021-12-31 0001844417 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001844417 us-gaap:CommonStockMember 2021-12-31 0001844417 us-gaap:PreferredStockMember 2021-12-31 iso4217:USD xbrli:shares xbrli:pure utr:Day utr:Year utr:Month iso4217:USD xbrli:shares uptd:Item uptd:item utr:D
Table of Contents
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 10-K
 

☒
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
 
ACT OF 1934
 
 

For the fiscal year ended December 31, 2022
 

or
 

☐
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
 
ACT OF 1934
 

For the transition period from           to         
 

Commission file number:  001-40608
 

TRADEUP ACQUISITION CORP.
(Exact name of registrant as specified in its charter)
 

Delaware
 
85-1314502
(State or other jurisdiction of

incorporation or organization)
 
(I.R.S. Employer

Identification No.)
 
437 Madison Avenue, 27th Floor

New York, NY
 
10022
(Address of principal executive offices)
 
(Zip Code)
 

Registrant’s telephone number, including area code:  (732) 910-9692
 

Securities registered pursuant to Section 12(b) of the Act:
 
 
Title of each class
 
Name of each exchange on which registered
Units, each consisting of one share of Common Stock and on-half of one Warrant
 
The Nasdaq Stock Market LLC
Common Stock, par value $0.0001 per share
 
The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
 
The Nasdaq Stock Market LLC
 

Securities registered pursuant to Section 12(g) of the Act:
None.
 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes
¨
No
x
 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes
¨
No
x
 

Indicate by check mark whether the registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes 
x
  No 
¨
 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes 
x
  No 
¨
 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
¨
 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
 
Large accelerated filer
¨
Accelerated filer
 
 
 
 
 
Non-accelerated filer
x
Smaller reporting company
x
 
 
 
 
 
 
Emerging Growth Company
x
 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
¨
 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  
x
  No 
¨
 

At June 30, 2022, the last business day of the registrant’s most recently completed second fiscal quarter, the aggregate market value of the common stock of the registrant held by non-affiliates of the registrant was $58,497,000
computed by the closing price thereof.
 

The number of shares of the common stock of the registrant outstanding as of
March 1
4
,
2023 was 2,329,920.
 

DOCUMENTS INCORPORATED BY REFERENCE
 

None.

 

Table of Contents

TRADEUP ACQUISITION CORP.
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2022
 


 
 
 
 
 


 
 
 


 
 
 
 
 
 




2
Table of Contents
 
  
FORWARD LOOKING STATEMENTS
  
 

This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, or the Exchange Act. The statements contained in this report that are not purely historical are forward-looking statements. Our forward-looking statements include, but are not limited to, statements regarding our or our management’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipates,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this report may include, for example, statements about our:
 
●
ability to complete our initial business combination;
 
  
●
success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;
 
●
officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination;
 
●
potential ability to obtain additional financing to complete our initial business combination;
 
●
pool of prospective target businesses;
 
●
the ability of our officers and directors to generate a number of potential investment opportunities;
 
●
potential change in control if we acquire one or more target businesses for stock;
 
●
the potential liquidity and trading of our securities;
 
●
the lack of a market for our securities;
 
●
use of proceeds not held in the trust account or available to us from interest income on the trust account balance; or
 
●
financial performance following our initial public offering.
  
The forward-looking statements contained in this report are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under the heading “Risk Factors.” Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable laws.

3
Table of Contents

PART I
ITEM 1. BUSINESS
  
In this Annual Report on Form 10-K (the “Form 10-K”), references to the “Company”, “UPTD” and to “we,” “us,” and “our” refer to TradeUP Acquisition Corp.
 
Overview
  
We are a blank check company formed as a Delaware corporation for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, which we refer to throughout this report as our initial business combination.
  
On July 19, 2021, we consummated our initial public offering (the “IPO”) of 4,000,000 units (the “Units”). Each Unit consists of one share of common stock, $0.0001 par value per share (the “Common Stock”), and one-half of one redeemable warrant (the “Warrant”), each whole Warrant entitling the holder thereof to purchase one share of Common Stock at an exercise price of $11.50 per share. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $40,000,000. Simultaneously with the closing of the IPO, we completed the private sale (the “Private Placement”) of 295,000 shares of Common Stock (the “Private Shares”) to the Company’s founders, TradeUP Acquisition Sponsor LLC (the “Sponsor”) and Tradeup INC., among which, the Sponsor purchased 236,000 Private Shares and Tradeup INC. purchased 59,000 Private Shares at a purchase price of $10.00 per Private Share, generating gross proceeds to the Company of $2,950,000 (the “Private Placement Proceeds”). The Private Shares are identical to the shares of Common Stock sold as part of the Units in the IPO, except that the Private Shares are not transferable, assignable or salable (except to our officers and directors and other persons or entities affiliated with or related to our founders, each of whom will be subject to the same transfer restrictions) until 30 days after the completion of our initial business combination. The proceeds of $ $40,800,000 ($10.20 per Unit) in the aggregate from the IPO and the Private Placement (the “IPO Proceeds”), were placed in a trust account (the “Trust Account”) established for the benefit of the Company’s public stockholders and the underwriters of the IPO with Wilmington Trust, National Association acting as trustee.


In connection with the IPO, the underwriters were granted an option to purchase up to 600,000 additional Units to cover over-allotments, if any (the “Over-allotment Option”). On July 19, 2021, the underwriters partially exercised the Over-allotment Option, and July 21, 2021, the underwriters purchased 430,000 Units (the “Option Units”) generating gross proceeds of $4,300,000, and net proceeds to the Company of approximately $4,214,000 in the aggregate after deducting the underwriter discount (the “Option Unit Proceeds”). Simultaneously with the issuance and sale of the Option Units, the Company completed the Private Placement sale of 17,200 additional Private Shares at a purchase price of $10.00 per share, among which, the Sponsor purchased 13,760 additional Private Shares and Tradeup INC. purchased 3,440 additional Private Shares, generating total proceeds of $172,000 (the “Private Placement Proceeds” and, together with the Option Unit Proceeds, the “Over-allotment Proceeds”). A total of $4,386,000 of the Over-allotment Proceeds were placed in the Trust Account. The IPO Proceeds and the Over-allotment Proceeds include $1,550,500 payable to the underwriters (the “Business Combination Fee”) pursuant to a certain business combination marketing agreement among us, US Tiger Securities, Inc. (“US Tiger”), EF Hutton, division of Benchmark Investments, LLC (“EF Hutton”) and R.F. Lafferty & Co., Inc., the representatives (the “Representatives”) of the underwriters of the IPO (the “Business Combination Marketing Agreement”).
  
Our management has broad discretion with respect to the specific application of the proceeds of the IPO and the Private Placement that are held out of the Trust Account, although substantially all the net proceeds are intended to be applied generally towards consummating a business combination and working capital.
 
Proposed Business Combination with Estrella
  
On September 30, 2022, we entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the “Merger Agreement”) among Tradeup Merger Sub Inc., a Delaware corporation and direct, wholly owned subsidiary of UPTD (“Merger Sub”), and Estrella Biopharma, Inc., a Delaware corporation (“Estrella”).
  
Estrella is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS®️ T-cell therapies with the capacity to address treatment and safety challenges for patients with blood cancers and solid tumors. Estrella’s mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer. For more information regarding the business of Estrella and the proposed Business Combination (as defined below), see the Registration Statement on Form S-4 (File No.: 333-267918) initially filed with the SEC on October 18, 2022, as amended from time to time (the “Form S-4”).
  
Pursuant to the Merger Agreement, among other things, in accordance with the General Corporation Law of the State of Delaware, as amended (the “DGCL”), Merger Sub will merge with and into the Estrella (the “Merger”), with Estrella surviving the Merger as a wholly owned subsidiary of UPTD (“Surviving Company”). The Merger will become effective at such time on the date of the closing of the Merger (the “Closing”) as the certificate of merger is duly filed with the Delaware Secretary of State or at such other time specified in the certificates of merger (the “Effective Time”). Effective as of the Closing, UPTD will change its name to “Estrella Immunopharma, Inc.” (“New Estrella”). The transactions contemplated by the Merger Agreement is herein referred to as the “Business Combination.”
  
Pursuant to the Merger Agreement, stockholders of Estrella immediately prior to the Effective Time collectively will receive from us, in the aggregate, a number of newly issued shares of Common Stock equal to: (i) $325,000,000 (the “Merger Consideration”), divided by (ii) $10.00 per share in consideration of converting their shares of common stock of Estrella, par value $0.0001 per share (the “Estrella Common Stock”). Each share of preferred stock of Estrella that is issued and outstanding immediately prior to the Effective Time will automatically convert into a number of shares of Estrella Common Stock in accordance with the certificate of incorporation of Estrella immediately prior to the Effective Time.


4
Table of Contents

The Merger also calls for additional agreements, including, among others, the Lock-Up Agreement and the Support Agreement, as described elsewhere in the Form S-4.

December 2022 Extension, Related Redemption and Extension Notes
  
On December 22, 2022, the Company held a special meeting of stockholders (the “2022 Special Meeting”) where the Company was approved by its stockholders to adopt the amended and restated certificate of incorporation to extend the date before which the Company must complete a business combination (the “Combination Deadline”) from January 19, 2023, by one month up to six times, to July 19, 2023 or such earlier date as determined by the board of directors of the Company (such monthly extension is herein referred to as the “Extension”). Upon the stockholders’ approval, on December 29, 2022, the Company filed a certificate of amendment to the amended and restated certificate of incorporation (the “Current Charter”) which became effective upon filing. Additionally, as a result of the 2022 Special Meeting, upon the stockholders’ approval, on December 29, 2022, UPTD and Wilmington Trust, National Association, as the trustee of the Trust Account, entered into the amendment to the Investment Management Trust Agreement dated July 14, 2021.
  
As a result of the 2022 Special Meeting, 3,519,780 shares of Common Stock were rendered for redemption and approximately $36.1 million was released from the Trust Account to pay such redeeming stockholders.
  
Under the Current Charter, the Company may extend the Combination Deadline until July 19, 2023 by depositing $45,511 (or $0.05 per share) into the Trust Account (the “Monthly Extension Payment”) for each monthly Extension. Pursuant to the Merger Agreement, Estrella made two Monthly Extension Payments to the Trust Account, as a result of which, the current Combination Deadline is March 19, 2023. The two Monthly Extension Payments were evidenced by two promissory notes (collectively, the “Extension Notes”) issued by the Company to Estrella, each in the principal amount of $45,511.
 
Outstanding Promissory Notes and Loans
  
As of the date hereof, we have outstanding loans from various parties in the aggregated amount of $598,600, which include (i) an unsecured promissory note dated July 25, 2022 (the “Running Lion Note”) in the amount of $204,000 to Running Lion Holdings Limited (“Running Lion”), a company limited by shares incorporated under the laws of British Virgin Islands, which is wholly owned and controlled by Mr. Weiguang Yang, the Co-Executive Officer and director of the Company, (ii) an unsecured promissory note dated July 25, 2022 (the “July 2022 Sponsor Note”) in the amount of $294,600 to Tradeup INC.,  (iii) an unsecured promissory note dated January 19, 2023 (the “January 2023 Sponsor Note”) in the amount of $50,000 to the Sponsor, to evidence a deposit that the Sponsor provided to the Company to pay its certain operating expenses, and (iv) an unsecured promissory note dated March 3, 2023 in the amount of $50,000 to Tradeup INC. (the “March 2023 Sponsor Note”, together with Running Lion Note July 2022 Sponsor Note, and January 2023 Sponsor Note, collectively the “Notes”).
  
In connection with the Extension, we issued the Extension Notes in the amount of $91,022 to Estrella to evidence the funds deposited into the Trust Account.
  
Potential Conflicts
  
Our executive officers and directors may have interests in the Business Combination or other alternative business combination that are different from, in addition to or in conflict with our stockholders. These interests include, among other things:
 
·
the fact that the Sponsor, Tradeup INC. and UPTD’s officers and directors (collectively, the “UPTD Initial Stockholders”) have agreed, as part of UPTD’s IPO and without any separate consideration provided by UPTD for such agreement, not to redeem any shares of Common Stock in connection with a stockholder vote to approve a proposed initial business combination;
  
·
the beneficial ownership by the Sponsor of an aggregate of 862,000 founder shares and 249,760 Private Shares, which would become worthless if UPTD does not complete a business combination within the applicable time period, as the Sponsor has waived any right to redemption with respect to these shares;
  
·
the beneficial ownership by Tradeup INC. of an aggregate of 104,750 founder shares and 31,220 Private Shares, which would become worthless if UPTD does not complete a business combination within the applicable time period, as Tradeup INC. has waived any right to redemption with respect to these shares. Tradeup INC. paid an aggregate of approximately $2,365, or $0.02 per share, for the Founders Shares and $312,200, or $10.00 per share, for the Private Shares;
  
·
Tradeup INC. is an affiliate of US Tiger, an underwriter of the IPO. US Tiger is a New York based investment bank. Both Tradeup INC. and US Tiger are owned by UP Fintech, a Nasdaq listed company (Nasdaq: TIGR). UP Fintech is an online brokerage firm focusing on global Chinese investors. UPTD has entered into the Business Combination Marketing Agreement to engage the Representatives, pursuant to which UPTD engages the Representatives as advisors in connection with UPTD’s potential business combination. UPTD will pay the Representatives the Business Combination Fee for such services upon the consummation of an initial business combination in an amount of $1,550,000, equal to 3.5% of the gross proceeds of the Initial Public Offering (exclusive of any fees which might become payable to third parties for supporting services related to a business combination), among certain percentage of the total Business Combination Fee, is payable to US Tiger. Such payment of the Business Combination Fee is contingent on completion of a business combination;
  
·
Mr. Jianwei Li, UPTD’S Chairman and Chief Executive Officer, is the managing member of the Sponsor, and as such may be deemed to have sole voting and investment discretion with respect to the shares of our Common Stock held by the Sponsor, including 862,000 founder shares and 249,760 Private Shares as described above. In addition, Mr. Jianwei Li directly holds 110,750 founder shares and 31,220 Private Shares, which would become worthless if UPTD does not complete a business combination within the applicable time period, as Mr. Li has waived any right to redemption with respect to these shares. For the shares directly held by Mr. Li, Mr. Li paid an aggregate of approximately $2,500, or $0.02 per share, for the founders shares and $312,200, or $10.00 per share, for the Private Shares;
 
·
each of the three independent directors of UPTD holds 10,000 founder shares, which would become worthless if UPTD does not complete a business combination within the applicable time period, as the independent directors have waived any right to redemption with respect to these shares. Each independent director of UPTD paid approximately $217.50, or $0.02 per share for such 10,000 founder shares. Further, each of the independent directors is entitled to purchase 10,000 founder shares from the Sponsor and Tradeup INC. upon the completion of the Business Combination at the original purchase price of approximately $0.02 per share, or $217.50 in total (80% from the Sponsor and 20% from Tradeup INC);

5
Table of Contents
  
 
·
in order to finance transaction costs in connection with an intended initial business combination, the founders, an affiliate of the founders, or certain of UPTD’s officers and directors may, but are not obligated to, loan UPTD funds as may be required. If UPTD completes the Business Combination, UPTD would repay such loaned amounts out of the proceeds of the Trust Account released to UPTD. Otherwise, such loans would be repaid only out of funds held outside the Trust Account. In the event that the Business Combination does not close, UPTD may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used to repay such loaned amounts. Up to $1,200,000 of such loans may be convertible into the working capital shares that may be issued upon conversion of such working capital loans (“Working Capital Shares”), at a price of $10.00 per share at the option of the lender. As of the date hereof, UPTD had $
598,600
outstanding under the working capital loans as evidenced by the Notes accordingly;
 
·
the founders and UPTD’s officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred related to identifying, investigating, and consummating an initial business combination, provided, that, if UPTD does not consummate its initial business combination, a portion of the working capital held outside the Trust Account may be used by UPTD to repay such reimbursements so long as no proceeds from the Trust Account are used for such repayment. As of the date hereof, the UPTD Initial Stockholders and their respective affiliates had not incurred any reimbursable out-of-pocket expenses;
  
·
the nomination of Ms. Pei Xu by UPTD as a director of New Estrella following the Closing; Ms. Xu is also the CFO of Zhongchao Inc. (Nasdaq: ZCMD) of which Mr. Weiguang Yang is the CEO;
  
·
the continued indemnification of current directors and officers of UPTD and the continuation of directors’ and officers’ liability insurance after the Business Combination;
  
·
the fact that the UPTD Initial Stockholders may be incentivized to complete the Business Combination, or an alternative initial business combination with a less favorable company or on terms less favorable to stockholders, rather than to liquidate, in which case the UPTD Initial Stockholders would lose their entire investment. As a result, the UPTD Initial Stockholders may have a conflict of interest in determining whether Estrella is an appropriate business with which to effectuate a business combination and/or in evaluating the terms of the business combination;
  
·
the fact that the UPTD Initial Stockholders collectively acquired 1,107,500 founder shares at a purchase price of approximately $0.023 per share and 312,200 Private Shares at a purchase price of $10.00 per share, representing 60.9% of issued and outstanding shares of our Common Stock prior to the Business Combination. However, the newly issued 32,500,000 shares of our Common Stock for the Merger Consideration is based on a deemed price per share of $10.00 per share. Therefore, the UPTD Initial Stockholders could make a substantial profit after the Business Combination from their acquisition of founder shares and/or Private Shares as discussed above, even if the Business Combination subsequently declines in value or is unprofitable for the public stockholder, or the public stockholder experience substantial losses in their investment in New Estrella; and
  
·
in addition to these interests of the UPTD Initial Stockholders, to the fullest extent permitted by applicable laws, our amended and restated certificate of incorporation (the “Current Charter”) waives certain applications of the doctrine of corporate opportunity in some circumstances where the application of any such doctrine would conflict with any fiduciary duties or contractual obligations they may have as of the date of the Current Charter or in the future, and UPTD will renounce any expectancy that any of the directors or officers of UPTD will offer any such corporate opportunity of which he or she may become aware to UPTD. UPTD does not believe that the pre-existing fiduciary duties or contractual obligations of its officers and directors materially impacted its search for an acquisition target. Further, UPTD does not believe that the waiver of the application of the corporate opportunity doctrine in the Current Charter had any impact on its search for a potential business combination target.
  
Subject to his or her fiduciary duties under Delaware law, none of the members of our management team who are also employed by, or directors of, the Sponsor or its affiliates have any obligation to present us with any opportunity for a potential business combination of which they become aware. Our Sponsor and directors and officers are also not prohibited from sponsoring, investing or otherwise becoming involved with, any other blank check companies, including in connection with their initial business combinations, prior to us completing our initial business combination. Our management team, in their capacities as directors, officers or employees of the Sponsor or its affiliates or in their other endeavors, may choose to present potential business combinations to the related entities described above, current or future entities affiliated with or managed by the Sponsor, or third parties, before they present such opportunities to us, subject to his or her fiduciary duties under Delaware law and any other applicable fiduciary duties. Our Current Charter provides that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of the company and it is an opportunity that we are able to complete on a reasonable basis.
  
As more fully discussed in “
Directors, Executive Officers and Corporate Governance — Conflicts of Interest
,” if any of our officers or directors becomes aware of an initial business combination opportunity that falls within the line of business of any entity to which he has pre-existing fiduciary or contractual obligations, he may be required to present such initial business combination opportunity to such entity prior to presenting such initial business combination opportunity to us. Our officers and directors currently have certain relevant fiduciary duties or contractual obligations to such other entities (as well as to us). We do not believe, however, that any fiduciary duties or contractual obligations of our executive officers would materially undermine our ability to complete our initial business combination. Our officers and directors have agreed to present to us all target business opportunities that have a fair market value of at least 80% of the assets held in the Trust Account (excluding the Business Combination Fee payable to our underwriters and taxes payable and interest previously released for working capital purposes on the income earned on the Trust Account ) while we are listed on NASDAQ (and all target business opportunities if we are delisted from NASDAQ) prior to presenting them to any other entity until the earlier of a business combination or our liquidation, subject to any pre-existing fiduciary or contractual obligations they may have. Our officers and directors have also agreed not to participate in the formation of, or become an officer or director of, any other special purpose acquisition company with a class of securities registered under the Exchange Act until we have entered into a definitive agreement regarding our initial business combination or we have failed to complete our initial business combination within the required time period.
  
 
6
Table of Contents
  
 
For more information on the foregoing conflicts of interest and the relevant pre-existing fiduciary duties or contractual obligations of our management team, see the section titled “
Directors, Executive Officers and Corporate Governance — Conflicts of Interest
.”
 
Status as a Public Company
  
We believe our structure will make us an attractive business combination partner to target businesses. As an existing public company, we offer a target business an alternative to the traditional initial public offering through a merger or other business combination. In this situation, the owners of the target business would exchange their shares of stock in the target business for shares of our stock or for a combination of shares of our stock and cash, allowing us to tailor the consideration to the specific needs of the sellers. Although there are various costs and obligations associated with being a public company, we believe target businesses will find this method a more certain and cost effective method to becoming a public company than the typical initial public offering. In a typical initial public offering, there are additional expenses incurred in marketing, road show and public reporting efforts that may not be present to the same extent in connection with a business combination with us.
  
Furthermore, once a proposed business combination is completed, the target business will have effectively become public, whereas an initial public offering is always subject to the underwriters’ ability to complete the offering, as well as general market conditions, which could delay or prevent the offering from occurring or could have negative valuation consequences. Once public, we believe the target business would then have greater access to capital and an additional means of providing management incentives consistent with stockholders’ interests. It can offer further benefits by augmenting a company’s profile among potential new customers and vendors and aid in attracting talented employees.
  
We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.
  
In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We intend to take advantage of the benefits of this extended transition period.
  
We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the completion of the IPO, (b) in which we have total annual gross revenue of at least $1.235 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our Common Stock that is held by non-affiliates exceeds $700 million as of the prior June 30th, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.
 
Financial Position
  
With funds in the Trust Account available for a business combination initially in the amount of $38,600,000, after payment of approximately $36.1 million to the redeeming stockholders in connection with the Extension and $1,550,500 for the Business Combination Fee, before fees and expenses associated with our initial business combination, we offer a target business a variety of options such as creating a liquidity event for its owners, providing capital for the potential growth and expansion of its operations or strengthening its balance sheet by reducing its debt or leverage ratio. Because we are able to complete our business combination using our cash, debt or equity securities, or a combination of the foregoing, we have the flexibility to use the most efficient combination that will allow us to tailor the consideration to be paid to the target business to fit its needs and desires. However, we have not taken any steps to secure third-party financing and there can be no assurance it will be available to us.
 
Effecting our Initial Business Combination
 
Selection of a Target Business and
Structuring
of Our Initial Business Combination
  
Nasdaq rules require that we must complete one or more business combinations having an aggregate fair market value of at least 80% of the value of the assets held in the Trust Account (excluding the Business Combination Fee and taxes payable on the interest earned on the Trust Account) at the time of our signing a definitive agreement in connection with our initial business combination. The Board determined that this test was met in connection with the proposed Business Combination.
 
Redemption Rights for Public Stockholders upon Completion of Our Initial Business Combination
  
We are providing our public stockholders with the opportunity to redeem all or a portion of their public shares in connection with our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes, if any, divided by the number of then outstanding public shares, subject to the limitations described herein. The amount in the Trust Account is anticipated to be approximately $10.20 per share, without taking into account interest earned on the Trust Account.
  
 
7
Table of Contents
  
 
The per-share amount we will distribute to investors who properly redeem their shares will not be reduced by the Business Combination Fee. However, the amount of the Business Combination Fee is fixed regardless of the level of redemptions from our Trust Account in connection with the Business Combination. As a result, as redemptions increase, the per-share impact of the Business Combination Fee will increase for each non-redeeming stockholder.
  
The UPTD Initial Stockholders have entered into a letter agreement by and among UPTD and the UPTD Initial Stockholders, dated July 14, 2021, in connection with the IPO (the “IPO Letter Agreement”), pursuant to which they have agreed to waive their redemption rights with respect to any founder shares and any Private Shares held by them in connection with the completion of our business combination. However, if any UPTD Initial Stockholders acquired public shares in or after the IPO, they will be entitled to liquidating distributions from the Trust Account with respect to such public shares if we fail to complete our initial business combination by July 19, 2023.
  
We will complete our initial business combination only if a majority of the outstanding shares of our Common Stock voted are voted in favor of the business combination. A quorum for such meeting will consist of the holders present in person or by proxy of shares of outstanding capital stock of the company representing a majority of the voting power of all outstanding shares of capital stock of the company entitled to vote at such meeting. The UPTD Initial Stockholders will count towards this quorum and have agreed to vote their founder shares, Private Shares, and any public shares purchased during or after the IPO in favor of our initial business combination. For purposes of seeking approval of the majority of our outstanding shares of our Common Stock voted, non-votes will have no effect on the approval of our initial business combination once a quorum is obtained. UPTD’s Initial Stockholders collectively own 1,419,
700 
shares of our Common Stock (including 1,107,500 founder shares and 312,200 Private Shares). As a result, in addition to the UPTD Initial Stockholders’ founder shares and Private Shares, we do not need additional shares to vote in favor of the business combination for it to be approved (assuming either all outstanding shares are voted or only the quorum is present and voted.
  
These quorums and voting thresholds, and the IPO Letter Agreement may make it more likely that we will consummate our initial business combination. Each public stockholder may elect to redeem its public shares irrespective of whether they vote, do not vote, or abstain, and if they do vote, irrespective of whether they vote for or against, or abstain from voting on the proposed transaction, and irrespective of whether they were a public stockholders on the record date for the special meeting in connection for the vote to approve the business combination.
 
Limitation on Redemption upon Completion of Initial Business Combination
  
If we do not conduct redemptions in connection with our business combination pursuant to the tender offer rules, the Current Charter provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect to more than an aggregate of 20% of the shares sold in the IPO, which we refer to as the “Excess Shares.” We believe this restriction will discourage stockholders from accumulating large blocks of shares, and subsequent attempts by such holders to use their ability to exercise their redemption rights against a proposed business combination to force us or our management to purchase their shares at a significant premium to the then-current market price or on other undesirable terms. Absent this provision, a public stockholder holding more than an aggregate of 20% of the public shares sold in the IPO could threaten to exercise its redemption rights if such holder’s shares are not purchased by us or our management at a premium to the then-current market price or on other undesirable terms. By limiting our stockholders’ ability to redeem no more than 20% of the public shares sold in the IPO, we believe we will limit the ability of a small group of stockholders to unreasonably attempt to block our ability to complete our business combination, particularly in connection with a business combination with a target that requires as a closing condition that we have a minimum net worth or a certain amount of cash. However, the Current Charter does not restrict our stockholders’ ability to vote all of their shares (including Excess Shares) for or against, or to abstain from voting on, our business combination.
  
In addition, the Current Charter provides that we will only redeem the public shares so long as (after such redemption) our net tangible assets will be at least $5,000,001 either immediately prior to or upon consummation of our initial business combination and after payment of the Business Combination Fee (so that we are not subject to the SEC’s “penny stock” rules). In the event the aggregate cash consideration we would be required to pay for all shares of our Common Stock that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the Business Combination exceed the aggregate amount of cash available to us, we will not complete a business combination or redeem any shares, and all shares of our Common Stock submitted for redemption will be returned to the holders thereof.
 
Tendering Stock Certificates in Connection with Redemption Rights
  
Public stockholder seeking to exercise their redemption rights, whether they are record holders or hold their shares in “street name,” are required to tender their certificates to our transfer agent up to two business days prior to the Special Meeting, or to deliver their shares to the transfer agent electronically using the Depository Trust Company’s DWAC (Deposit/Withdrawal At Custodian) System, at the holder’s option. Given the relatively short exercise period, it is advisable for public stockholder to use electronic delivery of their public shares.
  
There is a nominal cost associated with the above-referenced tendering process and the act of certificating the public shares or delivering them through the DWAC System. The transfer agent will typically charge the tendering broker $120.00 and it would be up to the broker whether or not to pass this cost on to the redeeming holder. However, this fee would be incurred regardless of whether or not we require holders seeking to exercise redemption rights to tender their shares. The need to deliver shares is a requirement of exercising redemption rights regardless of the timing of when such delivery must be effectuated.
  
 
8
Table of Contents
  
 
The foregoing is different from the procedures used by many blank check companies. In order to perfect redemption rights in connection with their business combinations, many blank check companies would distribute proxy materials for the stockholders’ vote on an initial business combination, and a holder could simply vote against a proposed business combination and check a box on the proxy card indicating such holder was seeking to exercise his or her redemption rights. After the business combination was approved, the company would contact such stockholder to arrange for him or her to deliver his or her certificate to verify ownership. As a result, the stockholder then had an “option window” after the completion of the business combination during which he or she could monitor the price of the company’s stock in the market. If the price rose above the redemption price, he or she could sell his or her shares in the open market before actually delivering his or her shares to the company for cancellation. As a result, the redemption rights, to which stockholders were aware they needed to commit before the stockholder meeting, would become “option” rights surviving past the completion of the business combination until the redeeming holder delivered its certificate. The requirement for physical or electronic delivery prior to the meeting ensures that a redeeming holder’s election to redeem is irrevocable once the business combination is approved.
  
Any request to redeem such shares, once made, may be withdrawn at any time up to the date set forth in the tender offer materials or the date of the stockholder meeting set forth in our proxy materials, as applicable. Furthermore, if a holder of a public share delivered its certificate in connection with an election of redemption rights and subsequently decides prior to the applicable date not to elect to exercise such rights, such holder may simply request that the transfer agent return the certificate (physically or electronically). It is anticipated that the funds to be distributed to holders of the public shares electing to redeem their shares will be distributed promptly after the completion of our business combination.
  
If our initial business combination is not approved or completed for any reason, then the public stockholder who elected to exercise their redemption rights would not be entitled to redeem their shares for the applicable pro rata share of the Trust Account. In such case, we will promptly return any certificates delivered by public holders who elected to redeem their shares.
  
If the Business Combination with Estrella is not completed, we may continue to try to complete a business combination with a different target by July 19, 2023 (or such later date as may be approved by UPTD stockholders in an amendment to its Current Charter).
 
Redemption of Public Shares and Liquidation if No Initial Business Combination
  
The Current Charter provides that we have until July 19, 2023 to complete our initial business combination. If we are unable to complete our business combination by July 19, 2023, we will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes (less up to $50,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholder’s rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and the Board, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Warrants, which will expire worthless if we fail to complete our business combination by July 19, 2023.
  
The UPTD Initial Stockholders have waived their rights to liquidating distributions from the Trust Account with respect to any founder shares and Private Shares held by them if we fail to complete our initial business combination within by July 19, 2023. However, if our founders, officers, or directors acquire public shares in or after the IPO, they will be entitled to liquidating distributions from the Trust Account with respect to such public shares if we fail to complete our initial business combination by July 19, 2023.
  
The UPTD Initial Stockholders have agreed, pursuant the IPO Letter Agreement, that they will not propose any amendment to the Current Charter (i) that would modify the substance or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination by July 19, 2023, or (ii) with respect to any other material provision relating to stockholders’ rights or pre-initial business combination activity, unless we provide the public stockholder with the opportunity to redeem their shares of our Common Stock upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes divided by the number of then outstanding public shares. However, we will only redeem the public shares so long as (after such redemption) our net tangible assets will be at least $5,000,001 either immediately prior to or upon consummation of our initial business combination and after payment of the Business Combination Fee (so that we are not subject to the SEC’s “penny stock” rules). If this optional redemption right is exercised with respect to an excessive number of public shares such that we cannot satisfy the net tangible asset requirement (described above) we would not proceed with the amendment or the related redemption of the public shares.
  
We expect that all costs and expenses associated with implementing our plan of dissolution, as well as payments to any creditors, will be funded from amounts remaining out of the approximately $500,000 of proceeds held outside the Trust Account, although we cannot assure you that there will be sufficient funds for such purpose. However, if those funds are not sufficient to cover the costs and expenses associated with implementing our plan of dissolution, to the extent that there is any interest accrued in the Trust Account not required to pay taxes on interest income earned on the Trust Account balance, we may request the trustee to release to us an additional amount of up to $50,000 of such accrued interest to pay those costs and expenses.
  
If we were to expend all of the net proceeds of the IPO and the sale of the Private Shares, other than the proceeds deposited in the Trust Account, and without taking into account interest earned on the Trust Account, the per-share redemption amount received by stockholders upon our dissolution would be approximately $10.20. The proceeds deposited in the Trust Account could, however, become subject to the claims of our creditors which would have higher priority than the claims of the public stockholders. We cannot assure you that the actual per-share redemption amount received by stockholders will not be substantially less than $10.20. Under Section 281(b) of the DGCL, our plan of dissolution must provide for all claims against us to be paid in full or make provision for payments to be made in full, as applicable, if there are sufficient assets. These claims must be paid or provided for before we make any distribution of our remaining assets to our stockholders. While we intend to pay such amounts, if any, we cannot assure you that we will have funds sufficient to pay or provide for all creditors’ claims.
  
 
9
Table of Contents
  
 
Although we will seek to have all vendors, service providers, prospective target businesses, or other entities with which we do business execute agreements with us waiving any right, title, interest, and claim of any kind in or to any monies held in the Trust Account for the benefit of the public stockholders, there is no guarantee that they will execute such agreements or even if they execute such agreements that they would be prevented from bringing claims against the Trust Account including but not limited to fraudulent inducement, breach of fiduciary responsibility, or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain an advantage with respect to a claim against our assets, including the funds held in the Trust Account. If any third party refuses to execute an agreement waiving such claims to the monies held in the Trust Account, our management will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party that has not executed a waiver if management believes that such third party’s engagement would be significantly more beneficial to us than any alternative. Examples of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third-party consultant whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver.
  
In addition, there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts, or agreements with us and will not seek recourse against the Trust Account for any reason. The Sponsor has agreed that it will be liable to us if and to the extent any claims by a third party for services rendered or products sold to us, or a prospective target business with which we have discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.20 per public share or (ii) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, due to reductions in value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under our indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, then the Sponsor will not be responsible to the extent of any liability for such third party claims We have not independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of our company. We have not asked the Sponsor to reserve for such indemnification obligations. Therefore, we cannot assure you that the Sponsor would be able to satisfy those obligations. As a result, if any such claims were successfully made against the Trust Account, the funds available for our initial business combination and redemptions could be reduced to less than $10.20 per public share. In such event, we may not be able to complete our initial business combination, and you would receive such lesser amount per share in connection with any redemption of the public shares. None of our officers will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target businesses.
  
In the event that the proceeds in the Trust Account are reduced below (i) $10.20 per public share or (ii) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, due to reductions in value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, and the Sponsor asserts that it is unable to satisfy its indemnification obligations or that it has no indemnification obligations related to a particular claim, our independent directors would determine whether to take legal action against the Sponsor to enforce its indemnification obligations. While we currently expect that our independent directors would take legal action on our behalf against the Sponsor to enforce its indemnification obligations to us, it is possible that our independent directors in exercising their business judgment may choose not to do so if, for example, the cost of such legal action is deemed by the independent directors to be too high relative to the amount recoverable or if the independent directors determine that a favorable outcome is not likely. We have not asked the Sponsor to reserve for such indemnification obligations and we cannot assure you that the Sponsor would be able to satisfy those obligations. Accordingly, we cannot assure you that due to claims of creditors the actual value of the per-share redemption price will not be less than $10.20 per public share.
  
Under the DGCL, stockholders may be held liable for claims by third parties against a corporation to the extent of distributions received by them in a dissolution. The pro rata portion of our Trust Account distributed to the public stockholder upon the redemption of the public shares in the event we do not complete our business combination by July 19, 2023 may be considered a liquidating distribution under Delaware law. If the corporation complies with certain procedures set forth in Section 280 of the DGCL intended to ensure that it makes reasonable provision for all claims against it, including a 60-day notice period during which any third-party claims can be brought against the corporation, a 90-day period during which the corporation may reject any claims brought, and an additional 150-day waiting period before any liquidating distributions are made to stockholders, any liability of stockholders with respect to a liquidating distribution is limited to the lesser of such stockholder’s pro rata share of the claim or the amount distributed to the stockholder, and any liability of the stockholder would be barred after the third anniversary of the dissolution.
  
Furthermore, if the pro rata portion of the Trust Account distributed to the public stockholder upon the redemption of the public shares in the event we do not complete our business combination within by July 19, 2023, is not considered a liquidating distribution under Delaware law and such redemption distribution is deemed to be unlawful, then pursuant to Section 174 of the DGCL, the statute of limitations for claims of creditors could then be six years after the unlawful redemption distribution, instead of three years, as in the case of a liquidating distribution. If we are unable to complete our business combination by July 19, 2023, we will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes or for working capital purposes (less up to $50,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholder’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and the Board, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. Accordingly, it is our intention to redeem the public shares as soon as reasonably possible by July 19, 2023 and, therefore, we do not intend to comply with those procedures. As such, our stockholders could potentially be liable for any claims to the extent of distributions received by them (but no more) and any liability of our stockholders may extend well beyond the third anniversary of such date.
  
 
10
Table of Contents
  
 
Because we will not be complying with Section 280, Section 281(b) of the DGCL requires us to adopt a plan, based on facts known to us at such time that will provide for our payment of all existing and pending claims or claims that may be potentially brought against us within the subsequent 10 years. However, because we are a blank check company, rather than an operating company, and our operations will be limited to searching for prospective target businesses to acquire, the only likely claims to arise would be from our vendors (such as lawyers, investment bankers, etc.) or prospective target businesses. As described above, pursuant to the obligation contained in our underwriting agreement, we will seek to have all vendors, service providers, prospective target businesses or other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the Trust Account. As a result of this obligation, the claims that could be made against us are significantly limited and the likelihood that any claim that would result in any liability extending to the Trust Account is remote. Further, the Sponsor may be liable only to the extent necessary to ensure that the amounts in the Trust Account are not reduced below (i) $10.20 per public share or (ii) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, due to reductions in value of the trust assets, in each case net of the amount of interest withdrawn to pay taxes and will not be liable as to any claims under our indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims.
  
If we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, the proceeds held in the Trust Account could be subject to applicable bankruptcy law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our stockholders. To the extent any bankruptcy claims deplete the Trust Account, we cannot assure you we will be able to return $10.20 per share to the public stockholder. Additionally, if we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, any distributions received by stockholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as either a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy court could seek to recover some or all amounts received by our stockholders. Furthermore, the Board may be viewed as having breached its fiduciary duty to our creditors and/or may have acted in bad faith, thereby exposing itself and our company to claims of punitive damages, by paying public stockholder from the Trust Account prior to addressing the claims of creditors. We cannot assure you that claims will not be brought against us for these reasons.
  
The public stockholder will be entitled to receive funds from the Trust Account only (i) in the event of the redemption of the public shares if we do not complete our business combination by March 19, 2023, subject to applicable law, (ii) in connection with a stockholder vote to approve an amendment to the Current Charter (a) to modify the substance or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of the public shares if we have not consummated an initial business combination by July 19, 2023 or (b) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity, or (iii) our completion of an initial business combination, and then only in connection with those public shares that such stockholder properly elected to redeem, subject to the limitations described in the S-1. In no other circumstances will a stockholder have any right or interest of any kind to or in the Trust Account. A stockholder’s voting in connection with the business combination alone will not result in a stockholder’s redeeming its shares to us for an applicable pro rata share of the Trust Account. Such stockholder must have also exercised its redemption rights as described above.
 
Lack of Business Diversification
For an indefinite period of time after the completion of our initial business combination, the prospects for our success may depend entirely on the future performance of a single business. Unlike other entities that have the resources to complete business combinations with multiple entities in one or several industries, it is probable that we will not have the resources to diversify our operations and mitigate the risks of being in a single line of business. In addition, we intend to focus our search for an initial business combination in a single industry. By completing our business combination with only a single entity, our lack of diversification may:
 
●
subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination, and
 
●
cause us to depend on the marketing and sale of a single product or limited number of products or services.
  
Limited Ability to Evaluate the Target’s Management Team
  
Although we intend to closely scrutinize the management of a prospective target business when evaluating the desirability of effecting our business combination with that business, our assessment of the target business’ management may not prove to be correct. In addition, the future management may not have the necessary skills, qualifications or abilities to manage a public company. Furthermore, the future role of members of our management team or of our board, if any, in the target business cannot presently be stated with any certainty. While it is possible that one or more of our directors will remain associated in some capacity with us following our business combination, it is presently unknown if any of them will devote their full efforts to our affairs subsequent to our business combination. Moreover, we cannot assure you that members of our management team will have significant experience or knowledge relating to the operations of the particular target business. The determination as to whether any members of our board of directors will remain with the combined company will be made at the time of our initial business combination.
  
Following a business combination, to the extent that we deem it necessary, we may seek to recruit additional managers to supplement the incumbent management team of the target business. We cannot assure you that we will have the ability to recruit additional managers, or that additional managers will have the requisite skills, knowledge or experience necessary to enhance the incumbent management.
 
Stockholders May Not Have the Ability to Approve our Initial Business Combination
  
We may conduct redemptions without a stockholder vote pursuant to the tender offer rules of the SEC. However, we will seek stockholder approval if it is required by law or applicable stock exchange rule, or we may decide to seek stockholder approval for business or other legal reasons. Presented in the table below is a graphic explanation of the types of initial business combinations we may consider and whether stockholder approval is currently required under Delaware law for each such transaction.
 
 
11
Table of Contents
  
 
Type of Transaction
 
Whether

Stockholder

 
Approval is

Required
 
Purchase of assets
 
No
 
Purchase of stock of target not involving a merger with the company
 
No
 
Merger of target into a subsidiary of the company
 
No
 
Merger of the company with a target
 
Yes
 
  
Under Nasdaq’s listing rules, stockholder approval would be required for our initial business combination if, for example:
 
 
●
we issue shares of Common Stock that will be equal to or in excess of 20% of the number of shares of our Common Stock then outstanding;
 
 
●
any of our directors, officers or substantial stockholders (as defined by Nasdaq rules) has a 5% or greater interest (or such persons collectively have a 10% or greater interest), directly or indirectly, in the target business or assets to be acquired or otherwise and the present or potential issuance of Common Stock could result in an increase in outstanding common shares or voting power of 5% or more; or
 
 
  
 
●
the issuance or potential issuance of Common Stock will result in our undergoing a change of control.
  
The decision as to whether we will seek stockholders approval of a proposed business combination in those instances in which stockholder approval is not required by applicable law or stock exchange listing requirements will be made by us, solely in our discretion, and will be based on business and legal reasons, which include a variety of factors, including, but not limited to: (i) the timing of the transaction, including in the event we determine stockholder approval would require additional time and there is either not enough time to seek stockholder approval or doing so would place the company at a disadvantage in the transaction or result in other additional burdens on the company; (ii) the expected cost of holding a stockholder vote; (iii) the risk that the stockholders would fail to approve the proposed business combination; (iv) other time and budget constraints of the company; and (v) additional legal complexities of a proposed business combination that would be time-consuming and burdensome to present to stockholders.
 
Potential Purchases of our Securities
  
In connection with the stockholder vote to approve the proposed Business Combination, the founders, directors, officers or advisors or their respective affiliates may privately negotiate transactions to purchase our Common Stock from stockholders who would have otherwise elected to have their shares redeemed in conjunction with a proxy solicitation pursuant to the proxy rules for a per-share pro rata portion of the Trust Account. None of UPTD’s founders, directors, officers or advisors or their respective affiliates will make any such purchases when they are in possession of any material non-public information not disclosed to the seller or during a restricted period under Regulation M under the Exchange Act. Such a purchase would include a contractual acknowledgement that such stockholder, although still the record holder of UPTD Common Stock, is no longer the beneficial owner thereof and therefore agrees not to exercise its redemption rights, and could include a contractual provision that directs such stockholder to vote such shares in a manner directed by the purchaser. In the event that the founders, directors, officers or advisors of UPTD or their affiliates purchase shares in privately negotiated transactions from public stockholder who have already elected to exercise their redemption rights, such selling stockholders would be required to revoke their prior elections to redeem their shares. Any such privately negotiated purchases may be effected at purchase prices that are below or in excess of the per-share pro rata portion of the Trust Account. The purpose of any such purchases of our Common Stock could be to vote such shares in favor of the Business Combination and thereby increase the likelihood of obtaining stockholder approval of the Business Combination or to satisfy the closing conditions pursuant to the Merger Agreement that requires UPTD to have, among the others, (i) net tangible assets no less than $5,000,0001, (ii) an aggregate of at least $20,000,000 Available Combined Cash Amount (as defined in the Merger Agreement); and (iii) at least $20,000,000 Merger Financing (as defined in the Merger Agreement), upon the completion of the Business Combination, where it appears that such requirement would otherwise not be met. Any such purchases of our Common Stock or our Warrants may result in the completion of Business Combination that may not otherwise have been possible. UPTD expects any such purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the extent such purchasers are subject to such reporting requirements.
  
In addition, if such purchases are made, the public “float” of our Common Stock or our Warrants and the number of beneficial holders of UPTD’s securities may be reduced, possibly making it difficult to obtain or maintain the quotation, listing or trading of our securities on a national securities exchange.
  
However, in the event the founders, directors, officers, or advisors of UPTD or their affiliates were to purchase shares or warrants from public stockholder, such purchases would by structured in compliance with the requirements of Rule 14e-5 under the Exchange Act including, in pertinent part, through adherence to the following:
  
     
the founders, directors, officers, or advisors of UPTD or their affiliates will purchase public shares or our Warrants from public stockholder outside the redemption process at a price no higher than the price offered through the redemption process;
  
     
the registration statement/proxy statement filed in connection with the Business Combination would include a representation that any of the public shares or our Warrants purchased by the founders, directors, officers, or advisors of UPTD or their affiliates from public stockholder outside the redemption process would not be voted in favor of approving the Business Combination;
  
 
12
Table of Contents
  
 
     
the founders, directors, officers, or advisors of UPTD or their affiliates do not possess any redemption rights with respect to the public shares or our Warrants or, if they possess such redemption rights, they have entered into a letter agreement pursuant to which they have waived such rights; and
  
     
UPTD will disclose in the Form 8-K to be filed prior to the holding of its stockholder meeting to approve the Business Combination the following material items:
  
a.       the number of the public shares or Warrants purchased by the founders, directors, officers, or advisors of UPTD or their affiliates from public stockholder outside the redemption process, along with the purchase price for such public shares or our Warrants;
  


b.      the purpose of the purchases of such public shares or Warrants by the founders, directors, officers or advisors of UPTD or their affiliates;
c.       the impact, if any, of the purchases of such public shares or Warrants by the founders, directors, officers, or advisors of UPTD or their affiliates on the likelihood that the Business Combination will be approved and consummated;
d.       the identity of the selling stockholders who sold such public shares or Warrants to the founders, directors, officers, or advisors of UPTD or their affiliates (if not purchased on the open market) or the nature of the selling stockholders (e.g., 5% security holders) who sold such public shares or our Warrants to the founders, directors, officers or advisors of UPTD or their affiliates; and
e.       the number of public shares or our Warrants for which UPTD has received redemption requests pursuant to its redemption offer.
  
Competition
  
In identifying, evaluating and selecting a target business for our business combination, we may encounter intense competition from other entities having a business objective similar to ours, including other blank check companies, private equity groups and leveraged buyout funds, and operating businesses seeking strategic acquisitions. Many of these entities are well established and have extensive experience identifying and effecting business combinations directly or through affiliates. Moreover, many of these competitors possess greater financial, technical, human and other resources than we do. Our ability to acquire larger target businesses will be limited by our available financial resources. This inherent limitation gives others an advantage in pursuing the acquisition of a target business. Furthermore, our obligation to pay cash in connection with our public stockholders who exercise their redemption rights may reduce the resources available to us for our initial business combination and our outstanding Warrants, and the future dilution they potentially represent, may not be viewed favorably by certain target businesses. Either of these factors may place us at a competitive disadvantage in successfully negotiating an initial business combination.
 
Facilities
  
Our executive offices are located at 437 Madison Avenue, 27th Floor, New York, New York 10022.
 
Employees
We currently have three executive officers including Messrs. Jianwei Li and Weiguang Yang, the Co-Chief Executive Officers and Ms. Luqi Wen, the Chief Financial Officer. These individuals are not obligated to devote any specific number of hours to our matters but they intend to devote as much of their time as they deem necessary to our affairs until we have completed our initial business combination. The amount of time they will devote in any time period will vary based on whether a target business has been selected for our initial business combination and the stage of the initial business combination process we are in. We do not intend to have any full-time employees prior to the completion of our initial business combination.
 
Periodic Reporting and Financial Information
  
We have registered our Units, Common Stock and Warrants under the Exchange Act and have reporting obligations, including the requirement that we file annual, quarterly and current reports with the SEC. In accordance with the requirements of the Exchange Act, our annual reports will contain financial statements audited and reported on by our independent registered public accountants.
  
We have filed a Registration Statement on Form 8-A with the SEC to voluntarily register our securities under Section 12 of the Exchange Act. As a result, we are subject to the rules and regulations promulgated under the Exchange Act. We have no current intention of filing a Form 15 to suspend our reporting or other obligations under the Exchange Act prior or subsequent to the consummation of our business combination.
  
We will provide stockholders with audited financial statements of the prospective target business as part of the tender offer materials or proxy solicitation materials sent to stockholders to assist them in assessing the target business. In all likelihood, these financial statements will need to be prepared in accordance with GAAP. We cannot assure you that any particular target business selected by us as a potential acquisition candidate will have financial statements prepared in accordance with GAAP or that the potential target business will be able to prepare its financial statements in accordance with GAAP. To the extent that this requirement cannot be met, we may not be able to acquire the proposed target business. While this may limit the pool of potential acquisition candidates, we do not believe that this limitation will be material.
  
We are required to evaluate our internal control procedures for the fiscal year ending December 31, 2022 as required by the Sarbanes-Oxley Act. Only in the event we are deemed to be a large accelerated filer or an accelerated filer will we be required to have our internal control procedures audited. A target company may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding adequacy of their internal controls. The development of the internal controls of any such entity to achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary to complete any such acquisition.
 
 
13
Table of Contents
  
 
Legal Proceedings
  
There is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their capacity as such.
  
ITEM 1A. RISK FACTORS
  
As a smaller reporting company, we are not required to make disclosures under this Item. Factors that could cause our actual results to differ materially from those in this Annual Report are any of the risks described in our final prospectus of the IPO dated July 19, 2021 and in the Form S-4. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Annual Report, there have been no material changes to the risk factors disclosed in our final prospectus dated July 19, 2021 or in the Form S-4, filed with the SEC, except we may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.
  
ITEM 1B. UNRESOLVED STAFF COMMENTS
  
Not applicable.
  
ITEM 2. PROPERTIES
  
We do not own any real estate or other physical properties materially important to our operations. We maintain our principal executive offices at 437 Madison Avenue, 27th Floor, New York, New York 10022. We consider our current office space, combined with the other office space otherwise available to our executive officers, adequate for our current operations.
  
ITEM 3. LEGAL PROCEEDINGS
  
We are not currently a party to any material litigation or other legal proceedings brought against us. We are also not aware of any legal proceeding, investigation or claim, or other legal exposure that has a more than remote possibility of having a material adverse effect on our business, financial condition or results of operations.
  
ITEM 4. MINE SAFETY DISCLOSURES
  
Not Applicable.
  
 
14
Table of Contents
  
 
PART II
 
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
  
Our Units began to trade on the Nasdaq Capital Market, or Nasdaq, under the symbol “UPTDU” on July 15, 2021. The Common Stock and Warrants comprising the Units began separate trading on Nasdaq on September 7, 2021, under the symbols “UPTD” and “UPTDW”, respectively.
 
Holders of Record
  
At
March 14,
2023, there were 6 holders of record of our Common Stock, 1 holder of record of our Units, and 1 holder of record of our separately traded Warrants. The number of record holders was determined from the records of our transfer agent.
 
Dividends
  
We have not paid any cash dividends on our shares of Common Stock to date and do not intend to pay cash dividends prior to the completion of an initial business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of a business combination. The payment of any dividends subsequent to a business combination will be within the discretion of our board of directors at such time. It is the present intention of our board of directors to retain all earnings, if any, for use in our business operations and, accordingly, our board of directors does not anticipate declaring any dividends in the foreseeable future. In addition, our board of directors is not currently contemplating and does not anticipate declaring any share dividends in the foreseeable future. Further, if we incur any indebtedness, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith.
 
Securities Authorized for Issuance Under Equity Compensation Plans
  
None.
 
Recent Sales of Unregistered Securities
  
The information of the Notes and Extension Notes contained under Item 2 of Part I above is incorporated herein by reference in response to this item. The issuance of the Notes and Extension Notes was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
 
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
  
None.
  
ITEM 6. SELECTED FINANCIAL DATA
  
As a smaller reporting company, we are not required to make disclosures under this Item.
  
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
  
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
 
Overview
  
We are a blank check company incorporated as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to complete our initial business combination using cash from the proceeds of the IPO and the Private Placement of the Private Shares, our capital stock, debt or a combination of cash, stock and debt.
  
We presently have no revenue, have had losses since inception from incurring formation and operating costs and have had no operations other than identifying and evaluating suitable acquisition transaction candidates. We have relied upon the sale of our securities and loans from the Sponsor to fund our operations.
  
On July 19, 2021, we consummated the IPO of 4,000,000 Units. Each Unit consists of one share of Common Stock, and one-half of one Warrant, each whole Warrant entitling the holder thereof to purchase one share of Common Stock at an exercise price of $11.50 per share. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $40,000,000. Simultaneously with the closing of the IPO, we completed the private sale (the “Private Placement”) of 295,000 Private Shares to the Company’s founders, the Sponsor and Tradeup INC., among which, the Sponsor purchased 236,000 Private Shares and Tradeup INC. purchased 59,000 Private Shares at a purchase price of $10.00 per Private Share, generating the Private Placement Proceeds to the Company of $2,950,000. The Private Shares are identical to the shares of Common Stock sold as part of the Units in the IPO, except that the Private Shares are not transferable, assignable or salable (except to our officers and directors and other persons or entities affiliated with or related to our founders, each of whom will be subject to the same transfer restrictions) until 30 days after the completion of our initial business combination. The IPO Proceeds of $40,800,000 ($10.20 per Unit) were placed in the Trust Account established for the benefit of the Company’s public stockholders and the underwriters of the IPO with Wilmington Trust, National Association acting as trustee.
 
15
Table of Contents
  


On July 19, 2021, the underwriters partially exercised the Over-allotment Option, and July 21, 2021, the underwriters purchased 430,000 Option Units generating gross proceeds of $4,300,000, and net proceeds to the Company of approximately $4,214,000 in the aggregate after deducting the underwriter discount. Simultaneously with the issuance and sale of the Option Units, the Company completed the Private Placement sale of 17,200 Additional Private Shares, among which, the Sponsor purchased 13,760 additional Private Shares and Tradeup INC. purchased 3,440 additional Private Shares, generating Private Placement Proceeds $172,000. A total of $4,386,000 of the Over-allotment Proceeds were placed in the Trust Account. The IPO Proceeds and the Over-allotment Proceeds include $1,550,500 Business Combination Fee pursuant to the Business Combination Marketing Agreement.

Our management has broad discretion with respect to the specific application of the net proceeds of the IPO and the Private Placement, although substantially all of the net proceeds are intended to be applied generally towards consummating a business combination.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to raise capital or to complete our initial business combination will be successful.
 
December 2022 Extension, Related Redemption and Extension Notes
  
UPTD initially had until January 19, 2023 to consummate an initial business combination. On December 22, 2022, UPTD held the 2022 Special Meeting, where the Company was approved by its stockholders to adopt the amended and restated certificate of incorporation to extend the Combination Deadline from January 19, 2023, by one month up to six times, to July 19, 2023 or such earlier date as determined by the board of directors of the Company. Upon the stockholders’ approval, on December 29, 2022, the Company filed a certificate of amendment to the amended and restated certificate of incorporation which became effective upon filing. Additionally, as a result of the 2022 Special Meeting, upon the stockholders’ approval, on December 29, 2022, UPTD and Wilmington Trust, National Association, as the trustee of the Trust Account, entered into the amendment to the Investment Management Trust Agreement dated July 14, 2021.
  
As a result of the 2022 Special Meeting, 3,519,780 shares of Common Stock were rendered for redemption and approximately $36.1 million was released from the Trust Account to pay such redeeming stockholders.
  
Under the Current Charter, the Company may extend the Combination Deadline until July 19, 2023 by depositing $45,511 (or $0.05 per share) of the Monthly Extension Payment into the Trust Account for each monthly Extension. Pursuant to the Merger Agreement, Estrella made two Monthly Extension Payments to the Trust Account, as a result of which, the current Combination Deadline is March 19, 2023. The two Monthly Extension Payments were evidenced by two Extension Notes issued by the Company to Estrella, each in the principal amount of $45,511.
  
As provided in the Merger Agreement, Estrella has agreed to, upon request by the founders of the Company, deposit the agreed reasonable amount to the Company’s trust in order to effectuate extension of the Company’s deadline to consummate a business combination. Pursuant to the Merger Agreement, Estrella made two Monthly Extension Payments to the Trust Account, as a result of which, the current Combination Deadline is March 19, 2023. The two Monthly Extension Payments were evidenced by two Extension Notes issued by the Company to Estrella, each in the principal amount of $45,511.
  
If UPTD is not able to consummate the Business Combination with Estrella or another business combination by up to July 19, 2023 (if extended, or such later date as may be approved by UPTD stockholders in an amendment to its Current Charter), UPTD must redeem 100% of the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to UPTD to pay its franchise and income taxes (less up to $50,000 of interest to pay dissolution expenses), divided by the number of then-outstanding public shares.
 
Proposed Business Combination with Estrella
  
After the consummation of the IPO, UPTD’s management began their search for a suitable target for a business combination. In addition, they were contacted by a number of individuals and entities with respect to potential business combination opportunities. UPTD has reviewed in varying degrees approximately 22 potential business combination candidates involved in various industries and sectors, including manufacturing, high technology, education, biotech and pharmaceutical, infrastructure, and energy. In May 2022, Estrella was introduced to UPTD. Since May 2022, management of UPTD and Estrella had several conference calls to discuss the proposed business combination and relevant business terms.
  
Estrella is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS®️ T-cell therapies with the capacity to address treatment and safety challenges for patients with blood cancers and solid tumors. Estrella’s mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer. For more information regarding the business of Estrella and the proposed Business Combination, see the Form S-4.
 
Merger Agreement
  
On September 30, 2022, we entered into the Merger Agreement among Merger Sub and Estrella. Pursuant to the Merger Agreement, among other things, in accordance with the DGCL, Merger Sub will merge with and into the Estrella, with Estrella surviving the Merger as the Surviving Company. The Merger will become effective at such time on the date of the Closing as the certificate of merger is duly filed with the Delaware Secretary of State or at the Effective Time. Effective as of the Closing, UPTD will change its name to “Estrella Immunopharma, Inc.”
  
 
16
Table of Contents
  
 
Pursuant to the Merger Agreement, stockholders of Estrella immediately prior to the Effective Time collectively will receive from us, in the aggregate, a number of newly issued shares of Common Stock equal to: (i) $325,000,000, divided by (ii) $10.00 per share in consideration of converting their shares of Estrella Common Stock. Each share of preferred stock of Estrella that is issued and outstanding immediately prior to the Effective Time will automatically convert into a number of shares of Estrella Common Stock in accordance with the certificate of incorporation of Estrella immediately prior to the Effective Time.
  
The Merger also calls for additional agreements, including, among others, the Lock-Up Agreement and the Support Agreement, as described elsewhere in the Form S-4 (as defined below), as amended from time to time, initially filed with the SEC on October 17, 2022.
 
Outstanding Promissory Notes and Loans
  
On July 25, 2022, we issued (i) the Running Lion Note in the amount of $204,000 to Running Lion and (ii) the July 2022 Sponsor Note in the amount of $294,600 to Tradeup INC. The proceeds of the Running Lion Note and July 2022 Sponsor Note, which may be drawn down from time to time until the Company consummates its initial business combination, will be used as general working capital purposes. On January 19, 2023, we issued the January 2023 Sponsor Note in the amount of $50,000 to the Sponsor, to evidence a deposit that the Sponsor provided to the Company to pay its certain operating expenses.
  
Pursuant to the Merger Agreement, Estrella made two Monthly Extension Payments to the Trust Account, as a result of which, the current Combination Deadline is March 19, 2023. The two Monthly Extension Payments were evidenced by two Extension Notes issued by the Company to Estrella, each in the principal amount of $45,511.
  
The payees of the Notes and Extension Notes (collectively, the “Payees”) have the right, but not the obligation, to convert the Extension Notes, in whole or in part, respectively, into private shares of the Common Stock (the “Conversion Shares”) of the Company, as described in the prospectus of the Company (File No.: 333-253322), by providing the Company with written notice of the intention to convert at least two business days prior to the closing of the business combination. The number of Conversion Shares to be received by the Payees in connection with such conversion shall be an amount determined by dividing (x) the sum of the outstanding principal amount payable to the Payees by (y) $10.00, respectively. Notwithstanding the foregoing, the Company shall have the obligation to pay to Estrella the funds amounting to the principal amount of the Extension Notes if the proposed Business Combination is terminated pursuant to the Merger Agreement. The Company shall refund the principal amount of the Extension Notes to Estrella fully within 5 business days of such termination.
  
The issuance of the Notes and Extension Notes was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
 
 
Results of Operations
  
Our entire activity from inception up to date was related to the Company’s formation, the IPO and general and administrative activities. Since the IPO, our activity has been limited to the evaluation of business combination candidates, and we will not be generating any operating revenues until the closing and completion of our initial business combination. We generate non-operating income in the form of interest income on investments. We are incurring expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
  
For   the year ended December 31, 2022, we had had net loss of $
996,104
, consisting of $1,368,219 of operating costs, consisting mostly of general and administrative expenses, $201,308 of franchise tax expenses
, and $80,648 of income taxes provision
, offset by $654,071 of interest income from investments in the Trust Account.
  
For the period from January 6, 2021 (inception) through December 31, 2021, we had net loss of $247,718, consisting of $178,992 of operating costs, consisting mostly of general and administrative expenses, and $70,154 of franchise tax expenses, offset by $1,428 of interest income from investments in the Trust Account.
 
Liquidity and Capital Resources
  
For the year ended December 31, 2022, cash used in operating activities was $1,043,848. As of December 31, 2022, we had cash outside the Trust Account of $40,802 available for working capital needs. All remaining cash is held in the Trust Account and is generally unavailable for our use, prior to an initial business combination, and is restricted for use either in a business combination or to redeem the shares of Common Stock. As of December 31, 2022, none of the amount on deposit in the Trust Account was available to be withdrawn as described above.
  
 
17
Table of Contents
  
 
Until consummation of the business combination, we will be using the funds not held in the Trust Account, and any additional funding that may be loaned to us by our Sponsor, for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the business combination.
  
If our estimates of the costs of undertaking in-depth due diligence and negotiating business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate its business prior to the business combination and will need to raise additional capital. In this event, our officers, directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we consummate an initial business combination, we would repay such loaned amounts out of the proceeds of the Trust Account released to us upon consummation of the business combination, or, at the lender’s discretion, up to $1,200,000 of such loans may be convertible into units of the post business combination entity at a price of $10.00 per share. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from our Trust Account would be used for such repayment. The terms of such loans by our initial stockholders, officers and directors, if any, have not been determined and no written agreements exist with respect to such loans.
  
Moreover, we may need to obtain additional financing either to consummate our initial business combination or because we become obligated to redeem a significant number of our public shares upon consummation of our initial business combination, in which case we may issue additional securities or incur debt in connection with such business combination. Subject to compliance with applicable securities laws, we would only consummate such financing simultaneously with the consummation of our initial business combination. Following our initial business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.
  
As of December 31, 2022, we had cash of $40,802 and a working deficit of $
1,020,642
. We have incurred and expect to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of a business combination.  In connection with our assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about our ability to continue as a going concern. The management’s plan in addressing this uncertainty is through the Promissory Notes – related parties and the working capital loans, as discussed above. In addition, if we are unable to complete a business combination by July 19, 2023, our board of directors would proceed to commence a voluntary liquidation and thereby a formal dissolution of us. There is no assurance that our plans to consummate a business combination will be successful by July 19, 2023. As a result, management has determined that such additional condition also raise substantial doubt about our ability to continue as a going concern. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.
 
Off-Balance Sheet Financing Arraignments
  
We have no obligations, assets or liabilities that would be considered off-balance sheet arrangements as of December 31, 2022. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
 
Contractual Obligations
  
As of December 31, 2022, we do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities.
  
The holders of the founder shares, the Private Shares, and any Conversion Shares will be entitled to registration rights pursuant to a registration and shareholder rights agreement entered into in connection with the IPO. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our initial business combination. We will bear the expenses incurred in connection with the filing of any such registration statements.
  
We are obligated to pay the Representatives the Business Combination Fee equal to 3.5% of the gross proceeds of the IPO and the sale of over-allotment Option Units. The Business Combination Fee of $1,550,500 will become payable to the Representatives from the amounts held in the Trust Account solely in the event that we complete a Business Combination.
  
As of the date hereof, we have outstanding loans from various related parties in the aggregated amount of $598,600, which include (i) the Running Lion Note in the amount of $204,000 to Running Lion, (ii) the July 2022 Sponsor Note in the amount of $294,600 to Tradeup INC., (iii) the January 2023 Sponsor Note in the amount of $50,000 to the Sponsor, to evidence a deposit that the Sponsor provided to the Company to pay its certain operating expenses, and (iv) the March 2023 Sponsor Note in the amount of $50,000 to Tradeup INC.. In connection with the Extension, we issued the Extension Notes in the amount of $91,922 to Estrella to evidence the funds deposited into the Trust Account.
 
Critical Accounting Policies
  
Use of Estimates
  
The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
 
  
18
Table of Contents
  
 
Investments held in Trust Account
  
At December 31, 2022, the assets held in the Trust Account were held in money market funds, which are invested in U.S. Treasury securities.
  
We classify its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 “Investments — Debt and Equity Securities.” Held-to-maturity securities are those securities which we have the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheet and adjusted for the amortization or accretion of premiums or discounts.
  
Warrants
  
We account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) ASC 480 “Distinguishing Liabilities from Equity” (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to our own Common Stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of our control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
  
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations.
  
Common Stock Subject to Possible Redemption
  
We account for our Common Stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common Stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Common Stock (including Common Stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, Common Stock are classified as stockholders’ equity. Our public shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, as of December 31, 2022 and 2021, shares of Common Stock subject to possible redemption are presented at redemption value of $10.25 and $10.20 per share, respectively, as temporary equity, outside of the stockholders’ equity section of our balance sheet. We recognize changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Common Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of shares of redeemable Common Stock are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital equals to zero.
 
Fair Value of Financial Instruments
  
The fair value of our assets and liabilities approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
  
The fair value of our financial assets and liabilities reflects management’s estimate of amounts that we would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, we seek to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
 
●
Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active market.
 
●
Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.
 
●
Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value.
 
Income Taxes
  
We account for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
  
ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
 
  
19
Table of Contents
  
 
We recognize accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. We are currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
  
We have identified the United States as its only “major” tax jurisdiction.
  
We may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. Our management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
  
We are incorporated in the State of Delaware and is required to pay franchise taxes to the State of Delaware on an annual basis.
  
On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (H.R. 5376) (the “IRA”), which, among other things, imposes a 1% excise tax on any domestic corporation that repurchases its stock after December 31, 2022 (the “Excise Tax”). The Excise Tax is imposed on the fair market value of the repurchased stock, with certain exceptions.
  
Because the Company is a Delaware corporation and our securities trades on Nasdaq, it is a “covered corporation” within the meaning of the IRA. The Excise Tax may apply to any redemptions of the Company’s common stock after December 31, 2022, including redemptions in connection with the Merger, unless an exemption is available. Issuances of securities in connection with the Merger are expected to reduce the amount of the Excise Tax in connection with redemptions occurring in the same calendar year, but the number of securities redeemed may exceed the number of securities issued. Further, the application of the Excise Tax in the event of a liquidation is uncertain. The Company is currently evaluating the impact it will have in the event of the Merger or liquidation.
 
Net Income (Loss) per Share
  
We comply with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, we first considered the undistributed income (loss) allocable to both the redeemable Common Stock and non-redeemable Common Stock and the undistributed income (loss) is calculated using the total net loss less any dividends paid. We then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable Common Stock. Any remeasurement of the accretion to redemption value of the Common Stock subject to possible redemption was considered to be dividends paid to the public stockholders
 
Recent Accounting Pronouncements
  
Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on our financial statements.
  
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
  
As a smaller reporting company, we are not required to make disclosures under this Item.
 
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
  
Our financial statements and the notes thereto begin on page F-1 of this Annual Report.
 
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
  
None.
 
ITEM 9A. CONTROLS AND PROCEDURES
 
Evaluation of Disclosure Controls and Procedures
  
Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal year ended December 31, 2022, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial and accounting officer have concluded that during the period covered by this report, our disclosure controls and procedures were not effective, due to the restatement related to the classification of redeemable ordinary shares as of  July 19, 2021 and management has identified a material weakness in internal controls related to the accounting for complex equity instruments in connection with our initial public offering. In light of this material weakness, we performed additional analyses as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the financial statements included in this Amendment present fairly in all material respects our financial position, results of operations and cash flows for the period presented.

20
Table of Contents
  
 
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
 
Management’s Annual Report on Internal Control over Financial Reporting
  
As required by SEC rules and regulations implementing Section 404 of the Sarbanes-Oxley Act, our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external reporting purposes in accordance with GAAP. Our internal control over financial reporting includes those policies and procedures that:
 
 
(1)
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of our company,
 
(2)
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and
 
(3)
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements. 
  
Because of its inherent limitations, internal control over financial reporting may not prevent or detect errors or misstatements in our financial statements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree or compliance with the policies or procedures may deteriorate. Management assessed the effectiveness of our internal control over financial reporting at December 31, 2022. In making these assessments, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control — Integrated Framework (2013). Based on our assessments and those criteria, management determined that we did not maintain effective internal control over financial reporting as of December 31, 2022, due solely to the material weakness in internal controls related to the accounting for complex equity instruments in connection with our initial public offering.    In light of this material weakness, we performed additional analyses as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the financial statements included in this Report present fairly in all material respects our financial position, results of operations and cash flows for the period presented.
  
This Annual Report on Form 10-K does not include an attestation report of internal controls from our independent registered public accounting firm due to our status as an emerging growth company under the JOBS Act.
 
Changes in Internal Control over Financial Reporting
  
There have been no changes in our internal control over financial reporting during the quarter ended December 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
ITEM 9B. OTHER INFORMATION
  
None.
 
ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
  
Not applicable.
  
 
21
Table of Contents
  
 
PART III
 
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
  
The following table sets forth information about our directors and executive officers as of the date of this annual report.
  
Name
 
Age
 
Position
Jianwei Li
 
44
 
Chairman, Co-Chief Executive Officer
Weiguang “James” Yang
 
40
 
Co-Chief Executive Officer, Director
Luqi “Lulu” Wen
 
41
 
Chief Financial Officer, Secretary
Weston Twigg
 
49
 
Director
Tao Jiang
 
53
 
Director
James Long
 
51
 
Director
  
Below is a summary of the business experience of each of our executive officers and directors:
 
Mr. Jianwei Li
 is our Co-CEO and chairman. Mr. Li was also Chairman and Co-Chief Executive Officer of another blank check company, TradeUP Global Corporation (Former Nasdaq: TUGC) (“TradeUP Global”), and in March 2022, became a director of SAI.TECH Global Corp. (Nasdaq: SAI), the post-combination entity of TradeUP Global upon its business combination with SAITECH Limited until his resignation in August 2022. Mr. Li has served as the founding and managing partner of Zhencheng Capital, an investment firm, specializing in early-stage investments since May 2016. From May 2015 to May 2016, Mr. Li served as Chief Investment Officer and Partner at ZhenFund, an early-stage investment firm. From July 2011 to May 2015, Mr. Li served as Vice President at Sequoia Capital China and led the investments in artificial intelligence hardware and corporate service sectors. From February 2007 to June 2011, Mr. Li served as Vice President at Fidelity Growth Partners Asia and oversaw investments in the technology, media, and telecom sector. From July 2004 to January 2007, Mr. Li was a consultant at Boston Consulting Group. Mr. Li holds his Bachelor’s and Master’s degrees from Beijing University of Posts and Telecommunications. Mr. Li was ranked #88 on 2020 Forbes China top 100 venture investors.
 
Mr. Weiguang (James) Yang
 is our Co-CEO and a director. Mr. Yang currently serves as the President, Chairman, and Chief Executive Officer of Zhongchao, Inc., a Nasdaq-listed company (Nasdaq: ZCMD), which he founded in 2012. From June 2013 to June 2016, Mr. Yang served as the first Chinese board member on the Global Alliance for Medical Education, a non -profit organization dedicated to the advancement of innovation in medical education throughout the world. From October 2005 to July 2012, Mr. Yang was the general manager at Medwork, a continuing medical education company. Mr. Yang obtained a Bachelor’s degree in Clinical Medicine Science (traumatic surgery) from Gannan Medical University in 2005. Mr. Yang also attended the master course of Social Medicine and Health Management as continuing education from 2006 to 2008 in Capital Medical University of China. From 2010 to 2012, Mr. Yang took part in the master course of Integrated Marketing Communication in Tsinghua University.
 
Ms. Luqi (Lulu) Wen 
is our Chief Financial Officer and secretary. Ms. Wen has been the financial director of Zhencheng Capital since May 2016. From January 2021 to April 2022, Ms. Wen served as Chief Financial Officer of TradeUP Global prior to the consummation of its business combination with SAI.TECH Global Corp. (Nasdaq: SAI). Form August 2011 to May 2016, Ms. Wen served as the senior finance manager in Harvest fund, a Chinese institutional asset manager. She also worked as a financial reporting manager at DHL-Sinotrans from 2007 through 2010 and senior financial analyst at Lenovo Greater China from 2005 to 2007. Ms. Wen received her Bachelor’s degree from Sichuan University in Business Administration and Master’s degree from the University of Leeds in International Finance. In addition, she holds CFA and ACCA designations.
 
Mr. Weston Twigg
 is one of our independent directors.
Since February 2023, Mr. Twigg has served as an independent director at Tungray Technologies, Inc., which provides customized industrial manufacturing solutions.
Since February 2023, Mr. Twigg has served as the Chief Financial Officer of INNO Holdings, Inc., a building technology company. Mr. Twigg served as a Managing Director and Equity Research Analyst leading the Industry 4.0 Software and Systems research practice at Piper Sandler, from July 2021 to September 2022. Before joining Piper Sandler, he was a Managing Director and Equity Research Analyst leading the semiconductor equity research group at KeyBanc Capital Markets from 2014 to 2021. Before joining KeyBanc Capital Markets, Mr. Twigg was an Associate Equity Analyst from 2005 to 2007, Senior Equity Analyst from 2007 to 2012, and Principal from 2012 to 2014 at Pacific Crest Securities until Pacific Crest Securities was acquired by KeyBanc Capital Markets in September 2014. Prior to joining Pacific Crest Securities, Mr. Twigg worked in the semiconductor industry as a senior engineer at Intel from 2000 to 2005, and before that, as a process engineer at Samsung from 1998 to 2000. Mr. Twigg received his MBA from the Michael G. Foster School of Business, University of Washington, his Master of Science in Chemical Engineering from Michigan State University, and his Bachelor’s degree in Chemistry from Albion College. Mr. Twigg was recognized as one of the Top Ten Stock Pickers in the U.S. by Financial Times in 2011.
 
Mr. Tao Jiang
 is one of our independent directors. Mr. Jiang is the Founder & Chairman of China Software Developer Community (“CSDN”), and the founding partner of GeekFounders. Mr. Jiang has over 25 years of experience in the software and internet industry as a programmer, entrepreneur, and angel investor. From March 2021 to April 2022, Mr. Jiang was a director of TradeUP Global prior to the consummation of its business combination with SAI.TECH Global Corp. (Nasdaq: SAI). In 1999, Mr. Jiang founded CSDN, a professional Chinese IT technology community, which currently has more than 31 million registered users, and is ranked 30th in Alexa global website traffic rank. In 2011, Mr. Jiang founded GeekFounders, and invested in a variety of high-tech startups. Prior to founding CSDN and GeekFounders, Mr. Jiang worked at Giant Network Group Co from 1992 to 1997 and Kingsoft Corporation in 1997 and led the development of Giant’s handwriting computer, PowerWord, and Herosoft Player. Mr. Jiang received his Bachelor’s degree from Sichuan University in computational mathematics and application software.
 
Mr. James Long
 is one of our independent directors. Mr. Long serves as the Chairman and CEO of MDLand International Corp., a digital healthcare company based in New York City providing cloud-based technology solutions to medical practices and healthcare organizations since October 2005. Previously, from 1998 to 2005, Mr. Long was a Vice President/Consultant at JPMorgan Chase, responsible for the development and the support of applications for treasury services solutions. Prior to JPMorgan Chase, from 1995 to 1997, Mr. Long was a system engineer at Periphonic (acquired by Nortel) to develop the first-generation natural language processing-based voice applications and was a principal engineer at Medical Systems for the federally-fund small business innovation research project. Mr. Long completed the Stanford Executive Program Flex from Stanford University in February 2022 and is currently a member of Alumni Association of the Graduate School of Business at Stanford. Mr. Long holds a Master of Science degree in Physics with an emphasis on digital signal processing from the University of Wisconsin and a Bachelor of Science degree in Physics with an emphasis on microcomputers from Zhongshan (Sun Yat-Sen) University.
 
  
22
Table of Contents
  
 
Our directors and officers will play a key role in identifying, evaluating, and selecting target businesses, and structuring, negotiating and consummating our initial acquisition transaction. Except as described below and under “
Directors, Executive Officers and Corporate Governance
—
Conflicts of Interest
,” none of these individuals is currently a principal of or affiliated with a public company or blank check company that executed a business plan similar to our business plan. We believe that the skills and experience of these individuals, their collective access to acquisition opportunities and ideas, their contacts, and their transaction expertise should enable them to identify successfully and effect an acquisition transaction, although we cannot assure you that they will, in fact, be able to do so.
 
Director Independence
  
NASDAQ listing standards require that a majority of our board of directors be independent as long as we are not a controlled company. An “independent director” is defined under the Nasdaq rules generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship which in the opinion of the company’s board of directors, would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of a director. Our board of directors has determined that each of Messrs. Twigg, Jiang and Long is an “independent director” as defined in the NASDAQ listing standards and applicable SEC rules. Our independent directors have regularly scheduled meetings at which only independent directors are present.
  
Audit Committee
  
Since our IPO, we have an audit committee of the board of directors. Messrs. Twigg, Jiang and Long serve as members of our audit committee. Mr. Twigg serves as chairman of the audit committee. Under the Nasdaq listing standards and applicable SEC rules, we are required to have three members of the audit committee all of whom must be independent. Messrs. Twigg, Jiang and Long are independent.
  
Each member of the audit committee is financially literate and our board of directors has determined that Mr. Twigg qualifies as an “
audit committee financial expert
” as defined in applicable SEC rules.
  
We have adopted an audit committee charter, which details the principal functions of the audit committee, including:
 
 
●
the appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and any other independent registered public accounting firm engaged by us;
 
 
●
pre-approving all audit and non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures;
 
 
●
reviewing and discussing with the independent auditors all relationships the auditors have with us in order to evaluate their continued independence;
 
 
●
setting clear hiring policies for employees or former employees of the independent auditors;
 
 
●
setting clear policies for audit partner rotation in compliance with applicable laws and regulations;
 
 
●
obtaining and reviewing a report, at least annually, from the independent auditors describing (1) the independent auditor’s internal quality-control procedures and (2) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within, the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues;
 
 
●
reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and
 
 
●
reviewing with management, the independent auditors, and our legal advisors, as appropriate, any legal, regulatory, or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities.
  
Compensation Committee
  
Since our IPO, we have a compensation committee of the board of directors. The members of our Compensation Committee are Messrs. Twigg, Jiang and Long. Mr. Jiang serves as chairman of the compensation committee. We have adopted a compensation committee charter, which details the principal functions of the compensation committee, including:
 
 
●
reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives, and determining and approving the remuneration (if any) of our Chief Executive Officer’s based on such evaluation in executive session at which the Chief Executive Officer is not present;
  
 
23
Table of Contents
  
 
 
●
reviewing and approving the compensation of all of our other executive officers;
 
 
●
reviewing our executive compensation policies and plans;
 
 
●
implementing and administering our incentive compensation equity-based remuneration plans;
 
 
●
assisting management in complying with our proxy statement and annual report disclosure requirements;
 
 
●
approving all special perquisites, special cash payments, and other special compensation and benefit arrangements for our executive officers and employees;
 
 
●
producing a report on executive compensation to be included in our annual proxy statement; and
 
 
●
reviewing, evaluating, and recommending changes, if appropriate, to the remuneration for directors.
  
Notwithstanding the foregoing, as indicated above, other than reimbursement of expenses and the business combination fee that we have agreed to pay to the Representatives, including US Tiger, an affiliate to our founder Tradeup INC., in connection with our business combination, no compensation of any kind, including finders, consulting or other similar fees, will be paid to any of our existing stockholders, officers, directors or any of their respective affiliates, prior to, or for any services they render in order to complete the consummation of a business combination although we may consider cash or other compensation to officers or advisors we may hire subsequent to the IPO to be paid either prior to or in connection with our initial business combination. Accordingly, it is likely that prior to the consummation of an initial business combination, the compensation committee will only be responsible for the review and recommendation of any compensation arrangements to be entered into in connection with such initial business combination.
  
The current charter of the Compensation Committee also provides that the compensation committee may, in its sole discretion, retain, or obtain the advice of a compensation consultant, legal counsel, or other adviser and will be directly responsible for the appointment, compensation, and oversight of the work of any such adviser. Before engaging or receiving advice from a compensation consultant, external legal counsel, or any other adviser, however, the compensation committee will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC.
  
Director Nominations
  
We do not have a standing nominating committee. In accordance with Rule 5605(e)(2) of the Nasdaq Rules, a majority of the independent directors may recommend a director nominee for selection by the board of directors. The board of directors believes that the independent directors can satisfactorily carry out the responsibility of properly selecting or approving director nominees without the formation of a standing nominating committee. As there is no standing nominating committee, we do not have a nominating committee charter in place.
  
The board of directors will also consider director candidates recommended for nomination by our stockholders during such times as they are seeking proposed nominees to stand for election at the next annual meeting of stockholders (or, if applicable, a special meeting of stockholders). Our stockholders that wish to nominate a director for election to our board of directors should follow the procedures set forth in our bylaws.
  
We have not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating nominees for director, our board of directors considers educational background, diversity of professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our stockholders.
 
Code of Ethics
  
We have adopted a code of ethics that applies to all of our executive officers, directors and employees. The code of ethics codifies the business and ethical principles that govern all aspects of our business.

Section 16(a) Beneficial Ownership Reporting Compliance
 

Section 16(a) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, requires our executive officers, directors and persons who beneficially own more than 10% of a registered class of our equity securities to file with the Securities and Exchange Commission initial reports of ownership and reports of changes in ownership of our shares of Common Stock and other equity securities. These executive officers, directors, and greater than 10% beneficial owners are required by SEC regulation to furnish us with copies of all Section 16(a) forms filed by such reporting persons.
 

Based solely on our review of such forms furnished to us and written representations from certain reporting persons, we believe that, during 2022, our directors, executive officers, and ten percent stockholders complied with all Section 16(a) filing requirements.
 


24
Table of Contents

ITEM 11. EXECUTIVE COMPENSATION
 

Employment Agreements
 

We have not entered into any employment agreements with our executive officers and have not made any agreements to provide benefits upon termination of employment.
 

Executive Officers and Director Compensation
 

None of our officers or directors has received any cash compensation for services rendered to us, except that our founders have transferred each independent director 10,000 founder shares immediately following the consummation of the IPO and have agreed to transfer additional 10,000 founder shares upon completion of our initial business combination provided that such independent director has stayed with us until the completion of our initial business combination.  Other than as set forth elsewhere in this report, no compensation of any kind, including finder’s and consulting fees, will be paid to our founders or any of their respective affiliates, for services rendered prior to or in connection with the completion of our initial business combination although we may consider cash or other compensation to officers or advisors we may hire subsequent to the IPO to be paid either prior to or in connection with our initial business combination. In addition, our officers, directors or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made to our founders or their affiliates.
 

After the completion of our initial business combination, directors or members of our management team who remain with us may be paid consulting or management fees from the combined company. All of these fees will be fully disclosed to stockholders, to the extent then known, in the tender offer materials or proxy solicitation materials furnished to our stockholders in connection with a proposed business combination. We have not established any limit on the amount of such fees that may be paid by the combined company to our directors or members of management. It is unlikely the amount of such compensation will be known at the time of the proposed business combination, because the directors of the post-combination business will be responsible for determining officer and director compensation. Any compensation to be paid to our officers will be determined, or recommended to the board of directors for determination, either by a compensation committee constituted solely by independent directors or by a majority of the independent directors on our board of directors.
 

Following a business combination, to the extent we deem it necessary, we may seek to recruit additional managers to supplement the incumbent management team of the target business. We cannot assure you that we will have the ability to recruit additional managers, or that additional managers will have the requisite skills, knowledge or experience necessary to enhance the incumbent management.
 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
 

The following table sets forth information regarding the beneficial ownership of our Common Stock as of the date of this annual report, by:
 
 
 
●
each person known by us to be the beneficial owner of more than 5% of the shares of our outstanding Common Stock;
 
 
 
●
each of our officers and directors; and
 
 
 
●
all of our officers and directors as a group.
 

Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all shares of Common Stock beneficially owned by them.
The following table does not reflect the record of beneficial ownership as indicated in the statements filed with the SEC pursuant section 13(d) or 13(g) that, to our best knowledge, such information is not complete or accurate.
The following table does not reflect record of beneficial ownership of the Warrants included in the Units sold in the IPO as these Warrants are not exercisable until the later of 30 days after the completion of our initial business combination, or 12 months from the closing of the IPO. As of the date hereof, there are 2,329,920 shares of Common Stock issued and outstanding.
 

 

25
Table of Contents
 
 
 
Amount and
 
Approximate
 
 
 
Nature of
 
Percentage of
 
 
 
Beneficial
 
Outstanding
 
Name and Address of Beneficial Owner(1)
 
Ownership
 
Common Stock
 
5% Stockholders of UPTD
 
 
 
 
 
TradeUP Acquisition Sponsor LLC (2)
 
1,111,760
 
47.72
%
Tradeup INC.(3)
 
135,970
 
5.84
%
Directors and Executive Officers of UPTD
 
 
 
 
 
Jianwei Li(2)
 
1,253,730
 
53.81
%
Weiguang Yang
 
—
 
—
 
Luqi Wen
 
—
 
—
 
Weston Twigg
 
10,000
 
*
 
Tao Jiang
 
10,000
 
*
 
James Long
 
10,000
 
*
 
All executive officers and directors as a group (6 individuals)
 
1,283,730
 
55.10
%
 
*
less than 1%.  
 

 
(1)
Unless otherwise noted, the business address of each of the following entities or individuals is c/o TradeUP Acquisition Corp., 437 Madison Avenue 27th Floor, New York, New York 10022
.
 
(2)
The Sponsor is the record holder of the shares of Common Stock reported herein. Mr. Jianwei Li, our Chairman and Chief Executive Officer, is the managing member of the Sponsor, and as such may be deemed to have sole voting and investment discretion with respect to the Common Stock held by the Sponsor.
 
(3)
Tradeup INC. is the record holder of the shares of Common Stock reported herein. The person having voting, dispositive or investment powers over Tradeup INC. is Mr. Xin Song. Mr. Song is also the President and sole director of Tradup INC.
 

The founder shares and Private Shares are subject to transfer restrictions pursuant to lock-up provisions in a letter agreement with us entered into by our founders (not including the anchor investors who purchase Units in the offering and certain membership interest in the Sponsor, if any), officers and directors. Those lock-up provisions provide that such securities are not transferable or salable (i) in the case of the founder shares, 50% of founder shares may not be transferred, assigned or sold until the earlier to occur of: (a) six months after the date of the consummation of our initial business combination, or (b) the date on which the closing price of our Common Stock equals or exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after our initial business combination and the remaining 50% of the founder shares may not be transferred, assigned or sold until six months after the date of the consummation of our initial business combination, or earlier, in either case, if, subsequent to our initial business combination, we consummate a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of our stockholders having the right to exchange their shares for cash, securities or other property, and (ii) in the case of the Private Shares, until 30 days after the completion of our initial business combination, except in each case (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any affiliate of our founders, any members of our founders, or any of their affiliates, officers, directors, direct and indirect equity holders, (b) in the case of an individual, by gift to a member of the individual’s immediate family, to a trust, the beneficiary of which is a member of the individual’s immediate family or an affiliate of such person, or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with the consummation of a business combination at prices no greater than the price at which the securities were originally purchased; (f) in the event of our liquidation prior to the completion of our initial business combination; or (g) by virtue of the laws of Delaware or our founders’ limited liability company agreement upon dissolution of our founders, provided, however, that in the case of clauses (a) through (e), or (g) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions.
 

 

26
Table of Contents
 

 

In addition, in order to finance transaction costs in connection with an intended initial business combination, our founders or an affiliate of our founders or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete an initial business combination, we would repay such loaned amounts. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used for such repayment. Up to $1,200,000 of such loans may be convertible into Private Shares at $10.00 per share at the option of the lender. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our founders or an affiliate of our founders as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in the Trust Account.
 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
 

Founder and Private Shares
 

On January 20, 2021, the Sponsor acquired 1,150,000 founder shares for an aggregate purchase price of $25,000. On February 11, 2021, in connection with a restructure of the Sponsor, the Sponsor forfeited 1,150,000 founder shares upon the receipt of the refund of purchase price of $25,000. On February 12, 2021, the Sponsor acquired 920,000 founder shares for a purchase price of $20,000 and the other founder Tradeup INC. acquired 230,000 founder shares for a purchase price of $5,000, respectively. Prior to the initial investment in the company of $25,000 by our founders, the company had no assets, tangible or intangible.
 

The number of founder shares issued was determined based on the expectation that such founder shares would represent approximately 20% of the outstanding shares upon completion of the IPO (excluding Private Shares and assuming that founders do not purchase any Units or public shares in the offering). Up to 42,500 founder shares were forfeited by our founders in connection with the underwriters’ partial exercise of the Over-Allotment Option. As a result, the Sponsor held 886,000 and Tradeup INC. held 110,750 founder shares, respectively. The founder shares may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder.
 

Our founders have transferred each independent director 10,000 founder shares immediately following the consummation of the IPO and have agreed to transfer additional 10,000 founder shares upon completion of our initial business combination provided that such independent director has stayed with us until the completion of our initial business combination.
 

As of December 31, 2022 and 2021, there were 1,107,500 founder shares issued and outstanding, net of the forfeiture of the 42,500 founder shares as the underwriters’ over-allotment is not exercised in full by September 1, 2021, 45-day from the date of the IPO. The aggregate capital contribution was $25,000, or approximately $0.02 per share.
 

The founders have agreed not to transfer, assign or sell 50% of its founder shares until the earlier to occur of: (A) six months after the date of the consummation of the Company’s initial business combination, or (B) the date on which the closing price of the Company’s Common Stock equals or exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after the Company’s initial business combination and the remaining 50% of the founder shares may not be transferred, assigned or sold until six months after the date of the consummation of the Company’s initial business combination, or earlier, in either case, if, subsequent to the Company’s initial business combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares for cash, securities or other property.
 

Our founders have purchased an aggregate of 312,200 Private Shares for a purchase price of $10.00 per share in the Private Placement simultaneously with the closing of the IPO and the underwriters’ partial exercise of Over-allotment Option. As such, our founders’ interest in this transaction is valued at between $3,
122
,000. The Private Shares sold in the Private Placement and issued upon conversion of working capital loans may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until 30 days after the completion of the Company’s initial business combination.
 

On March 4, 2022, pursuant to a certain securities transfer agreement, Tradeup INC. has transferred 110,750 founder shares, at $0.0232 per founder share and 31,220 Private Shares, at $10.00 per private share to Mr. Jianwei Li, our Chairman and Chief Executive Officer.
 

As more fully discussed in the section of this report entitled “
Directors, Executive Officers and Corporate Governance
— Conflicts of Interest,” if any of our officers or directors becomes aware of a business combination opportunity that falls within the line of business of any entity to which he or she has then-current fiduciary or contractual obligations, including our founders, he or she will honor his or her fiduciary or contractual obligations to present such opportunity to such entity. Our officers and directors currently have certain relevant fiduciary duties or contractual obligations to other entities that may take priority over their duties to us. Other than as set forth elsewhere in this report, no compensation of any kind, including finder’s and consulting fees, will be paid to our founders, existing officers, directors and advisors, or any of their respective affiliates, for services rendered prior to or in connection with the completion of an initial business combination although we may consider cash or other compensation to officers or advisors we may hire subsequent to the IPO to be paid either prior to or in connection with our initial business combination. In addition, these individuals will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made to our founders, officers, directors, advisors or our or their affiliates and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on our behalf.
 

Anchor Investors
 

During the IPO, each of certain anchor investors purchased up to 9.9% of the units in the IPO. In consideration of providing significant indications of interest, the Sponsor, TradeUP Acquisition Sponsor LLC, has sold these investors membership interests in the Sponsor, for nominal consideration, entitling them to an interest in an aggregate of up to 240,000 anchor founder shares or 40,000 anchor founder shares for each investor held by the Sponsor. The anchor founder shares are treated the same in all material respects as the founder shares held by the Sponsor as described in this report, except that such anchor founder shares shall have the right not to be subject to adjustments or cutbacks in the event the Sponsor agrees to any such adjustments or cutbacks (of its shares) in connection with our initial business combination. Our discussions with each anchor investor were separate and our arrangements with them are not contingent on each other. Further, to our knowledge, the anchor investors are not affiliated with each other and are not acting together with regards to our company, except that they may purchase certain membership interests in the Sponsor and Units in the IPO.

27
Table of Contents
  
 
Pursuant to the subscription agreements with the Sponsor, the anchor investors have not been granted any material additional stockholder or other rights, and are only being issued membership interests in the Sponsor with no right to control the Sponsor or vote or dispose of the anchor founder shares (which will continue to be held by the Sponsor until following our initial business combination). Further, the anchor investors are not required to: (i) hold any units, shares or warrants they may purchase in the IPO or thereafter for any amount time, (ii) vote any shares they may own at the applicable time in favor of our initial business combination or (iii) refrain from exercising their right to redeem their shares at the time of our initial business combination. The anchor investors are not founders and the Units they purchased in the IPO are not subject to any trading restrictions. As of the date of this report, based on the beneficial reporting made by investors and available to us through the SEC EDGAR filing system, to our best knowledge, those anchor investors sold their Units.
 
IPO Promissory Note
  
On January 19, 2021, the Sponsor has agreed to loan the Company up to $400,000 to be used for a portion of the expenses of the IPO. This loan is non-interest bearing, unsecured and is due at the earlier of (1) June 20, 2021 or (2) the closing of the IPO. The loan will be repaid upon the closing of the IPO out of the offering proceeds not held in the Trust Account. On June 19, 2021 the Sponsor has agreed to extend the maturity date of the loan to the Company to the earlier of August 31, 2021 or the closing date of the IPO. The outstanding balance under the promissory note was repaid at the closing of the IPO on July 19, 2021.
 
Working Capital Loans
  
In addition, in order to finance transaction costs in connection with an intended initial business combination, our founders or an affiliate of our founders or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete an initial business combination, we would repay such loaned amounts. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,200,000 of such loans may be convertible into Private Shares at $10.00 per share at the option of the lender. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our founders or an affiliate of our founders as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our Trust Account.
  
On July 25, 2022, we issued (i) the Running Lion Note in the amount of $204,000 to Running Lion, which is wholly owned and controlled by Mr. Weiguang Yang, our Co-Executive Officer and director and (ii) the July 2022 Sponsor Note in the amount of $294,600 to Tradeup INC., one of our Founders. On March 3, 2023, we issued the March 2023 Sponsor Note in the amount of $50,000 to Tradeup INC. The proceeds of the Running Lion Note, the July 2022 Sponsor Note and the March 2023 Sponsor Note, which may be drawn down from time to time until we consummate our initial Business Combination, will be used as general working capital purposes. On January 19, 2023, we issued the January 2023 Sponsor Note in the amount of $50,000 to the Sponsor, to evidence a deposit that the Sponsor provided to the Company to pay its certain operating expenses.
  
The Notes bear no interest and are payable in full upon the earlier to occur of (i) the consummation of our Business Combination or (ii) the Maturity Date. The following shall constitute an event of default: (i) a failure to pay the principal within five business days of the Maturity Date; (ii) the commencement of a voluntary or involuntary bankruptcy action, (iii) the breach of our obligations thereunder; (iv) any cross defaults; (v) an enforcement proceedings against us; and (vi) any unlawfulness and invalidity in connection with the performance of the obligations thereunder, in which case the Notes may be accelerated.
  
The Payees respectively have the right, but not the obligation, to convert their Notes, in whole or in part, respectively, into Conversion Shares, as described in our prospectus (File Number 333-253322), by providing us with written notice of the intention to convert at least two business days prior to the closing of the Business Combination. The number of Conversion Shares to be received by the Payees in connection with such conversion shall be an amount determined by dividing (x) the sum of the outstanding principal amount payable to such Payee by (y) $10.00.
  
As of the date hereof, we have outstanding loans from various related parties in the aggregated amount of $598,600, which include (i) the Running Lion Note in the amount of $204,000 to Running Lion, (ii) the July 2022 Sponsor Note in the amount of $294,600 to Tradeup INC., (iii) the January 2023 Sponsor Note in the amount of $50,000 to the Sponsor, to evidence a deposit that the Sponsor provided to the Company to pay its certain operating expenses, and (iv) the March 2023 Sponsor Note in the amount of $50,000 to Tradeup INC.

As of December 31, 2022 and 2021, the Company had borrowings of $498,000 and $0, respectively, under the working capital loans.
 
Due to a related party
  
For the year ended December 31, 2022, the Sponsor loaned us $50,000 to cover certain of our operating expenses. As of December 31, 2022, the total amount due to the Sponsor was $50,000 and such balance was converted into the January 2023 Sponsor Note on January 19, 2023.
  

 
28
Table of Contents
 
 
Others
  
After our initial business combination, members of our management team who remain with us may be paid consulting, management or other fees from the combined company with any and all amounts being fully disclosed to our stockholders, to the extent then known, in the tender offer or proxy solicitation materials, as applicable, furnished to our stockholders. It is unlikely the amount of such compensation will be known at the time of distribution of such tender offer materials or at the time of a shareholder meeting held to consider our initial business combination, as applicable, as it will be up to the directors of the post-combination business to determine executive and director compensation.
  
We have entered into a registration rights agreement with respect to the Private Shares sold in the Private Placement, the Private Shares issuable upon conversion of working capital loans (if any), and the founder shares.
  
We have engaged the Representatives of the underwriters and US Tiger as advisors in connection with our business combination pursuant to the Business Combination Marketing Agreement. We will pay the Representatives a cash fee for such services upon the consummation of our initial business combination in an amount equal to, in the aggregate, 3.5% of the gross proceeds of the IPO and the sale of the Option Units. As a result, the Representatives will not be entitled to such fee unless we consummate our initial business combination.
  
In connection with the Extension, Estrella deposited two Monthly Extension Payments of $91,002 in total into the Trust Account pursuant to the Merger Agreement, which was evidenced by the Extension Notes in the same amount to Estrella. If UPTD cannot complete its initial Business Combination by the Combination Deadline, it will be forced to dissolve and liquidate pursuant to the Current Charter. Estrella has the right, but not the obligation to convert the Extension Notes, in whole or in part, into shares of our Common Stock for an amount determined by dividing (x) the sum of the outstanding principal amount payable to Estrella by (y) $10.00. Notwithstanding the foregoing, UPTD shall have the obligation to pay to Estrella the funds amounting to the principal amount of the Estrella Note if the Business Combination is terminated pursuant to the Merger Agreement. UPTD shall refund the principal amount of the Extension Notes to Estrella fully within 5 business days of such termination.
 
RELATED PARTY POLICY
  
We have not yet adopted a formal policy for the review, approval or ratification of related party transactions. Accordingly, the transactions discussed above were not reviewed, approved or ratified in accordance with any such policy.
  
We have adopted a code of ethics requiring us to avoid, wherever possible, all conflicts of interests, except under guidelines or resolutions approved by our board of directors (or the appropriate committee of our board) or as disclosed in our public filings with the SEC. Under our code of ethics, conflict of interest situations will include any financial transaction, arrangement or relationship (including any indebtedness or guarantee of indebtedness) involving the company. A form of the code of ethics that was filed as an exhibit to the S-1 was adopted prior to the consummation of the IPO.
  
In addition, our audit committee is responsible for reviewing and approving related party transactions to the extent that we enter into such transactions. An affirmative vote of a majority of the members of the audit committee present at a meeting at which a quorum is present will be required in order to approve a related party transaction. A majority of the members of the entire audit committee will constitute a quorum. Without a meeting, the unanimous written consent of all of the members of the audit committee will be required to approve a related party transaction. We also require each of our directors and executive officers to complete a directors’ and officers’ questionnaire that elicits information about related party transactions.
  
These procedures are intended to determine whether any such related party transaction impairs the independence of a director or presents a conflict of interest on the part of a director, employee or officer.
  
To further minimize conflicts of interest, we have agreed not to consummate an initial business combination with an entity that is affiliated with any of our founders, officers or directors unless we, or a committee of independent directors, have obtained an opinion from an independent investment banking firm which is a member of FINRA or an independent accounting firm that our initial business combination is fair to our company from a financial point of view. Furthermore, other than as set forth elsewhere in this report and the S-1, no finder’s fees, reimbursements or cash payments will be made to our founders, existing officers, directors or advisors, or our or their affiliates, for services rendered to us prior to or in connection with the completion of our initial business combination although we may consider cash or other compensation to officers or advisors we may hire subsequent to the IPO to be paid either prior to or in connection with our initial business combination. In addition, the following payments will be made to our founders or their affiliates, none of which will be made from the proceeds of the IPO held in the Trust Account prior to the completion of our initial business combination:
 
 
●
Reimbursement for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination; and
 
 
●
Repayment of loans which may be made by our founders or an affiliate of our founders to finance transaction costs in connection with an intended initial business combination, the terms of which have not been determined nor have any written agreements been executed with respect thereto. Up to $1,200,000 of such loans may be convertible into working capital shares, at a price of $10.00 per share at the option of the lender.
  
Our audit committee will review on a quarterly basis all payments that were made to our founders or their affiliates.
  
 
29
Table of Contents
  
 
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
 
Public Accounting Fees
  
The following chart sets forth public accounting fees in connection with services rendered by Marcum (formerly Friedman LLP, prior to Friedman LLP combining with Marcum LLP effective September 1, 2022) for the year ended December 31, 2022 and for the period from January 6, 2021 (inception) through December 31, 2021.
  
2022
(1)
 
 
2021
 
Audit Fees
 
$
 
65,000
$
56,000
 
Audit-Related Fees
 
 
—
 
 
 
—
 
Tax Fees
 
 
—
 
 
 
—
 
All Other Fees
 
 
—
 
 
 
—
 
  
(1) Based on information provided by Friedman LLP (“Friedman”), the independent registered public accounting firm of the Company, effective September 1, 2022, Friedman continued to serve as the Company’s independent registered public accounting firm through October 10, 2022. On October 10, 2022, the Board of Directors and the Audit Committee of the Board approved the dismissal with Friedman and engagement of Marcum to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2022. Approximately $10,000 of the total fees for audit services during the year ended December 31, 2022 were provided by Marcum.
  
Audit fees were for professional services rendered by Marcum for the audit of our annual financial statements, and services that are normally provided by Marcum in connection with statutory and regulatory filings or engagements for that fiscal year, including in connection with our IPO. “Audit-related fees” are fees for assurance and related services by our principal accountant that are reasonably related to the performance of the audit or review of our financial statements and are not reported under “audit fees.”
 
Pre-Approval of Services
  
Because our audit committee was not formed until July 14, 2021, the audit committee did not pre-approve all of the foregoing services, although any services rendered prior to the formation of our audit committee were approved by our board of directors. All services subsequent to the formation of the audit committee have been approved by the audit committee.
 
 
30
Table of Contents
  

PART IV
 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
  
(a) Financial Statements:
 
 
(1)
The financial statements required to be included in this Annual Report on Form 10-K are included in Item 8 therein.
 
(2)
All supplemental schedules have been omitted since the information is either included in the financial statements or the notes thereto or they are not required or are not applicable.
 
(3)
See attached Exhibit Index of this Annual Report on Form 10-K
 
(b) Exhibits
 
Exhibit No.
 
Description
 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 

 
 
 
101.INS
 
XBRL Instance Document
 
 
 
101.SCH
 
XBRL Taxonomy Extension Schema Document
 
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document
 
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
 
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
  
104
 
Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
  
ITEM 16. FORM 10-K SUMMARY
  
None.
 
 
31
Table of Contents
  
 
SIGNATURES
  
Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
TRADEUP ACQUISITION CORP.
 
 
 
Dated:
March 14,
2023
By:
/s/ Jianwei Li
 
Name:
Jianwei Li
 
Title:
Chairman and Co-Chief Executive Officer
  
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 
Name
 
Position
 
Date
 
 
 
 
 
/s/ Jianwei Li
 
Co-Chief Executive Officer (Principal Executive Officer) and Chairman
 
March 14,
2023
Jianwei Li
 
 
 
 
 
 
 
 
 
/s/ Weiguang “James” Yang
 
Co-Chief Executive Officer and Director
 
 
March 14,
2023
Weiguang “James” Yang
 
 
 
 
 
 
 
 
 
/s/ Luqi “Lulu” Wen
 
Chief Financial Officer (Principal Financial and Accounting Officer)
 
 
March 14,
2023
Luqi “Lulu” Wen
 
 
 
 
 
 
 
 
 
/s/ Weston Twigg
 
Independent Director
 
 
March 14,
2023
Weston Twigg
 
 
 
 
 
 
 
 
 
/s/ Tao Jiang
 
Independent Director
 
March 14,
2023
Tao Jiang
 
 
 
 
 
 
 
 
 
/s/ James Long
 
Independent Director
 
March 14,
2023
James Long
 
 
 
 

32
Table of Contents
 
 

TRADEUP ACQUISITION CORP.
INDEX TO FINANCIAL STATEMENTS
 
 
 
 

F-1
Table of Contents
 
 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 

To the Stockholders and Board of Directors of
TradeUP Acquisition Corp.
 
Opinion on the Financial Statements
 
We have audited the accompanying balance sheet of
TradeUP Acquisition Corp.
(the “Company”) as of December 31, 2022, the related statements of operations, stockholders’ deficit and cash flows for the year ended December 31, 2022, and the related notes
 
(collectively referred to as the “financial statements”).  In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022, and the results of its operations and its cash flows for the year ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.
 
Explanatory Paragraph – Going Concern
 
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 1 to the financial statements, the Company’s
business plan is dependent on the completion of a business combination and the Company’s cash and working capital as of December 31, 2022 are not sufficient to complete its planned activities for a reasonable period of time, which is considered to be one year from the issuance date of the financial.
These conditions raise substantial doubt about the Company's ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
 
Basis for Opinion
 
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
 
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.
 
Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
 
/s/ Marcum
 LLP
 
 
Marcum
LLP
 
We have served as the Company’s auditor since 2021 (such date takes into account the acquisition of certain assets of Friedman LLP by Marcum LLP effective September 1, 2022)
 
East Hanover, New Jersey

March 1
4
, 2023


F-2
Table of Contents


 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 

To the Board of Directors and Stockholders of
TradeUP Acquisition Corp.
 
Opinion on the Financial Statements
 
We have audited the accompanying balance sheet of TradeUP Acquisition Corp. (the “Company”) as of December 31, 2021 and the related statements of operations, changes in stockholders’ deficit and cash flows for the period from January 6, 2021 (inception) through December 31, 2021 and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and the results of its operations and its cash flows for the period from January 6, 2021 (inception) through December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.
 
Basis for Opinion
 
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
 
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
 
Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
 
/s/Friedman LLP
 
 
Friedman LLP
 
We have served as the Company’s auditor since 2021.
 
New York, NY
March 29, 2022
 
 
 

 

TRADEUP ACQUISITION CORP.
BALANCE SHEETS
 
 
 
December 31, 2022
 
 
December 31, 2021
 
Assets
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
Cash
 
$
40,802
 
 
$
478,868
 
Prepaid expenses
 
 
11,625
 
 
 
137,166
 
Total current assets
 
 
52,427
 
 
 
616,034
 
 
 
 
 
 
 
 
 
 
Investments held in Trust Account
 
 
9,671,375
 
 
 
45,187,428
 
Total Assets
 
$
9,723,802
 
 
$
45,803,462
 
 
 
 
 
 
 
 
 
 
Liabilities, Temporary Equity, and Stockholders’ Deficit
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
Accounts payable and accrued expenses
 
$
329,166
 
 
$
3,000
 
Working capital loans - related parties
 
 
498,600
 
 
 
-
 
Due to a related party
 
 
50,000
 
 
 
-
 
Income tax payable
 
 
51,176
 
 
 
 
-
 
Franchise tax payable
 
 
144,127
 
 
 
70,154
 
Total current liabilities
 
 
1,073,069
 
 
 
73,154
 
 
 
 
 
 
 
 
 
 
Deferred tax liability
 
 
29,472
 
 
 
-
 
Deferred underwriters' marketing fees
 
 
1,550,500
 
 
 
1,550,500
 
Total Liabilities
 
 
2,653,041
 
 
 
1,623,654
 
 
 
 
 
 
 
 
 
 
Commitments and Contingencies
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common stock subject to possible redemption,
910,220
and
4,430,000
shares at
redemption
value of $10.25 and 10.20 per share as of December 31, 2022 and 2021, respectively
 
 
9,326,446
 
 
 
45,186,000
 
 
 
 
 
 
 
 
 
 
Stockholders’ Deficit:
 
 
 
 
 
 
 
 
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
 
 
-
 
 
 
-
 
Common stock, $0.0001 par value; 30,000,000 shares authorized; 1,419,700 shares issued and outstanding (excluding
910,220
and 4,430,000 shares subject to possible redemption as of December 31, 2022 and 2021, respectively)
 
 
142
 
 
 
142
 
Additional paid-in capital
 
 
-
 
 
 
-
 
Accumulated deficit
 
 
(2,255,827
)
 
 
(1,006,334
)
Total Stockholders' Deficit
 
 
(2,255,685
)
 
 
(1,006,192
)
Total Liabilities, Temporary Equity, and Stockholders' Deficit
 
$
9,723,802
 
 
$
45,803,462
 
 
 
The accompanying notes are an integral part of these financial statements.
 

 

F-4
Table of Contents
 
 
 
 

TRADEUP ACQUISITION CORP.
STATEMENTS OF OPERATIONS
 
 
For the
Year Ended
December 31, 2022
 
 
 
 
 
 
For the Period
from January 6, 2021
(inception) through
December 31, 2021
 
 
 
 
 
 
 
 
 
 
 
Formation and operating costs
 
$
1,368,219
 
 
$
178,992
 
Franchise tax expenses
 
 
201,308
 
 
 
70,154
 
Loss from Operations
 
 
(1,569,527
)
 
 
(249,146
)
 
 
 
            
Other income:
 
 
            
Dividend earned on investment held in Trust Account
 
 
654,071
 
 
 
1,428
 
 
 
 
            
Loss before income taxes
 
 
(915,456
)
 
 
(247,718
)
 
 
 
            
Income taxes provision
 
 
(80,648
)
 
 
-
 
 
 
 
            
Net Loss
 
$
(996,104
)
 
$
(247,718
)
 
 
 
            
Basic and diluted weighted average shares outstanding, common stock subject to possible redemption
 
 
4,343,211
 
 
 
2,033,677
 
Basic and diluted net (loss) income per share, common stock subject to possible redemption
 
$
(0.16
)
 
$
0.76
 
Basic and diluted weighted average shares outstanding, common stock attributable to TradeUP Acquisition Corp.
 
 
1,419,700
 
 
 
1,179,328
 
Basic and diluted net loss per share, common stock attributable to TradeUP Acquisition Corp.
 
$
(0.22
)
 
$
(1.52
)
 

The accompanying notes are an integral part of these financial statements.
 

 

F-5
Table of Contents
 
 
 

TRADEUP ACQUISITION CORP.
STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Additional
 
 
 
 
 
Total
 
 
 
Preferred stock
 
 
Common stock
 
 
Paid-in
 
 
Accumulated
 
 
Stockholders'
 
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Capital
 
 
Deficit
 
 
Deficit
 
Balance as of January 6, 2021 (inception)
 
 
-
 
 
$
-
 
 
 
-
 
 
$
-
 
 
$
-
 
 
$
-
 
 
$
-
 
Founders shares issued to the Sponsor
 
 
-
 
 
 
-
 
 
 
1,150,000
 
 
 
115
 
 
 
24,885
 
 
 
-
 
 
 
25,000
 
Forfeiture of Founders shares issued to the Sponsor
 
 
-
 
 
 
-
 
 
 
(1,150,000
)
 
 
(115
)
 
 
(24,885
)
 
 
-
 
 
 
(25,000
)
Founders shares issued to initial stockholders
 
 
-
 
 
 
-
 
 
 
1,150,000
 
 
 
115
 
 
 
24,885
 
 
 
-
 
 
 
25,000
 
Sale of public units through public offering
 
 
-
 
 
 
-
 
 
 
4,430,000
 
 
 
443
 
 
 
44,299,557
 
 
 
-
 
 
 
44,300,000
 
Sale of private placement shares
 
 
-
 
 
 
-
 
 
 
312,200
 
 
 
31
 
 
 
3,121,969
 
 
 
-
 
 
 
3,122,000
 
Underwriters' discount
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(886,000
)
 
 
-
 
 
 
(886,000
)
Underwriters' marketing fees
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(1,550,500
)
 
 
-
 
 
 
(1,550,500
)
Other offering expenses
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(582,974
)
 
 
-
 
 
 
(582,974
)
Forfeiture of common stock by initial stockholders
 
 
-
 
 
 
-
 
 
 
(42,500
)
 
 
(4
)
 
 
4
 
 
 
-
 
 
 
-
 
Reclassification of common stock subject to redemption
 
 
-
 
 
 
-
 
 
 
(4,430,000
)
 
 
(443
)
 
 
(43,516,256
)
 
 
-
 
 
 
(43,516,699
)
Allocation of offering costs to common stock subject to redemption
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
2,966,085
 
 
 
-
 
 
 
2,966,085
 
Accretion of carrying value to redemption value
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(3,876,770
 )
 
 
(758,616
 )
 
 
(4,635,386
 )
Net loss
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(247,718
 )
 
 
(247,718
 )
Balance as of December 31, 2021
 
 
-
 
 
 
-
 
 
 
1,419,700
 
 
 
142
 
 
 
-
 
 
 
(1,006,334
 )
 
 
(1,006,192
 )
Accretion of carrying value to redemption value
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(253,389
 )
 
 
(253,389
 )
Net loss
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(996,104
 )
 
 
(996,104
 )
Balance as of December 31, 2022
 
 
-
 
 
$
-
 
 
 
1,419,700
 
 
$
142
 
 
$
-
 
 
$
(2,255,827
 )
 
$
(2,255,685
 )
 
 
 
The accompanying notes are an integral part of these financial statements.
 
 
 

F-6
Table of Contents
 
 
 
 

TRADEUP ACQUISITION CORP.
STATEMENTS OF CASH FLOWS
 

 
 
For the
Year Ended
December 31, 2022
 
 
 
 
 
 
For the Period
From January 6, 2021
(inception) through
December 31, 2021
 
 
 
 
Cash Flows from Operating Activities:
 
 
 
 
 
 
 
 
Net loss
 
$
(996,104
)
 
$
(247,718
)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
 
 
 
 
 
Dividend earned on investment held in Trust Account
 
 
(654,071
)
 
 
(1,428
)
Deferred tax expense
 
 
29,472
 
 
 
-
 
Changes in operating assets and liabilities:
 
 
 
 
 
 
 
 
Prepaid expenses
 
 
125,540
 
 
 
(137,166
)
Accounts payable and accrued expenses
 
 
326,166
 
 
 
-
 
Income tax payable
 
 
51,176
 
 
 
-
 
Franchise tax payable
 
 
73,973
 
 
 
70,154
 
Net cash used in operating activities
 
 
(1,043,848
)
 
 
(316,158
)
 
 
 
 
 
 
 
 
 
Cash Flows from Investing Activities:
 
 
 
 
 
 
 
 
Purchase of investment held in trust account
 
 
-
 
 
 
(45,186,000
)
Withdraw of investment held in trust account
 
 
36,170,124
 
 
 
-
 
Net cash provided by (used in) investing activities
 
 
36,170,124
 
 
 
(45,186,000
)
 
 
 
 
 
 
 
 
 
Cash Flows from Financing Activities:
 
 
 
 
 
 
 
 
Proceeds from issuance of shares of Common Stock to the Sponsor
 
 
-
 
 
 
25,000
 
Return of proceeds from issuance of Common Stock to the Sponsor
 
 
-
 
 
 
(25,000
)
Proceeds from issuance of shares of Common Stock to initial stockholders
 
 
-
 
 
 
25,000
 
Proceeds from sale of public units through public offering
 
 
-
 
 
 
44,300,000
 
Proceeds from sale of private placement shares
 
 
-
 
 
 
3,122,000
 
Payment of underwriters' discount
 
 
-
 
 
 
(886,000
)
Payment of offering costs
 
 
-
 
 
 
(579,974
)
Common stock redemption
 
 
(36,112,943
)
 
 
 
-
 
Proceeds from issuance of promissory notes to related parties
 
 
-
 
 
 
300,000
 
Repayment on promissory note to related party
 
 
-
 
 
 
(300,000
)
Proceeds from issuance of working capital loans to related parties
 
 
498,600
 
 
 
-
 
Borrowings from a related party
 
 
50,000
 
 
 
-
 
Net cash
(used in) 
provided by financing activities
 
 
(35,564,343
)
 
 
45,981,026
 
 
 
 
 
 
 
 
 
 
Net Change in Cash
 
 
(438,066
)
 
 
478,868
 
 
 
 
 
 
 
 
 
 
Cash at beginning of year
 
 
 
 
478,868
 
 
 
-
 
Cash at end of year
 
$
40,802
 
 
$
478,868
 
 
 
 
 
 
 
 
 
 
Supplemental Disclosure of Non-cash Financing Activities
 
 
 
 
 
 
 
 
Offering costs included in accounts payable and accrued expenses
 
$
-
 
 
$
3,000
 
Deferred underwriters' marketing fees
 
$
-
 
 
$
1,550,500
 
Reclassification of common stock subject to redemption
 
$
-
 
 
$
43,516,699
 
Allocation of offering costs to common stock subject to redemption
 
$
-
 
 
$
2,966,085
 
Accretion of carrying value to redemption value
 
$
253,389
 
 
$
4,635,386
 
 
 
 
The accompanying notes are an integral part of these financial statements.
 
 
 

F-7
Table of Contents
  
 
TRADEUP ACQUISITION CORP.
NOTES TO
FINANCIAL STATEMENTS
DECEMBER 31, 2022
 
Note 1 — Organization and Business Operation
 

TradeUP Acquisition Corp. (the “Company”) is a blank check company incorporated as a Delaware corporation on January 6, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has selected December 31 as its fiscal year end.
 
 
As of December 31, 2022 and 2021, the Company had not commenced any operations. For the period from January 6, 2021 (inception) through December 31, 2022, the Company’s efforts have been limited to organizational activities as well as activities related to the Initial Public Offering (as defined below). The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of dividend and interest income from the proceeds derived from the Initial Public Offering (as defined below).
 
 
The registration statement for the Company’s initial public offering (the “Initial Public Offering”) became effective on July 14, 2021. On July 19, 2021, the Company consummated the Initial Public Offering of 4,000,000 units (the “Public Units”), at $10.00 per Public Unit, generating gross proceeds of $40,000,000 which is described in Note 4. On July 21, 2021, the underwriters partially exercised the over-allotment option and purchased 430,000 units (the “Option Units “, together with the Public Units, the “Units”) at a price of $10.00 per Option Unit, generating gross proceeds of $4,300,000. Each Unit consists of one share of common stock, $0.0001 par value per share (the “Common Stock”), and one-half of
one
redeemable warrant (the “Warrant”), each whole Warrant entitling the holder thereof to purchase one share of Common Stock at an exercise price of $11.50 per share. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $44,300,000 in total. Transaction costs in connection with the Initial Public Offering and the issuance and sale of Option Units amounted to $3,019,474, consisting of $886,000 of underwriting fees, $1,550,500 of Business Combination Fee (defined in Note 7 below) and $582,974 of other offering costs. Following the expiration of the over-allotment option, 42,500 Founder Shares (defined below) were subsequently forfeited.
 
 
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 295,000 shares of Common Stock (the “Private Placement Shares”) at a price of $10.00 per share in a private placement sale (the “Private Placement”) to the Company’s founders, or initial stockholders, include Tradeup INC. and the Company’s sponsor, TradeUP Acquisition Sponsor LLC, a Delaware limited liability company (the “Sponsor”), among which, the Sponsor purchased 236,000 Private Placement Shares and Tradeup INC. purchased 59,000 Private Placement Shares, generating gross proceeds of $2,950,000, which is described in Note 5. On July 21, 2021, the Company consummated the sale of additional 17,200 Private Placement Shares with the Sponsor and Tradeup INC. at a price of $10.00 per Private Placement share, among which, the Sponsor purchased 13,760 Private Placement Shares and Tradeup INC. purchased 3,440 Private Placement Shares, generating total proceeds of $172,000.
 
 
Following the closing of the Initial Public Offering on July 19, 2021, the issuance and sale of Option Units on July 21, 2021 and the issuance and sale of Private Placement Shares, $45,186,000 from the net proceeds of the sale of the Units and from the sale of Private Placement Shares was placed in a trust account (the “Trust Account”) maintained by Wilmington Trust, National Association as a trustee. The aggregate amount of $45,186,000 ($10.20 per Unit) will be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the long term (rather than on buying and selling businesses in the manner of a merchant bank or private equity fund), the Company intends to avoid being deemed an “investment company” within the meaning of the Investment Company Act. The Initial Public Offering is not intended for persons who are seeking a return on investments in government securities or investment securities. The Trust Account is intended as a holding place for funds pending the earliest to occur of either: (i) the completion of the Company’s initial Business Combination; (ii) the redemption of any public shares properly tendered in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation that would affect the substance or timing of the Company’s obligation to provide for the redemption of its public shares in connection with an initial Business Combination or to redeem 100% of its public shares if the Company has not consummated an initial Business Combination by the Combination Deadline (as defined below); or (iii) absent an initial Business Combination by the Combination Deadline, its return of the funds held in the Trust Account to its public stockholders as part of its redemption of the public shares. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public stockholders.
 
 
The Company’s initial Business Combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the Business Combination Fee and taxes payable and interest previously released for working capital purposes on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires an interest in the target sufficient for the post-transaction company not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully.
 

 
 
F-8
Table of Contents
  
 
The shares of Common Stock subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company initially had until January 19, 2023 to complete its initial Business Combination. On December 22, 2022, the Company held its special meeting of stockholders (the “Special Meeting”), where the Company was approved by its stockholders to amend the amended and restated certificate of incorporation to extend the date before which the Company must complete a Business Combination (the “Combination Deadline”) from January 19, 2023, by one month up to six times, to July 19, 2023, or such earlier date as determined by the board of directors of the Company (such monthly extension is herein referred to as the “Extension”). Upon the stockholders’ approval, on December 29, 2022, the Company filed a certificate of amendment to the amended and restated certificate of incorporation which became effective upon filing. If the Company is unable to complete the initial Business Combination by the Combination Deadline, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company for working capital purposes or to pay the Company’s taxes (less up to $50,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and its board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s Warrants, which will expire worthless if the Company fails to complete the Business Combination by the Combination Deadline. The founders (not including the anchor investors who purchase units in the Initial Public Offering and certain membership interest in the Sponsor, if any), officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed (i) to waive their redemption rights with respect to any Founder Shares, Private Placement Shares and any public shares held by them in connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their Founder Shares, Private Placement Shares and public shares in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Company’s public shares if the Company does not complete its initial Business Combination by the Combination Deadline or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity and (iii) to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares and Private Placement Shares held by them if the Company fails to complete an initial Business Combination by the Combination Deadline, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination by the Combination Deadline. If the Company submits it initial Business Combination to its stockholders for a vote, the Company will complete its initial Business Combination only if a majority of the outstanding shares of Common Stock voted are voted in favor of the initial Business Combination. In no event will the Company redeem its public shares of Common Stock in an amount that would cause its net tangible assets to be less than $5,000,001. In such case, the Company would not proceed with the redemption of public shares of Common Stock and the related Business Combination, and instead may search for an alternate Business Combination.
 
 
The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or by a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.20 per public share or (ii) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, then the Company’s Sponsor will not be responsible to the extent of any liability for such third party claims.
 
 
On December 22, 2022, the Company held the Special Meeting, where the Company was approved by its stockholders to amend the Investment Management Trust Agreement dated July 14, 2021 (the “Trust Agreement”), by and between the Company and Wilmington Trust, National Association (the “Trustee”) to extend the liquidation date from January 19, 2023 to July 19, 2023. In connection with the votes to approve the extension proposal, 3,519,780 public shares were rendered for redemption with 910,220 public shares remained outstanding.
 

Liquidity and Going Concern
 

As of December 31, 2022, the Company had cash of $40,802 and a working deficit of $
1,020,642
. The Company has incurred and expects to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of a Business Combination.
 
 
In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern. The management’s plan in addressing this uncertainty is through the Promissory Notes – related parties and the Working Capital Loans, as defined below (see Note 6). In addition, if the Company is unable to complete a Business Combination by the Combination Deadline, the Company’s board of directors would proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company. There is no assurance that the Company’s plans to consummate a Business Combination will be successful by the Combination Deadline. As a result, management has determined that such additional condition also raise substantial doubt about the Company’s ability to continue as a going concern. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.
 
 

F-9
Table of Contents
 
 
Merger Agreement
 

On September 30, 2022, the Company, Tradeup Merger Sub Inc., a Delaware corporation and direct, wholly owned subsidiary of the Company (“Merger Sub”), and Estrella Biopharma, Inc., a Delaware corporation (the “Estrella”), entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the “Merger Agreement”).
 
The merger consideration shares to be issued by the Company to the shareholder of Estrella is expected to be 32,500,000 shares of Common Stock.
 
Estrella is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS®️ T-cell therapies with the capacity to address treatment and safety challenges for patients with blood cancers and solid tumors. Estrella’s mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.
 
Pursuant to the Merger Agreement, among other things, in accordance with the General Corporation Law of the State of Delaware, as amended (the “DGCL”), Merger Sub will merge with and into Estrella (the “Merger”), with Estrella surviving the Merger as a wholly owned subsidiary of the Company (“Surviving Company”). The Merger will become effective at such time on the date of the closing of the Merger (the “Closing”) as the certificate of merger is duly filed with the Delaware Secretary of State or at such other time specified in the certificates of merger (the “Effective Time”). Effective as of the Closing, the Company will change its name to “Estrella Immunopharma, Inc.”
 
Inflation Reduction Act of 2022
 
On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its stockholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination), and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.
 
Note 2 — Significant Accounting Policies
 

Basis of Presentation
 
The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC.
 
Emerging Growth Company Status
 
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
 
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
 

F-10
Table of Contents
 
Use of Estimates
 
 
The preparation of these financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
 
Cash
 
 
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents.
 

Investments held in Trust Account
 
 
As of December 31, 2022 and 2021, the assets held in the Trust Account were held in money market funds, which are invested in U.S. Treasury securities.
 
 
The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 “Investments — Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheet and adjusted for the amortization or accretion of premiums or discounts.
 

Offering Costs
 
 
The Company complies with the requirements of FASB ASC Topic 340-10-S99-1, “
Other Assets and Deferred Costs – SEC Materials
” (“ASC 340-10-S99”) and SEC Staff Accounting Bulletin Topic 5A, “
Expenses of Offering
”.
Offering costs were $3,019,474 consisting principally of underwriting, legal, accounting and other expenses that are directly related to the Initial Public Offering and charged to stockholders’ equity upon the completion of the Initial Public Offering.
 

Warrants
 
 
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) ASC 480 “Distinguishing Liabilities from Equity” (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own Common Stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
 
 
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. (See Note 9).
 

Common Stock Subject to Possible Redemption
 
 
The Company accounts for its Common Stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common Stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Common Stock (including Common Stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Common Stock are classified as stockholders’ equity. The Company’s public shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of December 31, 2022 and 2021, Common Stock subject to possible redemption are presented at redemption value of $10.25 and $10.20 per share, respectively, as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Common Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Common Stock are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital equals to zero.
 
 
F-11
Table of Contents
 

Concentration of Credit Risk
 
 
Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. As of December 31, 2022 and 2021, $0 and approximately $229,000, respectively, was over the Federal Deposit Insurance Corporation (FDIC) limit.
 

Fair Value of Financial Instruments
 
 
The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
 
 
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
 
 
 
·
Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active market.
 
·
Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.
 
·
Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value.
 

Income Taxes
 
 
The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
 
 
ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
 
 
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
 
 
The Company has identified the United States as its only “major” tax jurisdiction.
 
 
The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
 
 
The Company is incorporated in the State of Delaware and is required to pay franchise taxes to the State of Delaware on an annual basis.
 
 
On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (H.R. 5376) (the “IRA”), which, among other things, imposes a 1% excise tax on any domestic corporation that repurchases its stock after December 31, 2022 (the “Excise Tax”). The Excise Tax is imposed on the fair market value of the repurchased stock, with certain exceptions.
 
 
Because the Company is a Delaware corporation and our securities trades on Nasdaq, it is a “covered corporation” within the meaning of the IRA. The Excise Tax may apply to any redemptions of the Company’s common stock after December 31, 2022, including redemptions in connection with the Merger, unless an exemption is available. Issuances of securities in connection with the Merger are expected to reduce the amount of the Excise Tax in connection with redemptions occurring in the same calendar year, but the number of securities redeemed may exceed the number of securities issued. Further, the application of the Excise Tax in the event of a liquidation is uncertain. The Company is currently evaluating the impact it will have in the event of the Merger or liquidation.
 

Net Income (Loss) per Share
 
 
The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable Common Stock and non-redeemable Common Stock and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable Common Stock. Any remeasurement of the accretion to redemption value of the Common Stock subject to possible redemption was considered to be dividends paid to the public stockholders. For the years ended December 31, 2022 and 2021, the Company has not considered the effect of the Warrants sold in the Initial Public Offering to purchase an aggregate of 2,215,000 shares in the calculation of diluted net income (loss) per share, since the exercise of the Warrants is contingent upon the occurrence of future events and the inclusion of such Warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into Common Stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic (income) loss per share for the period presented.
 

 
 
F-12
Table of Contents
 
 
 
The net income (loss) per share
presented
in the statement of operations is based on the following:
 
 
 
 
 
 
 
For the Period From
 
 
 
For the
 
 
January 6, 2021
 
 
 
Year Ended
 
 
(inception) through
 
 
 
December 31, 2022
 
 
December 31, 2021
 
 
 
 
 
 
Non-
 
 
 
 
 
Non-
 
 
 
Redeemable
 
 
Redeemable
 
 
Redeemable
 
 
Redeemable
 
 
 
Common
 
 
Common
 
 
Common
 
 
Common
 
 
 
Stock
 
 
Stock
 
 
Stock
 
 
Stock
 
Basic and diluted net income/(loss) per share:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Numerators:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocation of net loss including carrying value to redemption value
 
$
(941,679
)
 
$
(307,814
)
 
$
(3,090,769
)
 
$
(1,792,335
)
Accretion of carrying value to redemption value
 
 
253,389
 
 
 
—
 
 
 
4,635,386
 
 
 
—
 
Allocation of net income/(loss)
 
$
(688,290
)
 
$
(307,814
)
 
$
1,544,617
 
 
$
(1,792,335
)
Denominators:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted-average shares outstanding
 
 
4,343,211
 
 
 
1,419,700
 
 
 
2,033,677
 
 
 
1,179,328
 
Basic and diluted net income/(loss) per share
 
$
(0.16
)
 
$
(0.22
)
 
$
0.76
 
 
$
(1.52
)
 
 
Recent Accounting Pronouncements
 
 
Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.
 

Note 3 —
Investments
Held in Trust Account
 
 
As of December 31, 2022 and 2021, assets
held
in the Trust Account were comprised of $9,671,375 and $45,187,428, respectively, in money market funds which are invested in U.S. Treasury Securities.
 
 
The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2022 and
2021
and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
 
Description
 
Level
 
 
December 31, 2022
 
 
December 31, 2021
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Trust Account - U.S. Treasury Securities Money
Market
Fund
 
 
1
 
 
$
9,671,375
 
 
$
45,187,428
 
 
 
Note 4 — Initial Public Offering
 
 
Pursuant to the Initial Public Offering on July 19, 2021, the Company sold 4,000,000 Units at $10.00 per Public Unit, which does not include the 45-day option of the exercise of the underwriters’ 600,000 over-allotment option. On July 21, 2021, the underwriters partially exercised the over-allotment option and purchased 430,000 Option Units at a price of $10.00 per Option Unit, generating gross proceeds of $4,300,000.
 
 
The remaining 170,000 Option Units were expired on September 1, 2021. Transaction costs in connection with the Initial Public Offering and the issuance and sale of Option Units amounted to $3,019,474, consisting of $886,000 of underwriting fees, $1,550,500 of Business Combination Fee (defined in Note 7 below) and $582,974 of other offering costs.
 
 
Each Unit has an offering price of $10.00 and consists of one share of the Common Stock and one-half of one redeemable Warrant. The Company will not issue fractional shares. As a result, the warrants must be exercised in multiples of one whole Warrant. Each whole Warrant entitles the holder thereof to purchase one share of the Company’s Common Stock at a price of $11.50 per share, and only whole Warrants are exercisable. The Warrants will become exercisable on the later of 30 days after the completion of the Company’s initial Business Combination or 12 months from the closing of the Initial Public Offering, and will expire five years after the completion of the Company’s initial Business Combination or earlier upon redemption or liquidation.
 
 

F-13
Table of Contents
  
 
All of the 4,430,000 public shares sold as part of the Units in the Initial Public Offering contain a redemption feature which allows for the redemption of such public shares if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation, or in connection with the Company’s liquidation. In accordance with the Securities and Exchange Commission (the “SEC”) and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require Common Stock subject to redemption to be classified outside of permanent equity.
 
 
The Company’s redeemable Common Stock is subject to SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).
 
 
As of December 31, 2022 and 2021, 910,220 and 4,430,000 shares, respectively, of Common Stock subject to possible redemption reflected on the balance sheet are reconciled in the following table.
 
Common stock subject to possible redemption, July 19, 2021
 
$
44,300,000
 
Less:
 
 
 
Proceeds allocated to public warrants
 
 
(783,301
)
Offering costs of public shares
 
 
(2,966,085
)
Plus:
 
 
 
Accretion of carrying value to redemption value
 
 
4,635,386
 
Common stock subject to possible redemption, December 31, 2021
 
 
45,186,000
 
Less:
 
 
 
Redemptions
 
 
(36,112,943
)
Plus:
 
 
 
Accretion of carrying value to redemption value
 
 
253,389
 
Common stock subject to possible redemption, December 31, 2022
 
$
9,326,446
 
 
 
Note 5 — Private Placement
 
 
Simultaneously with the closing of the Initial Public Offering, the Sponsor and Tradeup INC. purchased an aggregate of 295,000 shares of Common Stock at a price of $10.00 per share, among which, the Sponsor purchased 236,000 Private Placement Shares and Tradeup INC. purchased 59,000 Private Placement Shares, generating total proceeds of $2,950,000. On July 21, 2021, the Company consummated the sale of additional 17,200 Private Placement Shares with the Sponsor and Tradeup INC., among which, the Sponsor purchased 13,760 Private Placement Shares and Tradeup INC. purchased 3,440 Private Placement Shares, at a price of $10.00 per Private Placement share, generating total proceeds of $172,000. The proceeds from the sale of the Private Placement Shares were held outside of the Trust Account and is available for the payment of offering costs and for working capital purposes. The Sponsor will be permitted to transfer the Private Placement Shares held by them to certain permitted transferees, including the Company’s officers and directors and other persons or entities affiliated with or related to it or them, but the transferees receiving such shares will be subject to the same agreements with respect to such securities as the founders. Otherwise, these Private Placement Shares will not, subject to certain limited exceptions, be transferable or salable until 30 days after the completion of the Company’s Business Combination.
 
 
Note 6 — Related Party Transactions
 

Founder and Private Placement Shares
 
 
On January 20, 2021, the Sponsor acquired 1,150,000 founder shares for an aggregate purchase price of $25,000. On February 11, 2021, in connection with a restructure of the Sponsor, the Sponsor forfeited 1,150,000 founder shares upon the receipt of the refund of purchase price of $25,000. On February 12, 2021, the Sponsor acquired 920,000 founder shares for a purchase price of $20,000 and Tradeup INC. acquired 230,000 founder shares for a purchase price of $5,000, respectively (collectively as the “Founder Shares”).
 
 
As of December 31, 2022 and 2021, there were 1,107,500 Founder Shares issued and outstanding. The aggregate capital contribution was $25,000, or approximately $0.02 per share.
 
 
The number of Founder Shares issued was determined based on the expectation that such Founder Shares would represent 20% of the outstanding shares upon completion of the Initial Public Offering.
 

 
 
F-14
Table of Contents
 
 
 
The founders have agreed not to transfer, assign or sell 50% of its Founder Shares until the earlier to occur of: (A) six months after the date of the consummation of the Company’s initial Business Combination, or (B) the date on which the closing price of the Company’s Common Stock equals or exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after the Company’s initial Business Combination and the remaining 50% of the Founder Shares may not be transferred, assigned or sold until six months after the date of the consummation of the Company’s initial Business Combination, or earlier, in either case, if, subsequent to the Company’s initial Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares for cash, securities or other property.
 
 
On July 19, 2021, the Company consummated the sale of 295,000 Private Placement Shares at a price of $10.00 per share in the Private Placement to the Sponsor and Tradeup INC., among which, the Sponsor purchased 236,000 Private Placement Shares and Tradeup INC. purchased 59,000 Private Placement Shares, generating gross proceeds of $2,950,000. On July 21, 2021, the Company consummated the sale of additional 17,200 Private Placement Shares with the Sponsor and Tradeup INC. at a price of $10.00 per Private Placement share, among which, the Sponsor purchased 13,760 Private Placement Shares and Tradeup INC. purchased 3,440 Private Placement Shares, generating total proceeds of $172,000. The Private Placement Shares are identical to the shares of Common Stock sold as part of the units in this Initial Public Offering, subject to limited exceptions. The Private Placement Shares will not be transferable, assignable or salable until 30 days after the completion of the Company’s initial Business Combination.
 

Working Capital Loans (Promissory Notes) — Related Parties
 
 
In order to finance transaction costs in connection with an intended initial Business Combination, the founders or an affiliate of the founders or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes the initial Business Combination, it would repay such loaned amounts. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used for such repayment. Up to approximately $1,200,000
of such loans may be convertible into Private Placement Shares, at a price of $10.00 per share at the option of the lender.
 
 
On January 19, 2021, the Sponsor has agreed to loan the Company up to $400,000 to be used for a portion of the expenses of the Initial Public Offering. This loan is non-interest bearing, unsecured and is due at the earlier of (1) June 20, 2021 or (2) the closing of the Initial Public Offering. The loan will be repaid upon the closing of the Initial Public Offering out of the offering proceeds not held in the Trust Account. On June 19, 2021 the Sponsor agreed to extend the maturity date of the loan to the Company to the earlier of August 31, 2021 or the closing date of the Initial Public Offering. The outstanding balance under the Promissory Note was repaid at the closing of the Initial Public Offering on July 19, 2021.
 
 
On July 25, 2022, the Company issued (i) Note A in the amount of $204,000 to Running Lion, which is wholly owned and controlled by Mr. Weiguang Yang, the Co-Executive Officer and director of the Company and (ii) the Note B in the amount of $294,600 to Tradeup INC., one of the Founders. The proceeds of the Notes, which may be drawn down from time to time until the Company consummates its initial Business Combination, will be used as general working capital purposes.
 
 
The Notes bear no interest and are payable in full upon the earlier to occur of (i) the consummation of the Company’s Business Combination or (ii) the
date of expiry of the term of the Company
 
(“
Maturity Date
”)
. The following shall constitute an event of default: (i) a failure to pay the principal within five business days of the Maturity Date; (ii) the commencement of a voluntary or involuntary bankruptcy action, (iii) the breach of the Company’s obligations thereunder; (iv) any cross defaults; (v) an enforcement proceedings against the Company; and (vi) any unlawfulness and invalidity in connection with the performance of the obligations thereunder, in which case the Notes may be accelerated.
 
 
The Payees respectively have the right, but not the obligation, to convert their Notes, in whole or in part, respectively, into Conversion Shares, as described in the prospectus of the Company (File Number 333-253322), by providing the Company with written notice of the intention to convert at least two business days prior to the closing of the Business Combination. The number of Conversion Shares to be received by the Payees in connection with such conversion shall be an amount determined by dividing (x) the sum of the outstanding principal amount payable to such Payee by (y) $10.00.
 
 
As of December 31, 2022 and 2021, the Company had borrowings of $498,600 and $0, respectively, under the working capital loans.
 
 
Due to a related party
 
 
For the year ended December 31, 2022, the Sponsor loaned the Company $50,000 to cover certain operating expenses of the Company. As of December 31, 2022, the total amount due to the Sponsor was $50,000 and such balance was converted into a promissory note on January 19, 2023
 
with the same term as the working capital loans as discussed above
.
 
 
 

F-15
Table of Contents
 
 
 

Note 7 — Commitments & Contingencies
 

Risks and Uncertainties
 
 
Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
 

Registration Rights
 
 
The holders of the Founder Shares, Private Placement Shares and Common Stock that may be issued upon conversion of working capital loans will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Common Stock). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
 

Underwriters Agreement
 
 
The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to an additional 600,000 Option Units to cover over-allotments, if any. On July 21, 2021, the Underwriters partially exercised the over-allotment option and purchased 430,000 Option Units at a price of $10.00 per Option Unit, generating gross proceeds of $4,300,000. The Company paid an underwriting discount of 2.00% of the gross proceeds of the Initial Public Offering and the sale of Option Units or $886,000 to the underwriters at the closing of the Initial Public Offering and the sale of Option Units.
 
 
Business Combination Marketing Agreement
 
 
The Company has engaged US Tiger Securities, Inc., EF Hutton, division of Benchmark Investments, LLC (“EF Hutton”) and R.F. Lafferty & Co., Inc. the representatives (the “Representatives”) of the underwriters of the Initial Public Offering in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company is obligated to pay the Representatives a cash fee (the “Business Combination Fee”) pursuant to a Business Combination Marketing Agreement for such services upon the consummation of the Company’s initial Business Combination, equal to 3.5% of the gross proceeds of the Initial Public Offering and the sale of over-allotment Option Units as discussed in Note 8.
 
 
Note 8 — Deferred Underwriters’ Business Combination Fees
 
 
The Company is obligated to pay the Representatives a deferred Business Combination Fee equal to 3.5% of the gross proceeds of the Initial Public Offering and the sale of over-allotment Option Units. Upon completion of the Business Combination, $1,550,500 will be paid to the underwriters from the funds held in the Trust Account.
 
 

Note 9 — Stockholders’ Deficit
 

Preferred stock
—The Company is authorized to issue 1,000,000 shares of preferred stock, par value $0.0001 per share and with such designations, voting and other rights and preferences as may be determined from time to time by the company’s board of directors. As of December 31, 2022 and 2021, there were no preference shares issued or outstanding.
 

Common stock
— The Company is authorized to issue up to 30,000,000 shares of Common Stock, par value $0.0001 per share. As of December 31, 2022 and 2021, there were 1,419,700 shares of Common Stock issued and outstanding, excluding 910,220 and 4,430,000 shares of Common Stock subject to possible redemption, respectively.
 
 
Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. The Company’s stockholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefor.
 
 

F-16
Table of Contents
 
 

Warrants
— In July 2021, the Company issued 2,215,000 Warrants in connection with the Initial Public Offering and the sale of the Option Units. Each whole Warrant entitles the registered holder to purchase one whole share of the Company’s Common Stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing on the later of 12 months from the closing of the Initial Public Offering or the completion of the initial Business Combination. Pursuant to the warrant agreement, a warrant holder may exercise its Warrants only for a whole number of shares of Common Stock. This means that only a whole Warrant may be exercised at any given time by a warrant holder. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. The Warrants will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.
 
 
The Company has agreed that as soon as practicable, but in no event later than 30 business days, after the closing of the initial Business Combination, it will use its reasonable commercially reasonable efforts to file, and within 60 business days following its initial Business Combination to have declared effective, a registration statement for the registration, under the Securities Act, of the shares of Common Stock issuable upon exercise of the Warrants. The Company will use its commercially reasonable efforts to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Warrants in accordance with the provisions of the warrant agreement. No Warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the Common Stock issuable upon exercise of the Warrants and a current prospectus relating to such shares of Common Stock. Notwithstanding the above, if the Company’s Common Stock is at the time of any exercise of a Warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Warrants who exercise their Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event it so elect, it will not be required to file or maintain in effect a registration statement, but it will be required to use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
 
 
Once the Warrants become exercisable, the Company may call the Warrants for redemption:
 
 
 
in whole and not in part;
 
 
 
at a price of $0.01 per Warrant;
 
 
 
upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and
 
 
 
if, and only if, the reported last sale price of the Common Stock equals or exceeds $16.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on third business day before the Company send the notice of redemption to the warrant holders.
 
 
The Company accounted for the 2,215,000 Warrants issued with the Initial Public Offering as equity instruments in accordance with ASC 480, “Distinguishing Liabilities from Equity” and ASC 815-40, “Derivatives and Hedging: Contracts in Entity’s Own Equity”. The Company accounted for the Warrant as an expense of the Initial Public Offering resulting in a charge directly to stockholders’ equity. The Company estimates that the fair value of the Warrants is approximately $0.8 million, or 0.36 per Unit
 
on issuance
.
 
 
Note 10 — Income Taxes
 
 
The Company’s taxable income primarily consists of dividend and
interest
earned on investments held in the Trust Account. 
 
 
The income tax provision (benefit) consists of the following:
 
 
 
 
For the
Year Ended
 
 
 
 
For the Period from
January 6, 2021
(inception) through
 
 
 
 
 
December 31, 2022
 
 
December 31, 2021
 
Current
 
 
 
 
 
 
 
 
Federal
 
$
51,176
 
 
$
—
 
State
 
 
—
 
 
 
—
 
Deferred
 
 
 
 
 
 
 
 
Federal
 
 
316,798
 
 
 
52,021
 
State
 
 
—
 
 
 
—
 
Valuation allowance
 
 
(287,326
)
 
 
(52,021
)
Income tax provision
 
$
80,648
 
 
$
—
 
 
 
A reconciliation of the statutory federal income tax rate to the Company’s effective tax rate is as follows:
 

 
 
F-17
Table of Contents
 
 
 
For the
Year Ended
 
 
 
 
For the Period from
January 6, 2021
(inception) through
 
 
 
 
 
December 31, 2022
 
 
December 31, 2021
 
U.S. statutory rate
 
 
21.0
%
 
 
21.0
%
Permanent difference on facilitated acquisition costs
 
 
(3.6
)
%
 
 
-
%
Change in valuation allowance
 
 
(26.2
)%
 
 
(21.0
)%
Effective tax rate
 
 
(8.8
)
%
 
$
0.0
%
 
 
The Company’s net deferred tax assets were as follows as of:
 

 
 
 
December 31, 2022
 
 
December 31, 2021
 
Deferred tax assets:
 
 
 
 
 
 
Start-up/organization costs
 
$
292,154
 
 
$
—
 
Net operating loss carryover
 
 
—
 
 
 
52,021
 
Deferred tax liability:
 
 
 
 
 
 
 
 
Accrued dividend income
 
 
(29,472
)
 
 
—
 
Total deferred tax
assets
 
 
262,682
 
 
 
52,021
 
Valuation allowance
 
 
(292,154
)
 
 
(52,021
)
Deferred tax liability, net
 
$
(29,472
)
 
$
—
 
 
As of December 31, 2022 and 2021, the Company had $0 and $247,718 of U.S. federal and state net operating loss carryovers available to offset future taxable income which do not expire.
 
In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax assets, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance of $292,154 and $52,021 as of December 31, 2022 and 2021, respectively.
 
 
Note 11 — Subsequent Events
 
 
As provided in the Merger Agreement Estrella has agreed to, upon request by the sponsors of the Company, deposit the agreed reasonable amount to the Company’s trust in order to effectuate extension of the Company’s Combination Period.  Pursuant to the Merger Agreement, Estrella has deposited made two monthly extension payments, each in the amount of $45,511, to the Trust Account in connection with two Extensions, as a result of which, the current Combination Deadline is March 19, 2023. Such two monthly extension payments were evidenced by two promissory notes issued by the Company to Estrella, each in the principal amount of $45,511.
 
 
On January 19, 2023, the Company issued an unsecured promissory note in the amount of $50,000 to the Sponsor
for working capital purposes
.

On March 3, 2023, the Company issued an unsecured promissory note in the amount of $50,000 to Tradeup INC. for working capital purposes.
 
 
 
 
F-18
 
 EX-4.5 2 rc018_ex4-5.htm EXHIBIT 4.5

Exhibit 4.5

 

DESCRIPTION OF SECURITIES

 

General

 

We are authorized to issue 30,000,000 shares of common stock, par value $0.0001, and 1,000,000 shares of preferred stock, par value $0.0001. No shares of preferred stock are currently outstanding. The following description summarizes the material terms of our securities. Because this description is only a summary, it may not contain all the information that is important to you.

 

Units

 

Each unit had an offering price of $10.00 and consists of one share of common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of our common stock at a price of $11.50 per share. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares of common stock. This means that only a whole warrant may be exercised at any given time by a warrant holder. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Accordingly, unless you purchase at least two units, you will not be able to receive or trade a whole warrant.

 

The common stock and redeemable warrants comprising the units began separate trading on September 7, 2021. Since the shares of common stock and redeemable warrants commenced separate trading, holders have the option to continue to hold units or separate their units into the component securities. Holders will need to have their brokers contact our transfer agent in order to separate the units into shares of common stock and warrants.

 

Common Stock 

 

As of the date of the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2022, 2,329,920 shares of our common stock are issued and outstanding, consisting of:

 

·910,220 shares of common stock issued in the IPO as part the units offered in the IPO; and

 

·1,419,700 shares of common stock held by our initial stockholders.

 

Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Unless specified in our amended and restated certificate of incorporation or bylaws, or as required by applicable provisions of the DGCL or applicable stock exchange rules, the affirmative vote of a majority of our shares of common stock that are voted is required to approve any such matter voted on by our stockholders. Our board of directors is divided into three classes, each of which generally serves for a term of three years with only one class of directors being elected in each year. There is no cumulative voting with respect to the election of directors, with the result that the holders of more than 50% of the shares voted for the election of directors can elect all of the directors. Our stockholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefor.

 

Because our amended and restated certificate of incorporation authorizes the issuance of up to 30,000,000 shares of common stock, if we were to enter into a business combination, we may (depending on the terms of such a business combination) be required to increase the number of shares of common stock which we are authorized to issue at the same time as our stockholders vote on the business combination to the extent we seek shareholder approval in connection with our business combination.

 

   

 

  

In accordance with NASDAQ corporate governance requirements, we are not required to hold an annual meeting until no later than one year after our first fiscal year end following our listing on NASDAQ. Under Section 211(b) of the DGCL, we are, however, required to hold an annual meeting of stockholders for the purposes of electing directors in accordance with our bylaws, unless such election is made by written consent in lieu of such a meeting. We may not hold an annual meeting of stockholders to elect new directors prior to the consummation of our initial business combination, and thus we may not be in compliance with Section 211(b) of the DGCL, which requires an annual meeting. Therefore, if our stockholders want us to hold an annual meeting prior to the consummation of our initial business combination, they may attempt to force us to hold one by submitting an application to the Delaware Court of Chancery in accordance with Section 211(c) of the DGCL.

 

We will provide our public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account as of two business days prior to the consummation of our initial business combination including interest earned on the funds held in the trust account and not previously released to us to pay our taxes, divided by the number of then outstanding public shares, subject to the limitations described herein. The amount in the trust account is initially anticipated to be approximately $10.20 per public share. The per-share amount we will distribute to investors who properly redeem their shares will not be reduced by the business combination fee we will pay to the underwriters. Our founders, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares and any private shares held by them in connection with the completion of our business combination. Unlike many blank check companies that hold shareholder votes and conduct proxy solicitations in conjunction with their initial business combinations and provide for related redemptions of public shares for cash upon completion of such initial business combinations even when a vote is not required by law, if a shareholder vote is not required by law and we do not decide to hold a shareholder vote for business or other legal reasons, we will, pursuant to our amended and restated certificate of incorporation, conduct the redemptions pursuant to the tender offer rules of the SEC, and file tender offer documents with the SEC prior to completing our initial business combination. Our amended and restated certificate of incorporation requires these tender offer documents to contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under the SEC’s proxy rules. If, however, shareholder approval of the transaction is required by law, or we decide to obtain shareholder approval for business or other legal reasons, we will, like many blank check companies, offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If we seek shareholder approval, we will complete our initial business combination only if a majority of the outstanding shares of common stock voted are voted in favor of the business combination. A quorum for such meeting will consist of the holders present in person or by proxy of shares of outstanding capital stock of the company representing a majority of the voting power of all outstanding shares of capital stock of the company entitled to vote at such meeting. However, the participation of our founders, officers, directors, advisors or their affiliates in privately-negotiated transactions, if any, could result in the approval of our business combination even if a majority of our public stockholders’ vote, or indicate their intention to vote, against such business combination. For purposes of seeking approval of the majority of our outstanding shares of common stock voted, non-votes will have no effect on the approval of our business combination once a quorum is obtained. We intend to give approximately 30 days (but not less than 10 days nor more than 60 days) prior written notice of any such meeting, if required, at which a vote shall be taken to approve our business combination. These quorums and voting thresholds, and the voting agreements of our initial stockholders, may make it more likely that we will consummate our initial business combination.

 

If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our business combination pursuant to the tender offer rules, our amended and restated certificate of incorporation will provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the shares of common stock sold in the IPO, which we refer to as the Excess Shares. However, we would not be restricting our stockholders’ ability to vote all of their shares (including Excess Shares) for or against our business combination. Our stockholders’ inability to redeem the Excess Shares will reduce their influence over our ability to complete our business combination, and such stockholders could suffer a material loss in their investment if they sell such Excess Shares on the open market. Additionally, such stockholders will not receive redemption distributions with respect to the Excess Shares if we complete the business combination. And, as a result, such stockholders will continue to hold that number of shares exceeding 15% and, in order to dispose such shares would be required to sell their stock in open market transactions, potentially at a loss.

 

   

 

  

If we seek shareholder approval in connection with our business combination, our founders, officers, and directors have agreed to vote their founder shares, private shares and any public shares purchased during or after the IPO in favor of our initial business combination. As a result, in addition to our founders, officers and directors’ founder shares and private shares, we do not need additional shares to be voted in favor of a transaction in order to have our initial business combination approved (assuming all outstanding shares are voted or only the quorum is present and voted). .. Additionally, each public shareholder may elect to redeem its public shares irrespective of whether they vote, do not vote or abstain, and if they do vote, irrespective of whether they vote for or against the proposed transaction, and irrespective of whether they were a public shareholder on the record date for the general meeting held to approve the proposed transaction (subject to the limitation described in the preceding paragraph).

 

Pursuant to our amended and restated certificate of incorporation, if we are unable to complete our business combination by July 19, 2023 by depositing $45,511 per month (or $0.05 per share per month) into the trust account, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds therefor, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to us to pay our taxes or for working capital purposes (less up to 50,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. Our founders, officers and directors have agreed to waive their rights to liquidating distributions from the trust account with respect to any founder shares and private shares held by them if we fail to complete our business combination by July 19, 2023. However, if our initial stockholders acquire public shares in or after the IPO, they will be entitled to liquidating distributions from the trust account with respect to such public shares if we fail to complete our business combination within the prescribed time period.

 

In the event of a liquidation, dissolution or winding up of the company after a business combination, our stockholders are entitled to share ratably in all assets remaining available for distribution to them after payment of liabilities and after provision is made for each class of stock, if any, having preference over the common stock. Our stockholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the common stock, except that we will provide our public stockholders with the opportunity to redeem their public shares for cash equal to their pro rata share of the aggregate amount then on deposit in the trust account, upon the completion of our initial business combination, subject to the limitations described herein.

 

Founder Shares and Private Shares

 

The founder shares and private shares are identical to the shares of common stock included in the units sold in the IPO, and holders of founder shares and private shares have the same stockholder rights as public stockholders, except that (i) the founder shares and private shares are subject to certain transfer restrictions, as described in more detail below, (ii) our founders, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed (A) to waive their redemption rights with respect to any founder shares, private shares and any public shares held by them in connection with the completion of our initial business combination, (B) to waive their redemption rights with respect to their founder shares, private shares and public shares in connection with a stockholder vote to approve an amendment to our amended and restated certificate of incorporation to (i) modify the substance or timing of our obligation to provide for the redemption of our public shares in connection with an initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 18 months from the closing of this offering or (ii) with respect to any other material provisions relating to stockholders’ rights or pre-initial business combination activity, and (C) to waive their rights to liquidating distributions from the trust account with respect to any founder shares and private shares held by them if we fail to complete our initial business combination by July 19, 2023, although they will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if we fail to complete our initial business combination within such time period, and (iii) are entitled to registration rights. If we submit our initial business combination to our public stockholders for a vote, our founders, officers and directors have agreed (and their permitted transferees will agree) pursuant to the letter agreement to vote any founder shares and private shares held by them and any public shares purchased during or after this offering (including in open market and privately-negotiated transactions ) in favor of our initial business combination.

 

   

 

 

With certain limited exceptions, our founders have agreed not to transfer, assign or sell 50% of its founder shares until the earlier to occur of: (A) six months after the date of the consummation of our initial business combination, or (B) the date on which the closing price of our common stock equals or exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after our initial business combination and the remaining 50% of the founder shares may not be transferred, assigned or sold until six months after the date of the consummation of our initial business combination, or earlier, in either case, if, subsequent to our initial business combination, we consummate a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of our shareholders having the right to exchange their shares for cash, securities or other property.

 

With certain limited exceptions, the private shares are not transferable, assignable or salable (except to our officers and directors and other persons or entities affiliated with or related to our founders, each of whom will be subject to the same transfer restrictions) until 30 days after the completion of our initial business combination.

 

Preferred Stock

 

Our amended and restated certificate of incorporation provides that shares of preferred stock may be issued from time to time in one or more series. Our board of directors is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. Our board of directors is able to, without shareholder approval, issue preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the common stock and could have anti-takeover effects. The ability of our board of directors to issue preferred stock without shareholder approval could have the effect of delaying, deferring or preventing a change of control of us or the removal of existing management. We have no preferred stock outstanding at the date hereof. Although we do not currently intend to issue any shares of preferred stock, we cannot assure you that we will not do so in the future. No shares of preferred stock are being issued or registered in the IPO.

 

Warrants

 

Each whole warrant entitles the registered holder to purchase one whole share of our common stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing on the later of 12 months from the closing of the IPO and 30 days after the completion of our initial business combination. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares of common stock. This means that only a whole warrant may be exercised at any given time by a warrant holder. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Accordingly, unless you purchase at least two units, you will not be able to receive or trade a whole warrant. The warrants will expire five years after the completion of our initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

 

We will not be obligated to deliver any shares of common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to our satisfying our obligations described below with respect to registration or a valid exemption from registration is available. No warrant will be exercisable and we will not be obligated to issue shares of common stock upon exercise of a warrant unless common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will we be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the share of common stock underlying such unit.

 

   

 

  

We have agreed that as soon as practicable, but in no event later than 30 business days, after the closing of our initial business combination, we will use our commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of common stock issuable upon exercise of the warrants, and we will use our commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of our initial business combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those common stocks until the warrants expire or are redeemed, as specified in the warrant agreement; provided that if our common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, we may, at our option, require holders of warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement, but we will use our commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If a registration statement covering the common stocks issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when we will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but we will use our commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In such event, each holder would pay the exercise price by surrendering the warrants for that number of common stocks equal to the quotient obtained by dividing (x) the product of the number of common stocks underlying the warrants, multiplied by the excess of the “Fair Market Value” (defined below) less the exercise price of the warrants by (y) the Fair Market Value. The “Fair Market Value” as used in this paragraph shall mean the volume weighted average price of the common stocks for the 10 trading days ending on the trading day prior to the date on which the notice of exercise is received by the warrant agent.

 

Redemption of warrants when the price per Common Stock equals or exceeds $16.50. Once the warrants become exercisable, we may redeem the outstanding warrants:

 

·in whole and not in part;
·at a price of $0.01 per warrant;
·upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and
·if, and only if, the closing price of the common stock equals or exceeds $16.50 per share  (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like)  for any 20 trading days within a 30-trading day period ending third business day before we send the notice of redemption to the warrant holders.

 

We will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the common stocks issuable upon exercise of the warrants is then effective and a current prospectus relating to those common stocks is available throughout the 30-day redemption period. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws.

 

We have established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled to exercise its warrant prior to the scheduled redemption date. However, the price of the common stock may fall below the $16.50 redemption trigger price  (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued.

 

No fractional common stocks will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional interest in a share, we will round down to the nearest whole number of the number of common stocks to be issued to the holder. If, at the time of redemption, the warrants are exercisable for a security other than the common stocks pursuant to the warrant agreement (for instance, if we are not the surviving company in our initial business combination), the warrants may be exercised for such security. At such time as the warrants become exercisable for a security other than the common stocks, the Company (or surviving company) will use its commercially reasonable efforts to register under the Securities Act the security issuable upon the exercise of the warrants.

 

Redemption procedures. A holder of a warrant may notify us in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the warrant agent’s actual knowledge, would beneficially own in excess of 9.8% (or such other amount as a holder may specify) of the common stocks issued and outstanding immediately after giving effect to such exercise.

 

   

 

 

Anti-Dilution Adjustments. If the number of outstanding common stocks is increased by a capitalization or share dividend paid in common stocks to all or substantially all holders of common stocks, or by a split-up of common stocks or other similar event, then, on the effective date of such capitalization or share dividend, split-up or similar event, the number of common stocks issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding common stocks. A rights offering made to all or substantially all holders of common stocks entitling holders to purchase common stocks at a price less than the “historical fair market value” (as defined below) will be deemed a share dividend of a number of common stocks equal to the product of (i) the number of shares of common stocks actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Common stocks) and (ii) one minus the quotient of (x) the price per share of common stock paid in such rights offering and (y) the historical fair market value. For these purposes, (i) if the rights offering is for securities convertible into or exercisable for common stocks, in determining the price payable for common stocks, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) “historical fair market value” means the volume weighted average price of the common stock as reported during the 10 trading day period ending on the trading day prior to the first date on which the shares of common stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

 

In addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to all or substantially all of the holders of common stocks on account of such common stocks (or other securities into which the warrants are then convertible), other than (a) as described above, (b) any cash dividends or cash distributions which, when combined on a per share basis with all other cash dividends and cash distributions paid on the common stocks during the 365-day period ending on the date of declaration of such dividend or distribution, does not exceed $0.50 (as adjusted to appropriately reflect any other adjustments and excluding cash dividends or cash distributions that resulted in an adjustment to the exercise price or to the number of common stocks issuable on exercise of each warrant) but only with respect to the amount of the aggregate cash dividends or cash distributions equal to or less than $0.50 per share, (c) to satisfy the redemption rights of the holders of common stocks in connection with a proposed initial business combination, (d) to satisfy the redemption rights of the holders of common stocks in connection with a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association that would affect the substance or timing of our obligation to provide for the redemption of our public shares in connection with an initial business combination or to redeem 100% of our public shares if we have not consummated an initial business combination within 18 months from the closing of the IPO, or (e) in connection with the redemption of our public shares upon our failure to complete our initial business combination, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each common stock in respect of such event.

 

If the number of outstanding common stocks is decreased by a consolidation, combination, reverse share split or reclassification of common stocks or other similar event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or similar event, the number of common stocks issuable on exercise of each warrant will be decreased in proportion to such decrease in issued and outstanding common stocks.

 

Whenever the number of common stocks purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of common stocks purchasable upon the exercise of the warrants immediately prior to such adjustment and (y) the denominator of which will be the number of common stocks so purchasable immediately thereafter.

 

In case of any reclassification or reorganization of the issued and outstanding shares of common stocks (other than those described above or that solely affects the par value of such shares of common stock), or in the case of any merger or consolidation of us with or into another entity (other than a consolidation or merger in which we are the continuing corporation and that does not result in any reclassification or reorganization of our issued and outstanding shares of common stock), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of us as an entirety or substantially as an entirety in connection with which we are dissolved, the registered holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the shares of common stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of common stocks or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately prior to such event.

 

   

 

 

The warrants will be issued in registered form under a warrant agreement between VStock Transfer, LLC, as warrant agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder for the purpose of (i) curing any ambiguity or correct any mistake, including to conform the provisions of the warrant agreement to the description of the terms of the warrants and the warrant agreement set forth in this prospectus, or defective provision (ii) amending the provisions relating to cash dividends on common stocks as contemplated by and in accordance with the warrant agreement or (iii) adding or changing any provisions with respect to matters or questions arising under the warrant agreement as the parties to the warrant agreement may deem necessary or desirable and that the parties deem to not adversely affect the rights of the registered holders of the warrants. You should review a copy of the warrant agreement, which will be filed as an exhibit to the registration statement of which this prospectus is a part, for a complete description of the terms and conditions applicable to the warrants.

 

The warrant holders do not have the rights or privileges of holders of common stocks and any voting rights until they exercise their warrants and receive common stocks. After the issuance of common stocks upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by stockholders.

 

No fractional warrants will be issued upon separation of the units and only whole warrants will trade. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest whole number the number of common stocks to be issued to the warrant holder.

 

We have agreed that, subject to applicable law, any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and we irrevocably submit to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. This provision does not apply to suits brought to enforce any liability or duty created under the Exchange Act or any claim for which the federal district courts of the United States of America are the sole and exclusive forum.

 

Dividends

 

We have not paid any cash dividends on our common stock to date and do not intend to pay cash dividends prior to the completion of a business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial conditions subsequent to completion of a business combination. The payment of any cash dividends subsequent to a business combination will be within the discretion of our board of directors at such time. If we increase the size of the offering, in which case we will effect a stock dividend immediately prior to the consummation of the offering in such amount as to maintain the ownership of founder shares by our initial stockholders prior to this offering at 20% of the issued and outstanding shares of our common stock upon the consummation of this offering. Further, if we incur any indebtedness, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith.

 

Our Transfer Agent and Warrant Agent

 

The transfer agent for our common stock and warrant agent for our warrants is VStock Transfer, LLC.

 

Listing of our Securities

 

Our units, common stock and warrants are listed on the Nasdaq Capital Market under the symbols “UPTDU,” “UPTD,” and “UPTDW,” respectively.

 

Registration Rights

 

The holders of the founder shares, private shares and shares that may be issued upon conversion of working capital loans will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of this offering, requiring us to register such securities for resale. The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of our initial business combination and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act. We will bear the expenses incurred in connection with the filing of any such registration statements.

 

The founder shares, private shares, and shares to be issued upon the conversion of certain working capital loans if such loans are provided by Tradeup INC., held or acquired by Tradeup INC. are deemed underwriters’ compensation by FINRA pursuant to FINRA Rule 5110(e)(1) and will be subject to a 180-day lock-up from the commencement of sales of the offering in accordance with FINRA Rule 5110(e)(1). We will bear the costs and expenses incurred in connection with filing any such registration statements.

 

   

 

 

 EX-31.1 3 rc018_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATION

 

I, Jianwei Li, certify that:

 

1. I have reviewed this report on Form 10-K for the year ended December 31, 2022, of TradeUP Acquisition Corp.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

    Date: March 14, 2023
     
  By: /s/ Jianwei Li
    Jianwei Li
    Chief Executive Officer (Principal Executive Officer)

 

   

 

 EX-31.2 4 rc018_ex31-2.htm EXHIBIT 31.2

 

Exhibit 31.2

 

CERTIFICATION

 

I, Luqi “Lulu” Wen, certify that:

 

1. I have reviewed this report on Form 10-K for the year ended December 31, 2022, of TradeUP Acquisition Corp.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

    Date: March 14, 2023
     
  By: /s/ Luqi “Lulu” Wen
    Luqi “Lulu” Wen
    Chief Financial Officer (Principal Financial and Accounting Officer)

 

   

 

 EX-32.1 5 rc018_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The undersigned hereby certifies, in his capacity as an officer of TradeUP Acquisition Corp. (the “Company”), for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

 

(1) The Annual Report of the Company on Form 10-K for the year ended December 31, 2022 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

    Date: March 14, 2023
     
  By: /s/ Jianwei Li
    Jianwei Li
    Chief Executive Officer (Principal Executive Officer)

 

   

 

 

 EX-32.2 6 rc018_ex32-2.htm EXHIBIT 32.2

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The undersigned hereby certifies, in her capacity as an officer of TradeUP Acquisition Corp. (the “Company”), for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of her knowledge:

 

(1) The Annual Report of the Company on Form 10-K for the year ended December 31, 2022 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

    Date: March 14, 2023
     
  By: /s/ Luqi “Lulu” Wen
    Luqi “Lulu” Wen
    Chief Financial Officer (Principal Financial and Accounting Officer)

 

   

 

 GRAPHIC 7 rc018_img01.jpg GRAPHIC begin 644 rc018_img01.jpg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end GRAPHIC 8 rc018_img02.jpg GRAPHIC begin 644 rc018_img02.jpg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end EX-101.SCH 9 uptd-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - BALANCE SHEETS (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - Organization and Business Operation link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Investments Held in Trust Account link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Initial Public Offering link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Private Placement link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Commitments & Contingencies link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Deferred Underwriters' Business Combination Fees link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Stockholders' Deficit link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Investments Held in Trust Account (Tables) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Initial Public Offering (Tables) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Income Taxes (Tables) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Organization and Business Operation (Details) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Significant Accounting Policies - Net Income (Loss) Per Share (Details) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Investments Held in Trust Account - Information about the Company's Assets (Details) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Initial Public Offering (Details) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Initial Public Offering - Reconciliation Of Temporary Equity (Details) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Private Placement (Details) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Related Party Transactions - Founder and Private Placement Shares (Details) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Related Party Transactions - Promissory Note and Related Party (Working Capital) Loans (Details) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Related Party Transactions - Due To a Related Party (Details) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Commitments & Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - Deferred Underwriters' Business Combination Fees (Details) link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - Stockholders' Deficit- Preferred Stock Shares (Details) link:presentationLink link:definitionLink link:calculationLink 1036 - Disclosure - Stockholders' Deficit - Common Stock Shares (Details) link:presentationLink link:definitionLink link:calculationLink 1037 - Disclosure - Stockholders' Deficit - Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 1038 - Disclosure - Income Taxes - Components Of Income Tax Provision (Benefit) (Details) link:presentationLink link:definitionLink link:calculationLink 1039 - Disclosure - Income Taxes - Schedule of reconciliation of the total income tax provision tax rate to the statutory federal income tax rate (Details) link:presentationLink link:definitionLink link:calculationLink 1040 - Disclosure - Income Taxes - Deferred Tax (Details) link:presentationLink link:definitionLink link:calculationLink 1041 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 10 uptd-20221231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 11 uptd-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 12 uptd-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 13 uptd-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 14 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover Page - USD ($)
 12 Months Ended
Dec. 31, 2022
Mar. 14, 2023
Jun. 30, 2022
Document Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2022    
Entity File Number 001-40608    
Entity Registrant Name TRADEUP ACQUISITION CORP.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 85-1314502    
Entity Address, Address Line One 437 Madison Avenue, 27th Floor    
Entity Address, City or Town New York,    
Entity Address State Or Province NY    
Entity Address, Postal Zip Code 10022    
City Area Code (732)    
Local Phone Number 910-9692    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
Entity Shell Company true    
Entity Common Stock, Shares Outstanding   2,329,920  
Entity Central Index Key 0001844417    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Amendment Flag false    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Public Float     $ 58,497,000
Auditor Name Marcum LLP    
Auditor Firm ID 688    
Auditor Location East Hanover, New Jersey    
Friedman LLP [Member]      
Document Information [Line Items]      
Auditor Name Friedman LLP    
Auditor Firm ID 711    
Auditor Location New York, NY    
Class A Common Stock      
Document Information [Line Items]      
Title of 12(b) Security Common Stock, par value $0.0001 per share    
No Trading Symbol Flag true    
Security Exchange Name NASDAQ    
Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50      
Document Information [Line Items]      
Title of 12(b) Security Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50    
No Trading Symbol Flag true    
Security Exchange Name NASDAQ    
Units, each consisting of one share of Class A Common Stock and one-half of one Warrant      
Document Information [Line Items]      
Title of 12(b) Security Units, each consisting of one share of Common Stock and on-half of one Warrant    
No Trading Symbol Flag true    
Security Exchange Name NASDAQ    
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.22.4
BALANCE SHEETS - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash $ 40,802 $ 478,868
Prepaid expenses 11,625 137,166
Total current assets 52,427 616,034
Investments held in Trust Account 9,671,375 45,187,428
Total Assets 9,723,802 45,803,462
Current liabilities:    
Accounts payable and accrued expenses 329,166 3,000
Working capital loans - related parties 498,600  
Due to a related party 50,000  
Income tax payable 51,176  
Franchise tax payable 144,127 70,154
Total current liabilities 1,073,069 73,154
Deferred tax liability 29,472  
Deferred underwriters' marketing fees 1,550,500 1,550,500
Total Liabilities 2,653,041 1,623,654
Commitments and Contingencies
Common stock subject to possible redemption, 910,220 and 4,430,000 shares at redemption value of $10.25 and 10.20 per share as of December 31, 2022 and 2021, respectively 9,326,446 45,186,000
Stockholders' Deficit:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Common stock, $0.0001 par value; 30,000,000 shares authorized; 1,419,700 shares issued and outstanding (excluding 910,220 and 4,430,000 shares subject to possible redemption as of December 31, 2022 and 2021, respectively) 142 142
Additional paid-in capital
Accumulated deficit (2,255,827) (1,006,334)
Total Stockholders' Deficit (2,255,685) (1,006,192)
Total Liabilities, Temporary Equity, and Stockholders' Deficit $ 9,723,802 $ 45,803,462
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.22.4
BALANCE SHEETS (Parenthetical) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Temporary Equity, Shares Outstanding 910,220 4,430,000
Temporary equity par value $ 10.25 $ 10.2
Preferred stock, par value, (per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common shares, par value, (per share) $ 0.0001 $ 0.0001
Common shares, shares authorized 30,000,000 30,000,000
Common shares, shares issued 1,419,700 1,419,700
Common shares, shares outstanding 1,419,700 1,419,700
Common stock subject to redemption    
Temporary Equity, Shares Outstanding 910,220 4,430,000
Temporary equity par value $ 10.25 $ 10.2
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.4
STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Formation and operating costs $ 1,368,219 $ 178,992
Franchise tax expenses 201,308 70,154
Loss from Operations (1,569,527) (249,146)
Other income:    
Dividend earned on investment held in Trust Account 654,071 1,428
Income taxes provision (80,648) 0
Loss before income taxes (915,456) (247,718)
Net Loss $ (996,104) $ (247,718)
Parent [Member]    
Other income:    
Weighted Average Number of Shares Outstanding, Basic 1,419,700 1,179,328
Weighted Average Number of Shares Outstanding, Diluted 1,419,700 1,179,328
Basic net loss (income) per common share $ (0.22) $ (1.52)
Diluted net loss per common share $ (0.22) $ (1.52)
Common stock subject to possible redemption    
Other income:    
Weighted Average Number of Shares Outstanding, Basic 4,343,211 2,033,677
Weighted Average Number of Shares Outstanding, Diluted 4,343,211 2,033,677
Basic net loss (income) per common share $ (0.16) $ 0.76
Diluted net loss per common share $ (0.16) $ 0.76
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.4
STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
Total
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
IPO [Member]
IPO [Member]
Preferred Stock [Member]
IPO [Member]
Common Stock [Member]
IPO [Member]
Additional Paid-in Capital [Member]
IPO [Member]
Retained Earnings [Member]
Private Placement [Member]
Private Placement [Member]
Preferred Stock [Member]
Private Placement [Member]
Common Stock [Member]
Private Placement [Member]
Additional Paid-in Capital [Member]
Private Placement [Member]
Retained Earnings [Member]
Balance at the beginning at Jan. 05, 2021 $ 0 $ 0 $ 0 $ 0 $ 0                    
Balance at the beginning (in shares) at Jan. 05, 2021   0 0                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Founders shares issued to the Sponsor 25,000 $ 0 $ 115 24,885 0                    
Founders shares issued to the Sponsor (in shares)   0 1,150,000                        
Forfeiture of Founders shares issued to the Sponsor (25,000) $ 0 $ (115) (24,885) 0                    
Forfeiture of Founders shares issued to the Sponsor (in shares)   0 (1,150,000)                        
Founders shares issued to initial stockholders 25,000 $ 0 $ 115 24,885 0                    
Founders shares issued to initial stockholders (in shares)   0 1,150,000                        
Underwriters' discount (886,000) $ 0 $ 0 (886,000) 0                    
Underwriters' marketing fees (1,550,500) 0 0 (1,550,500) 0                    
Other offering expenses (582,974) 0 0 (582,974) 0                    
Forfeiture of common stock by initial stockholders 0 $ 0 $ (4) 4 0 $ 44,300,000 $ 0 $ 443 $ 44,299,557 $ 0 $ 3,122,000 $ 0 $ 31 $ 3,121,969 $ 0
Forfeiture of common stock by initial stockholders (In shares)   0 (42,500)       0 4,430,000       0 312,200    
Reclassification of common stock subject to redemption (43,516,699) $ 0 $ (443) (43,516,256) 0                    
Reclassification of common stock subject to redemption (in shares)   0 (4,430,000)                        
Allocation of offering costs to common stock subject to redemption 2,966,085 $ 0 $ 0 2,966,085 0                    
Accretion of carrying value to redemption value (4,635,386) 0 0 (3,876,770) (758,616)                    
Net Loss (247,718) 0 0 0 (247,718)                    
Balance at the end at Dec. 31, 2021 (1,006,192) $ 0 $ 142 0 (1,006,334)                    
Balance at the end (in shares) at Dec. 31, 2021   0 1,419,700                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Accretion of carrying value to redemption value (253,389) $ 0 $ 0 0 (253,389)                    
Net Loss (996,104) 0 0 0 (996,104)                    
Balance at the end at Dec. 31, 2022 $ (2,255,685) $ 0 $ 142 $ 0 $ (2,255,827)                    
Balance at the end (in shares) at Dec. 31, 2022   0 1,419,700                        
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.4
STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash Flows from Operating Activities:    
Net loss $ (996,104) $ (247,718)
Adjustments to reconcile net loss to net cash used in operating activities:    
Dividend earned on investment held in Trust Account (654,071) (1,428)
Deferred tax expense 29,472  
Changes in operating assets and liabilities:    
Prepaid expenses 125,540 (137,166)
Accounts payable and accrued expenses 326,166
Franchise tax payable 73,973 70,154
Income tax payable 51,176  
Net cash used in operating activities (1,043,848) (316,158)
Cash Flows from Investing Activities:    
Purchase of investment held in trust account (45,186,000)
Withdraw of investment held in trust account 36,170,124  
Net cash provided by (used in) investing activities 36,170,124 (45,186,000)
Cash Flows from Financing Activities:    
Proceeds from issuance of shares of Common Stock to the Sponsor 25,000
Return of proceeds from issuance of Common Stock to the Sponsor (25,000)
Proceeds from issuance of shares of Common Stock to initial stockholders 25,000
Proceeds from sale of public units through public offering 44,300,000
Proceeds from sale of private placement shares 3,122,000
Payment of underwriters' discount (886,000)
Payment of offering costs (579,974)
Common stock redemption (36,112,943) 0
Proceeds from issuance of promissory notes to related parties 0 300,000
Repayment on promissory note to related party (300,000)
Proceeds from issuance of working capital loans to related parties 498,600  
Borrowings from a related party 50,000  
Net cash ( used in) provided by financing activities (35,564,343) 45,981,026
Net Change in Cash (438,066) 478,868
Cash at beginning of period 478,868
Cash at end of period 40,802 478,868
Supplemental Disclosure of Non-cash Financing Activities    
Offering costs included in accounts payable and accrued expenses 3,000
Deferred underwriters' marketing fees 1,550,500
Reclassification of common stock subject to redemption 43,516,699
Allocation of offering costs to common stock subject to redemption 2,966,085
Accretion of carrying value to redemption value $ 253,389 $ 4,635,386
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Organization and Business Operation
 12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Business Operation
Note 1 — Organization and Business Operation
 

TradeUP Acquisition Corp. (the “Company”) is a blank check company incorporated as a Delaware corporation on January 6, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has selected December 31 as its fiscal year end.
 
 
As of December 31, 2022 and 2021, the Company had not commenced any operations. For the period from January 6, 2021 (inception) through December 31, 2022, the Company’s efforts have been limited to organizational activities as well as activities related to the Initial Public Offering (as defined below). The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of dividend and interest income from the proceeds derived from the Initial Public Offering (as defined below).
 
 
The registration statement for the Company’s initial public offering (the “Initial Public Offering”) became effective on July 14, 2021. On July 19, 2021, the Company consummated the Initial Public Offering of 4,000,000 units (the “Public Units”), at $10.00 per Public Unit, generating gross proceeds of $40,000,000 which is described in Note 4. On July 21, 2021, the underwriters partially exercised the over-allotment option and purchased 430,000 units (the “Option Units “, together with the Public Units, the “Units”) at a price of $10.00 per Option Unit, generating gross proceeds of $4,300,000. Each Unit consists of one share of common stock, $0.0001 par value per share (the “Common Stock”), and one-half of
one
redeemable warrant (the “Warrant”), each whole Warrant entitling the holder thereof to purchase one share of Common Stock at an exercise price of $11.50 per share. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $44,300,000 in total. Transaction costs in connection with the Initial Public Offering and the issuance and sale of Option Units amounted to $3,019,474, consisting of $886,000 of underwriting fees, $1,550,500 of Business Combination Fee (defined in Note 7 below) and $582,974 of other offering costs. Following the expiration of the over-allotment option, 42,500 Founder Shares (defined below) were subsequently forfeited.
 
 
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 295,000 shares of Common Stock (the “Private Placement Shares”) at a price of $10.00 per share in a private placement sale (the “Private Placement”) to the Company’s founders, or initial stockholders, include Tradeup INC. and the Company’s sponsor, TradeUP Acquisition Sponsor LLC, a Delaware limited liability company (the “Sponsor”), among which, the Sponsor purchased 236,000 Private Placement Shares and Tradeup INC. purchased 59,000 Private Placement Shares, generating gross proceeds of $2,950,000, which is described in Note 5. On July 21, 2021, the Company consummated the sale of additional 17,200 Private Placement Shares with the Sponsor and Tradeup INC. at a price of $10.00 per Private Placement share, among which, the Sponsor purchased 13,760 Private Placement Shares and Tradeup INC. purchased 3,440 Private Placement Shares, generating total proceeds of $172,000.
 
 
Following the closing of the Initial Public Offering on July 19, 2021, the issuance and sale of Option Units on July 21, 2021 and the issuance and sale of Private Placement Shares, $45,186,000 from the net proceeds of the sale of the Units and from the sale of Private Placement Shares was placed in a trust account (the “Trust Account”) maintained by Wilmington Trust, National Association as a trustee. The aggregate amount of $45,186,000 ($10.20 per Unit) will be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the long term (rather than on buying and selling businesses in the manner of a merchant bank or private equity fund), the Company intends to avoid being deemed an “investment company” within the meaning of the Investment Company Act. The Initial Public Offering is not intended for persons who are seeking a return on investments in government securities or investment securities. The Trust Account is intended as a holding place for funds pending the earliest to occur of either: (i) the completion of the Company’s initial Business Combination; (ii) the redemption of any public shares properly tendered in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation that would affect the substance or timing of the Company’s obligation to provide for the redemption of its public shares in connection with an initial Business Combination or to redeem 100% of its public shares if the Company has not consummated an initial Business Combination by the Combination Deadline (as defined below); or (iii) absent an initial Business Combination by the Combination Deadline, its return of the funds held in the Trust Account to its public stockholders as part of its redemption of the public shares. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public stockholders.
 
 
The Company’s initial Business Combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the Business Combination Fee and taxes payable and interest previously released for working capital purposes on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires an interest in the target sufficient for the post-transaction company not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully.
  
 
The shares of Common Stock subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company initially had until January 19, 2023 to complete its initial Business Combination. On December 22, 2022, the Company held its special meeting of stockholders (the “Special Meeting”), where the Company was approved by its stockholders to amend the amended and restated certificate of incorporation to extend the date before which the Company must complete a Business Combination (the “Combination Deadline”) from January 19, 2023, by one month up to six times, to July 19, 2023, or such earlier date as determined by the board of directors of the Company (such monthly extension is herein referred to as the “Extension”). Upon the stockholders’ approval, on December 29, 2022, the Company filed a certificate of amendment to the amended and restated certificate of incorporation which became effective upon filing. If the Company is unable to complete the initial Business Combination by the Combination Deadline, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company for working capital purposes or to pay the Company’s taxes (less up to $50,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and its board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s Warrants, which will expire worthless if the Company fails to complete the Business Combination by the Combination Deadline. The founders (not including the anchor investors who purchase units in the Initial Public Offering and certain membership interest in the Sponsor, if any), officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed (i) to waive their redemption rights with respect to any Founder Shares, Private Placement Shares and any public shares held by them in connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their Founder Shares, Private Placement Shares and public shares in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Company’s public shares if the Company does not complete its initial Business Combination by the Combination Deadline or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity and (iii) to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares and Private Placement Shares held by them if the Company fails to complete an initial Business Combination by the Combination Deadline, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination by the Combination Deadline. If the Company submits it initial Business Combination to its stockholders for a vote, the Company will complete its initial Business Combination only if a majority of the outstanding shares of Common Stock voted are voted in favor of the initial Business Combination. In no event will the Company redeem its public shares of Common Stock in an amount that would cause its net tangible assets to be less than $5,000,001. In such case, the Company would not proceed with the redemption of public shares of Common Stock and the related Business Combination, and instead may search for an alternate Business Combination.
 
 
The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or by a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.20 per public share or (ii) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, then the Company’s Sponsor will not be responsible to the extent of any liability for such third party claims.
 
 
On December 22, 2022, the Company held the Special Meeting, where the Company was approved by its stockholders to amend the Investment Management Trust Agreement dated July 14, 2021 (the “Trust Agreement”), by and between the Company and Wilmington Trust, National Association (the “Trustee”) to extend the liquidation date from January 19, 2023 to July 19, 2023. In connection with the votes to approve the extension proposal, 3,519,780 public shares were rendered for redemption with 910,220 public shares remained outstanding.
 

Liquidity and Going Concern
 

As of December 31, 2022, the Company had cash of $40,802 and a working deficit of $
1,020,642
. The Company has incurred and expects to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of a Business Combination.
 
 
In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern. The management’s plan in addressing this uncertainty is through the Promissory Notes – related parties and the Working Capital Loans, as defined below (see Note 6). In addition, if the Company is unable to complete a Business Combination by the Combination Deadline, the Company’s board of directors would proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company. There is no assurance that the Company’s plans to consummate a Business Combination will be successful by the Combination Deadline. As a result, management has determined that such additional condition also raise substantial doubt about the Company’s ability to continue as a going concern. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.
 
 
Merger Agreement
 

On September 30, 2022, the Company, Tradeup Merger Sub Inc., a Delaware corporation and direct, wholly owned subsidiary of the Company (“Merger Sub”), and Estrella Biopharma, Inc., a Delaware corporation (the “Estrella”), entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the “Merger Agreement”).
 
The merger consideration shares to be issued by the Company to the shareholder of Estrella is expected to be 32,500,000 shares of Common Stock.
 
Estrella is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS®️ T-cell therapies with the capacity to address treatment and safety challenges for patients with blood cancers and solid tumors. Estrella’s mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.
 
Pursuant to the Merger Agreement, among other things, in accordance with the General Corporation Law of the State of Delaware, as amended (the “DGCL”), Merger Sub will merge with and into Estrella (the “Merger”), with Estrella surviving the Merger as a wholly owned subsidiary of the Company (“Surviving Company”). The Merger will become effective at such time on the date of the closing of the Merger (the “Closing”) as the certificate of merger is duly filed with the Delaware Secretary of State or at such other time specified in the certificates of merger (the “Effective Time”). Effective as of the Closing, the Company will change its name to “Estrella Immunopharma, Inc.”
 
Inflation Reduction Act of 2022
 
On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its stockholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination), and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Significant Accounting Policies
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Significant Accounting Policies
Note 2 — Significant Accounting Policies
 

Basis of Presentation
 
The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC.
 
Emerging Growth Company Status
 
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
 
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
 

Use of Estimates
 
 
The preparation of these financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
 
Cash
 
 
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents.
 

Investments held in Trust Account
 
 
As of December 31, 2022 and 2021, the assets held in the Trust Account were held in money market funds, which are invested in U.S. Treasury securities.
 
 
The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 “Investments — Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheet and adjusted for the amortization or accretion of premiums or discounts.
 

Offering Costs
 
 
The Company complies with the requirements of FASB ASC Topic 340-10-S99-1, “
Other Assets and Deferred Costs – SEC Materials
” (“ASC 340-10-S99”) and SEC Staff Accounting Bulletin Topic 5A, “
Expenses of Offering
”.
Offering costs were $3,019,474 consisting principally of underwriting, legal, accounting and other expenses that are directly related to the Initial Public Offering and charged to stockholders’ equity upon the completion of the Initial Public Offering.
 

Warrants
 
 
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) ASC 480 “Distinguishing Liabilities from Equity” (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own Common Stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
 
 
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. (See Note 9).
 

Common Stock Subject to Possible Redemption
 
 
The Company accounts for its Common Stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common Stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Common Stock (including Common Stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Common Stock are classified as stockholders’ equity. The Company’s public shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of December 31, 2022 and 2021, Common Stock subject to possible redemption are presented at redemption value of $10.25 and $10.20 per share, respectively, as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Common Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Common Stock are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital equals to zero.
 
 

Concentration of Credit Risk
 
 
Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. As of December 31, 2022 and 2021, $0 and approximately $229,000, respectively, was over the Federal Deposit Insurance Corporation (FDIC) limit.
 

Fair Value of Financial Instruments
 
 
The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
 
 
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
 
 
 
·
Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active market.
 
·
Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.
 
·
Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value.
 

Income Taxes
 
 
The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
 
 
ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
 
 
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
 
 
The Company has identified the United States as its only “major” tax jurisdiction.
 
 
The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
 
 
The Company is incorporated in the State of Delaware and is required to pay franchise taxes to the State of Delaware on an annual basis.
 
 
On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (H.R. 5376) (the “IRA”), which, among other things, imposes a 1% excise tax on any domestic corporation that repurchases its stock after December 31, 2022 (the “Excise Tax”). The Excise Tax is imposed on the fair market value of the repurchased stock, with certain exceptions.
 
 
Because the Company is a Delaware corporation and our securities trades on Nasdaq, it is a “covered corporation” within the meaning of the IRA. The Excise Tax may apply to any redemptions of the Company’s common stock after December 31, 2022, including redemptions in connection with the Merger, unless an exemption is available. Issuances of securities in connection with the Merger are expected to reduce the amount of the Excise Tax in connection with redemptions occurring in the same calendar year, but the number of securities redeemed may exceed the number of securities issued. Further, the application of the Excise Tax in the event of a liquidation is uncertain. The Company is currently evaluating the impact it will have in the event of the Merger or liquidation.
 

Net Income (Loss) per Share
 
 
The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable Common Stock and non-redeemable Common Stock and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable Common Stock. Any remeasurement of the accretion to redemption value of the Common Stock subject to possible redemption was considered to be dividends paid to the public stockholders. For the years ended December 31, 2022 and 2021, the Company has not considered the effect of the Warrants sold in the Initial Public Offering to purchase an aggregate of 2,215,000 shares in the calculation of diluted net income (loss) per share, since the exercise of the Warrants is contingent upon the occurrence of future events and the inclusion of such Warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into Common Stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic (income) loss per share for the period presented.
 

 
 
The net income (loss) per share
presented
in the statement of operations is based on the following:
 
 
 
 
 
 
 
For the Period From
 
 
 
For the
 
 
January 6, 2021
 
 
 
Year Ended
 
 
(inception) through
 
 
 
December 31, 2022
 
 
December 31, 2021
 
 
 
 
 
 
Non-
 
 
 
 
 
Non-
 
 
 
Redeemable
 
 
Redeemable
 
 
Redeemable
 
 
Redeemable
 
 
 
Common
 
 
Common
 
 
Common
 
 
Common
 
 
 
Stock
 
 
Stock
 
 
Stock
 
 
Stock
 
Basic and diluted net income/(loss) per share:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Numerators:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocation of net loss including carrying value to redemption value
 
$
(941,679
)
 
$
(307,814
)
 
$
(3,090,769
)
 
$
(1,792,335
)
Accretion of carrying value to redemption value
 
 
253,389
 
 
 
—
 
 
 
4,635,386
 
 
 
—
 
Allocation of net income/(loss)
 
$
(688,290
)
 
$
(307,814
)
 
$
1,544,617
 
 
$
(1,792,335
)
Denominators:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted-average shares outstanding
 
 
4,343,211
 
 
 
1,419,700
 
 
 
2,033,677
 
 
 
1,179,328
 
Basic and diluted net income/(loss) per share
 
$
(0.16
)
 
$
(0.22
)
 
$
0.76
 
 
$
(1.52
)
 
 
Recent Accounting Pronouncements
 
 
Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Investments Held in Trust Account
 12 Months Ended
Dec. 31, 2022
Investments Held in Trust Account  
Investments Held in Trust Account
 

Note 3 —
Investments
Held in Trust Account
 
 
As of December 31, 2022 and 2021, assets
held
in the Trust Account were comprised of $9,671,375 and $45,187,428, respectively, in money market funds which are invested in U.S. Treasury Securities.
 
 
The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2022 and
2021
and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
 
Description
 
Level
 
 
December 31, 2022
 
 
December 31, 2021
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Trust Account - U.S. Treasury Securities Money
Market
Fund
 
 
1
 
 
$
9,671,375
 
 
$
45,187,428
 
 
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.22.4
Initial Public Offering
 12 Months Ended
Dec. 31, 2022
Initial Public Offering.  
Initial Public Offering
Note 4 — Initial Public Offering
 
 
Pursuant to the Initial Public Offering on July 19, 2021, the Company sold 4,000,000 Units at $10.00 per Public Unit, which does not include the 45-day option of the exercise of the underwriters’ 600,000 over-allotment option. On July 21, 2021, the underwriters partially exercised the over-allotment option and purchased 430,000 Option Units at a price of $10.00 per Option Unit, generating gross proceeds of $4,300,000.
 
 
The remaining 170,000 Option Units were expired on September 1, 2021. Transaction costs in connection with the Initial Public Offering and the issuance and sale of Option Units amounted to $3,019,474, consisting of $886,000 of underwriting fees, $1,550,500 of Business Combination Fee (defined in Note 7 below) and $582,974 of other offering costs.
 
 
Each Unit has an offering price of $10.00 and consists of one share of the Common Stock and one-half of one redeemable Warrant. The Company will not issue fractional shares. As a result, the warrants must be exercised in multiples of one whole Warrant. Each whole Warrant entitles the holder thereof to purchase one share of the Company’s Common Stock at a price of $11.50 per share, and only whole Warrants are exercisable. The Warrants will become exercisable on the later of 30 days after the completion of the Company’s initial Business Combination or 12 months from the closing of the Initial Public Offering, and will expire five years after the completion of the Company’s initial Business Combination or earlier upon redemption or liquidation.
 
 

All of the 4,430,000 public shares sold as part of the Units in the Initial Public Offering contain a redemption feature which allows for the redemption of such public shares if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation, or in connection with the Company’s liquidation. In accordance with the Securities and Exchange Commission (the “SEC”) and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require Common Stock subject to redemption to be classified outside of permanent equity.
 
 
The Company’s redeemable Common Stock is subject to SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).
 
 
As of December 31, 2022 and 2021, 910,220 and 4,430,000 shares, respectively, of Common Stock subject to possible redemption reflected on the balance sheet are reconciled in the following table.
 
Common stock subject to possible redemption, July 19, 2021
 
$
44,300,000
 
Less:
 
 
 
Proceeds allocated to public warrants
 
 
(783,301
)
Offering costs of public shares
 
 
(2,966,085
)
Plus:
 
 
 
Accretion of carrying value to redemption value
 
 
4,635,386
 
Common stock subject to possible redemption, December 31, 2021
 
 
45,186,000
 
Less:
 
 
 
Redemptions
 
 
(36,112,943
)
Plus:
 
 
 
Accretion of carrying value to redemption value
 
 
253,389
 
Common stock subject to possible redemption, December 31, 2022
 
$
9,326,446
 
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.22.4
Private Placement
 12 Months Ended
Dec. 31, 2022
Private Placement.  
Private Placement
 
 
Note 5 — Private Placement
 
 
Simultaneously with the closing of the Initial Public Offering, the Sponsor and Tradeup INC. purchased an aggregate of 295,000 shares of Common Stock at a price of $10.00 per share, among which, the Sponsor purchased 236,000 Private Placement Shares and Tradeup INC. purchased 59,000 Private Placement Shares, generating total proceeds of $2,950,000. On July 21, 2021, the Company consummated the sale of additional 17,200 Private Placement Shares with the Sponsor and Tradeup INC., among which, the Sponsor purchased 13,760 Private Placement Shares and Tradeup INC. purchased 3,440 Private Placement Shares, at a price of $10.00 per Private Placement share, generating total proceeds of $172,000. The proceeds from the sale of the Private Placement Shares were held outside of the Trust Account and is available for the payment of offering costs and for working capital purposes. The Sponsor will be permitted to transfer the Private Placement Shares held by them to certain permitted transferees, including the Company’s officers and directors and other persons or entities affiliated with or related to it or them, but the transferees receiving such shares will be subject to the same agreements with respect to such securities as the founders. Otherwise, these Private Placement Shares will not, subject to certain limited exceptions, be transferable or salable until 30 days after the completion of the Company’s Business Combination.
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.22.4
Related Party Transactions
 12 Months Ended
Dec. 31, 2022
Related Party Transactions  
Related Party Transactions
Note 6 — Related Party Transactions
 

Founder and Private Placement Shares
 
 
On January 20, 2021, the Sponsor acquired 1,150,000 founder shares for an aggregate purchase price of $25,000. On February 11, 2021, in connection with a restructure of the Sponsor, the Sponsor forfeited 1,150,000 founder shares upon the receipt of the refund of purchase price of $25,000. On February 12, 2021, the Sponsor acquired 920,000 founder shares for a purchase price of $20,000 and Tradeup INC. acquired 230,000 founder shares for a purchase price of $5,000, respectively (collectively as the “Founder Shares”).
 
 
As of December 31, 2022 and 2021, there were 1,107,500 Founder Shares issued and outstanding. The aggregate capital contribution was $25,000, or approximately $0.02 per share.
 
 
The number of Founder Shares issued was determined based on the expectation that such Founder Shares would represent 20% of the outstanding shares upon completion of the Initial Public Offering.
 

 
 
 
 
 
The founders have agreed not to transfer, assign or sell 50% of its Founder Shares until the earlier to occur of: (A) six months after the date of the consummation of the Company’s initial Business Combination, or (B) the date on which the closing price of the Company’s Common Stock equals or exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after the Company’s initial Business Combination and the remaining 50% of the Founder Shares may not be transferred, assigned or sold until six months after the date of the consummation of the Company’s initial Business Combination, or earlier, in either case, if, subsequent to the Company’s initial Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares for cash, securities or other property.
 
 
On July 19, 2021, the Company consummated the sale of 295,000 Private Placement Shares at a price of $10.00 per share in the Private Placement to the Sponsor and Tradeup INC., among which, the Sponsor purchased 236,000 Private Placement Shares and Tradeup INC. purchased 59,000 Private Placement Shares, generating gross proceeds of $2,950,000. On July 21, 2021, the Company consummated the sale of additional 17,200 Private Placement Shares with the Sponsor and Tradeup INC. at a price of $10.00 per Private Placement share, among which, the Sponsor purchased 13,760 Private Placement Shares and Tradeup INC. purchased 3,440 Private Placement Shares, generating total proceeds of $172,000. The Private Placement Shares are identical to the shares of Common Stock sold as part of the units in this Initial Public Offering, subject to limited exceptions. The Private Placement Shares will not be transferable, assignable or salable until 30 days after the completion of the Company’s initial Business Combination.
 

Working Capital Loans (Promissory Notes) — Related Parties
 
 
In order to finance transaction costs in connection with an intended initial Business Combination, the founders or an affiliate of the founders or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes the initial Business Combination, it would repay such loaned amounts. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used for such repayment. Up to approximately $1,200,000
of such loans may be convertible into Private Placement Shares, at a price of $10.00 per share at the option of the lender.
 
 
On January 19, 2021, the Sponsor has agreed to loan the Company up to $400,000 to be used for a portion of the expenses of the Initial Public Offering. This loan is non-interest bearing, unsecured and is due at the earlier of (1) June 20, 2021 or (2) the closing of the Initial Public Offering. The loan will be repaid upon the closing of the Initial Public Offering out of the offering proceeds not held in the Trust Account. On June 19, 2021 the Sponsor agreed to extend the maturity date of the loan to the Company to the earlier of August 31, 2021 or the closing date of the Initial Public Offering. The outstanding balance under the Promissory Note was repaid at the closing of the Initial Public Offering on July 19, 2021.
 
 
On July 25, 2022, the Company issued (i) Note A in the amount of $204,000 to Running Lion, which is wholly owned and controlled by Mr. Weiguang Yang, the Co-Executive Officer and director of the Company and (ii) the Note B in the amount of $294,600 to Tradeup INC., one of the Founders. The proceeds of the Notes, which may be drawn down from time to time until the Company consummates its initial Business Combination, will be used as general working capital purposes.
 
 
The Notes bear no interest and are payable in full upon the earlier to occur of (i) the consummation of the Company’s Business Combination or (ii) the
date of expiry of the term of the Company
 
(“
Maturity Date
”)
. The following shall constitute an event of default: (i) a failure to pay the principal within five business days of the Maturity Date; (ii) the commencement of a voluntary or involuntary bankruptcy action, (iii) the breach of the Company’s obligations thereunder; (iv) any cross defaults; (v) an enforcement proceedings against the Company; and (vi) any unlawfulness and invalidity in connection with the performance of the obligations thereunder, in which case the Notes may be accelerated.
 
 
The Payees respectively have the right, but not the obligation, to convert their Notes, in whole or in part, respectively, into Conversion Shares, as described in the prospectus of the Company (File Number 333-253322), by providing the Company with written notice of the intention to convert at least two business days prior to the closing of the Business Combination. The number of Conversion Shares to be received by the Payees in connection with such conversion shall be an amount determined by dividing (x) the sum of the outstanding principal amount payable to such Payee by (y) $10.00.
 
 
As of December 31, 2022 and 2021, the Company had borrowings of $498,600 and $0, respectively, under the working capital loans.
 
 
Due to a related party
 
 
For the year ended December 31, 2022, the Sponsor loaned the Company $50,000 to cover certain operating expenses of the Company. As of December 31, 2022, the total amount due to the Sponsor was $50,000 and such balance was converted into a promissory note on January 19, 2023
 
with the same term as the working capital loans as discussed above
.
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments & Contingencies
 12 Months Ended
Dec. 31, 2022
Commitments & Contingencies  
Commitments & Contingencies
Note 7 — Commitments & Contingencies
 

Risks and Uncertainties
 
 
Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
 

Registration Rights
 
 
The holders of the Founder Shares, Private Placement Shares and Common Stock that may be issued upon conversion of working capital loans will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Common Stock). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
 

Underwriters Agreement
 
 
The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to an additional 600,000 Option Units to cover over-allotments, if any. On July 21, 2021, the Underwriters partially exercised the over-allotment option and purchased 430,000 Option Units at a price of $10.00 per Option Unit, generating gross proceeds of $4,300,000. The Company paid an underwriting discount of 2.00% of the gross proceeds of the Initial Public Offering and the sale of Option Units or $886,000 to the underwriters at the closing of the Initial Public Offering and the sale of Option Units.
 
 
Business Combination Marketing Agreement
 
 
The Company has engaged US Tiger Securities, Inc., EF Hutton, division of Benchmark Investments, LLC (“EF Hutton”) and R.F. Lafferty & Co., Inc. the representatives (the “Representatives”) of the underwriters of the Initial Public Offering in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company is obligated to pay the Representatives a cash fee (the “Business Combination Fee”) pursuant to a Business Combination Marketing Agreement for such services upon the consummation of the Company’s initial Business Combination, equal to 3.5% of the gross proceeds of the Initial Public Offering and the sale of over-allotment Option Units as discussed in Note 8.
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.22.4
Deferred Underwriters' Business Combination Fees
 12 Months Ended
Dec. 31, 2022
Deferred Underwriters' Business Combination Fees  
Deferred Underwriters' Business Combination Fees
Note 8 — Deferred Underwriters’ Business Combination Fees
 
 
The Company is obligated to pay the Representatives a deferred Business Combination Fee equal to 3.5% of the gross proceeds of the Initial Public Offering and the sale of over-allotment Option Units. Upon completion of the Business Combination, $1,550,500 will be paid to the underwriters from the funds held in the Trust Account.
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Deficit
 12 Months Ended
Dec. 31, 2022
Stockholders' Equity  
Stockholders' Deficit
Note 9 — Stockholders’ Deficit
 

Preferred stock
—The Company is authorized to issue 1,000,000 shares of preferred stock, par value $0.0001 per share and with such designations, voting and other rights and preferences as may be determined from time to time by the company’s board of directors. As of December 31, 2022 and 2021, there were no preference shares issued or outstanding.
 

Common stock
— The Company is authorized to issue up to 30,000,000 shares of Common Stock, par value $0.0001 per share. As of December 31, 2022 and 2021, there were 1,419,700 shares of Common Stock issued and outstanding, excluding 910,220 and 4,430,000 shares of Common Stock subject to possible redemption, respectively.
 
 
Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. The Company’s stockholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefor.
 
 
Warrants
— In July 2021, the Company issued 2,215,000 Warrants in connection with the Initial Public Offering and the sale of the Option Units. Each whole Warrant entitles the registered holder to purchase one whole share of the Company’s Common Stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing on the later of 12 months from the closing of the Initial Public Offering or the completion of the initial Business Combination. Pursuant to the warrant agreement, a warrant holder may exercise its Warrants only for a whole number of shares of Common Stock. This means that only a whole Warrant may be exercised at any given time by a warrant holder. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. The Warrants will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.
 
 
The Company has agreed that as soon as practicable, but in no event later than 30 business days, after the closing of the initial Business Combination, it will use its reasonable commercially reasonable efforts to file, and within 60 business days following its initial Business Combination to have declared effective, a registration statement for the registration, under the Securities Act, of the shares of Common Stock issuable upon exercise of the Warrants. The Company will use its commercially reasonable efforts to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Warrants in accordance with the provisions of the warrant agreement. No Warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the Common Stock issuable upon exercise of the Warrants and a current prospectus relating to such shares of Common Stock. Notwithstanding the above, if the Company’s Common Stock is at the time of any exercise of a Warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Warrants who exercise their Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event it so elect, it will not be required to file or maintain in effect a registration statement, but it will be required to use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
 
 
Once the Warrants become exercisable, the Company may call the Warrants for redemption:
 
 
 
in whole and not in part;
 
 
 
at a price of $0.01 per Warrant;
 
 
 
upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and
 
 
 
if, and only if, the reported last sale price of the Common Stock equals or exceeds $16.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on third business day before the Company send the notice of redemption to the warrant holders.
 
 
The Company accounted for the 2,215,000 Warrants issued with the Initial Public Offering as equity instruments in accordance with ASC 480, “Distinguishing Liabilities from Equity” and ASC 815-40, “Derivatives and Hedging: Contracts in Entity’s Own Equity”. The Company accounted for the Warrant as an expense of the Initial Public Offering resulting in a charge directly to stockholders’ equity. The Company estimates that the fair value of the Warrants is approximately $0.8 million, or 0.36 per Unit
 
on issuance
.
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes
 12 Months Ended
Dec. 31, 2022
Income Taxes  
Income Taxes
Note 10 — Income Taxes
 
 
The Company’s taxable income primarily consists of dividend and
interest
earned on investments held in the Trust Account. 
 
 
The income tax provision (benefit) consists of the following:
 
 
 
 
For the
Year Ended
 
 
 
 
For the Period from
January 6, 2021
(inception) through
 
 
 
 
 
December 31, 2022
 
 
December 31, 2021
 
Current
 
 
 
 
 
 
 
 
Federal
 
$
51,176
 
 
$
—
 
State
 
 
—
 
 
 
—
 
Deferred
 
 
 
 
 
 
 
 
Federal
 
 
316,798
 
 
 
52,021
 
State
 
 
—
 
 
 
—
 
Valuation allowance
 
 
(287,326
)
 
 
(52,021
)
Income tax provision
 
$
80,648
 
 
$
—
 
 
 
A reconciliation of the statutory federal income tax rate to the Company’s effective tax rate is as follows:
 

 
 
 
 
 
For the
Year Ended
 
 
 
 
For the Period from
January 6, 2021
(inception) through
 
 
 
 
 
December 31, 2022
 
 
December 31, 2021
 
U.S. statutory rate
 
 
21.0
%
 
 
21.0
%
Permanent difference on facilitated acquisition costs
 
 
(3.6
)
%
 
 
-
%
Change in valuation allowance
 
 
(26.2
)%
 
 
(21.0
)%
Effective tax rate
 
 
(8.8
)
%
 
$
0.0
%
 
 
The Company’s net deferred tax assets were as follows as of:
 

 
 
 
December 31, 2022
 
 
December 31, 2021
 
Deferred tax assets:
 
 
 
 
 
 
Start-up/organization costs
 
$
292,154
 
 
$
—
 
Net operating loss carryover
 
 
—
 
 
 
52,021
 
Deferred tax liability:
 
 
 
 
 
 
 
 
Accrued dividend income
 
 
(29,472
)
 
 
—
 
Total deferred tax
assets
 
 
262,682
 
 
 
52,021
 
Valuation allowance
 
 
(292,154
)
 
 
(52,021
)
Deferred tax liability, net
 
$
(29,472
)
 
$
—
 
 
As of December 31, 2022 and 2021, the Company had $0 and $247,718 of U.S. federal and state net operating loss carryovers available to offset future taxable income which do not expire.
 
In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax assets, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance of $292,154 and $52,021 as of December 31, 2022 and 2021, respectively.
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.22.4
Subsequent Events
 12 Months Ended
Dec. 31, 2022
Subsequent Events  
Subsequent Events
Note 11 — Subsequent Events
 
 
As provided in the Merger Agreement Estrella has agreed to, upon request by the sponsors of the Company, deposit the agreed reasonable amount to the Company’s trust in order to effectuate extension of the Company’s Combination Period.  Pursuant to the Merger Agreement, Estrella has deposited made two monthly extension payments, each in the amount of $45,511, to the Trust Account in connection with two Extensions, as a result of which, the current Combination Deadline is March 19, 2023. Such two monthly extension payments were evidenced by two promissory notes issued by the Company to Estrella, each in the principal amount of $45,511.
 
 
On January 19, 2023, the Company issued an unsecured promissory note in the amount of $50,000 to the Sponsor
for working capital purposes
.

On March 3, 2023, the Company issued an unsecured promissory note in the amount of $50,000 to Tradeup INC. for working capital purposes.
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.22.4
Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Use of Estimates
Use of Estimates
 
 
The preparation of these financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash
Cash
 
 
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents.
Investments held in Trust Account
Investments held in Trust Account
 
 
As of December 31, 2022 and 2021, the assets held in the Trust Account were held in money market funds, which are invested in U.S. Treasury securities.
 
 
The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 “Investments — Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheet and adjusted for the amortization or accretion of premiums or discounts.
Offering Costs
Offering Costs
 
 
The Company complies with the requirements of FASB ASC Topic 340-10-S99-1, “
Other Assets and Deferred Costs – SEC Materials
” (“ASC 340-10-S99”) and SEC Staff Accounting Bulletin Topic 5A, “
Expenses of Offering
”.
Offering costs were $3,019,474 consisting principally of underwriting, legal, accounting and other expenses that are directly related to the Initial Public Offering and charged to stockholders’ equity upon the completion of the Initial Public Offering.
Warrants
Warrants
 
 
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) ASC 480 “Distinguishing Liabilities from Equity” (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own Common Stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
 
 
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. (See Note 9).
Common Stock Subject to Possible Redemption
Common Stock Subject to Possible Redemption
 
 
The Company accounts for its Common Stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common Stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Common Stock (including Common Stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Common Stock are classified as stockholders’ equity. The Company’s public shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of December 31, 2022 and 2021, Common Stock subject to possible redemption are presented at redemption value of $10.25 and $10.20 per share, respectively, as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Common Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Common Stock are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital equals to zero.
Concentration of Credit Risk
Concentration of Credit Risk
 
 
Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. As of December 31, 2022 and 2021, $0 and approximately $229,000, respectively, was over the Federal Deposit Insurance Corporation (FDIC) limit.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
 
 
The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
 
 
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
 
 
 
·
Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active market.
 
·
Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.
 
·
Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value.
Income Taxes
Income Taxes
 
 
The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
 
 
ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
 
 
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
 
 
The Company has identified the United States as its only “major” tax jurisdiction.
 
 
The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
 
 
The Company is incorporated in the State of Delaware and is required to pay franchise taxes to the State of Delaware on an annual basis.
 
 
On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (H.R. 5376) (the “IRA”), which, among other things, imposes a 1% excise tax on any domestic corporation that repurchases its stock after December 31, 2022 (the “Excise Tax”). The Excise Tax is imposed on the fair market value of the repurchased stock, with certain exceptions.
 
 
Because the Company is a Delaware corporation and our securities trades on Nasdaq, it is a “covered corporation” within the meaning of the IRA. The Excise Tax may apply to any redemptions of the Company’s common stock after December 31, 2022, including redemptions in connection with the Merger, unless an exemption is available. Issuances of securities in connection with the Merger are expected to reduce the amount of the Excise Tax in connection with redemptions occurring in the same calendar year, but the number of securities redeemed may exceed the number of securities issued. Further, the application of the Excise Tax in the event of a liquidation is uncertain. The Company is currently evaluating the impact it will have in the event of the Merger or liquidation.
Net Income (Loss) per Share
Net Income (Loss) per Share
 
 
The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable Common Stock and non-redeemable Common Stock and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable Common Stock. Any remeasurement of the accretion to redemption value of the Common Stock subject to possible redemption was considered to be dividends paid to the public stockholders. For the years ended December 31, 2022 and 2021, the Company has not considered the effect of the Warrants sold in the Initial Public Offering to purchase an aggregate of 2,215,000 shares in the calculation of diluted net income (loss) per share, since the exercise of the Warrants is contingent upon the occurrence of future events and the inclusion of such Warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into Common Stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic (income) loss per share for the period presented.
 

 
 
The net income (loss) per share
presented
in the statement of operations is based on the following:
 
 
 
 
 
 
 
For the Period From
 
 
 
For the
 
 
January 6, 2021
 
 
 
Year Ended
 
 
(inception) through
 
 
 
December 31, 2022
 
 
December 31, 2021
 
 
 
 
 
 
Non-
 
 
 
 
 
Non-
 
 
 
Redeemable
 
 
Redeemable
 
 
Redeemable
 
 
Redeemable
 
 
 
Common
 
 
Common
 
 
Common
 
 
Common
 
 
 
Stock
 
 
Stock
 
 
Stock
 
 
Stock
 
Basic and diluted net income/(loss) per share:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Numerators:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocation of net loss including carrying value to redemption value
 
$
(941,679
)
 
$
(307,814
)
 
$
(3,090,769
)
 
$
(1,792,335
)
Accretion of carrying value to redemption value
 
 
253,389
 
 
 
—
 
 
 
4,635,386
 
 
 
—
 
Allocation of net income/(loss)
 
$
(688,290
)
 
$
(307,814
)
 
$
1,544,617
 
 
$
(1,792,335
)
Denominators:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted-average shares outstanding
 
 
4,343,211
 
 
 
1,419,700
 
 
 
2,033,677
 
 
 
1,179,328
 
Basic and diluted net income/(loss) per share
 
$
(0.16
)
 
$
(0.22
)
 
$
0.76
 
 
$
(1.52
)
Recent Accounting Pronouncements
Recent Accounting Pronouncements
 
 
Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.22.4
Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of net income or loss per share
The net income (loss) per share
presented
in the statement of operations is based on the following:
 
 
 
 
 
 
 
For the Period From
 
 
 
For the
 
 
January 6, 2021
 
 
 
Year Ended
 
 
(inception) through
 
 
 
December 31, 2022
 
 
December 31, 2021
 
 
 
 
 
 
Non-
 
 
 
 
 
Non-
 
 
 
Redeemable
 
 
Redeemable
 
 
Redeemable
 
 
Redeemable
 
 
 
Common
 
 
Common
 
 
Common
 
 
Common
 
 
 
Stock
 
 
Stock
 
 
Stock
 
 
Stock
 
Basic and diluted net income/(loss) per share:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Numerators:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocation of net loss including carrying value to redemption value
 
$
(941,679
)
 
$
(307,814
)
 
$
(3,090,769
)
 
$
(1,792,335
)
Accretion of carrying value to redemption value
 
 
253,389
 
 
 
—
 
 
 
4,635,386
 
 
 
—
 
Allocation of net income/(loss)
 
$
(688,290
)
 
$
(307,814
)
 
$
1,544,617
 
 
$
(1,792,335
)
Denominators:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted-average shares outstanding
 
 
4,343,211
 
 
 
1,419,700
 
 
 
2,033,677
 
 
 
1,179,328
 
Basic and diluted net income/(loss) per share
 
$
(0.16
)
 
$
(0.22
)
 
$
0.76
 
 
$
(1.52
)
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.22.4
Investments Held in Trust Account (Tables)
 12 Months Ended
Dec. 31, 2022
Investments Held in Trust Account  
Schedule of assets that are measured at fair value on a recurring basis
The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2022 and
2021
and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
 
Description
 
Level
 
 
December 31, 2022
 
 
December 31, 2021
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Trust Account - U.S. Treasury Securities Money
Market
Fund
 
 
1
 
 
$
9,671,375
 
 
$
45,187,428
 
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.22.4
Initial Public Offering (Tables)
 12 Months Ended
Dec. 31, 2022
Initial Public Offering.  
Schedule of common stock reflected in the condensed balance sheet
As of December 31, 2022 and 2021, 910,220 and 4,430,000 shares, respectively, of Common Stock subject to possible redemption reflected on the balance sheet are reconciled in the following table.
 
Common stock subject to possible redemption, July 19, 2021
 
$
44,300,000
 
Less:
 
 
 
Proceeds allocated to public warrants
 
 
(783,301
)
Offering costs of public shares
 
 
(2,966,085
)
Plus:
 
 
 
Accretion of carrying value to redemption value
 
 
4,635,386
 
Common stock subject to possible redemption, December 31, 2021
 
 
45,186,000
 
Less:
 
 
 
Redemptions
 
 
(36,112,943
)
Plus:
 
 
 
Accretion of carrying value to redemption value
 
 
253,389
 
Common stock subject to possible redemption, December 31, 2022
 
$
9,326,446
 
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2022
Income Taxes  
Income tax provision
The income tax provision (benefit) consists of the following:
 
 
 
 
For the
Year Ended
 
 
 
 
For the Period from
January 6, 2021
(inception) through
 
 
 
 
 
December 31, 2022
 
 
December 31, 2021
 
Current
 
 
 
 
 
 
 
 
Federal
 
$
51,176
 
 
$
—
 
State
 
 
—
 
 
 
—
 
Deferred
 
 
 
 
 
 
 
 
Federal
 
 
316,798
 
 
 
52,021
 
State
 
 
—
 
 
 
—
 
Valuation allowance
 
 
(287,326
)
 
 
(52,021
)
Income tax provision
 
$
80,648
 
 
$
—
 
Schedule of reconciliation of the total income tax provision tax rate to the statutory federal income tax rate
A reconciliation of the statutory federal income tax rate to the Company’s effective tax rate is as follows:
 

 
 
 
 
 
For the
Year Ended
 
 
 
 
For the Period from
January 6, 2021
(inception) through
 
 
 
 
 
December 31, 2022
 
 
December 31, 2021
 
U.S. statutory rate
 
 
21.0
%
 
 
21.0
%
Permanent difference on facilitated acquisition costs
 
 
(3.6
)
%
 
 
-
%
Change in valuation allowance
 
 
(26.2
)%
 
 
(21.0
)%
Effective tax rate
 
 
(8.8
)
%
 
$
0.0
%
Summary of significant components of the Company's deferred tax assets
The Company’s net deferred tax assets were as follows as of:
 

 
 
 
December 31, 2022
 
 
December 31, 2021
 
Deferred tax assets:
 
 
 
 
 
 
Start-up/organization costs
 
$
292,154
 
 
$
—
 
Net operating loss carryover
 
 
—
 
 
 
52,021
 
Deferred tax liability:
 
 
 
 
 
 
 
 
Accrued dividend income
 
 
(29,472
)
 
 
—
 
Total deferred tax
assets
 
 
262,682
 
 
 
52,021
 
Valuation allowance
 
 
(292,154
)
 
 
(52,021
)
Deferred tax liability, net
 
$
(29,472
)
 
$
—
 
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.22.4
Organization and Business Operation (Details)
 12 Months Ended
Aug. 16, 2022
Sep. 01, 2021
shares
Jul. 21, 2021
USD ($)
$ / shares
shares
Jul. 19, 2021
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
Item
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Jul. 31, 2021
$ / shares
Jan. 19, 2021
shares
Subsidiary, Sale of Stock [Line Items]                
Proceeds from issuance of private placement         $ 3,122,000    
Sale price | $ / shares             $ 11.5  
Business Combination Fee         1,550,500      
Transaction costs         3,019,474      
Other offering costs         3,019,474      
Cash held outside the trust account         $ 40,802 478,868    
Aggregate purchase price           25,000    
Condition for future business combination number of businesses minimum | Item         1      
Payments for investment of cash in trust account         $ 45,186,000    
Condition for future business combination threshold net tangible assets         5,000,001      
Minimum net tangible assets upon consummation of business combination         $ 5,000,001      
Common shares, par value, (per share) | $ / shares         $ 0.0001 $ 0.0001    
Proceeds from sale of public units through public offering         $ 44,300,000    
Working Capital Earnings Deficit         $ 1,020,642      
Percentage of excise tax 1.00%              
Percentage of fair market value of shares repurchased 1.00%              
Temporary equity stock shares outstanding | shares         910,220 4,430,000    
Shareholders Of Estrella [Member] | Merger Agreement [Member]                
Subsidiary, Sale of Stock [Line Items]                
Common stock shares subscribed but not issued | shares         32,500,000      
Class A Common Stock                
Subsidiary, Sale of Stock [Line Items]                
Temporary Equity Stock Redeemed During The Period Shares | shares         3,519,780      
Temporary equity stock shares outstanding | shares         910,220      
IPO [Member]                
Subsidiary, Sale of Stock [Line Items]                
Number of units issued | shares       4,000,000        
Price per unit | $ / shares     $ 10.2 $ 10.2        
Proceeds from issuance initial public offering       $ 40,000,000        
Sale of Private Placement Warrants (in shares) | shares         2,215,000      
Underwriting fees         $ 886,000      
Sale price | $ / shares       $ 10        
Business Combination Fee         1,550,500      
Transaction costs         3,019,474      
Other offering costs         $ 582,974      
Aggregate purchase price       $ 45,186,000        
Payments for investment of cash in trust account     $ 45,186,000          
Obligation to redeem Public Shares if entity does not complete a business combination (as a percent)         100.00%      
Threshold minimum aggregate fair market value as a percentage of the net assets held in the Trust Account         80.00%      
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination         50.00%      
Threshold business days for redemption of public shares         10 days      
Maximum net interest to pay dissolution expenses         $ 50,000      
Exercise price of warrants | $ / shares         $ 0.36      
IPO [Member] | Warrant [Member]                
Subsidiary, Sale of Stock [Line Items]                
Number of warrants in a unit | shares         1      
IPO [Member] | Public Warrants                
Subsidiary, Sale of Stock [Line Items]                
Price per unit | $ / shares         $ 10      
Number of shares in a unit | shares         1      
Number of warrants in a unit | shares         1      
Exercise price of warrants | $ / shares         $ 11.5      
Private Placement [Member]                
Subsidiary, Sale of Stock [Line Items]                
Number of shares issued | shares     17,200 295,000        
Proceeds from issuance of private placement     $ 172,000 $ 2,950,000        
Sale price | $ / shares     $ 10 $ 10        
Over-Allotment Option [Member]                
Subsidiary, Sale of Stock [Line Items]                
Number of units issued | shares   170,000 430,000 600,000        
Price per unit | $ / shares     $ 10 $ 10        
Proceeds from issuance initial public offering     $ 4,300,000          
Sale of Private Placement Warrants (in shares) | shares     4,300,000          
Sale price | $ / shares     $ 10          
Proceeds from sale of public units through public offering     $ 44,300,000          
Sponsor | Private Placement [Member]                
Subsidiary, Sale of Stock [Line Items]                
Sale of Private Placement Warrants (in shares) | shares     13,760 236,000        
Number of shares issued | shares       295,000        
Proceeds from issuance of private placement     $ 172,000 $ 236,000        
Sale price | $ / shares     $ 10          
Founder Shares | Over-Allotment Option [Member]                
Subsidiary, Sale of Stock [Line Items]                
Forfeiture of Founder Shares | shares         42,500      
Trade Up Inc | Private Placement [Member]                
Subsidiary, Sale of Stock [Line Items]                
Sale of Private Placement Warrants (in shares) | shares     3,440 59,000       59,000
Proceeds from issuance of private placement       $ 2,950,000        
Sale price | $ / shares     $ 10          
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.22.4
Significant Accounting Policies (Details) - USD ($)
 12 Months Ended
Aug. 16, 2022
Dec. 31, 2022
Dec. 31, 2021
Unrecognized tax benefits accrued for interest and penalties    
Federal deposit insurance corporation   0 $ 229,000
Other offering costs   3,019,474  
Unrecognized Tax Benefits    
Temporary equity par value   $ 10.25 $ 10.2
Percentage of excise tax 1.00%    
IPO [Member]      
Anti-dilutive securities attributable to warrants (in shares)   2,215,000  
Other offering costs   $ 582,974  
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.22.4
Significant Accounting Policies - Net Income (Loss) Per Share (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Numerators:    
Accretion of carrying value to redemption value $ 253,389 $ 4,635,386
Allocation of net income/(loss) (996,104) (247,718)
Redeemable Common Stock    
Numerators:    
Allocation of net loss including carrying value to redemption value (941,679) (3,090,769)
Accretion of carrying value to redemption value 253,389 4,635,386
Allocation of net income/(loss) $ (688,290) $ 1,544,617
Denominators:    
Weighted-average shares outstanding, Basic 4,343,211 2,033,677
Weighted-average shares outstanding, Diluted 4,343,211 2,033,677
Basic net loss (income) per common share $ (0.16) $ 0.76
Diluted, net loss per common share $ (0.16) $ 0.76
Non Redeemable Common Stock    
Numerators:    
Allocation of net loss including carrying value to redemption value $ (307,814) $ (1,792,335)
Accretion of carrying value to redemption value 0 0
Allocation of net income/(loss) $ (307,814) $ (1,792,335)
Denominators:    
Weighted-average shares outstanding, Basic 1,419,700 1,179,328
Weighted-average shares outstanding, Diluted 1,419,700 1,179,328
Basic net loss (income) per common share $ (0.22) $ (1.52)
Diluted, net loss per common share $ (0.22) $ (1.52)
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.22.4
Investments Held in Trust Account - Information about the Company's Assets (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Net Investment Income [Line Items]    
Assets Held-in-trust, Noncurrent $ 9,671,375 $ 45,187,428
Level 1 | Recurring | U.S. Treasury Securities Money Market Fund    
Net Investment Income [Line Items]    
Assets Held-in-trust, Noncurrent $ 9,671,375 $ 45,187,428
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.22.4
Initial Public Offering (Details) - USD ($)
 12 Months Ended
Sep. 01, 2021
Jul. 21, 2021
Jul. 19, 2021
Dec. 31, 2022
Dec. 31, 2021
Jul. 31, 2021
Initial Public Offering            
Sale price           $ 11.5
Transaction Costs       $ 3,019,474    
Underwriting fees       886,000    
Other offering costs       582,974    
Business Combination Fee       $ 1,550,500    
Shares subject to forfeiture       4,430,000    
Class A common stock subject to possible redemption, outstanding (in shares)       910,220 4,430,000  
Public Warrants            
Initial Public Offering            
Public Warrants expiration term       5 years    
Initial Public Offering            
Initial Public Offering            
Number of units issued excluding underwriters     4,000,000      
Number of units issued     4,000,000      
Sale price     $ 10      
Purchase price, per unit   $ 10.2 $ 10.2      
Proceeds from issuance initial public offering     $ 40,000,000      
Transaction Costs       $ 3,019,474    
Business Combination Fee       $ 1,550,500    
Exercise price of warrants       $ 0.36    
Warrants exercisable term after the completion of a business combination       12 months    
Initial Public Offering | Public Warrants            
Initial Public Offering            
Purchase price, per unit       $ 10    
Number of shares in a unit       1    
Number of warrants in a unit       1    
Number of shares issuable per warrant       1    
Exercise price of warrants       $ 11.5    
Warrants exercisable term after the completion of a business combination       30 days    
Over-allotment option            
Initial Public Offering            
Number of units issued 170,000 430,000 600,000      
Sale price   $ 10        
Purchase price, per unit   $ 10 $ 10      
Underwriter exercise Period from initial public offering     45 days 45 days    
Proceeds from issuance initial public offering   $ 4,300,000        
Common stock subject to redemption            
Initial Public Offering            
Class A common stock subject to possible redemption, outstanding (in shares)       910,220 4,430,000  
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.22.4
Initial Public Offering - Reconciliation Of Temporary Equity (Details) - USD ($)
 5 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Jul. 19, 2021
Initial Public Offering.        
Proceeds allocated to public warrants $ (783,301)      
Offering costs of public shares (2,966,085)      
Accretion of carrying value to redemption value 4,635,386 $ 253,389    
Redemptions   (36,112,943) $ 0  
Common stock subject to possible redemption $ 45,186,000 $ 9,326,446 $ 45,186,000 $ 44,300,000
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.22.4
Private Placement (Details) - USD ($)
 12 Months Ended
Jul. 21, 2021
Jul. 19, 2021
Dec. 31, 2022
Dec. 31, 2021
Jul. 31, 2021
Jan. 19, 2021
Private Placement            
Sale price         $ 11.5  
Proceeds from issuance of private placement     $ 3,122,000    
Private Placement            
Private Placement            
Number of shares issued 17,200 295,000        
Sale price $ 10 $ 10        
Proceeds from issuance of private placement $ 172,000 $ 2,950,000        
Additional Units Sold Of Shares 17,200          
Restrictions on transfer period of time after business combination completion     30 days      
Private Placement | Sponsor            
Private Placement            
Number of shares issued   295,000        
Sale price $ 10          
Proceeds from issuance of private placement $ 172,000 $ 236,000        
Sale of Private Placement Warrants (in shares) 13,760 236,000        
Private Placement | Trade Up Inc            
Private Placement            
Sale price $ 10          
Proceeds from issuance of private placement   $ 2,950,000        
Sale of Private Placement Warrants (in shares) 3,440 59,000       59,000
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Related Party Transactions - Founder and Private Placement Shares (Details)
 9 Months Ended 12 Months Ended
Jul. 21, 2021
USD ($)
$ / shares
shares
Jul. 19, 2021
USD ($)
$ / shares
shares
Feb. 12, 2021
USD ($)
shares
Feb. 11, 2021
USD ($)
shares
Jan. 20, 2021
USD ($)
shares
Sep. 30, 2021
Dec. 31, 2022
USD ($)
item
$ / shares
shares
Dec. 31, 2021
USD ($)
shares
Jul. 31, 2021
$ / shares
Jan. 19, 2021
shares
Related Party Transaction [Line Items]                    
Sale price | $ / shares                 $ 11.5  
Proceeds from sale of private placement shares | $             $ 3,122,000    
Aggregate purchase price | $               $ 25,000    
Shares subject to forfeiture             4,430,000      
Common shares, shares issued             1,419,700 1,419,700    
Common shares, shares outstanding             1,419,700 1,419,700    
Private Placement                    
Related Party Transaction [Line Items]                    
Number of shares issued 17,200 295,000                
Sale price | $ / shares $ 10 $ 10                
Proceeds from sale of private placement shares | $ $ 172,000 $ 2,950,000                
Restrictions on transfer period of time after business combination completion             30 days      
Additional Units Sold Of Shares 17,200                  
Private Placement | Sponsor                    
Related Party Transaction [Line Items]                    
Number of shares issued   295,000                
Sale price | $ / shares $ 10                  
Proceeds from sale of private placement shares | $ $ 172,000 $ 236,000                
Number of warrants to purchase shares issued 13,760 236,000                
Private Placement | Trade Up Inc                    
Related Party Transaction [Line Items]                    
Sale price | $ / shares $ 10                  
Proceeds from sale of private placement shares | $   $ 2,950,000                
Number of warrants to purchase shares issued 3,440 59,000               59,000
Over-allotment option                    
Related Party Transaction [Line Items]                    
Sale price | $ / shares $ 10                  
Purchase price, per unit | $ / shares $ 10 $ 10                
Number of warrants to purchase shares issued 4,300,000                  
Initial Public Offering                    
Related Party Transaction [Line Items]                    
Sale price | $ / shares   $ 10                
Aggregate purchase price | $   $ 45,186,000                
Purchase price, per unit | $ / shares $ 10.2 $ 10.2                
Number of warrants to purchase shares issued             2,215,000      
Founder Shares                    
Related Party Transaction [Line Items]                    
Number of shares issued     230,000              
Aggregate purchase price | $     $ 5,000              
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders           50.00% 50.00%      
Restrictions on transfer period of time after business combination completion             6 months      
Founder Shares | Sponsor                    
Related Party Transaction [Line Items]                    
Number of shares issued     920,000   1,150,000          
Aggregate purchase price | $     $ 20,000 $ 25,000 $ 25,000          
Shares subject to forfeiture       1,150,000            
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares             $ 12.5      
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | item             20      
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | item             30      
Founder Shares | Private Placement                    
Related Party Transaction [Line Items]                    
Additional Units Sold Of Shares 17,200                  
Founder Shares | Over-allotment option                    
Related Party Transaction [Line Items]                    
Aggregate purchase price | $             $ 25,000      
Purchase price, per unit | $ / shares             $ 0.02      
Common shares, shares issued             1,107,500 1,107,500    
Common shares, shares outstanding             1,107,500 1,107,500    
Founder Shares | Initial Public Offering                    
Related Party Transaction [Line Items]                    
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders             20.00%      
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Related Party Transactions - Promissory Note and Related Party (Working Capital) Loans (Details) - USD ($)
Dec. 31, 2022
Jul. 25, 2022
Dec. 31, 2021
Jan. 19, 2021
Related Party Transaction [Line Items]        
Conversion Shares (per share amount)   $ 10    
Commercial Loan [Member]        
Related Party Transaction [Line Items]        
Bank Overdrafts $ 498,600   $ 0  
Running Lion        
Related Party Transaction [Line Items]        
Amount of unsecured promissory note   $ 204,000    
Trade Up Inc        
Related Party Transaction [Line Items]        
Amount of unsecured promissory note   $ 294,600    
Promissory Note with Related Party        
Related Party Transaction [Line Items]        
Maximum borrowing capacity of related party promissory note       $ 400,000
Related Party Loans | Working capital loans warrant        
Related Party Transaction [Line Items]        
Maximum borrowing capacity of related party promissory note $ 1,200,000      
Price of warrant $ 10      
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Related Party Transactions - Due To a Related Party (Details) - Sponsor
 12 Months Ended
Dec. 31, 2022
USD ($)
Related Party Transaction [Line Items]  
Related Party Transaction, Expenses from Transactions with Related Party $ 50,000
Due to Related Parties $ 50,000
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments & Contingencies (Details) - USD ($)
 12 Months Ended
Sep. 01, 2021
Jul. 21, 2021
Jul. 19, 2021
Dec. 31, 2022
Business Combination Marketing Agreement        
Percentage of proceeds of offering payable to underwriters, cash fee       3.50%
Initial Public Offering        
Units Issued During Period, Shares, New Issues     4,000,000  
Underwriter cash discount   $ 886,000    
Proceeds from issuance initial public offering     $ 40,000,000  
Percentage of underwriting discounts   2.00%    
Over-allotment option        
Underwriter exercise Period from initial public offering     45 days 45 days
Units Issued During Period, Shares, New Issues 170,000 430,000 600,000  
Proceeds from issuance initial public offering   $ 4,300,000    
Share price   $ 10    
Deferred offering costs   $ 430,000    
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Deferred Underwriters' Business Combination Fees (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Deferred Underwriters' Business Combination Fees    
Deferred underwriters' marketing fees $ 1,550,500 $ 1,550,500
Deferred business combination fee based on gross proceeds (in percentage) 3.50%  
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Deficit- Preferred Stock Shares (Details) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Stockholders' Equity    
Preferred shares, shares authorized 1,000,000 1,000,000
Preferred stock, par value, (per share) $ 0.0001 $ 0.0001
Preferred shares, shares issued 0 0
Preferred shares, shares outstanding 0 0
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Deficit - Common Stock Shares (Details) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Stockholders' Equity    
Common shares, shares authorized (in shares) 30,000,000 30,000,000
Common shares, par value (in dollars per share) $ 0.0001 $ 0.0001
Common shares, shares issued (in shares) 1,419,700 1,419,700
Common shares, shares outstanding (in shares) 1,419,700 1,419,700
Class A common stock subject to possible redemption, issued (in shares) 910,220 4,430,000
Class A common stock subject to possible redemption, outstanding (in shares) 910,220 4,430,000
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Deficit - Warrants (Details)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2022
USD ($)
Item
d
$ / shares
shares
Jul. 31, 2021
$ / shares
shares
Jul. 19, 2021
$ / shares
Class of Warrant or Right [Line Items]      
Sale price   $ 11.5  
Initial Public Offering      
Class of Warrant or Right [Line Items]      
Stock And Warrants Issued During Period Share Preferred Stock And Warrants | shares   2,215,000  
Sale price     $ 10
Number of warrants to purchase shares issued | shares 2,215,000    
Fair value of warrants | $ $ 0.8    
Exercise price of warrants $ 0.36    
Warrants      
Class of Warrant or Right [Line Items]      
Public Warrants expiration term   5 years  
Number of shares per warrant | shares   1  
Maximum period after business combination in which to file registration statement 30 days    
Period of time within which registration statement is expected to become effective 60 days    
Warrants | Redemption Of Warrants When Price Per Share Of Class Common Stock Equals Or Exceeds 16.50      
Class of Warrant or Right [Line Items]      
Warrant redemption condition minimum share price $ 16.5    
Redemption price per public warrant (in dollars per share) $ 0.01    
Threshold trading days for redemption of public warrants 20 days    
Threshold consecutive trading days for redemption of public warrants | Item 30    
Threshold number of business days before sending notice of redemption to warrant holders | d 3    
Redemption period 30 days    
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Components Of Income Tax Provision (Benefit) (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Current    
Federal $ 51,176 $ 0
State 0 0
Deferred    
Federal 316,798 52,021
State 0 0
Valuation allowance (287,326) (52,021)
Income tax provision $ 80,648 $ 0
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Schedule of reconciliation of the total income tax provision tax rate to the statutory federal income tax rate (Details)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Taxes    
U.S. statutory rate 21.00% 21.00%
Permanent difference on facilitated acquisition costs (3.60%) 0.00%
Change in valuation allowance (26.20%) (21.00%)
Effective tax rate (8.80%) 0.00%
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Deferred Tax (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets:    
Start-up/organization costs $ 292,154 $ 0
Net operating loss carryover 0 52,021
Deferred tax liability:    
Accrued dividend income (29,472) 0
Total deferred tax assets 262,682 52,021
Valuation allowance (292,154) (52,021)
Deferred tax liability, net of allowance (29,472) 0
Operating Loss Carryforwards $ 0 $ 247,718
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Subsequent Events (Details) - USD ($)
Mar. 19, 2023
Mar. 03, 2023
Jan. 19, 2023
Jan. 19, 2021
Promissory Note with Related Party        
Subsequent Event [Line Items]        
Maximum borrowing capacity of related party promissory note       $ 400,000
Subsequent Event [Member] | Estrella Biopharma, Inc [Member]        
Subsequent Event [Line Items]        
Assets Held-in-trust $ 45,511      
Subsequent Event [Member] | Promissory Note with Related Party        
Subsequent Event [Line Items]        
Maximum borrowing capacity of related party promissory note $ 45,511      
Subsequent Event [Member] | Trade Up Inc | Promissory Note with Related Party        
Subsequent Event [Line Items]        
Maximum borrowing capacity of related party promissory note   $ 50,000    
Subsequent Event [Member] | Sponsor        
Subsequent Event [Line Items]        
Maximum borrowing capacity of related party promissory note     $ 50,000  
XML 55 uptd-20221231_htm.xml IDEA: XBRL DOCUMENT 0001844417 2021-12-31 0001844417 2022-12-31 0001844417 2021-01-06 2021-12-31 0001844417 2022-01-01 2022-12-31 0001844417 2021-07-31 0001844417 2021-07-19 2021-12-31 0001844417 2021-01-01 2021-12-31 0001844417 2023-03-14 0001844417 2022-07-25 0001844417 2022-08-16 2022-08-16 0001844417 2022-06-30 0001844417 2021-07-19 0001844417 2021-01-05 0001844417 uptd:CommonStockSubjectToRedemptionMember 2022-12-31 0001844417 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryBondSecuritiesMember 2022-12-31 0001844417 uptd:WorkingCapitalLoansWarrantMember uptd:RelatedPartyLoansMember 2022-12-31 0001844417 uptd:PublicWarrantsMember us-gaap:IPOMember 2022-12-31 0001844417 uptd:FounderSharesMember us-gaap:OverAllotmentOptionMember 2022-12-31 0001844417 us-gaap:IPOMember 2022-12-31 0001844417 uptd:PublicWarrantsMember 2022-12-31 0001844417 uptd:SponsorMember 2022-12-31 0001844417 us-gaap:CommercialLoanMember 2022-12-31 0001844417 us-gaap:CommonClassAMember 2022-12-31 0001844417 uptd:MergerAgreementMember uptd:ShareholdersOfEstrellaMember 2022-12-31 0001844417 uptd:CommonStockSubjectToRedemptionMember 2021-12-31 0001844417 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryBondSecuritiesMember 2021-12-31 0001844417 uptd:FounderSharesMember us-gaap:OverAllotmentOptionMember 2021-12-31 0001844417 us-gaap:CommercialLoanMember 2021-12-31 0001844417 uptd:RedeemableCommonStockMember 2022-01-01 2022-12-31 0001844417 uptd:NonRedeemableCommonStockMember 2022-01-01 2022-12-31 0001844417 uptd:BusinessCombinationMarketingAgreementMember 2022-01-01 2022-12-31 0001844417 us-gaap:OverAllotmentOptionMember 2022-01-01 2022-12-31 0001844417 us-gaap:IPOMember 2022-01-01 2022-12-31 0001844417 uptd:FounderSharesMember us-gaap:OverAllotmentOptionMember 2022-01-01 2022-12-31 0001844417 us-gaap:PrivatePlacementMember 2022-01-01 2022-12-31 0001844417 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001844417 uptd:CommonStockSubjectToPossibleRedemptionMember 2022-01-01 2022-12-31 0001844417 us-gaap:ParentMember 2022-01-01 2022-12-31 0001844417 uptd:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds16.50Member us-gaap:WarrantMember 2022-01-01 2022-12-31 0001844417 uptd:FounderSharesMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001844417 uptd:FounderSharesMember 2022-01-01 2022-12-31 0001844417 uptd:FounderSharesMember uptd:SponsorMember 2022-01-01 2022-12-31 0001844417 uptd:FounderSharesMember us-gaap:OverAllotmentOptionMember 2022-01-01 2022-12-31 0001844417 uptd:PublicWarrantsMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001844417 us-gaap:WarrantMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001844417 uptd:UnitsEachConsistingOfOneShareOfClassCommonStockAndOneHalfOfOneWarrantMember 2022-01-01 2022-12-31 0001844417 us-gaap:CommonClassAMember 2022-01-01 2022-12-31 0001844417 uptd:WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember 2022-01-01 2022-12-31 0001844417 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001844417 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001844417 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001844417 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001844417 uptd:SponsorMember 2022-01-01 2022-12-31 0001844417 uptd:FriedmanLlpMember 2022-01-01 2022-12-31 0001844417 uptd:FounderSharesMember 2021-01-06 2021-09-30 0001844417 us-gaap:IPOMember 2021-07-19 2021-07-19 0001844417 uptd:SponsorMember us-gaap:PrivatePlacementMember 2021-07-19 2021-07-19 0001844417 us-gaap:PrivatePlacementMember 2021-07-19 2021-07-19 0001844417 us-gaap:OverAllotmentOptionMember 2021-07-19 2021-07-19 0001844417 uptd:TradeUpIncMember us-gaap:PrivatePlacementMember 2021-07-19 2021-07-19 0001844417 us-gaap:PrivatePlacementMember 2021-07-19 0001844417 us-gaap:OverAllotmentOptionMember 2021-07-19 0001844417 us-gaap:IPOMember 2021-07-19 0001844417 uptd:SponsorMember us-gaap:PrivatePlacementMember 2021-07-19 0001844417 uptd:TradeUpIncMember us-gaap:PrivatePlacementMember 2021-07-19 0001844417 us-gaap:OverAllotmentOptionMember 2021-07-21 2021-07-21 0001844417 uptd:SponsorMember us-gaap:PrivatePlacementMember 2021-07-21 2021-07-21 0001844417 us-gaap:PrivatePlacementMember 2021-07-21 2021-07-21 0001844417 us-gaap:IPOMember 2021-07-21 2021-07-21 0001844417 uptd:FounderSharesMember us-gaap:PrivatePlacementMember 2021-07-21 2021-07-21 0001844417 us-gaap:PrivatePlacementMember 2021-07-21 0001844417 uptd:SponsorMember us-gaap:PrivatePlacementMember 2021-07-21 0001844417 us-gaap:OverAllotmentOptionMember 2021-07-21 0001844417 us-gaap:IPOMember 2021-07-21 0001844417 uptd:TradeUpIncMember us-gaap:PrivatePlacementMember 2021-07-21 0001844417 uptd:RedeemableCommonStockMember 2021-01-06 2021-12-31 0001844417 uptd:NonRedeemableCommonStockMember 2021-01-06 2021-12-31 0001844417 us-gaap:RetainedEarningsMember 2021-01-06 2021-12-31 0001844417 us-gaap:AdditionalPaidInCapitalMember 2021-01-06 2021-12-31 0001844417 us-gaap:CommonStockMember 2021-01-06 2021-12-31 0001844417 us-gaap:PreferredStockMember 2021-01-06 2021-12-31 0001844417 uptd:CommonStockSubjectToPossibleRedemptionMember 2021-01-06 2021-12-31 0001844417 us-gaap:ParentMember 2021-01-06 2021-12-31 0001844417 us-gaap:PreferredStockMember us-gaap:IPOMember 2021-01-06 2021-12-31 0001844417 us-gaap:CommonStockMember us-gaap:IPOMember 2021-01-06 2021-12-31 0001844417 us-gaap:AdditionalPaidInCapitalMember us-gaap:IPOMember 2021-01-06 2021-12-31 0001844417 us-gaap:RetainedEarningsMember us-gaap:IPOMember 2021-01-06 2021-12-31 0001844417 us-gaap:IPOMember 2021-01-06 2021-12-31 0001844417 us-gaap:PreferredStockMember us-gaap:PrivatePlacementMember 2021-01-06 2021-12-31 0001844417 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2021-01-06 2021-12-31 0001844417 us-gaap:AdditionalPaidInCapitalMember us-gaap:PrivatePlacementMember 2021-01-06 2021-12-31 0001844417 us-gaap:RetainedEarningsMember us-gaap:PrivatePlacementMember 2021-01-06 2021-12-31 0001844417 us-gaap:PrivatePlacementMember 2021-01-06 2021-12-31 0001844417 us-gaap:OverAllotmentOptionMember 2021-09-01 2021-09-01 0001844417 uptd:PromissoryNoteWithRelatedPartyMember 2021-01-19 0001844417 uptd:TradeUpIncMember us-gaap:PrivatePlacementMember 2021-01-19 0001844417 uptd:FounderSharesMember uptd:SponsorMember 2021-01-20 2021-01-20 0001844417 uptd:FounderSharesMember uptd:SponsorMember 2021-02-11 2021-02-11 0001844417 uptd:FounderSharesMember uptd:SponsorMember 2021-02-11 0001844417 uptd:FounderSharesMember uptd:SponsorMember 2021-02-12 2021-02-12 0001844417 uptd:FounderSharesMember 2021-02-12 2021-02-12 0001844417 uptd:RunningLionHoldingsMember 2022-07-25 0001844417 uptd:TradeUpIncMember 2022-07-25 0001844417 us-gaap:IPOMember 2021-07-31 0001844417 us-gaap:WarrantMember 2021-07-31 0001844417 uptd:PromissoryNoteWithRelatedPartyMember us-gaap:SubsequentEventMember 2023-03-19 0001844417 us-gaap:SubsequentEventMember uptd:EstrellaBiopharmaIncMember 2023-03-19 0001844417 uptd:SponsorMember us-gaap:SubsequentEventMember 2023-01-19 0001844417 uptd:PromissoryNoteWithRelatedPartyMember uptd:TradeUpIncMember us-gaap:SubsequentEventMember 2023-03-03 0001844417 us-gaap:RetainedEarningsMember 2022-12-31 0001844417 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001844417 us-gaap:CommonStockMember 2022-12-31 0001844417 us-gaap:PreferredStockMember 2022-12-31 0001844417 us-gaap:RetainedEarningsMember 2021-01-05 0001844417 us-gaap:AdditionalPaidInCapitalMember 2021-01-05 0001844417 us-gaap:CommonStockMember 2021-01-05 0001844417 us-gaap:PreferredStockMember 2021-01-05 0001844417 us-gaap:RetainedEarningsMember 2021-12-31 0001844417 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001844417 us-gaap:CommonStockMember 2021-12-31 0001844417 us-gaap:PreferredStockMember 2021-12-31 iso4217:USD shares pure utr:Day utr:Year utr:Month iso4217:USD shares uptd:Item uptd:item utr:D 3 P10D NY 0001844417 FY false true true true 10-K true 2022-12-31 --12-31 2022 false 001-40608 TRADEUP ACQUISITION CORP. DE 85-1314502 437 Madison Avenue, 27th Floor New York, 10022 (732) 910-9692 Units, each consisting of one share of Common Stock and on-half of one Warrant NASDAQ Common Stock, par value $0.0001 per share NASDAQ Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 NASDAQ No No Yes Yes Non-accelerated Filer true true false true 58497000 2329920 Marcum LLP 688 Friedman LLP 711 East Hanover, New Jersey New York, NY 40802 478868 11625 137166 52427 616034 9671375 45187428 9723802 45803462 329166 3000 498600 50000 51176 144127 70154 1073069 73154 29472 1550500 1550500 2653041 1623654 910220 4430000 10.25 10.2 9326446 45186000 0.0001 0.0001 1000000 1000000 0 0 0 0 0.0001 0.0001 30000000 30000000 1419700 1419700 1419700 1419700 910220 4430000 142 142 -2255827 -1006334 -2255685 -1006192 9723802 45803462 1368219 178992 201308 70154 -1569527 -249146 654071 1428 -915456 -247718 80648 0 -996104 -247718 4343211 4343211 2033677 2033677 -0.16 -0.16 0.76 0.76 1419700 1419700 1179328 1179328 -0.22 -0.22 -1.52 -1.52 0 0 0 0 0 0 0 0 0 1150000 115 24885 0 25000 0 0 1150000 115 24885 0 25000 0 0 1150000 115 24885 0 25000 0 0 4430000 443 44299557 0 44300000 0 0 312200 31 3121969 0 3122000 0 0 0 0 -886000 0 -886000 0 0 0 0 -1550500 0 -1550500 0 0 0 0 -582974 0 -582974 0 0 -42500 -4 4 0 0 0 0 -4430000 -443 -43516256 0 -43516699 0 0 0 0 2966085 0 2966085 0 0 0 0 3876770 758616 4635386 0 0 0 0 0 -247718 -247718 0 0 1419700 142 0 -1006334 -1006192 0 0 0 0 0 253389 253389 0 0 0 0 0 -996104 -996104 0 0 1419700 142 0 -2255827 -2255685 -996104 -247718 654071 1428 29472 -125540 137166 326166 51176 73973 70154 -1043848 -316158 45186000 36170124 36170124 -45186000 25000 25000 25000 44300000 3122000 886000 579974 36112943 0 0 300000 300000 498600 50000 -35564343 45981026 -438066 478868 478868 40802 478868 3000 1550500 43516699 2966085 253389 4635386 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 1 — Organization and Business Operation</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="display:inline;"> </div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">TradeUP Acquisition Corp. (the “Company”) is a blank check company incorporated as a Delaware corporation on January 6, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has selected December 31 as its fiscal year end.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022 and 2021, the Company had not commenced any operations. For the period from January 6, 2021 (inception) through December 31, 2022, the Company’s efforts have been limited to organizational activities as well as activities related to the Initial Public Offering (as defined below). The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of dividend and interest income from the proceeds derived from the Initial Public Offering (as defined below).</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The registration statement for the Company’s initial public offering (the “Initial Public Offering”) became effective on July 14, 2021. On July 19, 2021, the Company consummated the Initial Public Offering of 4,000,000 units (the “Public Units”), at $10.00 per Public Unit, generating gross proceeds of $40,000,000 which is described in Note 4. On July 21, 2021, the underwriters partially exercised the over-allotment option and purchased 430,000 units (the “Option Units “, together with the Public Units, the “Units”) at a price of $10.00 per Option Unit, generating gross proceeds of $4,300,000. Each Unit consists of one share of common stock, $0.0001 par value per share (the “Common Stock”), and one-half of <div style="letter-spacing: 0px; top: 0px;;display:inline;">one</div> redeemable warrant (the “Warrant”), each whole Warrant entitling the holder thereof to purchase one share of Common Stock at an exercise price of $11.50 per share. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $44,300,000 in total. Transaction costs in connection with the Initial Public Offering and the issuance and sale of Option Units amounted to $3,019,474, consisting of $886,000 of underwriting fees, $1,550,500 of Business Combination Fee (defined in Note 7 below) and $582,974 of other offering costs. Following the expiration of the over-allotment option, 42,500 Founder Shares (defined below) were subsequently forfeited.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 295,000 shares of Common Stock (the “Private Placement Shares”) at a price of $10.00 per share in a private placement sale (the “Private Placement”) to the Company’s founders, or initial stockholders, include Tradeup INC. and the Company’s sponsor, TradeUP Acquisition Sponsor LLC, a Delaware limited liability company (the “Sponsor”), among which, the Sponsor purchased 236,000 Private Placement Shares and Tradeup INC. purchased 59,000 Private Placement Shares, generating gross proceeds of $2,950,000, which is described in Note 5. On July 21, 2021, the Company consummated the sale of additional 17,200 Private Placement Shares with the Sponsor and Tradeup INC. at a price of $10.00 per Private Placement share, among which, the Sponsor purchased 13,760 Private Placement Shares and Tradeup INC. purchased 3,440 Private Placement Shares, generating total proceeds of $172,000.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Following the closing of the Initial Public Offering on July 19, 2021, the issuance and sale of Option Units on July 21, 2021 and the issuance and sale of Private Placement Shares, $45,186,000 from the net proceeds of the sale of the Units and from the sale of Private Placement Shares was placed in a trust account (the “Trust Account”) maintained by Wilmington Trust, National Association as a trustee. The aggregate amount of $45,186,000 ($10.20 per Unit) will be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the long term (rather than on buying and selling businesses in the manner of a merchant bank or private equity fund), the Company intends to avoid being deemed an “investment company” within the meaning of the Investment Company Act. The Initial Public Offering is not intended for persons who are seeking a return on investments in government securities or investment securities. The Trust Account is intended as a holding place for funds pending the earliest to occur of either: (i) the completion of the Company’s initial Business Combination; (ii) the redemption of any public shares properly tendered in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation that would affect the substance or timing of the Company’s obligation to provide for the redemption of its public shares in connection with an initial Business Combination or to redeem 100% of its public shares if the Company has not consummated an initial Business Combination by the Combination Deadline (as defined below); or (iii) absent an initial Business Combination by the Combination Deadline, its return of the funds held in the Trust Account to its public stockholders as part of its redemption of the public shares. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public stockholders.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company’s initial Business Combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the Business Combination Fee and taxes payable and interest previously released for working capital purposes on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires an interest in the target sufficient for the post-transaction company not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;">  </div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> </div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The shares of Common Stock subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company initially had until January 19, 2023 to complete its initial Business Combination. On December 22, 2022, the Company held its special meeting of stockholders (the “Special Meeting”), where the Company was approved by its stockholders to amend the amended and restated certificate of incorporation to extend the date before which the Company must complete a Business Combination (the “Combination Deadline”) from January 19, 2023, by one month up to six times, to July 19, 2023, or such earlier date as determined by the board of directors of the Company (such monthly extension is herein referred to as the “Extension”). Upon the stockholders’ approval, on December 29, 2022, the Company filed a certificate of amendment to the amended and restated certificate of incorporation which became effective upon filing. If the Company is unable to complete the initial Business Combination by the Combination Deadline, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:hidden69480542">ten</span> business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company for working capital purposes or to pay the Company’s taxes (less up to $50,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and its board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s Warrants, which will expire worthless if the Company fails to complete the Business Combination by the Combination Deadline. The founders (not including the anchor investors who purchase units in the Initial Public Offering and certain membership interest in the Sponsor, if any), officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed (i) to waive their redemption rights with respect to any Founder Shares, Private Placement Shares and any public shares held by them in connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their Founder Shares, Private Placement Shares and public shares in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Company’s public shares if the Company does not complete its initial Business Combination by the Combination Deadline or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity and (iii) to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares and Private Placement Shares held by them if the Company fails to complete an initial Business Combination by the Combination Deadline, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination by the Combination Deadline. If the Company submits it initial Business Combination to its stockholders for a vote, the Company will complete its initial Business Combination only if a majority of the outstanding shares of Common Stock voted are voted in favor of the initial Business Combination. In no event will the Company redeem its public shares of Common Stock in an amount that would cause its net tangible assets to be less than $5,000,001. In such case, the Company would not proceed with the redemption of public shares of Common Stock and the related Business Combination, and instead may search for an alternate Business Combination.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or by a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.20 per public share or (ii) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, then the Company’s Sponsor will not be responsible to the extent of any liability for such third party claims.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="null;text-indent: 0px;;display:inline;">On December 22, 2022, the Company held the Special Meeting, where the Company was approved by its stockholders to amend the Investment Management Trust Agreement dated July 14, 2021 (the “Trust Agreement”), by and between the Company and Wilmington Trust, National Association (the “Trustee”) to extend the liquidation date from January 19, 2023 to July 19, 2023. In connection with the votes to approve the extension proposal, 3,519,780 public shares were rendered for redemption with 910,220 public shares remained outstanding.</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidity and Going Concern</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022, the Company had cash of $40,802 and a working deficit of $</div><div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;">1,020,642</div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">. The Company has incurred and expects to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of a Business Combination.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="background: none; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern. The management’s plan in addressing this uncertainty is through the Promissory Notes – related parties and the Working Capital Loans, as defined below (see Note 6). In addition, if the Company is unable to complete a Business Combination by the Combination Deadline, the Company’s board of directors would proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company. There is no assurance that the Company’s plans to consummate a Business Combination will be successful by the Combination Deadline. As a result, management has determined that such additional condition also raise substantial doubt about the Company’s ability to continue as a going concern. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="white-space: pre-wrap; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Merger Agreement</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On September 30, 2022, the Company, Tradeup Merger Sub Inc., a Delaware corporation and direct, wholly owned subsidiary of the Company (“Merger Sub”), and Estrella Biopharma, Inc., a Delaware corporation (the “Estrella”), entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the “Merger Agreement”).<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">The merger consideration shares to be issued by the Company to the shareholder of Estrella is expected to be 32,500,000 shares of Common Stock.</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="background: none; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Estrella is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS®️ T-cell therapies with the capacity to address treatment and safety challenges for patients with blood cancers and solid tumors. Estrella’s mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Pursuant to the Merger Agreement, among other things, in accordance with the General Corporation Law of the State of Delaware, as amended (the “DGCL”), Merger Sub will merge with and into Estrella (the “Merger”), with Estrella surviving the Merger as a wholly owned subsidiary of the Company (“Surviving Company”). The Merger will become effective at such time on the date of the closing of the Merger (the “Closing”) as the certificate of merger is duly filed with the Delaware Secretary of State or at such other time specified in the certificates of merger (the “Effective Time”). Effective as of the Closing, the Company will change its name to “Estrella Immunopharma, Inc.”</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Inflation Reduction Act of 2022</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its stockholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination), and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.</div></div> 1 4000000 10 40000000 430000 10 4300000 0.0001 1 1 11.5 10 44300000 3019474 886000 1550500 582974 42500 295000 10 236000 59000 2950000 17200 10 13760 3440 172000 45186000 45186000 10.2 1 0.80 0.50 5000001 50000 1 5000001 10.2 3519780 910220 40802 1020642 32500000 0.01 0.01 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 2 — Significant Accounting Policies</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><br/></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Basis of Presentation</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Emerging Growth Company Status</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of these financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Investments held in Trust Account</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022 and 2021, the assets held in the Trust Account were held in money market funds, which are invested in U.S. Treasury securities.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 “Investments — Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheet and adjusted for the amortization or accretion of premiums or discounts.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Offering Costs</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with the requirements of FASB ASC Topic 340-10-S99-1, “</div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Other Assets and Deferred Costs – SEC Materials</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">” (“ASC 340-10-S99”) and SEC Staff Accounting Bulletin Topic 5A, “</div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expenses of Offering</div></div><div style="white-space:pre-line; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">”. </div><div style="background: none; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Offering costs were $3,019,474 consisting principally of underwriting, legal, accounting and other expenses that are directly related to the Initial Public Offering and charged to stockholders’ equity upon the completion of the Initial Public Offering.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div> <div style="background: none; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="background: none; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) ASC 480 “Distinguishing Liabilities from Equity” (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own Common Stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. (See Note 9).</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Stock Subject to Possible Redemption</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Common Stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common Stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Common Stock (including Common Stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Common Stock are classified as stockholders’ equity. The Company’s public shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of December 31, 2022 and 2021, Common Stock subject to possible redemption are presented at redemption value of $10.25 and $10.20 per share, respectively, as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Common Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Common Stock are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital equals to zero.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/> <div style="margin-top: 0px; margin-bottom: 0px;"/><div style="margin-top: 0px; margin-bottom: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="margin-top: 0px; margin-bottom: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risk</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. As of December 31, 2022 and 2021, $0 and approximately $229,000, respectively, was over the Federal Deposit Insurance Corporation (FDIC) limit.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value of Financial Instruments</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0.25in; text-align: justify; text-indent: -0.25in; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="null;text-indent: 0px;;text-align:left;"><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 100%;"><tr><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; width: 13.5pt; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; width: 18pt; font-size: 10pt; line-height: 12pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;;text-indent: 0px;"><div style="font-size: 10pt; line-height: 12pt; font-family: Symbol; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">·</div></div></td><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active market.</div></div></td></tr><tr><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"> </div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"/></td><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; font-size: 10pt; line-height: 12pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;;text-indent: 0px;"><div style="font-size: 10pt; line-height: 12pt; font-family: Symbol; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">·</div></div></td><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</div></div></td></tr></table></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0.25in; text-align: justify; text-indent: -0.25in; line-height: 12pt; background: none;"/><div style="null;text-indent: 0px;;text-align:left;"><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 100%;"><tr><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; width: 13.5pt; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; width: 18pt; font-size: 10pt; line-height: 12pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;;text-indent: 0px;"><div style="font-size: 10pt; line-height: 12pt; font-family: Symbol; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">·</div></div></td><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value.</div></div></td></tr></table></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Income Taxes</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has identified the United States as its only “major” tax jurisdiction.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company is incorporated in the State of Delaware and is required to pay franchise taxes to the State of Delaware on an annual basis.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></div><div style="margin: 0px 0px 0px 0cm; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (H.R. 5376) (the “IRA”), which, among other things, imposes a 1% excise tax on any domestic corporation that repurchases its stock after December 31, 2022 (the “Excise Tax”). The Excise Tax is imposed on the fair market value of the repurchased stock, with certain exceptions.</div></div><div style="margin-bottom: 0px; margin-top: 0px; font-size: 10.8pt; background: none;;text-indent: 0px;"><div style="font-size: 10.8pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="margin: 0pt 0px 0pt 0cm; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt; background: none; text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Because the Company is a Delaware corporation and our securities trades on Nasdaq, it is a “covered corporation” within the meaning of the IRA. The Excise Tax may apply to any redemptions of the Company’s common stock after December 31, 2022, including redemptions in connection with the Merger, unless an exemption is available. Issuances of securities in connection with the Merger are expected to reduce the amount of the Excise Tax in connection with redemptions occurring in the same calendar year, but the number of securities redeemed may exceed the number of securities issued. Further, the application of the Excise Tax in the event of a liquidation is uncertain. The Company is currently evaluating the impact it will have in the event of the Merger or liquidation.</div></div><div style="margin: 0pt 0px 0pt 0cm; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt; background: none; text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-right: 0px; line-height: 12pt; background: none; text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-right: 0px; line-height: 12pt; background: none; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-right: 0px; line-height: 12pt; background: none; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net Income (Loss) per Share</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable Common Stock and non-redeemable Common Stock and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable Common Stock. Any remeasurement of the accretion to redemption value of the Common Stock subject to possible redemption was considered to be dividends paid to the public stockholders. For the years ended December 31, 2022 and 2021, the Company has not considered the effect of the Warrants sold in the Initial Public Offering to purchase an aggregate of 2,215,000 shares in the calculation of diluted net income (loss) per share, since the exercise of the Warrants is contingent upon the occurrence of future events and the inclusion of such Warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into Common Stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic (income) loss per share for the period presented.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The net income (loss) per share <div style="display:inline;">presented </div>in the statement of operations is based on the following:</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 100%;;margin-right : auto;;margin-right : auto;"><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">For the Period From</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">For the</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">January 6, 2021</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Year Ended</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">(inception) through</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px 0px 0.5pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2022</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2021</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Non-</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Non-</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Redeemable</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Redeemable</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Redeemable</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Redeemable</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Common</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Common</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Common</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Common</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px 0px 0.5pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Stock</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Stock</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Stock</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Stock</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 0px 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income/(loss) per share:</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0px 0px 0px 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Numerators:</div></div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 0px 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net loss including carrying value to redemption value</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(941,679</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(307,814</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(3,090,769</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(1,792,335</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0px 0px 0.5pt 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">253,389</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">4,635,386</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 1.25pt 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net income/(loss)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"/>(688,290<div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(307,814</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,544,617</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(1,792,335</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0px 0px 0px 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Denominators:</div></div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: none; border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 1.25pt 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average shares outstanding</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">4,343,211</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,419,700</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">2,033,677</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,179,328</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0px 0px 1.25pt 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income/(loss) per share</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(0.16</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(0.22</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">0.76</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(1.52</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> </div><div><div style="clear: both; max-height: 0px;"/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recent Accounting Pronouncements</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of these financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Investments held in Trust Account</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022 and 2021, the assets held in the Trust Account were held in money market funds, which are invested in U.S. Treasury securities.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 “Investments — Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheet and adjusted for the amortization or accretion of premiums or discounts.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Offering Costs</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with the requirements of FASB ASC Topic 340-10-S99-1, “</div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Other Assets and Deferred Costs – SEC Materials</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">” (“ASC 340-10-S99”) and SEC Staff Accounting Bulletin Topic 5A, “</div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expenses of Offering</div></div><div style="white-space:pre-line; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">”. </div><div style="background: none; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Offering costs were $3,019,474 consisting principally of underwriting, legal, accounting and other expenses that are directly related to the Initial Public Offering and charged to stockholders’ equity upon the completion of the Initial Public Offering.</div></div> 3019474 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div> <div style="background: none; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="background: none; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) ASC 480 “Distinguishing Liabilities from Equity” (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own Common Stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. (See Note 9).</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Stock Subject to Possible Redemption</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Common Stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common Stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Common Stock (including Common Stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Common Stock are classified as stockholders’ equity. The Company’s public shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of December 31, 2022 and 2021, Common Stock subject to possible redemption are presented at redemption value of $10.25 and $10.20 per share, respectively, as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Common Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Common Stock are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital equals to zero.</div></div> 10.25 10.2 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risk</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. As of December 31, 2022 and 2021, $0 and approximately $229,000, respectively, was over the Federal Deposit Insurance Corporation (FDIC) limit.</div></div> 0 229000 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value of Financial Instruments</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0.25in; text-align: justify; text-indent: -0.25in; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="null;text-indent: 0px;;text-align:left;"><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 100%;"><tr><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; width: 13.5pt; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; width: 18pt; font-size: 10pt; line-height: 12pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;;text-indent: 0px;"><div style="font-size: 10pt; line-height: 12pt; font-family: Symbol; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">·</div></div></td><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active market.</div></div></td></tr><tr><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"> </div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"/></td><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; font-size: 10pt; line-height: 12pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;;text-indent: 0px;"><div style="font-size: 10pt; line-height: 12pt; font-family: Symbol; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">·</div></div></td><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</div></div></td></tr></table></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0.25in; text-align: justify; text-indent: -0.25in; line-height: 12pt; background: none;"/><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 100%;"><tr><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; width: 13.5pt; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; width: 18pt; font-size: 10pt; line-height: 12pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;;text-indent: 0px;"><div style="font-size: 10pt; line-height: 12pt; font-family: Symbol; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">·</div></div></td><td style="border-width: initial; border-style: none; border-color: initial; padding: 0pt 0px; vertical-align: top; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value.</div></div></td></tr></table> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Income Taxes</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has identified the United States as its only “major” tax jurisdiction.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company is incorporated in the State of Delaware and is required to pay franchise taxes to the State of Delaware on an annual basis.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></div><div style="margin: 0px 0px 0px 0cm; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (H.R. 5376) (the “IRA”), which, among other things, imposes a 1% excise tax on any domestic corporation that repurchases its stock after December 31, 2022 (the “Excise Tax”). The Excise Tax is imposed on the fair market value of the repurchased stock, with certain exceptions.</div></div><div style="margin-bottom: 0px; margin-top: 0px; font-size: 10.8pt; background: none;;text-indent: 0px;"><div style="font-size: 10.8pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="margin: 0pt 0px 0pt 0cm; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt; background: none; text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Because the Company is a Delaware corporation and our securities trades on Nasdaq, it is a “covered corporation” within the meaning of the IRA. The Excise Tax may apply to any redemptions of the Company’s common stock after December 31, 2022, including redemptions in connection with the Merger, unless an exemption is available. Issuances of securities in connection with the Merger are expected to reduce the amount of the Excise Tax in connection with redemptions occurring in the same calendar year, but the number of securities redeemed may exceed the number of securities issued. Further, the application of the Excise Tax in the event of a liquidation is uncertain. The Company is currently evaluating the impact it will have in the event of the Merger or liquidation.</div></div> 0.01 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-right: 0px; line-height: 12pt; background: none; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net Income (Loss) per Share</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable Common Stock and non-redeemable Common Stock and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable Common Stock. Any remeasurement of the accretion to redemption value of the Common Stock subject to possible redemption was considered to be dividends paid to the public stockholders. For the years ended December 31, 2022 and 2021, the Company has not considered the effect of the Warrants sold in the Initial Public Offering to purchase an aggregate of 2,215,000 shares in the calculation of diluted net income (loss) per share, since the exercise of the Warrants is contingent upon the occurrence of future events and the inclusion of such Warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into Common Stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic (income) loss per share for the period presented.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The net income (loss) per share <div style="display:inline;">presented </div>in the statement of operations is based on the following:</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 100%;;margin-right : auto;;margin-right : auto;"><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">For the Period From</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">For the</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">January 6, 2021</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Year Ended</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">(inception) through</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px 0px 0.5pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2022</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2021</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Non-</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Non-</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Redeemable</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Redeemable</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Redeemable</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Redeemable</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Common</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Common</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Common</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Common</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px 0px 0.5pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Stock</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Stock</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Stock</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Stock</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 0px 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income/(loss) per share:</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0px 0px 0px 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Numerators:</div></div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 0px 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net loss including carrying value to redemption value</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(941,679</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(307,814</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(3,090,769</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(1,792,335</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0px 0px 0.5pt 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">253,389</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">4,635,386</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 1.25pt 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net income/(loss)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"/>(688,290<div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(307,814</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,544,617</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(1,792,335</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0px 0px 0px 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Denominators:</div></div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: none; border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 1.25pt 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average shares outstanding</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">4,343,211</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,419,700</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">2,033,677</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,179,328</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0px 0px 1.25pt 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income/(loss) per share</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(0.16</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(0.22</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">0.76</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(1.52</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td></tr></table> 2215000 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The net income (loss) per share <div style="display:inline;">presented </div>in the statement of operations is based on the following:</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 100%;;margin-right : auto;;margin-right : auto;"><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">For the Period From</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">For the</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">January 6, 2021</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Year Ended</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">(inception) through</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px 0px 0.5pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2022</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2021</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Non-</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Non-</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Redeemable</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Redeemable</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Redeemable</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Redeemable</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Common</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Common</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Common</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Common</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-top: none; border-bottom: none; padding: 0px 0px 0.5pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Stock</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Stock</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Stock</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Stock</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 0px 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income/(loss) per share:</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0px 0px 0px 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Numerators:</div></div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 0px 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net loss including carrying value to redemption value</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(941,679</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(307,814</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(3,090,769</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(1,792,335</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0px 0px 0.5pt 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">253,389</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">4,635,386</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 1.25pt 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net income/(loss)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"/>(688,290<div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(307,814</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,544,617</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(1,792,335</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0px 0px 0px 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Denominators:</div></div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: none; border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0in none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: 0in none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 1.25pt 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average shares outstanding</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">4,343,211</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,419,700</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">2,033,677</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,179,328</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0px 0px 1.25pt 7.2pt; vertical-align: bottom; width: 48%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: -0.1in; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income/(loss) per share</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(0.16</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(0.22</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">0.76</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(1.52</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td></tr></table> -941679 -307814 -3090769 -1792335 253389 0 4635386 0 -688290 -307814 1544617 -1792335 4343211 4343211 1419700 1419700 2033677 2033677 1179328 1179328 -0.16 -0.16 -0.22 -0.22 0.76 0.76 -1.52 -1.52 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recent Accounting Pronouncements</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 3 — <div style="display:inline;">Investments </div>Held in Trust Account</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022 and 2021, assets <div style="display:inline;">held </div>in the Trust Account were comprised of $9,671,375 and $45,187,428, respectively, in money market funds which are invested in U.S. Treasury Securities.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2022 and <div style="display:inline;">2021</div> and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</div></div><div style="margin-top: 1em; margin-bottom: 1em"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 100%;;margin-right : auto;;margin-right : auto;"><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0px; vertical-align: bottom; width: 61%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Level</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2022</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2021</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 61%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 61%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Trust Account - U.S. Treasury Securities Money <div style="display:inline;">Market</div> Fund</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; white-space: nowrap; text-align: center;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">9,671,375</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">45,187,428</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr></table><div style="clear: both; max-height: 0px;"/></div><div><div style="clear: both; max-height: 0px;"/></div><div><div style="clear: both; max-height: 0px;"/></div><div><div style="clear: both; max-height: 0px;"/></div><div><div style="clear: both; max-height: 0px;"/></div>  9671375 45187428 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2022 and <div style="display:inline;">2021</div> and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</div></div><div style="margin-top: 1em; margin-bottom: 1em"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 100%;;margin-right : auto;;margin-right : auto;"><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0px; vertical-align: bottom; width: 61%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Level</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2022</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2021</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 61%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: 0px none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 61%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Trust Account - U.S. Treasury Securities Money <div style="display:inline;">Market</div> Fund</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; white-space: nowrap; text-align: center;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">9,671,375</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; border-bottom: none; border-top: none; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">45,187,428</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr></table> 9671375 45187428 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 4 — Initial Public Offering</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Pursuant to the Initial Public Offering on July 19, 2021, the Company sold 4,000,000 Units at $10.00 per Public Unit, which does not include the 45-day option of the exercise of the underwriters’ 600,000 over-allotment option. On July 21, 2021, the underwriters partially exercised the over-allotment option and purchased 430,000 Option Units at a price of $10.00 per Option Unit, generating gross proceeds of $4,300,000.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The remaining 170,000 Option Units were expired on September 1, 2021. Transaction costs in connection with the Initial Public Offering and the issuance and sale of Option Units amounted to $3,019,474, consisting of $886,000 of underwriting fees, $1,550,500 of Business Combination Fee (defined in Note 7 below) and $582,974 of other offering costs.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Each Unit has an offering price of $10.00 and consists of one share of the Common Stock and one-half of one redeemable Warrant. The Company will not issue fractional shares. As a result, the warrants must be exercised in multiples of one whole Warrant. Each whole Warrant entitles the holder thereof to purchase one share of the Company’s Common Stock at a price of $11.50 per share, and only whole Warrants are exercisable. The Warrants will become exercisable on the later of 30 days after the completion of the Company’s initial Business Combination or 12 months from the closing of the Initial Public Offering, and will expire five years after the completion of the Company’s initial Business Combination or earlier upon redemption or liquidation.</div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">All of the 4,430,000 public shares sold as part of the Units in the Initial Public Offering contain a redemption feature which allows for the redemption of such public shares if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation, or in connection with the Company’s liquidation. In accordance with the Securities and Exchange Commission (the “SEC”) and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require Common Stock subject to redemption to be classified outside of permanent equity.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company’s redeemable Common Stock is subject to SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022 and 2021, 910,220 and 4,430,000 shares, respectively, of Common Stock subject to possible redemption reflected on the balance sheet are reconciled in the following table.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="margin-top: 1em; margin-bottom: 1em"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"/></div><table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;;margin-right : auto;"><tr><td style="width: 87%; padding: 0px 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Common stock subject to possible redemption, July 19, 2021</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></div></td><td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">44,300,000</div></div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Less:</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"/></div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Proceeds allocated to public warrants</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;">(783,301</div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;">)</div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Offering costs of public shares</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;">(2,966,085</div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;">)</div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"/></div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in 0.5pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></div></td><td style="width: 1%; padding: 0in 0in 0.5pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); border-bottom: 1pt solid windowtext; border-top: none; text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="border-top: none; border-image: initial; border-bottom: 1pt solid windowtext; width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">4,635,386</div></div></div></td><td style="width: 1%; padding: 0in 0in 0.5pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Common stock subject to possible redemption, December 31, 2021</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); border-bottom: none; border-top: 0px none; text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="border-top: 0px none; border-bottom: none; border-image: initial; width: 10%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">45,186,000</div></div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Less:</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"/></div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Redemptions</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;">(36,112,943</div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;">)</div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"/></div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in 0.5pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></div></td><td style="width: 1%; padding: 0in 0in 0.5pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); border-bottom: 1pt solid windowtext; border-top: none; text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="border-top: none; border-image: initial; border-bottom: 1pt solid windowtext; width: 10%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">253,389</div></div></div></td><td style="width: 1%; padding: 0in 0in 0.5pt; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in 1.25pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Common stock subject to possible redemption, December 31, 2022</div></div></div></td><td style="width: 1%; padding: 0in 0in 1.25pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; border-bottom: 2.5pt double windowtext; background-color: rgba(255, 255, 255, 0); border-top: 0px none; text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;;;display:inline;">$</div></div></div></td><td style="border-top: 0px none; border-bottom: 2.5pt double windowtext; border-image: initial; width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;;;display:inline;">9,326,446</div></div></div></td><td style="width: 1%; padding: 0in 0in 1.25pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;;;display:inline;"> </div></div></div></td></tr></table> 4000000 10 P45D 600000 430000 10 4300000 170000 3019474 886000 1550500 582974 10 1 1 1 1 11.5 P30D P12M P5Y 4430000 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022 and 2021, 910,220 and 4,430,000 shares, respectively, of Common Stock subject to possible redemption reflected on the balance sheet are reconciled in the following table.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="margin-top: 1em; margin-bottom: 1em"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"/></div><table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;;margin-right : auto;"><tr><td style="width: 87%; padding: 0px 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Common stock subject to possible redemption, July 19, 2021</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></div></td><td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">44,300,000</div></div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Less:</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"/></div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Proceeds allocated to public warrants</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;">(783,301</div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;">)</div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Offering costs of public shares</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;">(2,966,085</div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;">)</div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"/></div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in 0.5pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></div></td><td style="width: 1%; padding: 0in 0in 0.5pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); border-bottom: 1pt solid windowtext; border-top: none; text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="border-top: none; border-image: initial; border-bottom: 1pt solid windowtext; width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">4,635,386</div></div></div></td><td style="width: 1%; padding: 0in 0in 0.5pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Common stock subject to possible redemption, December 31, 2021</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); border-bottom: none; border-top: 0px none; text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="border-top: 0px none; border-bottom: none; border-image: initial; width: 10%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">45,186,000</div></div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Less:</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"/></div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Redemptions</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;">(36,112,943</div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;">)</div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"/></div></div></td><td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in 0.5pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></div></td><td style="width: 1%; padding: 0in 0in 0.5pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 9pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); border-bottom: 1pt solid windowtext; border-top: none; text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="border-top: none; border-image: initial; border-bottom: 1pt solid windowtext; width: 10%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">253,389</div></div></div></td><td style="width: 1%; padding: 0in 0in 0.5pt; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in 1.25pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Common stock subject to possible redemption, December 31, 2022</div></div></div></td><td style="width: 1%; padding: 0in 0in 1.25pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td><td style="width: 1%; padding: 0in; border-bottom: 2.5pt double windowtext; background-color: rgba(255, 255, 255, 0); border-top: 0px none; text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;;;display:inline;">$</div></div></div></td><td style="border-top: 0px none; border-bottom: 2.5pt double windowtext; border-image: initial; width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;;;display:inline;">9,326,446</div></div></div></td><td style="width: 1%; padding: 0in 0in 1.25pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: normal; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;;;display:inline;"> </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"/><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="clear:both;max-height:0pt;;text-indent: 0px;"/> 910220 4430000 44300000 783301 2966085 4635386 45186000 36112943 253389 9326446 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 5 — Private Placement</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the closing of the Initial Public Offering, the Sponsor and Tradeup INC. purchased an aggregate of 295,000 shares of Common Stock at a price of $10.00 per share, among which, the Sponsor purchased 236,000 Private Placement Shares and Tradeup INC. purchased 59,000 Private Placement Shares, generating total proceeds of $2,950,000. On July 21, 2021, the Company consummated the sale of additional 17,200 Private Placement Shares with the Sponsor and Tradeup INC., among which, the Sponsor purchased 13,760 Private Placement Shares and Tradeup INC. purchased 3,440 Private Placement Shares, at a price of $10.00 per Private Placement share, generating total proceeds of $172,000. The proceeds from the sale of the Private Placement Shares were held outside of the Trust Account and is available for the payment of offering costs and for working capital purposes. The Sponsor will be permitted to transfer the Private Placement Shares held by them to certain permitted transferees, including the Company’s officers and directors and other persons or entities affiliated with or related to it or them, but the transferees receiving such shares will be subject to the same agreements with respect to such securities as the founders. Otherwise, these Private Placement Shares will not, subject to certain limited exceptions, be transferable or salable until 30 days after the completion of the Company’s Business Combination.</div></div> 295000 10 236000 59000 2950000 17200 13760 3440 10 172000 P30D <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 6 — Related Party Transactions</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Founder and Private Placement Shares</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On January 20, 2021, the Sponsor acquired 1,150,000 founder shares for an aggregate purchase price of $25,000. On February 11, 2021, in connection with a restructure of the Sponsor, the Sponsor forfeited 1,150,000 founder shares upon the receipt of the refund of purchase price of $25,000. On February 12, 2021, the Sponsor acquired 920,000 founder shares for a purchase price of $20,000 and Tradeup INC. acquired 230,000 founder shares for a purchase price of $5,000, respectively (collectively as the “Founder Shares”).</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022 and 2021, there were 1,107,500 Founder Shares issued and outstanding. The aggregate capital contribution was $25,000, or approximately $0.02 per share.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The number of Founder Shares issued was determined based on the expectation that such Founder Shares would represent 20% of the outstanding shares upon completion of the Initial Public Offering.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> </div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The founders have agreed not to transfer, assign or sell 50% of its Founder Shares until the earlier to occur of: (A) six months after the date of the consummation of the Company’s initial Business Combination, or (B) the date on which the closing price of the Company’s Common Stock equals or exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after the Company’s initial Business Combination and the remaining 50% of the Founder Shares may not be transferred, assigned or sold until six months after the date of the consummation of the Company’s initial Business Combination, or earlier, in either case, if, subsequent to the Company’s initial Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares for cash, securities or other property.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On July 19, 2021, the Company consummated the sale of 295,000 Private Placement Shares at a price of $10.00 per share in the Private Placement to the Sponsor and Tradeup INC., among which, the Sponsor purchased 236,000 Private Placement Shares and Tradeup INC. purchased 59,000 Private Placement Shares, generating gross proceeds of $2,950,000. On July 21, 2021, the Company consummated the sale of additional 17,200 Private Placement Shares with the Sponsor and Tradeup INC. at a price of $10.00 per Private Placement share, among which, the Sponsor purchased 13,760 Private Placement Shares and Tradeup INC. purchased 3,440 Private Placement Shares, generating total proceeds of $172,000. The Private Placement Shares are identical to the shares of Common Stock sold as part of the units in this Initial Public Offering, subject to limited exceptions. The Private Placement Shares will not be transferable, assignable or salable until 30 days after the completion of the Company’s initial Business Combination.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: Calibri, sans-serif; background: none;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: Calibri, sans-serif; background: none;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;">Working Capital Loans (Promissory Notes) — Related Parties</div></div></div><div style="margin: 0px 0px 0px 0cm; text-align: justify; line-height: 12pt; font-family: Calibri, sans-serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); white-space: pre-wrap; background: none; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="margin: 0px 0px 0px 0cm; text-align: justify; line-height: 12pt; font-family: Calibri, sans-serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;">In order to finance transaction costs in connection with an intended initial Business Combination, the founders or an affiliate of the founders or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes the initial Business Combination, it would repay such loaned amounts. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used for such repayment. Up to approximately $1,200,000</div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> of such loans may be convertible into Private Placement Shares, at a price of $10.00 per share at the option of the lender.</div></div><div style="margin: 0px 0px 0px 0cm; text-align: justify; line-height: 12pt; font-family: Calibri, sans-serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div><div style="background: none; font-size: 10pt; letter-spacing: 0px; white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; text-decoration: none; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On January 19, 2021, the Sponsor has agreed to loan the Company up to $400,000 to be used for a portion of the expenses of the Initial Public Offering. This loan is non-interest bearing, unsecured and is due at the earlier of (1) June 20, 2021 or (2) the closing of the Initial Public Offering. The loan will be repaid upon the closing of the Initial Public Offering out of the offering proceeds not held in the Trust Account. On June 19, 2021 the Sponsor agreed to extend the maturity date of the loan to the Company to the earlier of August 31, 2021 or the closing date of the Initial Public Offering. The outstanding balance under the Promissory Note was repaid at the closing of the Initial Public Offering on July 19, 2021.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On July 25, 2022, the Company issued (i) Note A in the amount of $204,000 to Running Lion, which is wholly owned and controlled by Mr. Weiguang Yang, the Co-Executive Officer and director of the Company and (ii) the Note B in the amount of $294,600 to Tradeup INC., one of the Founders. The proceeds of the Notes, which may be drawn down from time to time until the Company consummates its initial Business Combination, will be used as general working capital purposes.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Notes bear no interest and are payable in full upon the earlier to occur of (i) the consummation of the Company’s Business Combination or (ii) the <div style="null;text-indent: 0px;;display:inline;">date of expiry of the term of the Company<div style="display:inline;"> <div style="null;text-indent: 0px;;display:inline;">(“</div></div></div>Maturity Date<div style="null;text-indent: 0px;;display:inline;">”)</div>. The following shall constitute an event of default: (i) a failure to pay the principal within five business days of the Maturity Date; (ii) the commencement of a voluntary or involuntary bankruptcy action, (iii) the breach of the Company’s obligations thereunder; (iv) any cross defaults; (v) an enforcement proceedings against the Company; and (vi) any unlawfulness and invalidity in connection with the performance of the obligations thereunder, in which case the Notes may be accelerated.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Payees respectively have the right, but not the obligation, to convert their Notes, in whole or in part, respectively, into Conversion Shares, as described in the prospectus of the Company (File Number 333-253322), by providing the Company with written notice of the intention to convert at least two business days prior to the closing of the Business Combination. The number of Conversion Shares to be received by the Payees in connection with such conversion shall be an amount determined by dividing (x) the sum of the outstanding principal amount payable to such Payee by (y) $10.00.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="background-color: initial; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; white-space: pre-wrap; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="margin: 0px 0px 0px 0cm; text-align: justify; line-height: 12pt; font-family: Calibri, sans-serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022 and 2021, the Company had borrowings of $498,600 and $0, respectively, under the working capital loans.</div></div><div style="margin: 0px 0px 0px 0cm; text-align: justify; line-height: 12pt; font-family: Calibri, sans-serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); white-space: pre-wrap; background: none; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Due to a related party</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">For the year ended December 31, 2022, the Sponsor loaned the Company $50,000 to cover certain operating expenses of the Company. As of December 31, 2022, the total amount due to the Sponsor was $50,000 and such balance was converted into a promissory note on January 19, 2023<div style="null;text-indent: 0px;;display:inline;"> </div><div style="null;text-indent: 0px;;display:inline;">with the same term as the working capital loans as discussed above</div>.</div></div> 1150000 25000 1150000 25000 920000 20000 230000 5000 1107500 1107500 1107500 1107500 25000 0.02 0.20 0.50 P6M 12.5 20 30 0.50 P6M 295000 10 236000 59000 2950000 17200 10 13760 3440 172000 P30D 1200000 10 400000 204000 294600 10 498600 0 50000 50000 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 7 — Commitments &amp; Contingencies</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Risks and Uncertainties</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Registration Rights</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The holders of the Founder Shares, Private Placement Shares and Common Stock that may be issued upon conversion of working capital loans will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Common Stock). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Underwriters Agreement</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to an additional 600,000 Option Units to cover over-allotments, if any. On July 21, 2021, the Underwriters partially exercised the over-allotment option and purchased 430,000 Option Units at a price of $10.00 per Option Unit, generating gross proceeds of $4,300,000. The Company paid an underwriting discount of 2.00% of the gross proceeds of the Initial Public Offering and the sale of Option Units or $886,000 to the underwriters at the closing of the Initial Public Offering and the sale of Option Units.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Business Combination Marketing Agreement</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has engaged US Tiger Securities, Inc., EF Hutton, division of Benchmark Investments, LLC (“EF Hutton”) and R.F. Lafferty &amp; Co., Inc. the representatives (the “Representatives”) of the underwriters of the Initial Public Offering in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company is obligated to pay the Representatives a cash fee (the “Business Combination Fee”) pursuant to a Business Combination Marketing Agreement for such services upon the consummation of the Company’s initial Business Combination, equal to 3.5% of the gross proceeds of the Initial Public Offering and the sale of over-allotment Option Units as discussed in Note 8.</div></div> P45D 600000 430000 10 4300000 0.02 886000 0.035 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 8 — Deferred Underwriters’ Business Combination Fees</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company is obligated to pay the Representatives a deferred Business Combination Fee equal to 3.5% of the gross proceeds of the Initial Public Offering and the sale of over-allotment Option Units. Upon completion of the Business Combination, $1,550,500 will be paid to the underwriters from the funds held in the Trust Account.</div></div> 0.035 1550500 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 9 — Stockholders’ Deficit</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Preferred stock</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">—The Company is authorized to issue 1,000,000 shares of preferred stock, par value $0.0001 per share and with such designations, voting and other rights and preferences as may be determined from time to time by the company’s board of directors. As of December 31, 2022 and 2021, there were no preference shares issued or outstanding.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Common stock</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">— The Company is authorized to issue up to 30,000,000 shares of Common Stock, par value $0.0001 per share. As of December 31, 2022 and 2021, there were 1,419,700 shares of Common Stock issued and outstanding, excluding 910,220 and 4,430,000 shares of Common Stock subject to possible redemption, respectively.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. The Company’s stockholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefor.</div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">— In July 2021, the Company issued 2,215,000 Warrants in connection with the Initial Public Offering and the sale of the Option Units. Each whole Warrant entitles the registered holder to purchase one whole share of the Company’s Common Stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing on the later of 12 months from the closing of the Initial Public Offering or the completion of the initial Business Combination. Pursuant to the warrant agreement, a warrant holder may exercise its Warrants only for a whole number of shares of Common Stock. This means that only a whole Warrant may be exercised at any given time by a warrant holder. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. The Warrants will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has agreed that as soon as practicable, but in no event later than 30 business days, after the closing of the initial Business Combination, it will use its reasonable commercially reasonable efforts to file, and within 60 business days following its initial Business Combination to have declared effective, a registration statement for the registration, under the Securities Act, of the shares of Common Stock issuable upon exercise of the Warrants. The Company will use its commercially reasonable efforts to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Warrants in accordance with the provisions of the warrant agreement. No Warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the Common Stock issuable upon exercise of the Warrants and a current prospectus relating to such shares of Common Stock. Notwithstanding the above, if the Company’s Common Stock is at the time of any exercise of a Warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Warrants who exercise their Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event it so elect, it will not be required to file or maintain in effect a registration statement, but it will be required to use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Once the Warrants become exercisable, the Company may call the Warrants for redemption:</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0.25in; text-align: justify; text-indent: -0.25in; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div><table style="border: none; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%; border-spacing: 0px;;margin-right : auto;"><tr><td style="padding: 0pt 0px; vertical-align: top; width: 0.25in; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="padding: 0pt 0px; vertical-align: top; width: 0.25in; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: Symbol; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: Symbol; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div></td><td style="padding: 0pt 0px; vertical-align: top; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part;</div></div></td></tr></table></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0.25in; text-align: justify; text-indent: -0.25in; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div><table style="border: none; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%; border-spacing: 0px;;margin-right : auto;"><tr><td style="padding: 0pt 0px; vertical-align: top; width: 0.25in; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="padding: 0pt 0px; vertical-align: top; width: 0.25in; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: Symbol; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: Symbol; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div></td><td style="padding: 0pt 0px; vertical-align: top; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">at a price of $0.01 per Warrant;</div></div></td></tr></table></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0.25in; text-align: justify; text-indent: -0.25in; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div><table style="border: none; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%; border-spacing: 0px;;margin-right : auto;"><tr><td style="padding: 0pt 0px; vertical-align: top; width: 0.25in; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="padding: 0pt 0px; vertical-align: top; width: 0.25in; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: Symbol; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: Symbol; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div></td><td style="padding: 0pt 0px; vertical-align: top; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and</div></div></td></tr></table></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0.25in; text-align: justify; text-indent: -0.25in; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div><table style="border: none; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%; border-spacing: 0px;;margin-right : auto;"><tr><td style="padding: 0pt 0px; vertical-align: top; width: 0.25in; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="padding: 0pt 0px; vertical-align: top; width: 0.25in; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: Symbol; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: Symbol; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div></td><td style="padding: 0pt 0px; vertical-align: top; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">if, and only if, the reported last sale price of the Common Stock equals or exceeds $16.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on <span style="-sec-ix-hidden:hidden69480686">third</span> business day before the Company send the notice of redemption to the warrant holders.</div></div></td></tr></table></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company accounted for the 2,215,000 Warrants issued with the Initial Public Offering as equity instruments in accordance with ASC 480, “Distinguishing Liabilities from Equity” and ASC 815-40, “Derivatives and Hedging: Contracts in Entity’s Own Equity”. The Company accounted for the Warrant as an expense of the Initial Public Offering resulting in a charge directly to stockholders’ equity. The Company estimates that the fair value of the Warrants is approximately $0.8 million, or 0.36 per Unit<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">on issuance</div>.</div></div> 1000000 1000000 0.0001 0.0001 0 0 0 0 30000000 30000000 0.0001 0.0001 1419700 1419700 1419700 1419700 910220 910220 4430000 4430000 2215000 1 11.5 P5Y P30D P60D 0.01 P30D 16.5 P20D 30 2215000 800000 0.36 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 10 — Income Taxes</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company’s taxable income primarily consists of dividend and <div style="letter-spacing: 0px; top: 0px;;display:inline;">interest </div>earned on investments held in the Trust Account. </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The income tax provision (benefit) consists of the following:</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div><table style="border: none; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%; margin-right: auto; border-spacing: 0px;;margin-right : auto;"><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0px; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">For the</div></div></div><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Year Ended</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">For the Period from</div></div></div><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">January 6, 2021 </div></div></div><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">(inception) through </div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0px 0px 0.5pt; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%; border-bottom: 1pt solid rgb(0, 0, 0);"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2022</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%; border-bottom: 1pt solid rgb(0, 0, 0);"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2021</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); padding: 0px 0px 0px 0in; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Current</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"> </div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); padding: 0px 0px 0px 6pt; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Federal</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;">51,176</div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); padding: 0px 0px 0px 6pt; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">State</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;">—</div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); padding: 0px; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Deferred</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); padding: 0px 0px 0px 6pt; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Federal</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">316,798</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">52,021</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); padding: 0px 0px 0px 6pt; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">State</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); padding: 0px 0px 0.5pt; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Valuation allowance</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left; border-bottom: 1pt solid rgb(0, 0, 0);"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-bottom: 1pt solid rgb(0, 0, 0);"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"/>(287,326<div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"/></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left; border-bottom: 1pt solid rgb(0, 0, 0);"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-bottom: 1pt solid rgb(0, 0, 0);"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(52,021</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); padding: 0px 0px 1.25pt; vertical-align: bottom; width: 74%; font-size: 10pt; border-top: 0in none;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Income tax provision</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0in none;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0in none;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">80,648</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0in none;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0in none;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr></table><div style="clear: both; max-height: 0px;"/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="background: none; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">A reconciliation of the statutory federal income tax rate to the Company’s effective tax rate is as follows:</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="background: none; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/> <div style="null;text-indent: 0px;;text-align:left;"> <div style="margin-top: 0px; margin-bottom: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table style="border: none; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%; margin-right: auto; border-spacing: 0px;"> <tr> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0px; vertical-align: bottom; width: 74%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">For the</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Year Ended</div></div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div> </td> <td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">For the Period from</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">January 6, 2021 </div></div></div> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">(inception) through </div></div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div> </td> </tr> <tr> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0px 0px 0.5pt; vertical-align: bottom; width: 74%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%; border-bottom: 1pt solid rgb(0, 0, 0);"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2022</div></div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%; border-bottom: 1pt solid rgb(0, 0, 0);"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2021</div></div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> </tr> <tr> <td style="background: rgb(204, 238, 255); padding: 0px; vertical-align: bottom; width: 74%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">U.S. statutory rate</div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left; border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">21.0</div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left; border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">21.0</div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div> </td> </tr> <tr> <td style="background: rgba(255, 255, 255, 0); padding: 0px; vertical-align: bottom; width: 74%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Permanent difference on facilitated acquisition costs</div> </div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"> </div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left; border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"> </div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(3.6</div> </div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)</div>%</div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left; border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"> </div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">-</div> </div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div><br/></div> </td> </tr> <tr> <td style="background: rgb(204, 238, 255); padding: 0px 0px 0.5pt; vertical-align: bottom; width: 74%; font-size: 10pt; border-top: 0in none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Change in valuation allowance</div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"/>(26.2<div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"/></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)%</div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(21.0</div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)%</div></div> </td> </tr> <tr> <td style="background: rgba(255, 255, 255, 0); padding: 0px 0px 1.25pt; vertical-align: bottom; width: 74%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Effective tax rate</div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">(8.8</div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">)</div><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">0.0</div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div> </td> </tr> </table> </div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company’s net deferred tax assets were as follows as of:</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; border-spacing: 0px; text-indent: 0px; width: 99%;;margin-right : auto;"> <tr> <td style="width: 74%; padding: 0px 0cm 0.5pt; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: normal; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> </div></div> </td> <td style="padding: 0in 0in 0.5pt; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: normal; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td colspan="2" style="padding: 0in; white-space: nowrap; vertical-align: bottom; width: 11%; border-bottom: 1pt solid black;"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; font-size: 10pt;"><div style="white-space: nowrap; font-size: 10pt;;font-weight:bold;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">December 31, 2022</div></div></div> </td> <td style="padding: 0in 0in 0.5pt; white-space: nowrap; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="padding: 0in 0in 0.5pt; white-space: nowrap; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td colspan="2" style="padding: 0in; white-space: nowrap; vertical-align: bottom; width: 11%; border-bottom: 1pt solid black;"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; font-size: 10pt;"><div style="white-space: nowrap; font-size: 10pt;;font-weight:bold;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">December 31, 2021</div></div></div> </td> <td style="padding: 0in 0in 0.5pt; white-space: nowrap; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> </tr> <tr> <td style="width: 74%; padding-top: 0px; padding-right: 5.4pt; padding-bottom: 0px; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin: 0px 0px 0px 0.13in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax assets:</div></div> </td> <td style="padding: 0in; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; text-align: center;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td colspan="2" style="padding: 0in; white-space: nowrap; vertical-align: bottom; width: 11%; background-color: rgb(204, 238, 255);"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: normal; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td style="padding: 0in; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: normal; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td style="padding: 0in; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: normal; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td colspan="2" style="padding: 0in; white-space: nowrap; vertical-align: bottom; width: 11%; background-color: rgb(204, 238, 255);"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: normal; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td style="padding: 0in; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: normal; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> </tr> <tr> <td style="width: 74%; padding-top: 0px; padding-right: 5.4pt; padding-bottom: 0px; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0.13in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Start-up/organization costs</div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">292,154</div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> </tr> <tr> <td style="width: 74%; padding-top: 0px; padding-right: 5.4pt; padding-bottom: 0px; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0.13in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Net operating loss carryover</div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">52,021</div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> </tr> <tr> <td style="width: 74%; padding-top: 0px; padding-right: 5.4pt; padding-bottom: 0px; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0.13in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax liability: </div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"> </div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"> </div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> </tr> <tr> <td style="width: 74%; padding-top: 0px; padding-right: 5.4pt; padding-bottom: 0.5pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0.13in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Accrued dividend income</div></div> </td> <td style="width: 1%; padding: 0in 0in 0.5pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding-top: 0in; padding-right: 0in; padding-left: 0in; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom; border-bottom: 1pt solid black;"> <div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 10%; padding-top: 0in; padding-right: 0in; padding-left: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom; border-bottom: 1pt solid black;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(29,472</div></div> </td> <td style="width: 1%; padding: 0in 0in 0.5pt; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; letter-spacing: 0px; top: 0px;;display:inline;">)</div></div> </td> <td style="width: 1%; padding: 0in 0in 0.5pt; white-space: nowrap; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 1%; padding-top: 0in; padding-right: 0in; padding-left: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom; border-bottom: 1pt solid black;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 10%; padding-top: 0in; padding-right: 0in; padding-left: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); vertical-align: bottom; border-bottom: 1pt solid black;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div> </td> <td style="width: 1%; padding: 0in 0in 0.5pt; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> </tr> <tr> <td style="width: 74%; padding: 0px 0cm; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Total deferred tax <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">assets</div></div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">262,682</div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">52,021</div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> </tr> <tr> <td style="background: rgb(204, 238, 255); width: 74%; padding: 0px 0cm 0.5pt; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Valuation allowance</div></div> </td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in 0in 0.5pt; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in; text-align: left; vertical-align: bottom; border-bottom: 1pt solid black;"> <div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); width: 10%; padding: 0in; white-space: nowrap; text-align: right; vertical-align: bottom; border-bottom: 1pt solid black;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(292,154</div></div> </td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in 0in 0.5pt; white-space: nowrap; text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; letter-spacing: 0px; top: 0px;;display:inline;">)</div></div> </td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in 0in 0.5pt; white-space: nowrap; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in; white-space: nowrap; text-align: left; vertical-align: bottom; border-bottom: 1pt solid black;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); width: 10%; padding: 0in; white-space: nowrap; text-align: right; vertical-align: bottom; border-bottom: 1pt solid black;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(52,021</div></div> </td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in 0in 0.5pt; white-space: nowrap; text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div> </td> </tr> <tr> <td style="width: 74%; padding: 0px 0cm 1.25pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax liability, net</div></div> </td> <td style="width: 1%; padding: 0in 0in 1.25pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom; border-bottom: 2.5pt double black; border-top: 0in none;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom; border-bottom: 2.5pt double black; border-top: 0in none;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(29,472</div></div> </td> <td style="width: 1%; padding: 0in 0in 1.25pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; letter-spacing: 0px; top: 0px;;display:inline;">)</div></div> </td> <td style="width: 1%; padding: 0in 0in 1.25pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom; border-bottom: 2.5pt double black; border-top: 0in none;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); vertical-align: bottom; border-bottom: 2.5pt double black; border-top: 0in none;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div> </td> <td style="width: 1%; padding: 0in 0in 1.25pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> </tr> </table> <div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022 and 2021, the Company had $0 and $247,718 of U.S. federal and state net operating loss carryovers available to offset future taxable income which do not expire.</div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;">In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax assets, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance of $292,154 and $52,021 as of December 31, 2022 and 2021, respectively.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The income tax provision (benefit) consists of the following:</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><table style="border: none; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%; margin-right: auto; border-spacing: 0px;;margin-right : auto;"><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0px; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">For the</div></div></div><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Year Ended</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">For the Period from</div></div></div><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">January 6, 2021 </div></div></div><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">(inception) through </div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div></td></tr><tr><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0px 0px 0.5pt; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%; border-bottom: 1pt solid rgb(0, 0, 0);"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2022</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%; border-bottom: 1pt solid rgb(0, 0, 0);"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2021</div></div></div></td><td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); padding: 0px 0px 0px 0in; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Current</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"> </div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); padding: 0px 0px 0px 6pt; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Federal</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;">51,176</div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); padding: 0px 0px 0px 6pt; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">State</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;">—</div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); padding: 0px; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Deferred</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"> </div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); padding: 0px 0px 0px 6pt; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Federal</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">316,798</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">52,021</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); padding: 0px 0px 0px 6pt; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">State</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); padding: 0px 0px 0.5pt; vertical-align: bottom; width: 74%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Valuation allowance</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left; border-bottom: 1pt solid rgb(0, 0, 0);"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-bottom: 1pt solid rgb(0, 0, 0);"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"/>(287,326<div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"/></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left; border-bottom: 1pt solid rgb(0, 0, 0);"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-bottom: 1pt solid rgb(0, 0, 0);"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(52,021</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td></tr><tr><td style="background: rgba(255, 255, 255, 0); padding: 0px 0px 1.25pt; vertical-align: bottom; width: 74%; font-size: 10pt; border-top: 0in none;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Income tax provision</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0in none;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0in none;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">80,648</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0in none;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0in none;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div></td><td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr></table> 51176 0 0 0 316798 52021 0 0 287326 52021 80648 0 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="background: none; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">A reconciliation of the statutory federal income tax rate to the Company’s effective tax rate is as follows:</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="background: none; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/> <div style="margin-top: 0px; margin-bottom: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table style="border: none; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%; margin-right: auto; border-spacing: 0px;"> <tr> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0px; vertical-align: bottom; width: 74%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">For the</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">Year Ended</div></div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div> </td> <td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">For the Period from</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">January 6, 2021 </div></div></div> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">(inception) through </div></div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div> </td> </tr> <tr> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0px 0px 0.5pt; vertical-align: bottom; width: 74%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; text-align: center;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; text-align: center; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%; border-bottom: 1pt solid rgb(0, 0, 0);"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2022</div></div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td colspan="2" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in; vertical-align: bottom; font-size: 10pt; white-space: nowrap; width: 11%; border-bottom: 1pt solid rgb(0, 0, 0);"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 31, 2021</div></div></div> </td> <td style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> </tr> <tr> <td style="background: rgb(204, 238, 255); padding: 0px; vertical-align: bottom; width: 74%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">U.S. statutory rate</div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left; border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">21.0</div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left; border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">21.0</div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div> </td> </tr> <tr> <td style="background: rgba(255, 255, 255, 0); padding: 0px; vertical-align: bottom; width: 74%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Permanent difference on facilitated acquisition costs</div> </div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"> </div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left; border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"> </div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(3.6</div> </div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)</div>%</div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"> </div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left; border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"> </div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">-</div> </div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div><br/></div> </td> </tr> <tr> <td style="background: rgb(204, 238, 255); padding: 0px 0px 0.5pt; vertical-align: bottom; width: 74%; font-size: 10pt; border-top: 0in none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Change in valuation allowance</div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"/>(26.2<div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"/></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)%</div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0in none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(21.0</div></div> </td> <td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)%</div></div> </td> </tr> <tr> <td style="background: rgba(255, 255, 255, 0); padding: 0px 0px 1.25pt; vertical-align: bottom; width: 74%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Effective tax rate</div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; text-align: left; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: 12pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;;text-indent: 0px;"><div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">(8.8</div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; line-height: 107%; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">)</div><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: 12pt; white-space: nowrap; margin-right: 0px;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; white-space: nowrap; text-align: right; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: right; margin-right: 0px; line-height: 12pt; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">0.0</div></div> </td> <td style="background: rgba(255, 255, 255, 0); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap; text-align: left;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div> </td> </tr> </table> 0.21 0.21 -0.036 0 -0.262 -0.21 -0.088 0 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company’s net deferred tax assets were as follows as of:</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; border-spacing: 0px; text-indent: 0px; width: 99%;;margin-right : auto;"> <tr> <td style="width: 74%; padding: 0px 0cm 0.5pt; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: normal; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> </div></div> </td> <td style="padding: 0in 0in 0.5pt; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: normal; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td colspan="2" style="padding: 0in; white-space: nowrap; vertical-align: bottom; width: 11%; border-bottom: 1pt solid black;"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; font-size: 10pt;"><div style="white-space: nowrap; font-size: 10pt;;font-weight:bold;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">December 31, 2022</div></div></div> </td> <td style="padding: 0in 0in 0.5pt; white-space: nowrap; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="padding: 0in 0in 0.5pt; white-space: nowrap; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td colspan="2" style="padding: 0in; white-space: nowrap; vertical-align: bottom; width: 11%; border-bottom: 1pt solid black;"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; font-size: 10pt;"><div style="white-space: nowrap; font-size: 10pt;;font-weight:bold;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">December 31, 2021</div></div></div> </td> <td style="padding: 0in 0in 0.5pt; white-space: nowrap; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> </tr> <tr> <td style="width: 74%; padding-top: 0px; padding-right: 5.4pt; padding-bottom: 0px; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin: 0px 0px 0px 0.13in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax assets:</div></div> </td> <td style="padding: 0in; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; text-align: center;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td colspan="2" style="padding: 0in; white-space: nowrap; vertical-align: bottom; width: 11%; background-color: rgb(204, 238, 255);"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: normal; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td style="padding: 0in; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: normal; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td style="padding: 0in; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: normal; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td colspan="2" style="padding: 0in; white-space: nowrap; vertical-align: bottom; width: 11%; background-color: rgb(204, 238, 255);"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: normal; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td style="padding: 0in; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin: 0px 0px 0px 0cm; text-align: center; line-height: normal; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> </tr> <tr> <td style="width: 74%; padding-top: 0px; padding-right: 5.4pt; padding-bottom: 0px; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0.13in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Start-up/organization costs</div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">292,154</div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> </tr> <tr> <td style="width: 74%; padding-top: 0px; padding-right: 5.4pt; padding-bottom: 0px; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0.13in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Net operating loss carryover</div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">52,021</div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> </tr> <tr> <td style="width: 74%; padding-top: 0px; padding-right: 5.4pt; padding-bottom: 0px; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0.13in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax liability: </div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"> </div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"> </div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: nowrap; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> </tr> <tr> <td style="width: 74%; padding-top: 0px; padding-right: 5.4pt; padding-bottom: 0.5pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0.13in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Accrued dividend income</div></div> </td> <td style="width: 1%; padding: 0in 0in 0.5pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding-top: 0in; padding-right: 0in; padding-left: 0in; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom; border-bottom: 1pt solid black;"> <div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 10%; padding-top: 0in; padding-right: 0in; padding-left: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom; border-bottom: 1pt solid black;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(29,472</div></div> </td> <td style="width: 1%; padding: 0in 0in 0.5pt; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; letter-spacing: 0px; top: 0px;;display:inline;">)</div></div> </td> <td style="width: 1%; padding: 0in 0in 0.5pt; white-space: nowrap; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 1%; padding-top: 0in; padding-right: 0in; padding-left: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom; border-bottom: 1pt solid black;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 10%; padding-top: 0in; padding-right: 0in; padding-left: 0in; white-space: nowrap; background-color: rgb(204, 238, 255); vertical-align: bottom; border-bottom: 1pt solid black;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div> </td> <td style="width: 1%; padding: 0in 0in 0.5pt; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> </tr> <tr> <td style="width: 74%; padding: 0px 0cm; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Total deferred tax <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">assets</div></div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">262,682</div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">52,021</div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> </tr> <tr> <td style="background: rgb(204, 238, 255); width: 74%; padding: 0px 0cm 0.5pt; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Valuation allowance</div></div> </td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in 0in 0.5pt; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in; text-align: left; vertical-align: bottom; border-bottom: 1pt solid black;"> <div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); width: 10%; padding: 0in; white-space: nowrap; text-align: right; vertical-align: bottom; border-bottom: 1pt solid black;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(292,154</div></div> </td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in 0in 0.5pt; white-space: nowrap; text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; letter-spacing: 0px; top: 0px;;display:inline;">)</div></div> </td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in 0in 0.5pt; white-space: nowrap; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in; white-space: nowrap; text-align: left; vertical-align: bottom; border-bottom: 1pt solid black;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="background: rgb(204, 238, 255); width: 10%; padding: 0in; white-space: nowrap; text-align: right; vertical-align: bottom; border-bottom: 1pt solid black;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(52,021</div></div> </td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in 0in 0.5pt; white-space: nowrap; text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div> </td> </tr> <tr> <td style="width: 74%; padding: 0px 0cm 1.25pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax liability, net</div></div> </td> <td style="width: 1%; padding: 0in 0in 1.25pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom; border-bottom: 2.5pt double black; border-top: 0in none;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom; border-bottom: 2.5pt double black; border-top: 0in none;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(29,472</div></div> </td> <td style="width: 1%; padding: 0in 0in 1.25pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; letter-spacing: 0px; top: 0px;;display:inline;">)</div></div> </td> <td style="width: 1%; padding: 0in 0in 1.25pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom; border-bottom: 2.5pt double black; border-top: 0in none;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div> </td> <td style="width: 10%; padding: 0in; white-space: nowrap; background-color: rgba(255, 255, 255, 0); vertical-align: bottom; border-bottom: 2.5pt double black; border-top: 0in none;"> <div style="margin: 0px 0in 0px 0cm; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">—</div></div> </td> <td style="width: 1%; padding: 0in 0in 1.25pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"> <div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; color: rgb(0, 0, 0); background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div> </td> </tr> </table> 292154 0 0 52021 29472 0 262682 52021 292154 52021 29472 0 0 247718 292154 52021 <div style="margin: 0px 0px 0px 0in; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;">Note 11 — Subsequent Events</div></div></div> <div style="margin: 0px 0px 0px 0in; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;">As provided in the Merger Agreement Estrella has agreed to, upon request by the sponsors of the Company, deposit the agreed reasonable amount to the Company’s trust in order to effectuate extension of the Company’s Combination Period.  Pursuant to the Merger Agreement, Estrella has deposited made two monthly extension payments, each in the amount of $45,511, to the Trust Account in connection with two Extensions, as a result of which, the current Combination Deadline is March 19, 2023. Such two monthly extension payments were evidenced by two promissory notes issued by the Company to Estrella, each in the principal amount of $45,511.</div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="margin: 0px 0px 0px 0in; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt; background: none; text-indent: 0px; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;, Times, serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;">On January 19, 2023, the Company issued an unsecured promissory note in the amount of $50,000 to the Sponsor <div style="text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; letter-spacing: 0px; top: 0px;;display:inline;">for working capital purposes</div>.</div></div></div> <div style="margin: 0px 0px 0px 0in; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt; background: none; text-indent: 0px; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;, Times, serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px; font-family: &quot;Times New Roman&quot;, Times, serif;;display:inline;"/><br/></div></div> <div style="margin: 0px 0px 0px 0in; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt; background: none; text-indent: 0px; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;, Times, serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px; font-family: &quot;Times New Roman&quot;, Times, serif;;display:inline;"/><div style="font-family: &quot;Times New Roman&quot;, Times, serif; letter-spacing: 0px; top: 0px;;display:inline;">On March 3, 2023, the Company issued an unsecured promissory note in the amount of $50,000 to Tradeup INC. for working capital purposes.</div></div><br/></div> 45511 45511 50000 50000 EXCEL 56 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 57 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 58 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 59 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 121 240 1 false 37 0 false 10 false false R1.htm 1001 - Document - Cover Page Sheet http://www.tradeupacquisitioncorp.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - BALANCE SHEETS Sheet http://www.tradeupacquisitioncorp.com/role/BalanceSheets BALANCE SHEETS Statements 2 false false R3.htm 1003 - Statement - BALANCE SHEETS (Parenthetical) Sheet http://www.tradeupacquisitioncorp.com/role/BalanceSheetsParenthetical BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - STATEMENTS OF OPERATIONS Sheet http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 1005 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT Sheet http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT Statements 5 false false R6.htm 1006 - Statement - STATEMENTS OF CASH FLOWS Sheet http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 1007 - Disclosure - Organization and Business Operation Sheet http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperation Organization and Business Operation Notes 7 false false R8.htm 1008 - Disclosure - Significant Accounting Policies Sheet http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 8 false false R9.htm 1009 - Disclosure - Investments Held in Trust Account Sheet http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccount Investments Held in Trust Account Notes 9 false false R10.htm 1010 - Disclosure - Initial Public Offering Sheet http://www.tradeupacquisitioncorp.com/role/InitialPublicOffering Initial Public Offering Notes 10 false false R11.htm 1011 - Disclosure - Private Placement Sheet http://www.tradeupacquisitioncorp.com/role/PrivatePlacement Private Placement Notes 11 false false R12.htm 1012 - Disclosure - Related Party Transactions Sheet http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactions Related Party Transactions Notes 12 false false R13.htm 1013 - Disclosure - Commitments & Contingencies Sheet http://www.tradeupacquisitioncorp.com/role/CommitmentsContingencies Commitments & Contingencies Notes 13 false false R14.htm 1014 - Disclosure - Deferred Underwriters' Business Combination Fees Sheet http://www.tradeupacquisitioncorp.com/role/DeferredUnderwritersBusinessCombinationFees Deferred Underwriters' Business Combination Fees Notes 14 false false R15.htm 1015 - Disclosure - Stockholders' Deficit Sheet http://www.tradeupacquisitioncorp.com/role/StockholdersDeficit Stockholders' Deficit Notes 15 false false R16.htm 1016 - Disclosure - Income Taxes Sheet http://www.tradeupacquisitioncorp.com/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 1017 - Disclosure - Subsequent Events Sheet http://www.tradeupacquisitioncorp.com/role/SubsequentEvents Subsequent Events Notes 17 false false R18.htm 1018 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPolicies 18 false false R19.htm 1019 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesTables Significant Accounting Policies (Tables) Tables http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPolicies 19 false false R20.htm 1020 - Disclosure - Investments Held in Trust Account (Tables) Sheet http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccountTables Investments Held in Trust Account (Tables) Tables http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccount 20 false false R21.htm 1021 - Disclosure - Initial Public Offering (Tables) Sheet http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingTables Initial Public Offering (Tables) Tables http://www.tradeupacquisitioncorp.com/role/InitialPublicOffering 21 false false R22.htm 1022 - Disclosure - Income Taxes (Tables) Sheet http://www.tradeupacquisitioncorp.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.tradeupacquisitioncorp.com/role/IncomeTaxes 22 false false R23.htm 1023 - Disclosure - Organization and Business Operation (Details) Sheet http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails Organization and Business Operation (Details) Details http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperation 23 false false R24.htm 1024 - Disclosure - Significant Accounting Policies (Details) Sheet http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesDetails Significant Accounting Policies (Details) Details http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesTables 24 false false R25.htm 1025 - Disclosure - Significant Accounting Policies - Net Income (Loss) Per Share (Details) Sheet http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails Significant Accounting Policies - Net Income (Loss) Per Share (Details) Details 25 false false R26.htm 1026 - Disclosure - Investments Held in Trust Account - Information about the Company's Assets (Details) Sheet http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccountInformationAboutTheCompanysAssetsDetails Investments Held in Trust Account - Information about the Company's Assets (Details) Details 26 false false R27.htm 1027 - Disclosure - Initial Public Offering (Details) Sheet http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails Initial Public Offering (Details) Details http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingTables 27 false false R28.htm 1028 - Disclosure - Initial Public Offering - Reconciliation Of Temporary Equity (Details) Sheet http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingReconciliationOfTemporaryEquityDetails Initial Public Offering - Reconciliation Of Temporary Equity (Details) Details 28 false false R29.htm 1029 - Disclosure - Private Placement (Details) Sheet http://www.tradeupacquisitioncorp.com/role/PrivatePlacementDetails Private Placement (Details) Details http://www.tradeupacquisitioncorp.com/role/PrivatePlacement 29 false false R30.htm 1030 - Disclosure - Related Party Transactions - Founder and Private Placement Shares (Details) Sheet http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails Related Party Transactions - Founder and Private Placement Shares (Details) Details 30 false false R31.htm 1031 - Disclosure - Related Party Transactions - Promissory Note and Related Party (Working Capital) Loans (Details) Sheet http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails Related Party Transactions - Promissory Note and Related Party (Working Capital) Loans (Details) Details 31 false false R32.htm 1032 - Disclosure - Related Party Transactions - Due To a Related Party (Details) Sheet http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsDueToARelatedPartyDetails Related Party Transactions - Due To a Related Party (Details) Details 32 false false R33.htm 1033 - Disclosure - Commitments & Contingencies (Details) Sheet http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails Commitments & Contingencies (Details) Details http://www.tradeupacquisitioncorp.com/role/CommitmentsContingencies 33 false false R34.htm 1034 - Disclosure - Deferred Underwriters' Business Combination Fees (Details) Sheet http://www.tradeupacquisitioncorp.com/role/DeferredUnderwritersBusinessCombinationFeesDetails Deferred Underwriters' Business Combination Fees (Details) Details http://www.tradeupacquisitioncorp.com/role/DeferredUnderwritersBusinessCombinationFees 34 false false R35.htm 1035 - Disclosure - Stockholders' Deficit- Preferred Stock Shares (Details) Sheet http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitPreferredStockSharesDetails Stockholders' Deficit- Preferred Stock Shares (Details) Details 35 false false R36.htm 1036 - Disclosure - Stockholders' Deficit - Common Stock Shares (Details) Sheet http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitCommonStockSharesDetails Stockholders' Deficit - Common Stock Shares (Details) Details 36 false false R37.htm 1037 - Disclosure - Stockholders' Deficit - Warrants (Details) Sheet http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails Stockholders' Deficit - Warrants (Details) Details 37 false false R38.htm 1038 - Disclosure - Income Taxes - Components Of Income Tax Provision (Benefit) (Details) Sheet http://www.tradeupacquisitioncorp.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails Income Taxes - Components Of Income Tax Provision (Benefit) (Details) Details 38 false false R39.htm 1039 - Disclosure - Income Taxes - Schedule of reconciliation of the total income tax provision tax rate to the statutory federal income tax rate (Details) Sheet http://www.tradeupacquisitioncorp.com/role/IncomeTaxesScheduleOfReconciliationOfTheTotalIncomeTaxProvisionTaxRateToTheStatutoryFederalIncomeTaxRateDetails Income Taxes - Schedule of reconciliation of the total income tax provision tax rate to the statutory federal income tax rate (Details) Details 39 false false R40.htm 1040 - Disclosure - Income Taxes - Deferred Tax (Details) Sheet http://www.tradeupacquisitioncorp.com/role/IncomeTaxesDeferredTaxDetails Income Taxes - Deferred Tax (Details) Details 40 false false R41.htm 1041 - Disclosure - Subsequent Events (Details) Sheet http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.tradeupacquisitioncorp.com/role/SubsequentEvents 41 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressStateOrProvince, uptd:ThresholdBusinessDaysForRedemptionOfPublicShares, uptd:ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders - uptd-20221231.htm 4 uptd-20221231.htm rc018_ex31-1.htm rc018_ex31-2.htm rc018_ex32-1.htm rc018_ex32-2.htm rc018_ex4-5.htm uptd-20221231.xsd uptd-20221231_cal.xml uptd-20221231_def.xml uptd-20221231_lab.xml uptd-20221231_pre.xml rc018_img01.jpg rc018_img02.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 62 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "uptd-20221231.htm": { "axisCustom": 2, "axisStandard": 14, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 401, "http://xbrl.sec.gov/dei/2022": 45 }, "contextCount": 121, "dts": { "calculationLink": { "local": [ "uptd-20221231_cal.xml" ] }, "definitionLink": { "local": [ "uptd-20221231_def.xml" ] }, "inline": { "local": [ "uptd-20221231.htm" ] }, "labelLink": { "local": [ "uptd-20221231_lab.xml" ] }, "presentationLink": { "local": [ "uptd-20221231_pre.xml" ] }, "schema": { "local": [ "uptd-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 357, "entityCount": 1, "hidden": { "http://www.tradeupacquisitioncorp.com/20221231": 2, "http://xbrl.sec.gov/dei/2022": 7, "total": 9 }, "keyCustom": 83, "keyStandard": 157, "memberCustom": 20, "memberStandard": 15, "nsprefix": "uptd", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.tradeupacquisitioncorp.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "uptd:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - Initial Public Offering", "menuCat": "Notes", "order": "10", "role": "http://www.tradeupacquisitioncorp.com/role/InitialPublicOffering", "shortName": "Initial Public Offering", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "uptd:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "uptd:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - Private Placement", "menuCat": "Notes", "order": "11", "role": "http://www.tradeupacquisitioncorp.com/role/PrivatePlacement", "shortName": "Private Placement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "uptd:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "12", "role": "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Commitments & Contingencies", "menuCat": "Notes", "order": "13", "role": "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingencies", "shortName": "Commitments & Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "uptd:DeferredUnderwritersMarketingFeesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Deferred Underwriters' Business Combination Fees", "menuCat": "Notes", "order": "14", "role": "http://www.tradeupacquisitioncorp.com/role/DeferredUnderwritersBusinessCombinationFees", "shortName": "Deferred Underwriters' Business Combination Fees", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "uptd:DeferredUnderwritersMarketingFeesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - Stockholders' Deficit", "menuCat": "Notes", "order": "15", "role": "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficit", "shortName": "Stockholders' Deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "16", "role": "http://www.tradeupacquisitioncorp.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "17", "role": "http://www.tradeupacquisitioncorp.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "18", "role": "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "19", "role": "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesTables", "shortName": "Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://www.tradeupacquisitioncorp.com/role/BalanceSheets", "shortName": "BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - Investments Held in Trust Account (Tables)", "menuCat": "Tables", "order": "20", "role": "http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccountTables", "shortName": "Investments Held in Trust Account (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "uptd:ScheduleOfReconciliationOfTemporaryEquity", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Initial Public Offering (Tables)", "menuCat": "Tables", "order": "21", "role": "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingTables", "shortName": "Initial Public Offering (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "uptd:ScheduleOfReconciliationOfTemporaryEquity", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "22", "role": "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "true" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - Organization and Business Operation (Details)", "menuCat": "Details", "order": "23", "role": "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "shortName": "Organization and Business Operation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:NatureOfOperations", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "0", "lang": null, "name": "uptd:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "reportCount": 1, "unique": true, "unitRef": "Unit_Item", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:IncomeTaxPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn12_31_2022", "decimals": null, "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "true" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - Significant Accounting Policies (Details)", "menuCat": "Details", "order": "24", "role": "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesDetails", "shortName": "Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:IncomeTaxPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn12_31_2022", "decimals": null, "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "true" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - Significant Accounting Policies - Net Income (Loss) Per Share (Details)", "menuCat": "Details", "order": "25", "role": "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails", "shortName": "Significant Accounting Policies - Net Income (Loss) Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022_RedeemableCommonStockMemberusgaapStatementClassOfStockAxis", "decimals": "0", "lang": null, "name": "uptd:NetLossIncludingAccretionOfCarryingValueToRedemptionValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsHeldInTrustNoncurrent", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - Investments Held in Trust Account - Information about the Company's Assets (Details)", "menuCat": "Details", "order": "26", "role": "http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccountInformationAboutTheCompanysAssetsDetails", "shortName": "Investments Held in Trust Account - Information about the Company's Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_USTreasuryBondSecuritiesMemberusgaapInvestmentTypeAxis", "decimals": "0", "lang": null, "name": "us-gaap:AssetsHeldInTrustNoncurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn07_31_2021", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SaleOfStockPricePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - Initial Public Offering (Details)", "menuCat": "Details", "order": "27", "role": "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "shortName": "Initial Public Offering (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "uptd:InitialPublicOfferingTextBlock", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "lang": null, "name": "uptd:SaleOfStockUnderwritingFees", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "uptd:ScheduleOfReconciliationOfTemporaryEquity", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P07_19_2021To12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "uptd:TemporaryEquityProceedsAllocatedToWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - Initial Public Offering - Reconciliation Of Temporary Equity (Details)", "menuCat": "Details", "order": "28", "role": "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingReconciliationOfTemporaryEquityDetails", "shortName": "Initial Public Offering - Reconciliation Of Temporary Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "uptd:ScheduleOfReconciliationOfTemporaryEquity", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P07_19_2021To12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "uptd:TemporaryEquityProceedsAllocatedToWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn07_31_2021", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SaleOfStockPricePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - Private Placement (Details)", "menuCat": "Details", "order": "29", "role": "http://www.tradeupacquisitioncorp.com/role/PrivatePlacementDetails", "shortName": "Private Placement (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R3": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://www.tradeupacquisitioncorp.com/role/BalanceSheetsParenthetical", "shortName": "BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn12_31_2022_CommonStockSubjectToRedemptionMemberusgaapStatementClassOfStockAxis", "decimals": "2", "lang": null, "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn07_31_2021", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SaleOfStockPricePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - Related Party Transactions - Founder and Private Placement Shares (Details)", "menuCat": "Details", "order": "30", "role": "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "shortName": "Related Party Transactions - Founder and Private Placement Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P02_12_2021To02_12_2021_FounderSharesMemberusgaapRelatedPartyTransactionAxis", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn07_25_2022", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - Related Party Transactions - Promissory Note and Related Party (Working Capital) Loans (Details)", "menuCat": "Details", "order": "31", "role": "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails", "shortName": "Related Party Transactions - Promissory Note and Related Party (Working Capital) Loans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn07_25_2022", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022_SponsorMemberusgaapRelatedPartyTransactionAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - Related Party Transactions - Due To a Related Party (Details)", "menuCat": "Details", "order": "32", "role": "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsDueToARelatedPartyDetails", "shortName": "Related Party Transactions - Due To a Related Party (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022_SponsorMemberusgaapRelatedPartyTransactionAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022_BusinessCombinationMarketingAgreementMemberusgaapTypeOfArrangementAxis", "decimals": "3", "first": true, "lang": null, "name": "uptd:PercentageOfProceedsOfOfferingPayableToUnderwritersCashFee", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - Commitments & Contingencies (Details)", "menuCat": "Details", "order": "33", "role": "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails", "shortName": "Commitments & Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022_BusinessCombinationMarketingAgreementMemberusgaapTypeOfArrangementAxis", "decimals": "3", "first": true, "lang": null, "name": "uptd:PercentageOfProceedsOfOfferingPayableToUnderwritersCashFee", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "uptd:DeferredUnderwritersMarketingFees", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1034 - Disclosure - Deferred Underwriters' Business Combination Fees (Details)", "menuCat": "Details", "order": "34", "role": "http://www.tradeupacquisitioncorp.com/role/DeferredUnderwritersBusinessCombinationFeesDetails", "shortName": "Deferred Underwriters' Business Combination Fees (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "uptd:DeferredUnderwritersMarketingFeesTextBlock", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "3", "lang": null, "name": "uptd:DeferredBusinessCombinationFeeBasedOnGrossProceeds", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "div", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn12_31_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1035 - Disclosure - Stockholders' Deficit- Preferred Stock Shares (Details)", "menuCat": "Details", "order": "35", "role": "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitPreferredStockSharesDetails", "shortName": "Stockholders' Deficit- Preferred Stock Shares (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R36": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn12_31_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1036 - Disclosure - Stockholders' Deficit - Common Stock Shares (Details)", "menuCat": "Details", "order": "36", "role": "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitCommonStockSharesDetails", "shortName": "Stockholders' Deficit - Common Stock Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:TemporaryEquitySharesOutstanding", "div", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "lang": null, "name": "us-gaap:TemporaryEquitySharesIssued", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn07_31_2021", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SaleOfStockPricePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1037 - Disclosure - Stockholders' Deficit - Warrants (Details)", "menuCat": "Details", "order": "37", "role": "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails", "shortName": "Stockholders' Deficit - Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn07_31_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis", "decimals": "INF", "lang": null, "name": "uptd:StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1038 - Disclosure - Income Taxes - Components Of Income Tax Provision (Benefit) (Details)", "menuCat": "Details", "order": "38", "role": "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails", "shortName": "Income Taxes - Components Of Income Tax Provision (Benefit) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1039 - Disclosure - Income Taxes - Schedule of reconciliation of the total income tax provision tax rate to the statutory federal income tax rate (Details)", "menuCat": "Details", "order": "39", "role": "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesScheduleOfReconciliationOfTheTotalIncomeTaxProvisionTaxRateToTheStatutoryFederalIncomeTaxRateDetails", "shortName": "Income Taxes - Schedule of reconciliation of the total income tax provision tax rate to the statutory federal income tax rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingCostsAndExpenses", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "4", "role": "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations", "shortName": "STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingCostsAndExpenses", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1040 - Disclosure - Income Taxes - Deferred Tax (Details)", "menuCat": "Details", "order": "40", "role": "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesDeferredTaxDetails", "shortName": "Income Taxes - Deferred Tax (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn01_19_2021_PromissoryNoteWithRelatedPartyMemberusgaapRelatedPartyTransactionAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1041 - Disclosure - Subsequent Events (Details)", "menuCat": "Details", "order": "41", "role": "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn03_19_2023_EstrellaBiopharmaIncMemberdeiLegalEntityAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "0", "lang": null, "name": "us-gaap:AssetsHeldInTrust", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn01_05_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT", "menuCat": "Statements", "order": "5", "role": "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit", "shortName": "STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "PAsOn01_05_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "6", "role": "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows", "shortName": "STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1007 - Disclosure - Organization and Business Operation", "menuCat": "Notes", "order": "7", "role": "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperation", "shortName": "Organization and Business Operation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1008 - Disclosure - Significant Accounting Policies", "menuCat": "Notes", "order": "8", "role": "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - Investments Held in Trust Account", "menuCat": "Notes", "order": "9", "role": "http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccount", "shortName": "Investments Held in Trust Account", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "uptd-20221231.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 37, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r371", "r372", "r373" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r371", "r372", "r373" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r371", "r372", "r373" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r371", "r372", "r373" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage", "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r375" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage", "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "trueItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r129", "r213", "r380", "r392" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r129", "r213", "r380", "r381", "r392" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "stringItemType" }, "uptd_AdditionalUnitsSoldOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of units sold as shares during the period.", "label": "Additional Units Sold Of Shares", "verboseLabel": "Additional Units Sold Of Shares" } } }, "localname": "AdditionalUnitsSoldOfShares", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/PrivatePlacementDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails" ], "xbrltype": "sharesItemType" }, "uptd_AdjustmentsToAdditionalPaidInCapitalStockIssuedUnderwritersMarketingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of adjustments to additional capital of underwriters marketing fees.", "label": "Adjustments To Additional Paid In Capital Stock Issued Underwriters Marketing Fees", "terseLabel": "Underwriters' marketing fees" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedUnderwritersMarketingFees", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "uptd_AgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement", "label": "Agreement [Axis]" } } }, "localname": "AgreementAxis", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "stringItemType" }, "uptd_AgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement", "label": "Agreement [Domain]" } } }, "localname": "AgreementDomain", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "domainItemType" }, "uptd_AllocationOfOfferingCostsToCommonStockSubjectToRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of Allocation of offering costs to common stock subject to redemption.", "label": "Allocation Of Offering Costs To Common Stock Subject To Redemption", "terseLabel": "Allocation of offering costs to common stock subject to redemption" } } }, "localname": "AllocationOfOfferingCostsToCommonStockSubjectToRedemption", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "uptd_AssetsHeldInTrustAccountPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of accounting policy for assets held in trust.", "label": "Assets Held In Trust Account, Policy [Policy Text Block]", "terseLabel": "Investments held in Trust Account" } } }, "localname": "AssetsHeldInTrustAccountPolicyPolicyTextBlock", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "uptd_BusinessCombinationFee": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of business combination fee.", "label": "Business Combination Fee", "terseLabel": "Business Combination Fee" } } }, "localname": "BusinessCombinationFee", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "monetaryItemType" }, "uptd_BusinessCombinationMarketingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to business combination marketing agreement", "label": "Business Combination Marketing Agreement", "terseLabel": "Business Combination Marketing Agreement" } } }, "localname": "BusinessCombinationMarketingAgreementMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails" ], "xbrltype": "domainItemType" }, "uptd_ChangeInValueOfCommonStockSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of change in value of common stock subject to possible redemption, classified as non-cash investing and financing activity.", "label": "Change In Value Of Common Stock Subject To Possible Redemption", "terseLabel": "Reclassification of common stock subject to redemption" } } }, "localname": "ChangeInValueOfCommonStockSubjectToPossibleRedemption", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "uptd_ClassOfWarrantOrRightPriceOfWarrantsOrRights": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Price of Warrants or Rights", "terseLabel": "Price of warrant" } } }, "localname": "ClassOfWarrantOrRightPriceOfWarrantsOrRights", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails" ], "xbrltype": "perShareItemType" }, "uptd_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.", "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Consecutive Trading Days", "terseLabel": "Threshold consecutive trading days for redemption of public warrants" } } }, "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "integerItemType" }, "uptd_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days for stock price trigger considered for redemption of warrants.", "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Trading Days", "terseLabel": "Threshold trading days for redemption of public warrants" } } }, "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "durationItemType" }, "uptd_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption price per share or per unit of warrants or rights outstanding.", "label": "Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights", "terseLabel": "Redemption price per public warrant (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "perShareItemType" }, "uptd_CommonStockSubjectToPossibleRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to common stock subject to possible redemption.", "label": "Common stock subject to possible redemption" } } }, "localname": "CommonStockSubjectToPossibleRedemptionMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "uptd_CommonStockSubjectToPossibleRedemptionShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of the shares of common stock subject to possible redemption.", "label": "Common Stock Subject To Possible Redemption Shares", "terseLabel": "Reclassification of common stock subject to redemption (in shares)" } } }, "localname": "CommonStockSubjectToPossibleRedemptionShares", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "uptd_CommonStockSubjectToPossibleRedemptionValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of common stock subject to possible redemption.", "label": "Common Stock Subject To Possible Redemption Value", "terseLabel": "Reclassification of common stock subject to redemption" } } }, "localname": "CommonStockSubjectToPossibleRedemptionValue", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "uptd_CommonStockSubjectToRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing shares subject to possible redemption.", "label": "Common stock subject to redemption" } } }, "localname": "CommonStockSubjectToRedemptionMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheetsParenthetical", "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails" ], "xbrltype": "domainItemType" }, "uptd_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.", "label": "Condition for future business combination number of businesses minimum", "terseLabel": "Condition for future business combination number of businesses minimum" } } }, "localname": "ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "integerItemType" }, "uptd_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The threshold net tangible assets which the reporting entity must maintain in order to proceed with a business combination utilizing the proceeds of the offering.", "label": "Condition for future business combination threshold Net Tangible Assets", "terseLabel": "Condition for future business combination threshold net tangible assets" } } }, "localname": "ConditionForFutureBusinessCombinationThresholdNetTangibleAssets", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "monetaryItemType" }, "uptd_DeferredBusinessCombinationFeeBasedOnGrossProceeds": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of deferred business combination fee based on gross proceeds.", "label": "Deferred Business Combination Fee Based on Gross Proceeds", "terseLabel": "Deferred business combination fee based on gross proceeds (in percentage)" } } }, "localname": "DeferredBusinessCombinationFeeBasedOnGrossProceeds", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/DeferredUnderwritersBusinessCombinationFeesDetails" ], "xbrltype": "percentItemType" }, "uptd_DeferredOfferingCostsNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of balance sheet date of underwriting fees payable or deferred, classified as noncurrent.", "label": "Deferred underwriting fee payable", "terseLabel": "Deferred offering costs" } } }, "localname": "DeferredOfferingCostsNoncurrent", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "uptd_DeferredTaxLiabilitiesAccruedDividendIncome": { "auth_ref": [], "calculation": { "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesDeferredTaxDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred tax liabilities accrued dividend income.", "label": "Deferred Tax Liabilities Accrued Dividend Income", "negatedLabel": "Accrued dividend income" } } }, "localname": "DeferredTaxLiabilitiesAccruedDividendIncome", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "uptd_DeferredUnderwritersMarketingFees": { "auth_ref": [], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 12.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of deferred underwriters marketing fees.", "label": "Deferred underwriters' marketing fees", "terseLabel": "Deferred underwriters' marketing fees", "verboseLabel": "Deferred underwriters' marketing fees" } } }, "localname": "DeferredUnderwritersMarketingFees", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets", "http://www.tradeupacquisitioncorp.com/role/DeferredUnderwritersBusinessCombinationFeesDetails" ], "xbrltype": "monetaryItemType" }, "uptd_DeferredUnderwritersMarketingFeesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "n/a", "label": "Deferred Underwriters' Business Combination Fees" } } }, "localname": "DeferredUnderwritersMarketingFeesAbstract", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "xbrltype": "stringItemType" }, "uptd_DeferredUnderwritersMarketingFeesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of deferred underwrites marketing fees.", "label": "Deferred Underwriters Marketing Fees [Text Block]", "terseLabel": "Deferred Underwriters' Business Combination Fees" } } }, "localname": "DeferredUnderwritersMarketingFeesTextBlock", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/DeferredUnderwritersBusinessCombinationFees" ], "xbrltype": "textBlockItemType" }, "uptd_DeferredUnderwritingFeePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of underwriting fee payable deferred during the period, classified as non-cash investing and financing activity.", "label": "Deferred Underwriting Fee Payable", "terseLabel": "Deferred underwriters' marketing fees" } } }, "localname": "DeferredUnderwritingFeePayable", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "uptd_DerivativeWarrantLiabilitiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of derivative warrant liabilities", "label": "Derivative Warrant Liabilities [Policy Text Block]", "terseLabel": "Warrants" } } }, "localname": "DerivativeWarrantLiabilitiesPolicyTextBlock", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "uptd_EffectiveIncomeTaxReconciliationPermanentDifferenceOnAcquisitionCostsPercentage": { "auth_ref": [], "calculation": { "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesScheduleOfReconciliationOfTheTotalIncomeTaxProvisionTaxRateToTheStatutoryFederalIncomeTaxRateDetails": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective income tax reconciliation permanent difference on acquisition costs percentage.", "label": "Effective Income Tax Reconciliation Permanent Difference On Acquisition Costs Percentage", "terseLabel": "Permanent difference on facilitated acquisition costs" } } }, "localname": "EffectiveIncomeTaxReconciliationPermanentDifferenceOnAcquisitionCostsPercentage", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesScheduleOfReconciliationOfTheTotalIncomeTaxProvisionTaxRateToTheStatutoryFederalIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "uptd_EstrellaBiopharmaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Estrella biopharma, inc.", "label": "Estrella Biopharma, Inc [Member]" } } }, "localname": "EstrellaBiopharmaIncMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "uptd_FederalDepositInsuranceCorporation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of federal of deposit insurance corporation.", "label": "Federal Deposit Insurance Corporation", "terseLabel": "Federal deposit insurance corporation" } } }, "localname": "FederalDepositInsuranceCorporation", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "uptd_ForfeitureOfCommonStockByInitialStockholdersShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of forfeiture of common stock by initial stockholders value.", "label": "Forfeiture of Common Stock By Initial Stockholders Shares", "terseLabel": "Forfeiture of common stock by initial stockholders (In shares)", "verboseLabel": "Forfeiture of Founder Shares" } } }, "localname": "ForfeitureOfCommonStockByInitialStockholdersShares", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "uptd_ForfeitureOfCommonStockByInitialStockholdersValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of forfeiture of common stock by initial stockholders .", "label": "Forfeiture Of Common Stock By Initial Stockholders Value", "terseLabel": "Forfeiture of common stock by initial stockholders" } } }, "localname": "ForfeitureOfCommonStockByInitialStockholdersValue", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "uptd_FounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to founder shares.", "label": "Founder Shares", "terseLabel": "Founder Shares" } } }, "localname": "FounderSharesMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails" ], "xbrltype": "domainItemType" }, "uptd_FranchiseTaxExpense": { "auth_ref": [], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of franchise tax expense incurred during the period.", "label": "Franchise Tax Expense", "terseLabel": "Franchise tax expenses" } } }, "localname": "FranchiseTaxExpense", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "uptd_FranchiseTaxPayable": { "auth_ref": [], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 10.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to franchise tax.", "label": "Franchise tax payable", "terseLabel": "Franchise tax payable" } } }, "localname": "FranchiseTaxPayable", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "uptd_FriedmanLlpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Friedman LLP [Member]" } } }, "localname": "FriedmanLlpMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "uptd_IncreaseDecreaseFranchiseTaxPayable": { "auth_ref": [], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of franchise tax payable.", "label": "Increase Decrease Franchise Tax Payable", "terseLabel": "Franchise tax payable" } } }, "localname": "IncreaseDecreaseFranchiseTaxPayable", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "uptd_InitialPublicOfferingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Initial Public Offering." } } }, "localname": "InitialPublicOfferingAbstract", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "xbrltype": "stringItemType" }, "uptd_InitialPublicOfferingTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on information about initial public offering.", "label": "Initial Public Offering [Text Block]", "terseLabel": "Initial Public Offering" } } }, "localname": "InitialPublicOfferingTextBlock", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "uptd_InvestorsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investors .", "label": "Investors [Axis]" } } }, "localname": "InvestorsAxis", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "stringItemType" }, "uptd_InvestorsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investors .", "label": "Investors [Domain]" } } }, "localname": "InvestorsDomain", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "domainItemType" }, "uptd_MaximumNetInterestToPayDissolutionExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Maximum net interest to pay dissolution expenses", "terseLabel": "Maximum net interest to pay dissolution expenses" } } }, "localname": "MaximumNetInterestToPayDissolutionExpenses", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "monetaryItemType" }, "uptd_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after completion of a business combination in which the reporting entity is required to file a registration statement with the SEC.", "label": "Maximum Period After Business Combination In Which To File Registration Statement", "terseLabel": "Maximum period after business combination in which to file registration statement" } } }, "localname": "MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "durationItemType" }, "uptd_MergerAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Merger agreement .", "label": "Merger Agreement [Member]", "terseLabel": "Merger Agreement [Member]" } } }, "localname": "MergerAgreementMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "domainItemType" }, "uptd_MinimumNetTangibleAssetsUponConsummationOfBusinessCombination": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Minimum net tangible assets upon consummation of business combination", "terseLabel": "Minimum net tangible assets upon consummation of business combination" } } }, "localname": "MinimumNetTangibleAssetsUponConsummationOfBusinessCombination", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "monetaryItemType" }, "uptd_NetLossIncludingAccretionOfCarryingValueToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net Loss Including Accretion Of Carrying Value To Redemption Value.", "label": "Net Loss Including Accretion Of Carrying Value To Redemption Value", "terseLabel": "Allocation of net loss including carrying value to redemption value" } } }, "localname": "NetLossIncludingAccretionOfCarryingValueToRedemptionValue", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "uptd_NetProceedsFromInitialPublicOffering": { "auth_ref": [], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public, net of underwriting discounts paid.", "label": "Net Proceeds From Initial Public Offering", "terseLabel": "Proceeds from sale of public units through public offering", "verboseLabel": "Proceeds from sale of public units through public offering" } } }, "localname": "NetProceedsFromInitialPublicOffering", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "uptd_NonRedeemableCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to non redeemable common stock.", "label": "Non Redeemable Common Stock" } } }, "localname": "NonRedeemableCommonStockMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails" ], "xbrltype": "domainItemType" }, "uptd_NumberOfSharesIssuedPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of shares in a unit.", "label": "Number of Shares Issued Per Unit", "terseLabel": "Number of shares in a unit" } } }, "localname": "NumberOfSharesIssuedPerUnit", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "sharesItemType" }, "uptd_NumberOfSharesSubjectToForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.", "label": "Number Of Shares Subject To Forfeiture", "terseLabel": "Shares subject to forfeiture" } } }, "localname": "NumberOfSharesSubjectToForfeiture", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails" ], "xbrltype": "sharesItemType" }, "uptd_NumberOfWarrantsIssuedPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of warrants in a unit.", "label": "Number of Warrants Issued Per Unit", "terseLabel": "Number of warrants in a unit" } } }, "localname": "NumberOfWarrantsIssuedPerUnit", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "sharesItemType" }, "uptd_OfferingCostsIncludedInAccountsPayableAndAccruedExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of offering costs included in accounts payable and accrued expenses.", "label": "Offering Costs Included In Accounts Payable And Accrued Expenses", "terseLabel": "Offering costs included in accounts payable and accrued expenses" } } }, "localname": "OfferingCostsIncludedInAccountsPayableAndAccruedExpenses", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "uptd_OfferingCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for offering costs.", "label": "Offering Costs [Policy Text Block]", "terseLabel": "Offering Costs" } } }, "localname": "OfferingCostsPolicyTextBlock", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "uptd_OtherOfferingCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other offering costs of the period date.", "label": "Other Offering Costs", "terseLabel": "Other offering costs" } } }, "localname": "OtherOfferingCosts", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "uptd_PaymentOfUnderwritersDiscount": { "auth_ref": [], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow of payment of underwriting discount.", "label": "Payment Of Underwriters Discount", "negatedLabel": "Payment of underwriters' discount" } } }, "localname": "PaymentOfUnderwritersDiscount", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "uptd_PaymentsForInvestmentOfCashInTrustAccount": { "auth_ref": [], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash outflow for investment of cash in trust account.", "label": "Payments for investment of cash in trust account", "negatedLabel": "Purchase of investment held in trust account", "verboseLabel": "Payments for investment of cash in trust account" } } }, "localname": "PaymentsForInvestmentOfCashInTrustAccount", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "uptd_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of shares which the reporting entity is obligated to redeem if a business combination is not consummated using the offering proceeds within a specified period.", "label": "Percentage Obligation To Redeem Public Shares If Entity Does Not Complete A Business Combination", "terseLabel": "Obligation to redeem Public Shares if entity does not complete a business combination (as a percent)" } } }, "localname": "PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "percentItemType" }, "uptd_PercentageOfExciseTax": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of\u00a0excise\u00a0tax", "label": "Percentage of excise tax", "terseLabel": "Percentage of excise tax" } } }, "localname": "PercentageOfExciseTax", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "uptd_PercentageOfFairMarketValueOfSharesRepurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of fair market value of shares repurchased", "label": "Percentage of fair market value of shares repurchased", "terseLabel": "Percentage of fair market value of shares repurchased" } } }, "localname": "PercentageOfFairMarketValueOfSharesRepurchased", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "percentItemType" }, "uptd_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The expected ownership percentage by the founders after completion of the proposed public offering.", "label": "Percentage Of Issued And Outstanding Shares After The Initial Public Offering Collectively Held By Initial Stockholders", "terseLabel": "Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders" } } }, "localname": "PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails" ], "xbrltype": "percentItemType" }, "uptd_PercentageOfProceedsOfOfferingPayableToUnderwritersCashFee": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to percentage of proceeds of offering payable to underwriters, cash fee.", "label": "Percentage of Proceeds of Offering Payable to Underwriters, Cash Fee", "terseLabel": "Percentage of proceeds of offering payable to underwriters, cash fee" } } }, "localname": "PercentageOfProceedsOfOfferingPayableToUnderwritersCashFee", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails" ], "xbrltype": "percentItemType" }, "uptd_PercentageOfUnderwritingDiscounts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to percentage of underwriting discounts.", "label": "Percentage of Underwriting Discounts", "terseLabel": "Percentage of underwriting discounts" } } }, "localname": "PercentageOfUnderwritingDiscounts", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails" ], "xbrltype": "percentItemType" }, "uptd_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after filing within which the registration statement filed with the SEC is expected to become effective.", "label": "Period Of Time Within Which Registration Statement Is Expected To Become Effective", "terseLabel": "Period of time within which registration statement is expected to become effective" } } }, "localname": "PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "durationItemType" }, "uptd_PrivatePlacementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Private Placement." } } }, "localname": "PrivatePlacementAbstract", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "xbrltype": "stringItemType" }, "uptd_PrivatePlacementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on information about private placement.", "label": "Private Placement [Text Block]", "terseLabel": "Private Placement" } } }, "localname": "PrivatePlacementTextBlock", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/PrivatePlacement" ], "xbrltype": "textBlockItemType" }, "uptd_ProceedsFromBorrowingsFromARelatedParty": { "auth_ref": [], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from borrowings from a related party", "label": "Proceeds from borrowings from a related party", "terseLabel": "Borrowings from a related party" } } }, "localname": "ProceedsFromBorrowingsFromARelatedParty", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "uptd_ProceedsFromIssuanceOfSharesOfCommonStockToSponsor": { "auth_ref": [], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of shares of Common Stock to the Sponsor.", "label": "Proceeds From Issuance Of Shares Of Common Stock To Sponsor", "terseLabel": "Proceeds from issuance of shares of Common Stock to the Sponsor" } } }, "localname": "ProceedsFromIssuanceOfSharesOfCommonStockToSponsor", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "uptd_ProceedsFromIssuanceOfWorkingCapitalLoansToRelatedParties": { "auth_ref": [], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of working capital loans to related parties", "label": "Proceeds from issuance of working capital loans to related parties", "terseLabel": "Proceeds from issuance of working capital loans to related parties" } } }, "localname": "ProceedsFromIssuanceOfWorkingCapitalLoansToRelatedParties", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "uptd_PromissoryNoteWithRelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for promissory note with related party.", "label": "Promissory Note with Related Party", "terseLabel": "Promissory Note with Related Party" } } }, "localname": "PromissoryNoteWithRelatedPartyMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails", "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "uptd_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents a redeemable warrant (Public Warrant) that entitles the holder to purchase shares of common stock subject to adjustment.", "label": "Public Warrants", "terseLabel": "Public Warrants" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "domainItemType" }, "uptd_RedeemableCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to redeemable common stock.", "label": "Redeemable Common Stock" } } }, "localname": "RedeemableCommonStockMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails" ], "xbrltype": "domainItemType" }, "uptd_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds16.50Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption Of Warrants When Price Per Share Of Class Common Stock Equals Or Exceeds 16.50.", "label": "Redemption Of Warrants When Price Per Share Of Class Common Stock Equals Or Exceeds 16.50", "terseLabel": "Redemption Of Warrants When Price Per Share Of Class Common Stock Equals Or Exceeds 16.50" } } }, "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds16.50Member", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "domainItemType" }, "uptd_RedemptionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption period.", "label": "Redemption Period", "terseLabel": "Redemption period" } } }, "localname": "RedemptionPeriod", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "durationItemType" }, "uptd_RelatedPartyLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for related party loans.", "label": "Related Party Loans", "terseLabel": "Related Party Loans" } } }, "localname": "RelatedPartyLoansMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails" ], "xbrltype": "domainItemType" }, "uptd_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after completion of a business combination during which the shares or warrant may not be transferred.", "label": "Restrictions On Transfer Period Of Time After Business Combination Completion", "terseLabel": "Restrictions on transfer period of time after business combination completion" } } }, "localname": "RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/PrivatePlacementDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails" ], "xbrltype": "durationItemType" }, "uptd_ReturnOfProceedsFromIssuanceOfCommonStockToSponsor": { "auth_ref": [], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Return of proceeds from issuance of Common Stock to the Sponsor.", "label": "Return Of Proceeds From Issuance Of Common Stock To The Sponsor", "negatedLabel": "Return of proceeds from issuance of Common Stock to the Sponsor" } } }, "localname": "ReturnOfProceedsFromIssuanceOfCommonStockToSponsor", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "uptd_RunningLionHoldingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Running Lion Holdings Limited.", "label": "Running Lion", "terseLabel": "Running Lion" } } }, "localname": "RunningLionHoldingsMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails" ], "xbrltype": "domainItemType" }, "uptd_SaleOfStockOtherOfferingCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of other offering costs incurred.", "label": "Sale of Stock, Other Offering Costs", "terseLabel": "Other offering costs" } } }, "localname": "SaleOfStockOtherOfferingCosts", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails" ], "xbrltype": "monetaryItemType" }, "uptd_SaleOfStockUnderwritingFees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of offering fees incurred and paid for underwriters.", "label": "Sale of Stock, Underwriting fees", "terseLabel": "Underwriting fees" } } }, "localname": "SaleOfStockUnderwritingFees", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails" ], "xbrltype": "monetaryItemType" }, "uptd_ScheduleOfReconciliationOfTemporaryEquity": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the ordinary shares subject to possible redemption reflected on the balance sheet.", "label": "Schedule Of Reconciliation Of Temporary Equity", "terseLabel": "Schedule of common stock reflected in the condensed balance sheet" } } }, "localname": "ScheduleOfReconciliationOfTemporaryEquity", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingTables" ], "xbrltype": "textBlockItemType" }, "uptd_ShareholdersOfEstrellaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shareholders of estrella .", "label": "Shareholders Of Estrella [Member]", "terseLabel": "Shareholders Of Estrella [Member]" } } }, "localname": "ShareholdersOfEstrellaMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "domainItemType" }, "uptd_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for sponsor.", "label": "Sponsor", "terseLabel": "Sponsor" } } }, "localname": "SponsorMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/PrivatePlacementDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsDueToARelatedPartyDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "uptd_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock And Warrants Issued During Period Shares Preferred Stock And Warrants.", "label": "Stock And Warrants Issued During Period Share Preferred Stock And Warrants", "terseLabel": "Stock And Warrants Issued During Period Share Preferred Stock And Warrants" } } }, "localname": "StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "sharesItemType" }, "uptd_TemporaryEquityIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of issuance costs related to temporary equity.", "label": "Temporary Equity, Issuance Costs", "negatedLabel": "Offering costs of public shares" } } }, "localname": "TemporaryEquityIssuanceCosts", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingReconciliationOfTemporaryEquityDetails" ], "xbrltype": "monetaryItemType" }, "uptd_TemporaryEquityPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of accounting policy for temporary equity.", "label": "Temporary Equity, Policy [Policy Text Block]", "terseLabel": "Common Stock Subject to Possible Redemption" } } }, "localname": "TemporaryEquityPolicyPolicyTextBlock", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "uptd_TemporaryEquityProceedsAllocatedToWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of gross proceeds allocated from temporary equity to warrants.", "label": "Temporary Equity , Proceeds Allocated To Warrants", "negatedLabel": "Proceeds allocated to public warrants" } } }, "localname": "TemporaryEquityProceedsAllocatedToWarrants", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingReconciliationOfTemporaryEquityDetails" ], "xbrltype": "monetaryItemType" }, "uptd_TemporaryEquityStockRedeemedDuringThePeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary equity stock redeemed during the period shares", "label": "Temporary Equity Stock Redeemed During The Period Shares" } } }, "localname": "TemporaryEquityStockRedeemedDuringThePeriodShares", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "sharesItemType" }, "uptd_ThresholdBusinessDaysForRedemptionOfPublicShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Threshold business days for redemption of public shares", "terseLabel": "Threshold business days for redemption of public shares" } } }, "localname": "ThresholdBusinessDaysForRedemptionOfPublicShares", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "durationItemType" }, "uptd_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Threshold minimum aggregate fair market value as a percentage of the net assets held in the Trust Account", "verboseLabel": "Threshold minimum aggregate fair market value as a percentage of the net assets held in the Trust Account" } } }, "localname": "ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "percentItemType" }, "uptd_ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of business days before sending notice of redemption to warrant holders.", "label": "Threshold Number of Business Days Before Sending Notice of Redemption to Warrant Holders", "terseLabel": "Threshold number of business days before sending notice of redemption to warrant holders" } } }, "localname": "ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "integerItemType" }, "uptd_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination", "terseLabel": "Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination" } } }, "localname": "ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "percentItemType" }, "uptd_TradeUpIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Trade Up Inc, one of Company's founders.", "label": "Trade Up Inc", "terseLabel": "Trade Up Inc" } } }, "localname": "TradeUpIncMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/PrivatePlacementDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails", "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "uptd_TransactionCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of transaction costs incurred.", "label": "Transaction Costs", "terseLabel": "Transaction costs", "verboseLabel": "Transaction Costs" } } }, "localname": "TransactionCosts", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "monetaryItemType" }, "uptd_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.", "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Stock Price Trigger", "terseLabel": "Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails" ], "xbrltype": "perShareItemType" }, "uptd_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "When determining the condition for transfer of shares without restriction after a business combination, the number of consecutive trading days used to observe the share price.", "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Consecutive Trading Days", "terseLabel": "Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails" ], "xbrltype": "integerItemType" }, "uptd_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "When determining the condition for transfer of shares without restriction after a business combination, the number of days in which the share price must exceed the specified amount.", "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Trading Days", "terseLabel": "Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails" ], "xbrltype": "integerItemType" }, "uptd_UnderwriterCashDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the cash underwriting discount per unit.", "label": "Underwriter cash discount", "terseLabel": "Underwriter cash discount" } } }, "localname": "UnderwriterCashDiscount", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "uptd_UnderwriterExerciseOptionPeriodFromDateOfInitialPublicOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents the period from which underwriter need to exercise the shares or units underwritten from the date of initial public offering.", "label": "Underwriter Exercise Option Period From The Date Of Initial Public Offering", "terseLabel": "Underwriter exercise Period from initial public offering" } } }, "localname": "UnderwriterExerciseOptionPeriodFromDateOfInitialPublicOffering", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails", "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails" ], "xbrltype": "durationItemType" }, "uptd_UnderwritingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of underwriting fee.", "label": "Underwriting Fees", "terseLabel": "Underwriting fees" } } }, "localname": "UnderwritingFees", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "monetaryItemType" }, "uptd_UnitsEachConsistingOfOneShareOfClassCommonStockAndOneHalfOfOneWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Units Each Consisting Of One Share Of Class Common Stock And One Half Of One Warrant [Member]", "terseLabel": "Units, each consisting of one share of Class A Common Stock and one-half of one Warrant" } } }, "localname": "UnitsEachConsistingOfOneShareOfClassCommonStockAndOneHalfOfOneWarrantMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "uptd_UnitsIssuedDuringPeriodSharesNewIssues": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of new units issued during the period.", "label": "Units Issued During Period, Shares, New Issues", "positiveLabel": "Founders shares issued to initial stockholders (in shares)", "verboseLabel": "Number of units issued" } } }, "localname": "UnitsIssuedDuringPeriodSharesNewIssues", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails", "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "uptd_UnitsIssuedDuringPeriodSharesNewIssuesExcludingUnderwriters": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of new units issued during the period excluding underwriters.", "label": "Units Issued During Period Shares New Issues, Excluding Underwriters", "terseLabel": "Number of units issued excluding underwriters" } } }, "localname": "UnitsIssuedDuringPeriodSharesNewIssuesExcludingUnderwriters", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails" ], "xbrltype": "sharesItemType" }, "uptd_UnitsIssuedDuringPeriodValueNewIssues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new unit issued during the period.", "label": "Units Issued During Period, Value, New Issues", "verboseLabel": "Founders shares issued to initial stockholders" } } }, "localname": "UnitsIssuedDuringPeriodValueNewIssues", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "uptd_WarrantRedemptionConditionMinimumSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum trading price for the reporting entity's stock which must be achieved as a condition for redemption of the warrant.", "label": "Warrant Redemption Condition Minimum Share Price", "terseLabel": "Warrant redemption condition minimum share price" } } }, "localname": "WarrantRedemptionConditionMinimumSharePrice", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "perShareItemType" }, "uptd_WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Each Whole Warrant Exercisable For One Share Of Class Common Stock At Exercise Price [Member]", "terseLabel": "Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50" } } }, "localname": "WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "uptd_WarrantsOrRightsOutstandingExercisableTermAfterBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The warrants exercisable term after the completion of a business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Warrants or Rights Outstanding Exercisable Term After Business Combination", "terseLabel": "Warrants exercisable term after the completion of a business combination" } } }, "localname": "WarrantsOrRightsOutstandingExercisableTermAfterBusinessCombination", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails" ], "xbrltype": "durationItemType" }, "uptd_WithdrawOfInvestmentHeldInTrustAccount": { "auth_ref": [], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Withdraw of investment held in trust account", "label": "Withdraw of investment held in trust account", "terseLabel": "Withdraw of investment held in trust account" } } }, "localname": "WithdrawOfInvestmentHeldInTrustAccount", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "uptd_WorkingCapitalEarningsDeficit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital earnings deficit.", "label": "Working Capital Earnings Deficit" } } }, "localname": "WorkingCapitalEarningsDeficit", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "monetaryItemType" }, "uptd_WorkingCapitalLoansRelatedPartiesCurrent": { "auth_ref": [], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 9.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital loans related parties current", "label": "Working capital loans related parties current", "terseLabel": "Working capital loans - related parties" } } }, "localname": "WorkingCapitalLoansRelatedPartiesCurrent", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "uptd_WorkingCapitalLoansWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Working capital loans warrant.", "label": "Working capital loans warrant", "terseLabel": "Working capital loans warrant" } } }, "localname": "WorkingCapitalLoansWarrantMember", "nsuri": "http://www.tradeupacquisitioncorp.com/20221231", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r12" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 11.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r1", "r73", "r82" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Income tax payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r6", "r367" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 17.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r214", "r215", "r216", "r389", "r390", "r391", "r411" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).", "label": "Adjustments to Additional Paid in Capital, Other", "terseLabel": "Other offering expenses" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "auth_ref": [ "r49", "r50" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "terseLabel": "Allocation of offering costs to common stock subject to redemption" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts": { "auth_ref": [ "r46" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from issuance costs from a share-lending arrangement entered into, in contemplation of a convertible debt offering or other financing.", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs", "terseLabel": "Underwriters' discount" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "verboseLabel": "Anti-dilutive securities attributable to warrants (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r72", "r81", "r97", "r113", "r152", "r154", "r156", "r160", "r174", "r175", "r177", "r178", "r179", "r180", "r181", "r183", "r184", "r249", "r253", "r266", "r367", "r400", "r401", "r415" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r94", "r102", "r113", "r160", "r174", "r175", "r177", "r178", "r179", "r180", "r181", "r183", "r184", "r249", "r253", "r266", "r367", "r400", "r401", "r415" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "verboseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrust": { "auth_ref": [ "r384" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.", "label": "Assets Held-in-trust", "terseLabel": "Assets Held-in-trust" } } }, "localname": "AssetsHeldInTrust", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r384" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Assets Held-in-trust, Noncurrent", "terseLabel": "Assets Held-in-trust, Noncurrent", "verboseLabel": "Investments held in Trust Account" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets", "http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccountInformationAboutTheCompanysAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BankOverdrafts": { "auth_ref": [ "r14", "r45" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of payments made in excess of existing cash balances, which will be honored by the bank but reflected as a loan to the entity. Overdrafts generally have a very short time frame for correction or repayment and are therefore more similar to short-term bank financing than trade financing.", "label": "Bank Overdrafts" } } }, "localname": "BankOverdrafts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Significant Accounting Policies" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r33", "r96", "r354" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash", "verboseLabel": "Cash held outside the trust account" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r28", "r33", "r35" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash at end of period", "periodStartLabel": "Cash at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r28", "r65" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net Change in Cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Supplemental Disclosure of Non-cash Financing Activities" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r98", "r99", "r100", "r113", "r132", "r133", "r135", "r137", "r141", "r142", "r160", "r174", "r177", "r178", "r179", "r183", "r184", "r189", "r190", "r192", "r196", "r203", "r266", "r353", "r379", "r385", "r393" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheetsParenthetical", "http://www.tradeupacquisitioncorp.com/role/CoverPage", "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r51", "r53" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r204" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price of warrants" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Number of shares issuable per warrant", "verboseLabel": "Number of shares per warrant" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r204" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Sale of Private Placement Warrants (in shares)", "verboseLabel": "Number of warrants to purchase shares issued" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/PrivatePlacementDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r51", "r53" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommercialLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A loan, whether secured or unsecured, to a company for purposes such as seasonal working capital needs, inventory financing, equipment purchases and acquisitions.", "label": "Commercial Loan [Member]" } } }, "localname": "CommercialLoanMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r16", "r77", "r86" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments & Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r44", "r172", "r173", "r352", "r399" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments & Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Class A Common Stock" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CoverPage", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r389", "r390", "r411" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common shares, par value, (per share)", "verboseLabel": "Common shares, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheetsParenthetical", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitCommonStockSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common shares, shares authorized", "verboseLabel": "Common shares, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheetsParenthetical", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitCommonStockSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common shares, shares issued", "verboseLabel": "Common shares, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheetsParenthetical", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitCommonStockSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r5", "r49" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common shares, shares outstanding", "verboseLabel": "Common shares, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheetsParenthetical", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitCommonStockSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesSubscribedButUnissued": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Common Stock, Shares Subscribed but Unissued", "terseLabel": "Common stock shares subscribed but not issued" } } }, "localname": "CommonStockSharesSubscribedButUnissued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r5", "r367" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 16.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.0001 par value; 30,000,000 shares authorized; 1,419,700 shares issued and outstanding (excluding 910,220 and 4,430,000 shares subject to possible redemption as of December 31, 2022 and 2021, respectively)" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred tax assets:" } } }, "localname": "ComponentsOfDeferredTaxAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesDeferredTaxDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r80", "r146" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]", "terseLabel": "Current" } } }, "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r387", "r406", "r408" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails": { "order": 5.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r387", "r406", "r408" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "State" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r47", "r186" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion Shares (per share amount)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r66", "r67", "r185", "r274", "r360", "r361" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Maximum borrowing capacity of related party promissory note" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails", "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r402" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal, State and Local, Tax Expense (Benefit)", "terseLabel": "Federal" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]", "terseLabel": "Deferred" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r31", "r60", "r234", "r240", "r241", "r387" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred tax expense" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r220", "r221" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 13.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r387", "r407", "r408" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "State" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r229" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesDeferredTaxDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r58", "r405" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesDeferredTaxDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "verboseLabel": "Net operating loss carryover" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": { "auth_ref": [ "r58", "r405" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesDeferredTaxDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.", "label": "Deferred Tax Assets, Tax Deferred Expense, Other", "terseLabel": "Start-up/organization costs" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r230" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesDeferredTaxDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r54", "r404" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesDeferredTaxDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Deferred tax liability, net of allowance" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Gross [Abstract]", "terseLabel": "Deferred tax liability:" } } }, "localname": "DeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesDeferredTaxDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r11", "r176", "r177", "r178", "r182", "r183", "r184", "r279", "r388" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "terseLabel": "Due to a related party" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r76", "r87", "r176", "r177", "r178", "r182", "r183", "r184", "r279", "r388" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.", "label": "Due to Related Parties" } } }, "localname": "DueToRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsDueToARelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Basic and diluted net loss per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r109", "r121", "r122", "r123", "r124", "r125", "r130", "r132", "r135", "r136", "r137", "r139", "r258", "r259", "r328", "r330", "r356" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic net loss (income) per common share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r109", "r121", "r122", "r123", "r124", "r125", "r132", "r135", "r136", "r137", "r139", "r258", "r259", "r328", "r330", "r356" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted net loss per common share", "verboseLabel": "Diluted, net loss per common share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r37", "r38" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "verboseLabel": "Net Income (Loss) per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r223" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesScheduleOfReconciliationOfTheTotalIncomeTaxProvisionTaxRateToTheStatutoryFederalIncomeTaxRateDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesScheduleOfReconciliationOfTheTotalIncomeTaxProvisionTaxRateToTheStatutoryFederalIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r114", "r223", "r242" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesScheduleOfReconciliationOfTheTotalIncomeTaxProvisionTaxRateToTheStatutoryFederalIncomeTaxRateDetails": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "U.S. statutory rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesScheduleOfReconciliationOfTheTotalIncomeTaxProvisionTaxRateToTheStatutoryFederalIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r403", "r409" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesScheduleOfReconciliationOfTheTotalIncomeTaxProvisionTaxRateToTheStatutoryFederalIncomeTaxRateDetails": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Change in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesScheduleOfReconciliationOfTheTotalIncomeTaxProvisionTaxRateToTheStatutoryFederalIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r49", "r92", "r106", "r107", "r108", "r116", "r117", "r118", "r120", "r126", "r128", "r140", "r161", "r205", "r214", "r215", "r216", "r236", "r237", "r257", "r267", "r268", "r269", "r270", "r271", "r272", "r275", "r332", "r333", "r334" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r61", "r62" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "verboseLabel": "Schedule of assets that are measured at fair value on a recurring basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccountTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r187", "r206", "r207", "r208", "r209", "r210", "r211", "r261", "r288", "r289", "r290", "r360", "r361", "r362", "r363", "r364" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccountInformationAboutTheCompanysAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r260", "r261", "r262", "r263", "r265" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccountInformationAboutTheCompanysAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments Held in Trust Account" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "verboseLabel": "Investments Held in Trust Account" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccount" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r187", "r206", "r211", "r261", "r288", "r362", "r363", "r364" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccountInformationAboutTheCompanysAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccountInformationAboutTheCompanysAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r187", "r206", "r207", "r208", "r209", "r210", "r211", "r288", "r289", "r290", "r360", "r361", "r362", "r363", "r364" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccountInformationAboutTheCompanysAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r264", "r265" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccountInformationAboutTheCompanysAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r63", "r64" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r158", "r159", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r188", "r201", "r255", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r359", "r395", "r396", "r397", "r418", "r419", "r420", "r421", "r422", "r423", "r424" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GainLossOnInvestments": { "auth_ref": [ "r22", "r43", "r378" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment.", "label": "Gain (Loss) on Investments", "terseLabel": "Dividend earned on investment held in Trust Account" } } }, "localname": "GainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "Initial Public Offering" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails", "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r18", "r71", "r78", "r89", "r152", "r153", "r155", "r157", "r329", "r358" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r114", "r224", "r227", "r233", "r238", "r243", "r245", "r246", "r247" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r115", "r127", "r128", "r151", "r222", "r239", "r244", "r331" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income taxes provision", "totalLabel": "Income tax provision" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r105", "r218", "r219", "r227", "r228", "r232", "r235" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r30" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r30" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Increase (Decrease) in Income Taxes Payable", "terseLabel": "Income tax payable" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r30" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r21", "r150" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "negatedLabel": "Dividend earned on investment held in Trust Account" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccountInformationAboutTheCompanysAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccountInformationAboutTheCompanysAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r13", "r113", "r160", "r174", "r175", "r177", "r178", "r179", "r180", "r181", "r183", "r184", "r250", "r253", "r254", "r266", "r357", "r400", "r415", "r416" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r10", "r75", "r85", "r367", "r386", "r398", "r413" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities, Temporary Equity, and Stockholders' Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities, Temporary Equity, and Stockholders' Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r15", "r95", "r113", "r160", "r174", "r175", "r177", "r178", "r179", "r180", "r181", "r183", "r184", "r250", "r253", "r254", "r266", "r367", "r400", "r415", "r416" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r143", "r149" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "Organization and Business Operation" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperation" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r111" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash ( used in) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r111" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows from Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r28", "r29", "r32" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r19", "r32", "r79", "r88", "r93", "r103", "r104", "r108", "r113", "r119", "r121", "r122", "r123", "r124", "r127", "r128", "r134", "r152", "r153", "r155", "r157", "r160", "r174", "r175", "r177", "r178", "r179", "r180", "r181", "r183", "r184", "r259", "r266", "r358", "r400" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Allocation of net income/(loss)", "totalLabel": "Net Loss", "verboseLabel": "Net Loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent [Abstract]", "terseLabel": "Numerators:" } } }, "localname": "NetIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income:" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingCostsAndExpenses": { "auth_ref": [], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.", "label": "Operating Costs and Expenses", "terseLabel": "Formation and operating costs" } } }, "localname": "OperatingCostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r152", "r153", "r155", "r157", "r358" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from Operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r57" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Operating Loss Carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]", "terseLabel": "Over-allotment option" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails", "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Parent [Member]" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": { "auth_ref": [ "r383" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.", "label": "Payments for Repurchase of Redeemable Noncontrolling Interest", "negatedLabel": "Common stock redemption", "negatedTerseLabel": "Redemptions" } } }, "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingReconciliationOfTemporaryEquityDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r27" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Payment of offering costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r4", "r189" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value, (per share)", "verboseLabel": "Preferred stock, par value, (per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheetsParenthetical", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitPreferredStockSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized", "verboseLabel": "Preferred shares, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheetsParenthetical", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitPreferredStockSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r4", "r189" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued", "verboseLabel": "Preferred shares, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheetsParenthetical", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitPreferredStockSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding", "verboseLabel": "Preferred shares, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheetsParenthetical", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitPreferredStockSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r4", "r367" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 15.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r101", "r170", "r171", "r355" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/PrivatePlacementDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r24" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Proceeds from issuance initial public offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails", "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r24" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from issuance of shares of Common Stock to initial stockholders" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r24" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Proceeds from issuance of private placement", "verboseLabel": "Proceeds from sale of private placement shares" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/PrivatePlacementDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r25" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party Debt", "terseLabel": "Proceeds from issuance of promissory notes to related parties" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r93", "r103", "r104", "r110", "r113", "r119", "r127", "r128", "r152", "r153", "r155", "r157", "r160", "r174", "r175", "r177", "r178", "r179", "r180", "r181", "r183", "r184", "r248", "r251", "r252", "r259", "r266", "r329", "r358", "r365", "r366", "r382", "r400" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r212", "r278", "r279" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/PrivatePlacementDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails", "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r91", "r278", "r279", "r414" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsDueToARelatedPartyDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails", "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsDueToARelatedPartyDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails", "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r68" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsDueToARelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsDueToARelatedPartyDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r212", "r278", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r414" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/PrivatePlacementDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails", "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r276", "r277", "r279", "r280", "r281" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r26" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "negatedLabel": "Repayment on promissory note to related party" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r7", "r50", "r84", "r335", "r336", "r367" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 18.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r92", "r116", "r117", "r118", "r120", "r126", "r128", "r161", "r214", "r215", "r216", "r236", "r237", "r257", "r332", "r334" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails", "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/PrivatePlacementDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Sale price" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/PrivatePlacementDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Income tax provision" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "verboseLabel": "Summary of significant components of the Company's deferred tax assets" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of net income or loss per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of reconciliation of the total income tax provision tax rate to the statutory federal income tax rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Net Investment Income [Line Items]" } } }, "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccountInformationAboutTheCompanysAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": { "auth_ref": [ "r20", "r23", "r90" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.", "label": "Investment Income [Table]" } } }, "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccountInformationAboutTheCompanysAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r69", "r70" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsDueToARelatedPartyDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Balance at the end (in shares)", "periodStartLabel": "Balance at the beginning (in shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Purchase price, per unit", "verboseLabel": "Price per unit" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r98", "r99", "r100", "r113", "r132", "r133", "r135", "r137", "r141", "r142", "r160", "r174", "r177", "r178", "r179", "r183", "r184", "r189", "r190", "r192", "r196", "r203", "r266", "r353", "r379", "r385", "r393" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheetsParenthetical", "http://www.tradeupacquisitioncorp.com/role/CoverPage", "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r17", "r49", "r92", "r106", "r107", "r108", "r116", "r117", "r118", "r120", "r126", "r128", "r140", "r161", "r205", "r214", "r215", "r216", "r236", "r237", "r257", "r267", "r268", "r269", "r270", "r271", "r272", "r275", "r332", "r333", "r334" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheetsParenthetical", "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails", "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesDetails", "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r116", "r117", "r118", "r140", "r315" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheetsParenthetical", "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails", "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesDetails", "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r4", "r5", "r49", "r50" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Founders shares issued to the Sponsor (in shares)", "verboseLabel": "Number of shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/PrivatePlacementDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r4", "r5", "r49", "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Founders shares issued to the Sponsor", "verboseLabel": "Aggregate purchase price" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r4", "r5", "r49", "r50" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedLabel": "Forfeiture of Founders shares issued to the Sponsor (in shares)" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r4", "r5", "r49", "r50" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Forfeiture of Founders shares issued to the Sponsor" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r5", "r8", "r9", "r42", "r367", "r386", "r398", "r413" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 14.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance at the end", "periodStartLabel": "Balance at the beginning", "totalLabel": "Total Stockholders' Deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets", "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders' Deficit:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r52", "r112", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r202", "r205", "r256" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders' Deficit" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r273", "r283" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r273", "r283" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r273", "r283" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r273", "r283" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r282", "r284" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/PrivatePlacementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails", "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/PrivatePlacementDetails", "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsFounderAndPrivatePlacementSharesDetails", "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]", "terseLabel": "Initial Public Offering", "verboseLabel": "Private Placement" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/PrivatePlacementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of accretion of temporary equity to its redemption value during the period.", "label": "Temporary Equity, Accretion to Redemption Value", "terseLabel": "Accretion of carrying value to redemption value" } } }, "localname": "TemporaryEquityAccretionToRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingReconciliationOfTemporaryEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.", "label": "Temporary Equity, Accretion to Redemption Value, Adjustment", "negatedLabel": "Accretion of carrying value to redemption value", "terseLabel": "Accretion of carrying value to redemption value" } } }, "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfCashFlows", "http://www.tradeupacquisitioncorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r174", "r177", "r178", "r179", "r183", "r184" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/BalanceSheets": { "order": 19.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "terseLabel": "Common stock subject to possible redemption", "verboseLabel": "Common stock subject to possible redemption, 910,220 and 4,430,000 shares at redemption value of $10.25 and 10.20 per share as of December 31, 2022 and 2021, respectively" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheets", "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingReconciliationOfTemporaryEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r0", "r48" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary Equity, Par or Stated Value Per Share", "terseLabel": "Temporary equity par value" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheetsParenthetical", "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Issued", "terseLabel": "Class A common stock subject to possible redemption, issued (in shares)" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitCommonStockSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "terseLabel": "Class A common stock subject to possible redemption, outstanding (in shares)", "verboseLabel": "Temporary equity stock shares outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/BalanceSheetsParenthetical", "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitCommonStockSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r158", "r159", "r188", "r201", "r255", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r395", "r396", "r397", "r418", "r419", "r420", "r421", "r422", "r423", "r424" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/CommitmentsContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_USTreasuryBondSecuritiesMember": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities greater than ten and as long as thirty years, are interest bearing, and are backed by the full faith and credit of the United States government.", "label": "US Treasury Bond Securities [Member]", "terseLabel": "U.S. Treasury Securities Money Market Fund" } } }, "localname": "USTreasuryBondSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InvestmentsHeldInTrustAccountInformationAboutTheCompanysAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r217", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r225" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Unrecognized tax benefits accrued for interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnsecuredDebt": { "auth_ref": [ "r2", "r74", "r83" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Unsecured Debt", "terseLabel": "Amount of unsecured promissory note" } } }, "localname": "UnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/RelatedPartyTransactionsPromissoryNoteAndRelatedPartyWorkingCapitalLoansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r39", "r40", "r41", "r144", "r145", "r147", "r148" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r231" ], "calculation": { "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "negatedLabel": "Valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/OrganizationAndBusinessOperationDetails", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r412" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Public Warrants expiration term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/InitialPublicOfferingDetails", "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WarrantsNotSettleableInCashFairValueDisclosure": { "auth_ref": [ "r61" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of warrants not settleable in cash classified as equity.", "label": "Warrants Not Settleable in Cash, Fair Value Disclosure", "terseLabel": "Fair value of warrants" } } }, "localname": "WarrantsNotSettleableInCashFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/StockholdersDeficitWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r131", "r137" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted-average shares outstanding, Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r130", "r137" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "verboseLabel": "Weighted-average shares outstanding, Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails", "http://www.tradeupacquisitioncorp.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]", "terseLabel": "Denominators:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tradeupacquisitioncorp.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails" ], "xbrltype": "stringItemType" } }, "unitCount": 10 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r36": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r368": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r369": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r371": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r372": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r373": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r374": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r375": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r376": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r377": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r399": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r418": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r419": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r421": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r422": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r423": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r424": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r44": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "20A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=SL6757427-112606", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(3),(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 63 0001575872-23-000353-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001575872-23-000353-xbrl.zip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

LZ 7CRK8^H M^Z:4FPX7:Q6.?>T9<=:#(#MU-0:+60S7=+%E5D%NW@JN&KI4R2UJY#80_!^)&YD$$J>G5-C017M*32-Y2O56J M4H9&(,6\S1'PAB%4>(AMHPPX_8Z<+))R.AJ/2#$+)&)U(68,/.VNJS,!_ M"ET'3B5BI,NJ( V$KGVWB>&06!R%%"LRC#X+P# VL&%Z. CRK6G4*\UZT&S+ MOF==%\9);&>;.-O$V2;K:IL!^^Z^SI58SYP69!,^ MVMG)JG=,%!.!L1.H/->%AFM/\?5E.2VWS5/=A M.N>&P,;],YX:961JE+PY+,4;WP*YK)6(=FFW: MCJZJ4#!I6?F1(&7?3/0;5SELJO0'T&>L5#W=-/J*"R=K,A],5XBX!]A#2,DQ M'FY3]Y2GG)56ADYQ1#KW R@.(YASM!Q.F_-D2I6-,-B;L,64$VL=&'@=Y1/Q M,=DXJ^QNC_#2X;!T@#C[3+?8(:P60^M#].G8'3%Y)9\MTS&@Q8%(*R#=Y<&&*W>+,O#'9*J'X]4+I$[U3K6J&->66&;,E;\^%YX;2 MX'%#Z=H54$,G6RT^BP,M'^%WX(MLXT;K*;2(/6"">*)IB!?9P8Y+L3 ,8H):TV+-K92DYA-&9'5UF$ M?CN]^)@YSTN.]KJN=?H-A=/4GNZAK:NHT5BVULO4@5N4W^JSOZ<@@SL[+=9M M=SNM:9+L^/2$;> ?IL "_ONSGL6!G86IKO"RA;W\5,IU?5"=/4M]!RM-+J^Y MO+(5:G,9R&)]\$"O!BDY*O0[[$>ZQY_1$K:]^JDIM'"N?[9)P=2%<[.79T -++$[X=UZ$P(%-6_L$V]L.UWA=$5C=G15=86M-C'_9QR% MF&6'8:Q#_J\HEDE6(:)X"E NY5VJM8!UTGQ=<)O^ HG6YU>1/4V8(C@/&! K M3H>ZJ'A*Y1VHYK2=/Q49M6-8(6KK2DLJ<:-T@]7>V!2!JY0\3S-VZ15T@E.LG*>K>^0[0'W=[\"'+;)E\,]B>>$P,A6&[8%0\95S M?"%4[=A0&F@>]; &%%;LP_W*:M76[ANZ';/2QM%UR#JM'="84V1J46C,+X*T M;[)>@$S*F8?HC$>26GOM=HW::8 XGL&N&_GY;Z?5:>^9I.() +O=Z;:Z<*G\ MS;ZLN ED7@#.'LU.E26V2'/-RZJ" 8"A'Y&C!?-,B^6BS4-6SLPC]$W*\8 072OCBFRBSJQ#"A#GV%7LY-O8T>B= W%T/!(DM,MI1\+2LS-3_0-34 M4X@8]$)E7]_J1^:&6P?4M7K1GP.#J*0XI"D[K4EJP$T6PDX%(;FGPXWHU;/> M=$WM86K#O,S ,7[NOJY[9HM#4%L>:A^@T7O9GV+OTE@TLD)_NEW@/G 78.\" M[%V ?8,#[!>9$?HY"[]$&5V(SJ\)OU_!M%&'FAUJ7A6ENMAZ[OV"Z8U=IU( MI>4X@-J(^?I.EX73-LK"%&3VZX)BE+&JHPD.L0$@W'8(.)?*JI4KQ-<@0W@N MNM004C?R"\@ X=N)VJ;M79+@2RZ_3 M&.C[,$>-2/Z1K=R^46@0H[T;IMX\ZVQ;W\21;7YYX"4O6]DY&\:-Q]*CLL,( MJJU[\O:CQ[S6;REE%U[7S?-RC?6@HCRCK=J1<%SDVRX/9XH9J MCXSM%\Z^%QN!295-7G.##JWQ@".PE%H)RM/2N.>EPS30YXBZZG(O@)M4[D+7 M!H-*>[H564*]8( ,U+*+]LF.F-= DW&QNYJX$;$GU?037&/.W-I(#JN=1;%' MC5U-TY)"9S+,<3".ZG*,$/$L91GWI8?L#Q)]*--A]AD,1+CI&9XWF=641:+] M2X9'D8F4C'6!,Q$/L=5H3_>V')#3";X1I0VL.I/2]IB9BT7*=F:%4TS3.#2; MXUR! MB8P5'A8_LGDI5FJ79QT%]')]!F#>0B5-*YM*SA-(K>H^;#TX N,=8G+NW1$S4I DE@VM09,UW+LKD0'7K91 M8>8ET8=#; C&U!"V,83GKZ,8U095/[1M+;*H.,R>JH3,5?6#'PG=S,@*GWDV M5)]]!?:P)_]<"_[PDLA[6>?]0"E9ZP!I38_56%\4Y'!MTW9T97%ML4_1[9C3 M"FTZ[%VNV-/H^1P*'RIDQ&SC$_X;[*PJUF?MV>MXDE[M6CQS)#=#15EQ+ ZNY*$ M>7YTF&EW@QI'(J12KR"++60DI/_2M(T7+&]4F\,1%/J58K2X!00\>ED#/=_F ME5(!YR"8=2B?]3"\@H_##Q Z]D !$\B.2J!P%*1*&Q!:!Q5?ABWW5'^(+9ME%_S?2;<^"NQ'H:H+,>U8%[0;X8Q*Y:"AQB8KPUW0 \I!6ZJ010G^>[I-FPMC$A!#S5VC,XZFM0X 8V'-%^@)_/0/!^W%T4]XX)=.M[W5;NL L22W]HW8QT@M?:-533 UZBB# M3@!ETA"(,G4]EDP><=&3C#G5HN!6D"$=)%1SK"NON\Z46*8+ZQ3KY#%(5>,9 M$4M4"TVNA%535I_JT&IZFW72F#?4GPA.9H;'*7HJE(]N"K5&U>5RE6E_@3C57@_32*]1,OM&(]9C6-M M)&)*[*X)?ZNM["+KHX- ETY_HS%5"]7*=+T!3#>+@?%5G@U5$_Q$$4]T]']+ M06@Z)#;&K8GV4W(X"DP2V+SADCB,7@!GO>BFD!5V@R?H,8;(^=;Q4 @0I,XH M=28U&NSH=A8U#NLM=I!5!*@/6<.X-)/JVRI51-!$A2U*T"4R$?J+(5YQ3'&Z M2-V!'-I)%.SUPM0*CFR*,T/V'YONQ@,YJN1+5S9+E[T><"R#8%WID3U^#_WH M.O.E9ZLM5PB:NGY3.D%'^0XH/%+1T[CX812B7]OL#T5/EJI&Y#&;=#AH0AMU MN"5\!OW"@S$PA'9#90X8&UBA*Z-7WZT$5D?(Z9M-QJWSL&5P$-15MZM,U1Z"9&6ARL7F*4'QFE,)[A=E'GTQ69?BE"1%#41^]4Y9/R4 M]2\L)+KJS-:KR#/MG;SI:9KD(#,?M7-<.?3>F!U=59!U0'6,_DRQ]4'^26N= M:D+0Z(,>@IG>HCSWGB!(A >ENI<&C$#MV7*W/^5Y*T'B","3T0RE[*$< 1DM MYINLABDRN#P<=14I(RDJ> JB)9 DAK;8IS3&4P",_M=%]JPXI;#]XIG)= %; M&V$?LF(3UYKLE%+Z"ZD]CR)32X(WGZI>NCD8R:H(9"!*AZ0:_59$7;@9!N9E M.SBP_?+*ASHZ E"KH\+J-JRJP I#<>4<'0,^)QMMV!?H%B.Z($L.;TFG9@$' M=9D6FG0:)TZMSUL9$W8:*(SY$U,PE(O<=QJF\3NZJAKF>([@=JG3@;+*3HC] M3;BTCFK6Y?8PD:JE+:ZB9"EH"ZS_32)&BZ);,PDUL#?UP(N5]NIDD[75"Z(; MYLN _[E1)$;DE;L&H=>!Y+9'Y;=M3'@FU8QPQB668JIRK=3+"NQE%DUYG36S M=;+/R;[&[.@*R[ZI"24$)H\P[#((N)6 F=0C.8$(#]U<,DS)-97$Y331V MN;O4I'U6ZRZS#5M!->"4EDDI+J$Y"& >IM-C>"YDI;U ME]9SI[2>0IH.@$G;'SFOL_K9UO%'U-QG7R-7GJ<(Q,HK>BU.A1DIG'IE([13!+78@Y';7@<7B>JX(W3[%";11X1%&"?2]- M" KG95LZ[4K^$"4NDS.P-36YO_6$?9Z?H2$SVZ"8<>US_V47"P^TD>+9!,P# MP((J"E*3PCX2H1+JY0.Z..O3U6J2N>4KF#=\\_!8*E5=H=SL&-&ZRE79J"B4 MTVFAE@2'C MO."5"38VI;D*YP1UY=O0N-0&L(EO]3$(EX*!4JS7&.H"H7ER;!D&DZA'G%Y$ MIE-*'<]NV147SE,Q\\J^JTX29F66[RL(2>Z385RGMS06MQ%.><584U]"!]'4 M!8[GD!PES.RRF>H;7(N:;;M?D_KNX D7'W#QZAOV-0#ELJ88A^R_S M,HM&Y%*5PKR\1/9%&><DC+[B"*5CZ&O-XT &JY:VRL"-S$N8=#E ' MVNX&6KFJ@G<3%)85(J36;^10:X5?=MN98]J()J-)4<=9B%%2IS"S(!E0M9I< M0&*?1Q#PXRC-<&;!':E2M*(EI;^0KLX: YN3B+(%#J,KJ]5SM9$-08;M519F MO"!R&WT$+*YKYV:+D+IT;88]N.?%J9@"-73)]'(I78TH".V:(0#18)I2&<64 M!^KQ !%U%F24QX]CZ#C<*81&=(1C#(SA8;&-9U[Z=N(,0F.Y;"'E PE-_DG" M.HWC-$YC=G15-8X^,Z9T28J>AD_3+_1<('2:"7+S&_H#[&F2XD$6!%WM"*RM M63K0S3*W<1ACG4V1>?JP#B4M:IF$_S266H0"QAAPM69;911Z969/%M!O5C2< M3AC))BN=UI$U@W*]>)*:52"KZ+L.<%%;9V7.N3Z=4]MB ZNA3))IQ9#)C_!P M*ODQGCDZH^F0RV8 7$)!!5)W0L_HG8]0;]:#=?E]EL(U6;SW(V+F$^IE_ART M!(%DY'.@25KB?2LU7^J^Z6ST7MII?_S]\'-KFI;5Q=&*!Y^$F/2Z;0Y\:I.6 M1ES2CO33@#)EJ5%L[F*A1-H",.KI%#C[1"7;S +2C..2XA$F]/$$BK;!%O% MC>8092$@.M7!Y"*39OZIO6=%__WDX;*QV,W1<&5+!S*@L? K"3/08+PM!.3L MD7EK!N"R[@9B,0V=RI")_!OQ)/$MHUK/E": T_5.U[L=;6P MRM9]^"2=?NN M9)TK6><$I5-]S=]1I_I6(*7)^4_FJZ92\%V3P815T:@F!H53P ]78(61:QVF M?(7EMXS)A#_!GW28B.>'-F73''X*'2*F?2@4YD75Y73_8],&V"^TV1 WPDL3 M$\&AC5BZ&/YGS+T30":.27 "F1B MUKFX30?HB5#T93+#\]#*?>%AQ"Y3CG'!0E1C2NR:M/&:+PPKEV#G#6V"CZ?> M5QC.NF_PS![!F3G:Z&%I,NJ"6G8:S(H:L.D*U!Y6N^7[,4_]-!!TGY]Z)D0& M81K,".C0E_"KY/&8CH^Q:YYNDO(@[&2F5>,!_ !A-2Z196;^N.(+$W7--HMK)#X;L!U M@K=9(]9KU%N#;%N8HNDZ;+C51 MD8^5EV,++;%&6F0L=J_\O>V_:W#:2I0M_ MOQ'W/R"JJR?D")JMU4O73$>P9+E*W;;E*\I=;\^7CB20%%$& 186R>Q?_YXM M$PD0E.0JV2;(C(FNL4@BD>O)YVS/29:ND,=!F>?%'JQ M:!YLW@.N-3J)T,BHC4%J*6_N&F+72MI!TC[1LE%MWXF*B1IZR@U1V$B"YD&D MN,"".;;>,9FCX8^"Z0@_PE*P T^FS)!_.N6]5R:EJ*@ CY P29(2'[CZS283 MB^:55K9S2%DN<4AVAIR7QX63=36-B9^S+?%I-]64F8W6O87,JPE;LZ)]17/M MFL/K( I):0>4X35MQ 8=9PZKD+L+ 0@*4H*$L8DQ+-'>KFJ&4Q!,A 94SI5C M.,9B0"VE^CH#'402WI @)%=AR0BQ _#9BXLB'1"08F6X*B_T'0"G2;K$+JTQ M0A4D;<5^4F@PCS\N;2Q&$M?E;]FO8*O.2NR#,Q4@KYO7" 5NL)3$^!)T!&GC M( '$A/RJ5,&.B^M2_?D[,',+'M-\PQJ'58'1>W2!U\Y$9LQ3['12=5PS=* 2 M/M,ZXH%Q3B?JI5L'XY QH)E=6H@XFGR#)NB7N5<0WN>F]97?WA%X:G&+RYV8 M. 0!7714@R"J)+@#IY0R0J#Y&Y54M@T* 7$PG@,=T0-LT)*=#^N"Y88ET M0U4&)EU8U0%':[8#D5RMX"712$QAY#I7B+:V"JEFENRYU4C==2_G#"&.4HWT M/'4@-'UUF\.ME#>=WG)XD+0+033N?<3>L6X 8^=C>0M%IL*PO$%1Z$V&C1D)N*E2"_H3E^;;F42'+LT<7]<9:_4//K3..95I-KU?UE%5 M[A+)[/TBQPM;Q?G#N 'FOB0V[1B'4)>G; B2E>@MIVIW3&3L=CF47++UG-N'.E,-CUL#$ 5'Z70M^DGG1843+J>!>D7%V+# MLU;W3O)EI\0\>F<46[TF-J! 5J*."2:4ZC;>X,&.G?!Y60P*WX /\""@KWK) MGNNULG[@Z&ZUTH,#?5#0=AT&4 A!..TK%)NAAY-XPT,8?F"L7WY,9X$[=,,!V(HNOFYBP9?IXM=G?^VB33D +A6*I(9 \L MFA0TY"1X2UD8N,WR.>R6&AQE&.((LZ^O,<3::"/UQ>T@$H%^]PW)B0$+.>>2 M2%KJM(+[>KG:(0F(G.B92J9_L'M&F>,%L\;'>WH6IVY5U;)9G.?7*KHF(QS1 M9\XR!%#"KAYEF!,7@QZ-%[)FLZ?&)*7648QF+8& MN,U.M"&2F%W $0.Y^"S6M%CO#ZG*,54WF3Q:E10F*K2A2?Q1)X\-8]EP\/CP M-<2R]+!NR9TAAR)>NKAKG&C4AKSI#$WE(C>NSG,_(-W=R];#IVU;T;["IP_6 M5,)!WXUXLHUX"S=.]5. ^086ZXA(G@0 8&92?1^Q6QN56NI M8SJHQFPM,7=BJ1LV/L&8QYQ2?8U:+G6D_[X;YB\1Z\+C3]6I+#3#P'B'K*T= MM]\1]A^7KDE.!<_VGT9L8B"/'#H%HV;%->NG?MJP=,%MA?,UR3',HVR 'V<* M )T&+_D576VW)XQ3\"C?P[6'\CNDO%\C^>[@A!N_53&MDKS$U%LCN]TZ^A^5 M2RI#BSQBT++W(19JYG"TPP+6[A- )4XX!*D3K)T8?-5%"=A=2D&B4'(70W4< M)J=!,U^ML;1^54.6B)98=@$K0YEI@E(;1CYRSO[L7BH<(V[:B?84( M[0I?Y9KK>-7FL2G7\1K*N$%=#N+W7'S?S\%BDJK)BLU%MM&[8NQNJ&SL(Z!44G/,I6&J%)FTK?4U'UO5\0(%) M6D7<%W2S4Q,4(B<+028FBBU:-V?;1(]J*7F2Q,)XBG'8C;P\-W#]_]BOHL+)^ O"X! M^6#?9R#[#&0O*?W=M_TKZN\^GX&\+3;1'W6HJD+;!&2)>6"%CSQ0J/,Y/K?! M'51;1KTMQ,*BHFQ!1J,$+\4)F5_0YX;9)\''-.,8+4PY,:F+,&7LM3,EKZU6 M321>-=.SH@1?4!$Y-1F43,WV$Z-]YW4"C2J-V[*AB;9<RO%M'.XCZ-I8Y:0KEU:E,R, M_3 1PWN<"UV@.6))OKXXO=%%R2FG,%3Z3)?A\$EP7Y?(/M"BH1XT#,;4SYJ: M'Q.48$F8 ][91,J:*WK7)O'3YK_>CGS=H/^_HSY1F0_'T,T%-F)'-0.43D% M-MR^$>!?2;9#(_/5;#]CN*(M%,^R+#+9)K*? B?Y5;H2IRU;#-M<)'6UP]Q+ MY,!P-(>!N&@&C6@Q.;QB-Z(=W;06I1IS%Q17NW9]_[43^(X 6F;)]4&TG7&S MS6S >A5V*R'J<7.A&A$BWK3HU:NM6=&^HF!V[DXQ[ET1OLFK11EB,%89FS(_ M"BG3;[($Y";>-%V_ O&";40-]EB*06/W/+QW'F,V\:"9V['^GK W=K=[S>F$ M];3);2D,&A9$.3_5Z(37XO-?0QO<#(@D7&,Y@FNZ^P;+<)-)]FHEB]OI@3P8 M:7:?=UQTG8'>MS6)OW'!Y[JL\D9D-E^]:Z,T #79N#ARKWWUI6\S]#:=6QW^ M,QCN3:QOX7N^_IP-$.E)F>5_,8Y&7-._9'EK7Y!/4(KP*%O7)M=3G;,VQ,GL M4_878X6;S/FAPTX$R/Q&+Y'D96A^V4@N;4P@4@:8#6P0NF0S! 7F(DCD95T? MHIZ$U>W4B-VQ[ERSV65Z%-4A(Y8EXD["W5\6#GU25''IJ28IMDR:)5D ]93/ MS41%6+VPG(F#=$*9,!DED4##.IE:#4Y4NF8*P@)K7:&B$2FT& &J@18 6KE^ M?B=^:$VA15LK2451CN6"Q%W?X6>^BY/;9/LZ"*9#!9:HDT*+\]CC$X]/MF=% M^XI/KKH##KOJN-:Q.U3:IENDD Z-6FXC$E%4LWNC%]?6,EP7 O<6[5=.#-P= ML4*D6WX9BTW737FO=DRXQ"$U)J^F5W)W"Q86 MU3G&RB4Z+,TQP758B2ES8U)KFZ6&$ M,0(R!9RQ_SEF/ZZ#N,;&UYG\ > PR,[ID6O698$J2?L]>_8ZCK?P!,D2,?. M;V8P@DK=H]N=B]$:R;B]+E360HRV1>942HS+8J66(H'8EAEYA[')5[S)MLK= MV7N_YN_+8 Z:V,00*')B R5W_]!CJ!TM;6O'U%X:LV/7_7\7YO M-+A@=]>HKR?UM3$,1GJ*=XY-"T;T@W$,=8Y2$_K>ST+&X?2W9-( M1-RR'3E!QF]X+Z4;<3Y+\9'L8Q,M8-G.!*XA?6-GI$'>VBB -LW"BA,P.!## MX-\[E2#W93+FY3#X<6GW@E1_79OF)VR$I@V:TB6G6"0B]:.FL,>-\=<-DB-? MZ&:_2Z;W4(PPM&S*?XY/#G622&CO_WRW_QW]+0S=+@QT=/D(#6!#%V-!'1EH&UCZ( M5'=U9W[-7)+65AL>OUC9;4]%[C^R:MG#C>AAB(RV"@S='\# MB;P;Z8^XD>3HCB1= :3 &2:5&$/J%>5)V=" MW7=NBNMYANW%[R3:=M.MW=) M?78Y88>\*CK% MI^_U:Y";QWP]L-5ABV+NQ""V.F"BT)P^FXH_' #(Z5QP0) +O^7,<1QC'<]; M)U.=1,BU0@UYQNAIKA$AV;P) MMP8IB%/*0>5O)DQ9QAQK Q,@UEX(%<_Y6Y.F&81T]Y,72))L2N7IKQ# M9_T$=M414Z#TP"GN@%XYIEC#]^%.;\ZTAST2;4;L$P5;K@LYU)NM(FF4Q7GA9NY+=]TO7P8O(5A M9I3-O;ZHP#TK11VC#>0DSW+=V5A+7"F.*-'1M6Z$6%+*<^VZ-)&@M0FNMH=C\CP0V+85[2L0>&V%KUH78M)(SS.A%Q2;'CL)];:XGI/!E5=8W;PFEV>I MR!5MBFJQ2$1"4IV:$*T!=-VV+KG.>_ZN_"43&6(O;%5K*W?T:F!K-'5UN=DB MT9<4&,IC($ MO;/<%>PMQH$9A=JL&_$.BT0?INS#E'V8\J[;E\9N3O-;M>1] M^@Z$_,]&]#JFIY$D=2'2/!>D:0.<3^M+;-?!B8>;V[:B?94&OS!&#+.4G$%N MA6=3H;@C?[-- 4;EFZ@J,OPWKQ)=\*X0J#@^.W48V!K<7V[3EA4^GHI]04CI MB%@ Z=JS!H,"/8LU%P##H9)>(4L7,OUH";0.8ZE]M/9-& ]L4;9E$..:D":+ M/GC/5HXZFY"C*YAP*D86A6LXOK,X1)B9*),T*C!YN> BY'=IWH7ILZD"PMQ- M8A_HGJ/"*?)IYZF#XI[*7R*1%+,8(5T$5[O<)&SK XY_;Z2/7S>ODGP%E61W MV- //!NZ9T/?0KGI]8JM7[FMNK2^"KMY6B5)1[QR6VI]UQ*U+%^E2^N%;6M# M#4&$P8))P' =#>V*8W?CT)ZP,=:F%6@BH(NA-5_R,^ROW0'\D>S5QFW0XS_/JG<%2BG>FE>U-M@A:%NP MK0];\VA[=^:WUXF^@"[;]_UVT!=1Z)I#12ORXG&=>/R%#6]WHLX^C.._)_E? MOA)VWM0I:R;*YWI" +SW^^K/)QAA2%,)*'*0P^59ANRJ;S&WY>M]GD:_X9L+Z_@]V-SO#%@8P8,,@Y-9A#0U6KN!)I,-?P<=[( M^L-DO\^0>)NR$SU:Z\O^_&RTMBE;S".V?FRPST)L&[.Y>K*WO/SRIK)-W6A] MW5%O&875,"U.L2(7L5;$$16IE)R/S\=GF[#G/#;KRT[TEC2/RS8#EVW$QNK) MOO)RRUO2-GFS]757.;BLQEZF]"Q#M1YJFAZ-]67_>4N91V1?=(/]2W].4,;& M[*Z>;"XOP.Z$929?UN=>^JS9C5NYOIZX#T33\DX5D?K-&O-7P!OS.(H2 M[16FGF[F.R'M5]@^;O&N+=X[_=TD;EVO;[9+6D+FY;'?*9NV4[!B1E%4<*O- M5,Y<>Z?9? ZPAY(_A8):>/$U5H:@Z@((F9 \D)C_IL'A_I^-";$N@U6WB!"K MU:I.X=,22W/B'O+ZTW9=3QYK>:RU-9OY6]^B'FMM^";Q6,OOE(?L%*GMU*@O M-4#>YSBDZD5YHUIYX9+'[ZDBB/0T3IG.F8U?;.QZ$LP4TBB?_!E;N,ZUPCKE M6 8-T%<9[%&SX2Q80#M(EHRW)9<[2VR5](/]SH>?#*2CR9(AG_EK;4VN+)=$ M6*E,1F23:&DS]-"W<<$%W:GN$W-#XY>+#!DH8^)F1G;L4*] T9#,=_!(E6#X M(+2"54>0:!K+C[AP$LUW^)Q!H$2\C9\OLEO&ICQ96/'K!_C'PX(JON(AWJ*# MV[Q#O]'MZ>?3;]'[IG1U8KT0\#I"GW2$+=TP_=T9&Z48^-VQ4;N#BN99J/L@ M "Q%3 W^13V"2I9<9YSI+*5V+9AUE:*7"B)PL08.#R"V8#=#M!A M@H6(2.H7F;P*-I>48C5!_%CZ%2=:13UU3%Y')44AV1[49W['M\Q8V\@0=DIWQ216BMPCIA M, )_@0?LF/SOB/(WE,3=H;]>(HOKVB_<8]H M@C->;V,/PZ5W9F*3:HUMKW#?JOH?OHZNKZ.[R>#G\QB#WUO=R! _V;"2L0ZK MG.3QKN-@K]ELVXKV]7"?IPBQ4LT(TQ*OK13"78?JNHI>#^@GTXP,'L5@G0,5 ML&Y<9/QO>" F=+M@=V>@X(=)K$J802P7N\CC&_@#E))47V0NOS@P6)Z]J[>[4"<-C:&\F=;^A8^*5R8M5^KU)DV MPI>?ED1Q'L8E@\IV_6#^"?F"*4]!H:OW*36/WP5P6N&C+'<+ZU[EL'V#41C" MA);#X!TL/G[UX?W5*YM2\6B33P ^ M+Z2S^,0)!FUC3G@>U0 :M[-A0/%-L$;T-7Z*,T3J$$K7*)!3(BO2V'@# M5M.#)$NOI:,3G6I8%9RA[#;E#W--DR=J)LP5]/$ZUYI5?)@C_4GG(>[.N"R< MRM4!B:R"M?+PCC'BN67;!8V.MTBQ,DI\%1UV_H+W/#KO8553["L_R-8&VLTR MP?DP.'=5;JLC?L:VE.FSV]/9DW8=ZRYUR(.H*1#HS,L&=,>()Y\C*9)%V#K$\CRD4,])U.>0 PYW:FX%&T(=%"X%GE$M[M4&!:P\^5/U>\\"C^S:%O MB8FN*.+0*M;=>VRJ;C)+;=!UJ=0'9+*L8TGPUTG\42?Q+ ,9@6^>E KTK>;R M-&QQ:]^0T0DHX(]BRALMI<'W)X/]_7W\W\& [#D83Z.N MX977>!'B*I3P MB)$EIG=VO4.>> USF"+B>%"K@Z!:.&:J1+O;K1M1W+(%KL25U"HO'#GMF#/E M%-;7.0I0-&[JTCU7=^Y423/\1>4@3DH^9K79;;7/G5N)>H=/8@?J[I#@F6C- M-R>N]Y!W")OEBLY+5\RMN<9SR1+ [L"Q +>#(UHH^^]!>G>.IG/RJ^99O3I# 2I M$1!"?>%P_X=IDJF2_GWPPX-DH D"K1.&'!QK$%!;)RFLN<= %8 [5:BC@9%^ MJ"Y\)(<-@E*$A2AE,6>)+G$*^T33OQ+!BY,N]X'Q9>&=G:M(?$+8:>>UB!H" MEL@8I%M_85QB7I!Y0;8U*]I70?9S=@MJ8SYHNFWO51\'#]8?;Q$ZN@:B.M;\ MUDBX->KB8 6-L1X#**W,*]"N$X6"!4A%L97"9Z;9@EH=SC7N[OYO3C;MA5MC'"\ MG$^R9+/<8.V^?;'0U&<'SPZ/?KAS)WR;*0G>NAW: V M",K59F^^!KY?9RS%/*TXTG*=66OH(L_(A$A12V1J1'O5#.:';C65BJ\CIL#8 MJ29KJ-Q>W4U]I87<1#GG;ZYM6U%_<_F;:R=OKEQ?QQBM29*]*.$:0N7G+^(7 M-W\'<$59'_I*Y$&G.;WMP,VUA%\ZUG;)V':L76LN.W,G6C?F(UVXO_,2Y;&) MHP)=8U'#'\:>JUC<1EVSX^].?W?Z%=W:\.#'VH&K4<,-VB;.:R3BI?6D39:2 M:24[LK$S6WMRP!\, MJ./[@QI"D&!B7\$:=0-C[!!:'U=G:A\**W4B>OLH60 M1QT=__D'-],2.GUP:+K;E5GG[+X%;)NGDURKCT_5%-[R5Y7X(?^]OW_P;W3?Z&I!["-P.K_[VQ5- "54INBH+O[[+^IOK06\=R6]I/1W MWTZNJ+_[>I QXPT2WB#A#1*],:5'&>GG$NU.EH:5V&"V8$A0O0WWO],0D>44 MN$,!]:9MB;I;"3RF'U'X(,%?,A)045:>%@X8)^N*&Q[(V=?UL[!@7B=%SXNR5\PWW9%CU_L?)BE M&MXM$]W_-F.].Y'LAKK3,%,30YRO6=H]C3P^OA (OA2![STB1>/[EO MA VGTT-&^6"TY9U'7A)Z2?@E)*'^W=:Z>S*],.F9O,)TJ+$<&1Q_36YAU^VL M?ZMT43;ICEKL8Y39M4D,"M^@ZNM&'?/^FO ]X^X?8-P%O66A2S(A;MS"^AMY MVXZJ)S5Y*#L3*R?3)?%YZ!N55*HTM00*IH$DJM-V7\:)15M1PL5@>"GF6YSHC M9M[HHUD05*),>)^IVCIEOD25#.#LA+,4TR<&P:R:*R:ZY%D' ?+(42>*54R MR8;!!>P--8'7PXQC9 :7;0T212R+K=WD$ B:FBJ3)6TO9=DA;6?J%R+-9XS$ MG$0U(_58V#1V#=-9"'\E\5"Z)4L(+IID16H=9V[^/QU4X'9&,3-S(9I[K28'75_59%&]8 M=^406K J;U2U-8![8+G3IA7I^%&<5"9@9EE7$DN6=5+KP#)'8D9HK&]UQ/F@ M"BG38/E 1V=.M/9:#X,S+E!C-Z$4V6$2;2H[4PEO@Y47-WJE\DQ1A>A,GU:) M0S[+Y^7.J=@D;6![+RKO2=ZD7 Y?_<3K8O;7KZ'5Q)P?'GK$XQ&/1SP>\>PLXCF;+Y)LJ3W@Z0W@Z9LWN)]7UJ,>R5]T$%8Y M6N*2I:E+EFN] FORPK',$;:PTOU+C14?WFO^X M(I+BFCKX8BH(C>_CA#SN&9;1@B'2EU+0C+Z^P9[82MJFJ/BJ4P =]50XIC#U MJAYLFN1Z?FC9D_BB.Y^PM'1:BKP-8:U-!GP]X5Q""T:$-L*G-"QM;H)F?F&S M6LZ]L^F%D\?3'D][/+VK>/H]70YP"5[:TELHQ.L+]KRNINDA=T\@M[6VC::.[4BM]?<4E2 MY2L2>B&X32O:=R'()#,*:W77=/!C2_\.?R K#:_UBZ>CA@#B^L )'NL\IJ 8 M/O7MTGXL.*7>*3=U<-@EF(;!J.!ZXE52#HQ:Z]0Y)>F&!=FY%99$IL@XZK+9 MO$K87-$MK4E!IH&GF16NI"D;I1=CQ2CTKA[WP0G76"U0O-'@'%&?2_R7(_/7 MW12L:A.IQ:3 H/VZ,K%-5W14;Z]R>]FYU2O:8]G)!9NPV$.D6S&-*" -5.K$ M42;!.L^(?Q*-MVT+HBJHCJ#Y*1KRR,8ZU;FEZZ)\(2G7D0'$,C&?]?>%")A& M_S *M2A 3F/+<[)U4KBK :@K<9\(,F&P=3KVP(0K=@V.)B;5;"^>X"@UC(3K M9+2QZD^CT7L2R"%@T:S$CF#4Y3*KZBHA. U8:E:M1,O6UE4 H!7-F:IC-!L! MK2$&>D88_$S=DXNOH_?W]9;#BB49O7Y7NV/2Z3;H7#XR73"1Q[+SD/\C6EWK7V:HBM ;L V*)):Q9@DEK-T] MO\6 Y_E[4FLR?UA>NU$)ILI,KO57VS^8MN:%>WQQ89B2H0+B7#)A=&BXD-S M6)X;[01YEK #*JHP>74JZ?'3N CA%TNM,)^%[!ZO=*C12?$KUDP'Z1)LMFN6'1"]!%:.\9Q3D5*$;A6L@5W[Z) M)KRMTH[/20)!4Y/F@.ERN&^PSG?ZW':VO M=.3K*_GZ2CTZIMLI=G9 I&[-J+8!VG]>8,,;@)])\!X!KT:)Y0.&O8Z^92O: MUX-\A5G^05R@ \M6;L TQFLAG0!]+3:./-!]KY'N($6M4(D*2R?:B5%>B)JN MKE6<%B7:4DEG!F66U/;".*1@3@ 3G5Y=7(XW;L-XC+-M(L!CG L1&1=Y+A(V?'@_AQ%(^!W,I! ;L-,[60K!X-<4(#MM%!J8:071S;QZ!'R,?47.2H<%BQT M)D1LO0]&$?\+IPU&:GM!9,I,D 3#^)AFMZF0-!D'^JV;)4?)7O'<=@T=#"HI M,N*FCUL,:]F:3E+PF,PC^?KIW^T%HN"%7&+ *$G+Q=$7OA!A)SYT;2#0+]*=2+TCCO;64XIT/D.S&=@6;M;U2]".9KWJ:4W);Q M_S=]9F(K#G)KA1-OD)ST(+>O-YP'N8\+\7AYLV8KV54Z\P_#'Q2(!F#9) MM+^*_=';V)7KZQ'[PU?Q,=VRAQ@]BTY^771=Q:L_LE?QX3!X?WGQ_NSRZOS, M7[W^_&_9BO95+M2,*6BE0-M-KA5SE*,1P>1W+6;+ @-[@OIHNX:A>([6!2F^ M0@33CF'B%]3J8TZM)2[L/$[#>(%O6>4Z_ /\AI1+ 6^,(TG",QENW'A QVT@ M^62N"4)2V)Q?\4>W2,S=X-G..@@:D82>PU1+;:EN[*OK>=CTL^&A3E]%G8W7^[B>/>+P8V+(5 M[:MX^*5VG]4^&$6IEIP.0GDL*Z%%-1:B(^\$$Q7!A$JME$X,$8$1\H:A(X?2 M.V\5U\W$]MM-($_*#6 NYUUAHN+YH/U6_6E!WCUV(\THZQ-KDG#9E5S/D<$/ M2[C$4G8%F0E-.9U[G%_&QS3H\G:M=SQM^@GPN*:O LWCFL?%-<\(LAS/\92K MJ2Z77;AF]4<6UQP/@[?G[\Z"\>CUV=6_@E?GX],W%^,/E]Z>XX7!MJUH7X4$ MNE)&&^E*<1=0,O?\W;P5Q[$/J[E5/,*/M?M6Z85W)Q'XV"<"^T1@+R7]G;>] MJ^GOO!Y0ZG_%3=57G>8S:>E7#1_/_TU$>G&7O<-^1V:.T>55<'Z^:Y)G0X_# M%S'A[L0@=^[0=U@[7Y A\P2F]:,NIUF>=YW^U1]9:^?),'@[NOS'V57P^N(R MN#S[Z7Q\=3EZ=_5??WIQ>/#\AS'%D5^\"\[^WX?SJW\-X!=O1E<49'YQ^H^? M+]Z\.KN$!JZNSB['P>C=J^!\//X '[W_<'GZ\VA\-@XN7LNSF'_RX?+$L2A/RU_,W MX4$OEG,06P%*CL/]'SZ\OWKU@?Y]\ .VQBES)YPRQVR&Z\MP8!9H'EN^8K>' M!=+L8A :]I/8V5/32VQ++THBM B>\YM6.UBX/30=Q+<['_\BGP_0&RP$SLER M4^W,V[6_MTJ?Z[WBMFV@U.///X _?Q9^^6P:7"*VB';]VO= ;MM6M*\'>50& M:Y;+[<_#1\=.DNZ^K0[AXVD&6C7]9OE.5O(1"%Q"8QR M3KDBPGRBY6>6% X:30MD20%@EI8>!GL8[&&PA\$["X-?Q5@2*HT\8ZZ'OUNV MHGT]P'7%QS)8J#BB_)-0%;,@,H?5)( 4,X6\<11FX]@?D0I.E5SB1'*%J68D ML)DB6G7AW6IA M>=PH<;B@/FN5IYBF,PABRKX9(&,O&6T;I8+QIP#B=(Y,8AT),,VRE:UQ/6PX M./7U:)H-=C=A!XG)RC)\I#[+[:LIJL.QJ-4==39T'DSJ0XF[P;+((D+&R8JY[KRRXYMD.%8-(6&\9;@;O%V0HK)IA&.34I=<1)5T3"*%E;>.3H=>XK MD!H/=@*5D>.B4?"N,H^YB&*8P98G%X&PZ*GK7%/2.E5B2E,N0,M*&.XFKZQX M9<4K*UY9V5EE95S7Z!Y5Y0P.QW_0T@.7VGE15%0'[@-Y2,\ )8!0!E $0*/@ M>_E]HE*OY7@M9\M6M*\G_QTTY0&-!S0>T'A L[. YE)C;'@P5@E;<3ZDN;Z. M"W@CX)H:[>SZ'>=1R[:M:%^/]Q55J9YB1J4QQ5%H:5:*Z?+L4PD:!W[%GZ&E M2I%#FF,WL:Y'<(C/O5=Y&9P':I+=4'VT.(7=M\BXY#>:?.*4+493^#>J-G%* M$9Q96G"9!*P5$5.9$.J5T8#N[1(ZRN<8%[NH ;><#G 9\'?![P M[2S@>U_EX4P5C/;$2N6(39#W5%8)9#E&*('P'DVQ]@W=">;9?$/QH",V3SST MZQGT^R*+U]CYZ$[P:78TV;NMX&\NV"8/MU3A[44UUTW>"O^6W MZF#[J_]1K_Z#?;K5G\, U34%@'9<_1T_LE?_3?ZZ0Q+25I*$*1$_C > MGU^\(\H/^,&;?XW/B>JCQ@>G%^]>G5^9WUR>C3^\N:*?8'6L$7[A:4"\E-FR M%>VKH+FBH-XDR6X1-2 @J KR?J Y#>1"LBQBFPW8%3:.O^LN*U[,J%KY!),* M521ANK]6:2B!WU*=JFZ4:G+5P>KX94H^&(KII:!TXU;12:%O*=W2%&IGZ#,, M3G5.(=VNWZGACC$AYEWC+'2) 7+0LXF&*4$O4U)%T /X\%;ET=,DRS[B1#E= MI4H5<7J#E7FE(CRV">/DGJ"IZ\UCV=V#9BQN=W\3Z M=M(V[:B?3V_IM)7,$E4^C$(9SK\:.Q+S3@<*M?U2B=<"\Q\85 6XC%) M0*!,O0J^+B@"A^MT21$OG5]C,IG)82PH1U-_"F_!=.$/J=:8^97F,F=U,J@D16H"PW@85,=A1>J>EUI!R:(4) #I_?V%Q[OL\OL$DO/<)G'>33NE^,:;<5D>\ +R%DQ9 M9 -X\%5)!DW50G*,$9N<7C^M<#S-8MN[N]>]]-JV%>V)]%K12CMT-D/R^])0 M[]YRJ?IJ/B=@:. .B(#CP?[^/OZ/"&E/1G4O4R!9BREHP<(T$ MB#*F)*F\AY\( ?(*"A4R9(I9/WQY0LO61*0F&OZ4]0'Q%*'!E!S*Q: AU7'I MKKCX47#^[G0(BPF3? T+%H>SYD_-JD3!X=&SKA>WVW*>.'G9^4")99#-8G>M M0N.!QG)T8_3W9GF:DT"M'@Y>GLAB7:W@>%*H^-(- *63,@72CHM/Y;@?Z)][IJV,K]_I%*8J MYQEW&%CP&!*$@*DK"%#D?-;H:J\C<5F_PN"$A(4!-UOO$#JS,# XMG-+"%-4 MDU^Q>+.9&S77-1NA)0:!USX)*GAI$ASM!Y%:XIM+8?UNM\Z M=2]$8.WA5CFL#^P3/N,+W _6M7"5P\T1C,(0A@>RIT#P%! GH19TLA5FN)?XF0.>[6$X5(G!L$[&AB,=U04 M61@+2A1-&W8M_DIO5.SF]E[!WCFQ\Y4RSSQU3)WH%KF__T_ M7NQLI-CY?3:#QQ[I5EW1CUI/\K\G^5]V!R!V#Y;;HY;J_^&+[N_2P;/ARPC&=7_?N5T^NQM_O!3 JM5H1<6ATI4J@1\9VPOK01@D %.> M9"7IX1<+=@2BFD1-8F/KFK16@N,C5NOX:5&I[S'!#(Y8%^1WI;JLOU^U :@% M?/DIGC,_/SQ\>$#6+Z,JJNOK7%\3]2SIK)&.JM":&YQ>4[P:ZI/K#3^6T #[ M9/]NWY*4K MC=QESCD:'!_?\6C#4'.'D>;[@^>';) 9P6*A U66] 7;E\R$-?>6??P^7;_# M?F#4]G5-2G@A]&QP.+_>U7J6?Z/SA6ZK2AO,P0G;4N5.S MX2Z)\ <._U;=F;_SEH;B/AF&G1>U,XV#I#KMUU[0>T&_*4>YK[O%"_I-%O2_ M(.N:D>"8U!.GE90 P)H#Z,M$>8XHF:.?!*<3=F:/&U4A<"*9%LAS38%+\!A5 M1"@P'SI89A7[4O$!^A&5BU#H_C?QEQRF]/"@T-JU&8;PW;1*O,S^5C*;34H' M>KYB=X+/O)/PRR]8\("X(N^8]GMNQQS3VY8@YW/A_DBY00VZ)=9O/=P_/*R9 M:0?!I8127>K(D-!V<-?N>H#MEKL_=W!%^WKL/[R_>F5N+DKYB"1H\>\JK51N M?6!'HMA(X/3]]00OTJ 6$H?4!OR77C?3"9NJ2'B,T=8%S;S5Y!\8!,R>X/J# MD.F:7%8W7'T-W6&-*$2LXA=E"XXO%8YJP_]0DCQ"R@/2P$KR'-7)@90TDH'V MQJET_%:K&+W2*L*9XC20]IP,L#,8FSV'!9P%U0);*N)/5/L/?5I9PX]X1*&L M6!M0JSR)T7M&4]FH=RW4L1W5\YI1F\=%BFD1$UF M[3 #[MXEU1\9/6U#',;#(E.I6_@NB4LU/6MXV08!17>1#\Z=,'<&S],;F#?Z MY&UM%I9FC%^,=H6XB[$#$Q#YSU_LKTN< M((]]CM(TE_#[O(F76P$:1\^&!P',5T)"52&G4*(I L&F)S:C^Z4^,%TVV+2> M,S=0+2J]1/$296M6M*\2Y8-0FP(6XYK(P2D(C!)9)ER AD6%[P.H@MH;B)OO]X?[)W5VH"W]\A:!+#11Z^OOI8BV!35-08.R MB[*DYNTGAUCHH!$8])8(-&J@,PC.BA(D6:*XCDUYFZWO@ UC:X&N%F!T0KU" M,Z5=TQ47&)($_3:3Q4%2]W2!Y+:FLM"A8'5XH%V8!R/>:B1O%A&Z;X8KB67& M!Y0#:(X7<(&H. R= M$345Z:U![S,2P>27MC3Z@1'6$H)+;>0 \S+.@Q7IL":MF513[!_EVI!)@_3M M"A5S;274FM3.R,C%EI5GC7''2W8OV;UD]Y*]YY+]?,J60! 9%&"#4K8I -?& MLU/4IA5R1"#!E .=\34@,-@XW,3G>_%4<+V.!M8XC ZTVC2,V)\#,*WYF_K< ML'_':#5HFAO11MY2*IZ(X7..8I:M @'F9YI+P>3WF]P)8J7 ^23F$:*E&*!9 M@>8)29.)Q0WNMIHHPDD^TRM$<+D9> M9%PJV''0R69 .2\9QK""#.<$%&LB@:[1L,4F@A,SS54:SC!B"A]$FS5R.*A/ ML&7W$EP\7JWOF2>#[=K2+VD%]E*1)16M+D9^I84N8'[A4!!.D!LBK[,LXMN(L_L_YFGB%%:_2 RWG7P9F' MV]NVHGT]XB.'_\HD#=4F">(*0Z!FC1).YM0$0"7AOAAI.DF]GQ*QL"4!+6%F MN4;&6JO%>6I3= CG -YRPJRE$&NG;"TR)/M8 M&UV?+; 2)72PT.)@2$G'M+)LU7I1N7$<1IIM*$4+0?@X>%][ZBY3DW%#],L MPF$<2H7$9)+.7'!(B0N\8;*K*4Q#E9,+3'5\'TXPT*8Z367 M; H6L,79\(PM39(LBU"&6S9+XMH*RFH.8GIHA5Q]-<9<(RHFT39#6XF(-GTC M9@D,5%QDM];\$,RJ.49MSN<5LLDNBU+/R6Q#U)59SF$D27S#\2JV@U-<4:X9 M@-T;!J]--0*WD!5:??+(,(18H0D-V=4R"TU=FG\]'B'1:ZW MC7C;B*]0Y;-R'FH5:;MA=QW@>,BZ;2O:UW-\D09CO2@Y#^%HW^0AW.K5I('V M(18.,_EX7$T::N]#8C&X 5-4!?I+BG^@0MBV$5&S63C[ZJ?3-P/W7<0,0)6O M^$?L+Y-7U5$/37=H4>4W\8T!@]*:I%",[76J_I$0$9 _KLX7425[1C&M MQG@$(TDXH4 ,J2T@KVBEI'#=+H3*$7I?.=NE'K$I"C;6R,B#J!F>&9?T%STE4%PGH9#*6VP MNX?"5V MYUZ%M1';ZKH0XOE<1S'[Q!=YS#1WJ_H97:+\-S&1@R:6ZU#CUY0O6[$"W A8 M'31<_ZF^A2T_MU)H@["25^QV;88?^1!Q/;MJ)] ME?F.B4\E1291.12L51=/4.8&< .3&N9+J1/Q!L3'TP\+UT8JON5Q1;%6#>LG M9K<581Y/0.[II-#,+R3RWWB9@SWZW90Y>'22W3[A##3AO&&>A9AM>/C_!PYK M4LND.#X[12OE15AF* H/GK.Y=X<%D7=D[Z@C>]M\UMX]_0?)[?F"1Y MJUC7&>^'^UQ<#)!3X^=XY$D[QM_SFYA.BTMTK6OMY?'@&;?6J,IUQ:&%C;HH MJ[VK"[&U7S40MD))N(UR=9L&40;_6<%^0K;3+%EF48*ED0G>8J^V2]'#2#\CVE%M\SB9+8*@JS_)@( M*PT' JCR-1V%>,%M\31#A]&J+.=DV*(6KY"-8F'JGYDLV1V&P5ZT;]N*]E6T M>P(73^#BQ9@78ST78X3YU%)KB_AJ9;)]]/=T\M2-C=DV"F;C@# MA>9T !"N)&X1_"B;P)H(B&.F&/)]D->A^3[R,-W.LH3"".'?6#%X8+)&I1/D M,UE(P;[:7R*RJ7:5[#F]/:5WTHNXRJSM>)M.K&'YM!(MHPY4;?:Q8.]UG.#\ M#?\:'!T=/3T\.3HZ/'Q"%.>,]TP\IV5E1WLGE@&&<>,$Q:$-R*3J@89:W4P2 M@$AD9"E),%M<'*EET73?A!+-*6UUY_)>-=A55N9$RA:*U\\*?%YI<;ZEN Z& M+8#B2\.ZF0+3M8AX)S6ROTG23AX^[.;>)U9@ /Z;+C=X7MI7B"'0D=%*E]!1 MN#1^PN8V&>*&PD[:-IE$+M?7&1G(W47A?MLM7.]7 \Z=N\YAUN&^4=O9VINO M8Y<'\?3^G"[*4J.I(V+S=KW@-O;@Q6T.*-?8S\_JF3O0:95(26I8^I/6YD-7 M)4472Q>=BI4[>!7XRWW;5K3/E[LM'G_O]7Y+7&G1:CER_HP)&GP?'.^I)WN']CJ%CZN<>1]&(4F;@Y='1ZYS<(>EA7?L?0/' MGI]_[UC=B0QA/Q[O/;:_OB1#(L'UBX5$37IGL4?K6[:B#Q]A(^/GCQ^^;^1C MKG+B5@50ZA-.1_8MA.W/Q4KZOE#XB,\(:'GQ+23,PK'*D+A@/*Q57 MBD#/%R7@QKZ7N-F8=,S2T7%-=ND64K9-M$YA=N:QTP-]HY+*AB??P\[&C&BW M$DF-9L6)ELZ1^05-'K7/--?%^5=ZHE+Z_2N(9/ MZQ<)!;(8"8D-R"4]EJ_1E&,KV'%M>HYE1W^.Z^-MNWXFFKIL2(\-'=,>!H F M^AJ)XZ;0RY3*: $NS'(NI*78E63&JZJ(2]G0P&-4##E*\Q;9F10'E$:5#J(8 MSBMYL;N]SEZN?!6YLA.WD]]+VW5'!;]S=*O=?YWE[M[A_Z)\76J%MQY&T-CB MI$<'3I 5=_WK@I>?GRV>!@__C.H?1E M>0>4ZI/]S39L#49&W[_8'SP[?F$ROVQ9!G)!HKEW2[9.-IT6FBI" M??_LY'BP__R@"W )$K:0J[/XA8K<"6 PM;&I#E\/CYX/G!B]6;\OF+P@\'QX0LO>+WWSWN?O&/&.V9^GV/F3?Q;%4=H(24Z=4E=N=1% M5N6A]BZ:74"*.[6B?3W6!NS=;7["JHZBT?WPT>''\8AB, M".RMMV11BQ@3&T>ZHW8CY53L#U[L'P;J1L4)1<>B);^=#9=B:A^\CN)!YRI. M^4MH/+ZO-F1L<^P 3U9I\SWH.($!#^HP9*R3<&<"G[2)D#&/J780-@2-!#HF MGETDMUE3#8C>(.4W*7"XDU[HCFG%+6&BTTP,[-T5-FG)ZD%S<#2&PW*68R-0 M7$VR&T^:X^6U7]'M54 \^^SB#[///O?LLYY]UDM*?_=M_XKZNZ\'-CFO!#]H MW3Y0)%U7 =HU5"W:86NQR9>4-(G1>VO53M81,DY-+,Y(D&YK)KQQN"!H_Q?/CS.N^Q$2,' M#[@-225=\V-L ^[3&YU(>BCV@2EQ,,%T.HU#>DVBT$\"_2UBV!0JAX%QP5@N M)WCW"[@4+GN!F.T5.IB%%3M?\(U(K9/'#9;(![1;:$KYEF5K_8 &@[.6,R^0 M*5M+H8>IOLY BMC8PWK'M&L:#@RR2F2851,#4& MS@+>A$(U0*\/.,%6IG-YX)H&4:SOK0I[[U8+S@9^("C JUDXT1(TI.: M?\6)"]\?# Z9%MXR#6"G[8P8UG=<=.(#P4+QMM> L,ON9:9J]$OL!M9 %O*- M-L^\++'F%:Z9W.Z::-BJFL$-YAIHNV?1N@VOPMC\>G[:-GK"0^MM_63Y7K-X MAFFE7CE"&;@I6\9LV@2&/@\A$K5&#=<$$E2OO37E J_,Z-TZ P.[\^D V17D7UUYI;4$UW GR&;I^N7)>JV<.[[+$U< MAE5^5;T6H'!620E725850O,C@._S9@5+VR=)1FKH V9P*H[M%&X&=@>[@.ZS M=A-ZVM$2C[^;:U!1"8E9[B9_3_A[8GM6M*_WQ,/"7)Q@%K3_68",M47"N/S] MF5P/GS8)2?]"TW PV#_$')W#+[UWO][*4B:SJ.1$35\ M"[K7,^@K4[@>1+X:[B1R3D4V IK(U74W"[])"A4)257 M.C%;Q65MSVA>;]WQ1D-7])RO7MN4XH[&TH(*Z6"L?<9V6+BC\U:5LJ*K:-=K MF[D]JM.UQ\A5J/(H^#&#_UKUN.,71?!A0T)P.1I_L)26A_L'QT\/3@:& M_/(5J->@E%82,/4A%9YQ0@UJ@NJ_2H,S4HWKET[B!%5EF.E3LY"T+#]E7(>< M1CJ0EX*02]4UEQ6:46245?2,^ES0Y/,]7HAYI:@FR,](@"'**L!(W!V:W[H# M8:,#C:EFM;5^N^T_FM8#A@XY[C,R0,=("F!&OR2*1U%.F$(4IKXK"1H:A1<& &$)!M\P"4*7&;B6T!'I=!!QHX43! M7Q/9XR1-<*/@HM9V)T9_8@Z0EN="3G^3);"1T+B64/QQ;?M"8*[A'8JY(!(< M00&_-N>D*FBFA M?(8.87#?_B)PZQKKS$[CREF/N]MJUH4"*]Y3IZSYAVMP:7%B(3(0MF_R7J%< M-A0/M3NH*EFGF:YLT1W&L#Y/9D?S9!ZRSXZ?_[%]UI-Q]O$P?(8F@=?66C#*X1*X3N<64;(T N#ITXD<_((.OH+CGEZ+1TEU&R%(@XTR@FT$[9$A72H_ MU:JDO#;,-7Y'J@!^.HL7!:MR -0Z\9^KQL MY6D,J2F"&Y7'2AR:G%=MFC)5MGCH-&'D3H/?P ,QC)@]>N3[Y.I7E,L-BP S MIR2#_*XIJI5YG P*[*9<)HI<6G8\7)MAW68&C2X1$_U"\_BE6_60KBL%#Y9: M?D@69]XU&S1\V[AII]=KG/ M+K>_1HM=+G%5%_6]NNLHR>/>;5O1OA[GN]QB@D@)C2'"2;+T^BF:.PDC#6IK M,\;B-6%SG7F^\B5A:=N2@ZIW&"QY>;!M*]I7>8!N!8FI-)[*:48AUQ*R-! / M%5>]&\MG)EMFM92;\;"0YI28,"FGB@_-<]$H_*.:OZ#L#FR-.V:>L)&:336Q M([A)&,'9:=(<7=&(7$)/F-O1N?JH)1"XG,';0/#!RD6H7GY"[PK%+\VRO&32 M;?LMVP>T#$-+B&O]HI8;KG2Z1=+6U%\6O^DBOKY>/L45-U[.KAEL!ZHV?F,= M1 5HS#@Z]$'IWRK-,XZ>I]_!1RZ+JW*IU23\X=8/OV8M, R=N>1(,^?PW\[. M^CO!WPE;LZ)]O1.D4$ CTI6*4<)1OM2P-0N8*Z)S+.BSSBJ2KT%Z@KP!:0)/ M'PU/_FRN%^@P)<8T\SU,Y0>BV%&<_8]AOK!<2496N>"""TQ\P(0+%NUK7\S\ MSB9JD>OA;WV!6/062&=XTFQMG&N6JURN5ALS=A4EZ!F77QHHF&_%>?,.] M?JMRF-W/Z[,[ P3WNX"P+8-*VX,2.*+N0LTK;WIY,'@)2](H".W,3,US(#-D MU"//@UP+[(T8K?>7>'])[2]!^T#8#,9^GR68E+1Y3I-'7.D. +4U8]O*7&!*1P4R&,K;RF;2&/ #:^<*)75/3*1FG9UKJ1+KD'U,3;(>/ MNM%VS.A@4H?PAYP9<8UO7O=,66M@QH_1-4YC8^KJCK5G1\0JY?R.V+NHZ,H0 M;FJ*;LBEP'%(H7%1#"/-C?F(XLW,S.RPL'M?B%9RWVK,7] M/JQ;-K9M&]4V8-S/5%;/G4)QQKW7L)#NNJ[CM==M6]&^GNQ1V16J2IX15@/7 MN^=OD3+ ?#V'+BUQ*C]JX>XT+C0,=.#*D1R^]&$X'D)+6H'JN70CN'9W\WAQ ML&TKVE=Q\(L.P@1./DP/.72;AY5(@ ",WZ@$#45NF"<+"ICPIW.%E.'ELHL: M9S0^#4 )B,/@Z'#?Q&*Z:(%H60Y_ )DTX4)E9_ Z:&M4 MH$6/3&V;)$J][N.UA&XMX1=*+_:4#?[VW[85[>L!_H4O)P3W5&]4#BC>[L+O MJ^DZ?BH8(49^AIK'H?%YG&+Y$+[5)Y323WDG+6X]HEKCUUAZ-^(5F )&8,9R MNA-K5EQ5P<6>QQQ.'%PCTQG>GP V[N3=*YAXSY+JO1Z-?[2L>@A+CE_L.Z1Z M^&P5%S,.WJN=8.1^8DQB<$A-TT>-V$:QW_C9"Z3K>Z4IO8D8-JB0QBRVN3LF;RVBPA]C(N,D2!,97%E:Z:79'"0(C2%-3B,K&, MA+@%J+AM&.T'_2NYEDR0"R':3K4"XU$X$:("V;MCN7,)B(9_S;.( M+VI[9IG&LB6O0[AJL<[8>A$U6#WYIJB-%-:N56)DW43E%P;%][^TV))*1AHA M ?T#^BQ9];;K7Z+?JY$P<9W-.57P!U:ATT;'-U$R9B1\0Y)(;6K\]$-B:"6W M\C XG2'EDHU/-T$N4>,ETZZ^A]EU2L8&FF8D3Z+KZIH"\I$AH"A,]YQP';RA M%H;.N&]R^@]R16Z<0<'S1CZZE:$! IW"&^_A.%"-J4L=:0ZIV_6+S4.5;5O1 MOI[QEB$"5:C&.2[J<[PPYSBWY[C+\T!YT8ZQH/9$?+;B;ST0Z[J$E!6J1*YY MIT][7#;M"5W6CIV$+NM:NZ[5=5;%X,=SC.:,R=4%]P<#&2=[#A!R=1((DHLP:%"(4(59VS4^ T2 69 MB L]) Z+E"OS629T3NQFAG7)^):7.9ISU[0!@L'*N##-C.^&P4B@*ROY',S6 M- *L-.*6O!,+E&WN8J6XE)DOT_4[YLVA,&4TV6T28"J6>N+63=*THA?S7 W) MPI7CHB;+P3H.5&H:_@%_2OE#_,P3-=J9-6ZX5=URM<1$X2@#6<+'%65&Q;2NZ7:*B M7:UB16CD>IJ *N9F>MNX%^/JH8 +$2&&[LXI#P(*K@9=>BT5J.'V@H]45)]&MUJ:-C#K;W0M+^# A8RU,434XQT#NI*N_$J[6B>:KNDO/8V29_+ M$,ZRV\YY,@4=XU"O&:>$ DUM(6YG@F:QSI%'BZI=5H64A#3AVVMVH(W%(I/< MRBCPYUVCH^;=LMS3M5[TUPV2:5](@[GK-NJA2.,+*6BL&Z<;+RRB]Q9FA*Z__AC;[J M:=Z="_V__O3RV?.7ZRQ(WA3W<%/,]S M3.Y .51-,6)'T'^;[QG!R-+VO,!XZ>54>N?1G\WKDXI'+SDINCUP\@S;!P-5PB%ZL+J40H9)T W75;?& CXN#3//+G;T7;G*96@NU*??(4$ M'RNS;2O:US/$@=HH_GQ_N!>WX;W"CP9=UJJ=Q*3E#$=+&F" 5_)J2N,V[0AA?7'+<(39ZBSPW]?34 M21HUF0DFF]5H!RM_WE(((K\.^6,F25S,-'&EI %F>Q3!/,LQ*.BC)JN(2BE5 MBPTP"6>)!)3(LG[FJ3XH/D59]7!B_J,C'\;H1?/6K&A?1;.5%4E!H6,Y)D86 M-E192+108-E41&;V; AQAWN"XP6I$,,BCPMMHQO7UHK!&.DPCR0,#V+ZJ9V)P0K_"04LZH(OKX6& MBX(C*YV5IY5&(I6YY"@.W+I!=!%A2&B\XS67?:[?CN;Z>>#P^,!A=XH/O?3% MAWSQ(2^B^B>B_(KN-&QYK!VXXVBFKTIS@V4&JS%4.EJC3,$/F3P%E+PJ=?1D MQ]9'_-JU/FV*I%+B%RA95&8GO?-Q>"/\P.0,FAZQK;6S5_+5>F2:3F- 3?7-S$L&AD%F4F9J[>B NFZ3!=J29K_@'N)3#'( MZZF(JS,!A?4F9IV7T_*0LSK;>>W27ZG;MJ(]EGR4@\RY'<2AAJ;"#W!;PC_' M)=>I+NC@9BE(#7'AS-6O66YH\U!V_5KE<1'%H3_9_F1OU8KV^&3/U9(-T0XI MH%1#:)NCIQHN?27DA2516*\8J"WE"9+843*_XS(@<%/H[C<4U)4ZE$8.#UZDL;X!/LNTWJG^5+DOY;H+-RJ/,_B\+8$80B$S2Q+7E*&= M@PP2=5LP-61-X1!$F68"2W8A, ZBSF;(B5?WI 4+)4M@+ PPI-"." M)F]U@@'QL$]FO2/K]G+3R\UME)M7WN2Y(2PI^Q/]'1A"V$F4((>B GZ?3A"'5I8$OP8A#S\@:L_?S\'(8G!P] M?_8DV,,'3,'4RY$)AI-R4,W"4DB>?0U *)XOLH+"*@[^#,@D% G#8F0)H&6. MR"H,C.CBH OB>5Y4.0 0XAXNA20[(-=3A]'([=H9O^5*?6J6,JL_1P'(';,L M1!1 +_1(C0(G=3\B[L. D9EE#O\4ZD4O"Y=X.>CEX-;)P1]UJ) @#8_N*=-< MXFE7-8!Q)0V"(>3,<^HGD\^5BA2]4T6D?AM( *HRXB5$=8C**=MVC%7)*5 P MUXJT19$B("Y7A! JF%A4 M.H2+@")EL!&V]QYEW2CVW[]SAR\D'QNUH8)Q/-O1I M>?;7[P#82VK/WINL*)Y0>9@QUB[9=:SGT?NVK6A?C_0OFCT@7'[+30) I.Y$ M_3=*>&-1B]'X1TI&.'P&KSY3.8+O(GAOCCBQ/EO>X$@CGPZ\4KP:I7'1["4D M&>!FS6/ CQ1MB:D1)D'/*7 D58\X[@76J_T-D4-/X[RH"Z<+QH1)BPM^ 5EC M&F].DBR\Z[4K]<1;+U_Y_KXW(N)422CUE:K"NKC(:X1S0_E^HALL81$PQR.- M"J+SIB"=$M/TN.?E \8(,@"ZNFRR0+/LQA)?H%T!AG*1N-27JDMY-S(AG<'? M,Q_#8$1:5BL51Q*- MK'NP[L'ZKH+U2XVI+%1A4N[_]WF69F@T\>6J/&+?PA7MZ[E^VQ& --%)K&^T MT#,0Y K9HLF65+;-4J@2%06-;W0CX9=@'O)(#+#.9VT/55&V*/%QIQ*-J@.W MN3$$E,TR.'6N]\8;0;]!D1 O+OQU_ZVO^_/_5D$<_<]WL$OG!Y.J^/?^P<&_ M\8_GZK<*R7#A!']GDB/O_-'?,"'RZNQM\'PT#/[?A]&[J_.KT=7Y/\^"T;M7 M^,$;\_>K\_'IFXOQA\NS<3#Z\>+#5?!V=/F/LZO@\GS\CXW;7AY?;)O \/CB M8>0PZ'DOYBI)*,/+%"N7"I9D9%.4FU8V0AKGZJ-V[(4F1:R6,6IZ()WOV[FI,R&O\X?W[-_3WZ/)?P:O1U6C7+V0/L;9M1?LJ."[66$NL^Q# M%?/QY9K\6-=8@S4-D!$H>/WT@-UC *Q&G!1R22C-(RR/L'8-87UQF]Y.#'(+ M1.H?QF)'!+-><@)N <*Y"XNM_LABL9?#X/3GT;N?SL;!^3M"8*_.QZ.?+L\$ MD_UR?O5S,#H]O?@ B P_N'AG_CQ_]Q,]4&.YVE2VZU>\!VW;MJ)]E3#OH"D/ ML3S$VC6(M6UHR@.GQP5.QXR)5 @/YUE2= *GU1_5P&D$R.GBW=7EQ1NV7+V_ MO#@]>X5NPHV[*A]Q[_@3WHOQ[-P)/ZL+Q2 )29T <"I'EXQ4[[$60X1^OHT[ MHUY!\0I*7Y#NHY[S#^)P1S*WA7.IM,XQ"1S*N)BOJ^MV<305D<6RL\I; N?R0\P923U*9: MU\G<-C0QQ1_%79J3[[))1MH[ -"M?V:E@W0.8'7@QN*@I#SN[$YO]&?4 @TB.-<2%>[:E.L8IJIZLEKOI&Q.;O,'V@HJT7]2^ M7 N'6! *YK-&W1"30Z4P+_ZSJ.:P.E(--XWD]SIRB1I+F&91R8H U3Q6YPU_ M]MFIY5[,R0@CQ=/GQ4#B(V$89+9QQQ)3!:1J+JPJPNP_K](X-+K_X]NZS/>@ M9L)X"M1 1;>GI-H8-I<"];5*39$"T.W5 J8+&J/* AD78Z1[FS/LJ: L%>%8U(>+3 GQLSL/@MN:;*:RN[ M+TUFHT?87F?:KA7MJQ 8.452 (("$G00(""B*A$S?XP>&SS^")#&[)[AI3_> M/S8>P+'*)RK5Q=.+3XE>(GH=M" @H]AB@:1Q:&!!=P'ZM"9)7,P,!>)Y>EI68.#>1Q%B<;B!?22HS\_:(6^I(Q_O V_ YNY"2^:3I^OL7V@@[NP M=_JZ2?8.GGSK'=(2,"^/_2[9M%VRD&)6$I-$*%.G!*0H6@IA%6,>-%2Z ##2 M\&!"]'T55A[$,!ZTD'(@3:ZG"=R'&*QLS!WA2ES;OOR"_U 6YI1NFKSMC[W!C;D6_,S9J9]QIX^#XTL8]1K4H MV/6(_K1&D.P"BTR4;0/'FMC43N.%XV/$^Q!Y=..%,+-@3;4TBDOK9)UHM%_, M581%>B6*M=6FE$;_C[*7;LL&Q? M+TH>ZTJNW0XP4*R"2;=L7L>PE)(O W==E9K[CW),.)Z5\C>P8FR6NQJIN1M% M(:4K.+R'=GY=YLEPG3!LA#EO@A?!.WN]LW2GC8N/1KA)^";V?:*I8!MTQOB8)_4$ M"=^8Y"-RRB#,#F6W2?Y=I*]S32*5\AGC6@,ACZ_QJ6*D8NU2Q1=39;X83ZL> M!DYM$13#&-.Y/C7WX8L#?5S)OJ5LR;GZ*/[K0LL;:0$:R8:5Z468QW0#!'!! MH',:!D>9K5PG+H;]1[,U1H=^1KFP%_FU2EWE"W]\!==:= M#IZ<*RI+>.[T8 M7SS!"5Z)&Z(0H\,?Z(OKG())7^=JKF^S_&.P=[A_UD$WA03_[GS#B-MB/E&?-WBRS17 .=3<^;E43K"G?^ MKT^KO2>M5J+>?$ZM!U4>5.TRJ+I:(87&.^DU2$7HRM-_U 7#1(0@$8>"5Q2E MR0CA9Z8=%\ TS^8BN2.-AE#F?;B.BY)()D20NQ=##.\5P@A\$-]2D21&_H^Y MQH6Z#F :;D&$BN?1H=;X^\6/8Z+5\/O0ISOX= >?[K"KZ0ZGM?KGLQH\)MO1 M%>WK6;]"PQ;;L"=:I]"T:\_Y/$.*0_'U6Z5R>&P=N1FKD/16HP"B8DJF!$S. M!2V./>EBX5_"C'P4J\#* X//ZZ8';!ZP><#F =O. K8.ENP3)L"&29^AG7.: M=;%DK_ZH9LG^<1A<7/U\=AFQ'@0XT',[PC M_-P=PNL#3WB] X377DKZ.V]G5]/?>3VPRGS%3=57G>;S+!OO5RT;S_]-A<[B MN,NB47])EHS1Y55P?GZ^:\)G@TZ$MU/ZTWR7G?(%F2 /]BU+0M>I7OV1M5,> M[*.=\O+L].KB7[R\N1U=GP4\7 M_SR[?#=Z=WJVT4+!1K-L,B3Q '-3EK.OXN,*LZ RK)) D6^L&6MFIRV;-2#4 M)*M**6XI4D!X6UH%'=R:H1'F6IK$,L6I$QS)MJG&5'_P'_?@;QX'K3.+M!B6 M> ,[TN+BD-7GS^XGXN!^6&K(XP=20P8-.Q9\N/@4D!DKF"30VUZ2=O15(GX> MH'JGYKIC_[;*,(.>R+"'FFK>;'V!6'8@1=KNR?6WHM;9IULZZ+]=/J-73WOOFNW*$=^/=8I;#I@C?Q0T7;-]]&7A7HR^;Z MO#OSFV^LARH+WWQG[?BM>7SSF(]#OV_\GOL%7E*I])IH M1P_W?_B[@D[3OP]^"/ZEVL0^=TJT3=EG'N#W9?=]]J6Y*5O,0_U^;+#C_1YN M+@_Z^[*]>BN_//S?O,VT'O0/@E<28/:81GL/_7=[O[VI?HL-[']3)95!_;_H M]!',&![P^POS"UK)/-CW8'\%[!_T;&-YH-^7K=5+N>5!_N9M)$;X-8&Z1?AC M'>:Z5/G26_C]CGM<"W]19FEP=1M?>V/^1NVH7;\C-V6+>7S?CPUV_+*'F\MC M_+YLK][*+X_S-V\S>8.]WU./3DV@L@#C[3\'QF_"7O(0OB\[K)=F+@_?^[&Y M3HYZMK$\=._+UNJEW/*P??,VTA^![1NC#GKHOG'[BL+J@S>9CZ??K/VTZ_?@ MIFPQC^'[L<%./B?$9E,VE\?Q?=E>O95?'LMOWF:Z!\N;"AZ;0+?JF54]I?+V M4BK_J)/L-D"ZXZ"HYC Y2T.&/*D*^$E1!/K3 CJKTY"XD;4*9_C_D5JYBTPY MC6K&Y;_ZS>#+[.Y2F=W.3=;<+,/#(ZQ3^3MWWH:4M?@:X]P"X;HR!L:W<0E3 M%_Y1QL"W^3!8Q_#6WB(NV$"L04WT7!.!.POO(,S,/+N@>R<4CI9A@'/S)@YN M%5Q(29$%AKV%?K8^EQ/O-95F8+E2X'P146I_OP/O@I MR28J@9;RA:"K8.]UEL_AN7>JB-1O?PVN/OQT^B38DQR^YH.2S?=D0/V)T^"M MRN%6/=P_/!P$$QVJN8;[V%RCV*OQZ'QX=7;ZL_OF8;!G7@9?0V-X:X/8+T%E MFD_BE/L%IS$NZ5)O=;Y:P+=Q6=07O?O8;5S.L%EZZ9MX#OLG"BIH*PFP.$*N M"SC\_%/H_ZBZ!BE ["3/X/)AQUS \_!OTHJW0 [ 2LWX*AA-=0U_H$5F%*> M^_^= C\&-X>(V9YJY;0L8-GP^!UGLW-GR>PP>Q7 ]/GNK^\0\[K5YLM@GU_+UU6 M)77Y-0R+>MK=$>JUO/WO54*O/'!>?]+Q^G_"NX+W.,LH3O%%8PT'+U9F9K"# MJ:+>)/ (3J\[=)@5+&P%7<9$AC@M=0+2FC#<3.71KC2\M&+I) M?U_K25XA*#S#V^RG/;F%#R<05P:B(N?,9*.^% MNFUW'L=3ZG"6@KRXAH,WUU&L^+C 4$"GF4M'F_.Z?TQ]5*GM\Z A"V"\:5$E MI>+N_9A1^/TI?XB["?I9+>HM#(*WH/W^(^ >0,HYGMR#YS\PSGVK"I!;]J-( M7^<:I.<4._2CCG_%!C^D,8Y0CN![>"$_>\6CF%=I'-(Q*AI2*P?A Y/ZIQR[B =L6!$< ,35N5F[7'=-AUR>S3T>\:Y8QC78[_[L9]E M!]LC!^:3#D:PW82!-7)BD8KS$H15GL/FA%N"[JO"8!)[70V"FN*/4.)ZB/B_ MLRR]!K"9#0 @A$/XO: ^F- "<9+@Q1J?_>_IVU< T&#^ >89)*0)^L%=>F@O M,;Y;C]R+5L )#:(%I^(<,!?>![K0P22#>QWNR?D$.\DWJ""]$=S]"J_^*8#) MMW"3AO#A653QQ8/=AU4)GB[R;!J7099?JS3^#V.[B'Z-8X(N89,JNL&F"-? M5,1IFMU8&#B7MK5I&QZ!=;^>82TN?/HVRY-(1GL!*X1]A5OZA ?,T.C0&?"M M#!60B\ZA80*-#+Q@'-#:QP%?ZG!Y5WC=KO9 UL+9"MFD5#!GN%%6KG6^PW$L MI[#+J"F:,/A], [9"+97YJK",F-A4%0Y=&?YA._\GU2: @HT,^Q<_;3.^R=. M)T@M4;#A:1_@&.>$)J"_55Z0I6V<$7BS[\==^;-6">"HMS0/M BJ<,=?CYMZ M!"]]AG,+__\%#4K 8T<7L< V0@M9'5B(?7ZRL2!EEGTDQ&Y VDJOSP%K7N>T M94"K^:@)5IVZ2 RD95"9:IW+YFZ=<,]&* :7;!E(K MR(=DB!@M\C@1\Y-Y6]L4LMK-59,2- /]$*1 JO9_13F+P=5""8G44.75SV^>CN,T ]R0%O9B?F[ $=^UO.A. M7[$Y:"-9%F2K>*,!:67!3[E6>.&R&<"T=2*7_/-ZM\"FT#'. QHSU^$<>GX, MH!04B19>^=$LU2B: Q(J2K%SKC5\<&,XY4U4\4;KB&PZB QR7G,8&N\G/82/ M XSH8"A:P.-L=3E]/:)WC4Y/1_ &:V[T%H[M'.?NXH2^WF)?P<*QCAUE5PP; MJ3:A%KCS%IJV7QU?,0S6G!>WWP^?!1K_FC&L#O5S1S4F).(X% Z/6+&D]6VY MB\CMLSIBO BOJA3TRV5P9=P#L2Z,(88-+(L\NXGAR@A".+S9'.8"+2T1_)'' M;$2HIBHLJQSOZ2)+*K&_\V0&V[NQ/FL)\":_ _J=OWMW$?P,9Q?>7-2&L$D5 MTT>.]Z9I@N%7.2O-Q@Q\Y)5=9;CWSWZK$$!< B(CY^A(H%"B%;>1[O6'QQ(H>U_8BX7\U=SX6*S'VD[")H';0Q. M'VL""('M^/?%P+9_PA,TX24K9ZH<< L@R$**P'.:&*MY 1*0&SEX^?*%-++O M'J\:_,,M\O;'48W-WX* 5-"'GU";(M/=.)QE68)'VD#^00O!_Z(*T#:N2P3H MU"#;_-!$*291-"W.<"K0L"R=C4TG\97Q-6RM<8G;JFZ;A]WI7G7LL-@N32HU M-DHF,;ELDT1?ZV%K_\*XL^N4!+ZRUR<.^RI;P(6!72;B^0\9 M[NX;\(:0M8!MFFY'T!C/,-<&'H-OW_GD2*E2J,:E*G4M8)Y?_YYS,K,6J00" MA*@JG>FQ#5)5KF=?6=LPVH8-.;S"@'&DG!_)CQF*_Y*3Z4$696=]29E,]D%= M WU'LGK@%F2FB M0/4L;-TRZ[R$Z)(U2L4S3!M8+F@7DPD*=K#[4,$%^RH)]<)@,N6EP39I1)D) MWINWI:8KU )BWE2[9M/IB8_"PGY^3=8)C>??TEL?P03:/&>-H2>7,Y*\OCRK M:F5N=;R#B9%??-'O"D $#]<8JBOTBJ-XE@#,1R;H,8UQZG=@#QA#Z*D?4ESI M/=RH 4@(,%@H4>6@9VD36>A9<1-YT+!AE7A+6E23XEH"+&AQ!H21\0YN"O 9 M8"N91CE1, 4[/!4:ISAR[DJ- 3@6_W QGNQ4Q?B1#BT@E-!)SX=^W--Q_ MH[X$@%@('G7][ $;SN=HE+&>=IHDE8_@C)T;%$XQM '4JR1&@#T/;E3X9Q Z M+>,L#@.:ZAP07H5YC"D(B(^P#NLYK2T7(!6D-/2(Z^ V.9UZUMEKD8ZEJ$;N MDZ6HNO'[YT]*6%!/@\6HG!B%QS,3BE9,4C@^PU$^?_B$OQ5=9\3@6R1/7)&- M8TQ104,4;6SHV4!&FO7AL?T;^=(1DFYM&B6NX06)LZ,?RW'XU!R*3,M&4UGC MF:;NN=GRL6(VWCX?UX6,55V[01)YMZTYDX4-? ]2 :D80?[ZJ!"M_:_SSS0? M'E2D6F@?F\(#[L#3D6VS3--*DE$R1:V&]FSG'UN(Q'9'PN&FW, U.DX\$&:V:W_*)L()BUE]IS'"D' M ^Z\VQWTCHMH C]G(F@NZB]G8 W^ P">@VX$1< B(\Y"!JAY@Q?9 MU[KX6NSA4T_<(3DWL(G>-)TT+GK-Y6D9HK,7 ;3 [V%_NXO!_F:-+#H7L\N MMZRH2>X$IX#Q.P.00;[OR!',\JOT;N1M9$]$@ZBI@*.O$_[;GOG:G"3,7/Q< M[P_D&=M&L?2TS'J)E.Q3HE/5<2O+4UB.4I+%%H 9D+$8GMVOLW4#B9>Y]'T20.$H#%=PP3X/U M,F(7)H_&0>+!NGQ2+]!!BE-9?B&BA*8?)1Z>,&Y@-(*%H2%O 7V'*;UX3!E# M-TH,I>\'2.LCK/]Q&R3IJ=P2LVHA=\(P9ZPH)/0: N$$(@HVV,S']KP-M>>M MLM)CT_;3 );V,"]U&I]_DCIH9T2\*EQQ':T!;-^IT(W6%9E/#R\^'/Y?@<5T M*$,K!O%(A@Z&]Y/;7$LZ$@[I/\#7M.N4!$8J@0._9#K\0!6",$ S]M"S"_^" M"(41#"1#D507HF28UNYIBT/?ZLIE81Q6A'91UQY1.1FM7Z-8JD,O19AX<-BF M=HUG TQ!S40QDXI,4JPD!<*O2S(6<1(UAH%$RB%S'Q6C&B"1Q M_(K&RH1=,9;79$2 _-T(,#8G9J(31,+&TR!X6?.<3-+&@$X?Y0M<4/R+,7- MCD OTI(_!5WDSH3>!@D_'+JZ'DS^\/Z3.%<4FH$1A#(,;[5E0\OR:3@':!8D M>V.\1JZ4TUGY#8_)V@%KFM E: W#U*C^# (V!MQ0@DC+A#ZBK$WN?9?RG9:X M8YG=L3F]A1":BWY$B?OB^$A#@5Y^:3P0WA;N_BKQL'RDB$!E)X\:4#N#"/"Q^ ML?C5L!NM*Q[K+'$4J$[.SUHH*!&'0DF%4'9H43;M%#''E=OWL%X*?$6^J@/W M(BO!S4PPES%.L;+#7)H1E22GKK""V/)]N6;G0B)I4]Y"V'X\Q["ZWWI*I M!49)PE4068-*457VW& ]$O7TVE?F6]] ME/A#G;93SFC0I3OT$@IOK1"4O$"#Q!H"B49QL>C>_,3SYD]D+O3YU4R\M@[2 M-@M='+$](ZCJ>XEWE-@?G.7L!K !]8X"; M3GV!9/_-V_T7AY(9(K._RY!2-4@A66EH /K$:H;FV,/7P\379,M#6D25./V)+4+*[$EB2V)#4&F%^:C[(EJ>) 4BEIBRU)E864")[7 ME:>5#,78I0Y1J:%FE,M])-L0?#!1A<\6._58@&H6SV$!B@6HQ@#S2[-&%J J M#B0L0#&D/%R *DA.V@MG6Z6%09SVE:(N#"[6,#2EVK(L$D_>: >9+CY IBV6 MI)K%?%B28DFJ,<#\TCR2):F* PE+4@PIRT!*,(BE;OFNQ9_4)8@!YD&(L>4Q M#"HCC'/R$TSK;F5-FTH=A*;B-HZRU=U>]%Q:(DNWGY6>SO6.;W=,";)GE1;:\'(>ILMM*U-%856R,Q7AD6ZY&'Z0DBB4#6/M91C?%AH8Y N?#10%R'E!1&'Y891@*U[XX@2; MV^YV=E%V_)(:#\7%SG^C$#A)O"L:WDF& MS'GS)JP\=&SCPZS>8Q3#@SBM3A_-4D0+"9]D!P0L<$> $;#$X5CZ5XH2,W*O M9-6 82C=JZ%$>/V8SGV8O7J1OOH'UO9LI6(NC)3FLYHSSUM"VYLEUW+%_FH3 MH 5R%U?+!N-!J[95TMCBQQ:DQP/S2M@2V.%4<2-CB MQ)#R%)=@0%TH=:@;S!VYD9&.PFE K4RN FGZK >#_^C^Z6BD\=2U\0B2A#AV MU4@<4WMW#.TZTUTMTYBW8E574QG#VGCN>WFJ0LP();.5Z\.97>F:K^0^+%N> M-I79)BOS>]8])R<)=N.]9$9P3QJ'Y>@EV.SKK0J5O13HB M+NOAB/,N&!H[R6!#4M/'DS)O;<2?R*N-(V>?3('+U=95ULM?CEWT3 MJJF2WV[W#(ZF(.^*8#-SB!4\ON.',$LOTKO1MY&]D0T1AC9 M1M\2_+<]\[4Y29BY^+G>7Q1XKE..!D^^E?5?!BF[BZ^B/W<5OTDQ#M7H]U<_ MQ<'P&^BWW^)0.BH!,/XK<0$[7[V_I , +GH$TZ*OYK?7\OW,!=Y[DTP1F9M!/G:M!M'8Y6..LK,3H&V M*'&J8\/X#/LU66AJ##"_-#MDH:GB0,)"$T/*PX0FE(4R*:@@,!5[ GF2BYTU MC9^P<,3"46. ^:79'@M'%0<2%HX84I:!%'* M/R\Q82F(^'9'!SH58J58?&H@QV'QB<6GQ@#S2S-&%I\J#B0L/C&D+ ,I,HI M5D))*2O0D!;6OTVK-Z 8-0V#'[=9C0)3BX""ZG7- UM.*PF5+;1%Q0Q8DFH6 M\V%)BB6IQ@#S2_-(EJ0J#B0L23&D+"5)925(/4]@P7 JM5%GMU1K(45QAN1PZZEM @RLL M+W7!IT&,SG[J'&"3<@%[U56@R0"V&'" I%.EXD%P#0BOS=8QT - >GU=/AZ(2[=*ZR-C$7^1B/70UIDJ_:-\)1@B9>ZC(\X.3UJMW2 @^\K MW10LC7 H6V +3G@^-=F_%=_A,/+K&"$L8;<)&#E*/%WZSZ8N1RY @PQQM]0P MUO-0_YQ*ES:*PYE,9_7#A&-$<3#\/@X\/:8U[+P5#4,2(40L5\:G1%JP+H_9J@T_0JQYX!/7$0WF-=]U1WD(YHIS(Q* M7%!BOR?=S0G["T7*:V6<@*@]_@MTS?)$S=^\VU(Z",H&R"*Q[B)5++A+3G30 M.2.\!WLJ-T'XW9)((G%FQK;X0Z%D W3Q2EX93HV=VUWMP->;&H7!Y*YM 7SJ M7O3S^R/&G-]C2XR#&W6-/]S'"%*V66R3I4]9R>&XL)6\"$("F]320=KI=' K M3F7DR+]2.>SB^*A*Y'R%=FMNR51M O; EDP?C*PK3H.)D4.B3>==+(TT[4;K MBLQ_ K,.J**[:<24&@Y\@ZYH*LR:'9WH_H2A(].VBU\28.Y[;SI[6VI[J[=M MV;;A5_@MAL?!,?\'6PQ:7;?0.S+3AU%?3+4C>,M^HY>CM!0!#-KH/:8#XJ+^ M4/.?@W3BN>HZ+T>5+V0(NB"R]DCS8KA7^"@,8?E);-0Y(]J DJYWA394%7JW M=GU:(LE""F?W$M'YV?&H=4"FG-]S#X>D]8/P0_7X[WZ:^FP5;[GLL50:=2EY M=JBJ)%\P@68"O9$$>@$9(R6#%,-4TTC)RQ!I@8.&PXR4@@XQLI1'6M*)QK2\ MB5(X">7;DVH2T^E(8UW$'GJ14M^ID2W0N0#S[5,Z%AL*1'.DQ-G05Q_NU$;E M3)32='%4G'@K"*TC"H1(=",AR["1U O>VFZ+L]D=:"NT&XUQ36:W*L]'"BLT M]N62\XV +GNX'\\+;DR+OF"HX(!@NY&*<9QX;&..!K>>O(F87C*];,R-UI5> MVFZ<*.R02.6!0*8B=$WKUMYD1D+",G*'+8%E1B;)1/P%U(EZ<>O>FT1&)G#* M:,V: +JCU/D=:*[Y"LFAKX8JBB2(A 7O.#F]@@B;*I&X?*70B^YIFQQ>%%R< M+7.2:S"5TM+\8*U%Y,D2_4@ 2=*+IK98]DC1Q41VM%0R'>DF3_ 4NO1"%VU1 M+?'=#VX\Y5PIZ[JR;@-<;JRN4&!O%5\/U32)C;TN;]A"CUCD!)-6:J*21C2& M PFMZT^+ZW ?-#Y\%J?=6_-T?(-)Z1H1KU%]'U;;X*'F9L:F[:X=H\G$\=H=L+V7QLF$W6E"S;K6G43MJ@,CT,,7GPICFNV^VY+;X@TJFD!/@ M[,8'B6GL3C&./ C):(8!F&%\'X=TM[F[+0!=**(^29* M!#Y,0N"+L/SC'SIE31P.*3:TN]_?I806J1V<%+.)[^0?;-D8RFA)%6P*GZ$' MX&8C)*%2Q=F%Q$V?I! M&1RYG@F:F=D;SIPNFR)_R=R>1O/K6@AZ\)0.ZDR"] N3T$<^R?09:UL?2SJ" M$0T. U^@L3U7M&INN:2!1NKN$].V_JL0I"*;080'DYV;60GY2_+!K!?'1WAR MB9W;:*C8@"DIJY>,6JO1=A OTY$ATF#D;LZ3)F"N<%VI9@!4[OZ M4[M&Z1/KU^(W61!I 'O^@UIL8$8),D,=]V)2VC N!VFPHLW$?N;,W.#>,+IKO]0J9[8XB/MSQWI;U*,0S7Z_=5/P)"^=3K= M;[$N;B"'NM3PJ_>7= "DLL&- >_Y[;5\/W,1I3=2I$IS)SQ+6;IJ4J0L\$$M MT7Z^XMLS>Y*8_%<2#M9$_IMC76[>CAH&M/>[34Z H;C.[Z_<6$VZ@R3ZUNGN M?Z-?NJE:],JRG#L?>H]LYO+XL^AVV^+X?X^/OEZ>_,^Q.#K[?'Y\>G%X>7)V M6D%*R,X6IA9,+9:E%L<49T8UO@ZQ4M=$BY>5PVJVFM=?DF.K>2,Y2G,!]MG2 MT0KUVS -365D6*9D.*MSMZ E4#K>1#J*QLF]'*>5HFR[H4@D4W2QJC!-_<60 MXG3JC;9H-P4;6;YC^2XOWZ64XRQ/.=)23/E"ETTO+:)DC0G4R4@W6GO5M3_\26I9PMEVRK M.*=2:5;VVRY H-O+E"ONF[G')!O&0HUC>VA"/ M!*;S8]=+RW6'K\OWYZU^N^ M/=#\.E>$O+SF>.'BERPE7@Y5]Y3=?OAYU;^0.):Z,\#;*B#R@^NWI_>6EM=W MTB+N01+O!"/@BL/O $MIN7V BR34RN+XR!H(,4]C-JC3>&<.VJ#Y=@I5[@;;K.K4^C.=J+WS9 46Z^I($Z(UG MJ]_:N# X0:RL@E7EL"ZZC M,,S*MLVU30-"I979$I#6QYJ=Y>:IJYNS4Y94 M65)E@%VOI'HXBDV5\H?Q]QDF.%&3 5%L_29L5^KF%7#DRVDGMY1!6Q,$C8K!"FQTP;6"HPS[8XU-458DI5&:D\] MJE5()0KSW5B,\(#UWW59*I^J85%5*_HFU@U5@.LK7!,<$YP%;=;T%@T\=^CJ M2.;<]X7PY[D*BV7L/"NH6"Z(%&S(,Y7,/!?X+C):*K@U ?"(LW!L9>M Y,_: ME,R=/4N[VD6WFET*2$;4527QT[XJT.L2=^V_!JT.9 M1+J+36YYYMT@BG?RF67YO9N1%EX%L++'?*7QT[V.#HWNF9H( MMT%)_'3)0UG\=*^-=0Z^?CFY_+')Y^$)\/3P__OG&)?5B2MW>.@M5Q5':\2-KU!2J*QFF31OG MJM[DZN\4J^ZDQBMLTJ)_1L>8;I%BW<:#VU\K1=F?2;RXJ])C#:''(/^JR,=" M / 3SRM)>)U-27[U?B9-76=/FRTO3J6>@8AVI].%0]/9S(+2L&'DO_W];W_# MC&OXYV^YK&LSJGDXH]OZ8YU0;7E+N@ \^?31?*ZT/J^9U&HQ<1W'@P',)/U? MEKKT5WJI-<"C3<"1/&SCM6 >^PN $BQT4^"HO@"S_^;M?F4@9H;X[.\RU%01 M:BCN45>2,J['P2TZGK7_KDQB(S]G6N)Q[Q2WDLY542CNH+,"SE,=0\2LJ;S;3)AW-%!_@K MRV8LF[%LQK(9RV8LFS&79=F,H68-4)/K?5DNFE'W%H$S3]M-D- X^J7^P00< M_<+1+[4"V)62[*^^A]'GE)M_XT:4&P2<-\9,IIEF'#J3V[3+\N5$)ZOK8''4 M=RA:&U.2Q'5 J7U(^EW_6D4QA9=/@QL5ZA0XDS5O^R4OZ%8UVXY+V62V25LL M:&"SGV MY*,8?M.I];H]5M9L[/A(3),P2B1V0;%M3OI;SC9&S,,/5]NFQ8I):AO /65A M]2U;92.+?G+UBDW:* 7>R^$P"6$%]CY$$U!BJ?NZYZZ,(_%/&882+T>7_PCQJE@?Y0X="-:"U911./VK#!7/V.<.0M//[H MY%Z$B9X W(O'^01<#W@@I4W:-;;%83&:#4N@!*,6?@!KQ?7V6OW>?FN_UUF$ MUVX4)93.ZN1]JS5(QF@$^V!YA^4=!E@&V$WJ9[2W9#\C;%&TD^]9)+T;X*OV M1#0&&ON5OE?X;WOF:W.2,'/Q<[T_:I!T1WX>]T%:41^DAM+@IWBF5D5&Q"SQ M6(>/*W<6Y)U)SX@OK!(@UV6(8XA;+\3U M-@_DZ@I;#\MZ/Z2J71H>9X*D:@&8FP>73 J9%#(I? Y2.,6JCB[6<60R6'F8 MW"@R:")@6 OFZ,_-9+HU@BZF;XV .!;S:@-;#Q/S3F6L#FAM%#5GO9;UWHWEOC:"+Z5LC((ZEO=K UL.D MO3_2K 26\BH/DDP%F0HR%7P&*GB6I1RHFB/,Q#QPDI#WPD,LE1G&$^ZU9WNV*T M4W3:>WB$3$$WFH+6C62RF%D?R'N@F&GS_IE0U@0NF5 RH:P40-85\AY&*'49 M$ VM5 N$"69-X'.C".:2NCDNH=?9;8E>_QW\M;>W_2*6(E;%5P9CFUUJ9/;, M-;2Z,8#=HJJ!.",+HPNC!W8>["Z%)1=&'NPNC"Z,+FI"D68;^8!GX4A.+3IR.QU=M^!(^I"I8PGV$^4R4^ M4P>4V3Q-AG%C/;C1;76[W=;;-YTZHT=-L8,Y2EVQACD*#G;5S(5)Z=' M[:W^8^Q<5<2..O$3UD;JAC,K=SN^**JP9L)X\DRVKOY>:__M8RQ=E424&N$) M\Y2ZX0KS%.8IC"?WX\E>^]UN/;"D<88OQHK*8L4*C%QWF8/9T,4H4G<4>6"V MY K2)^L*KXUG".QFE-/-:>RZ+)YJ@ZC M$*,0DH^SBJC!ZL M=]13[Z@LNK NPKCR7+CRKM?M-0I9:H0KS%OJAR_,6YBW,*XP;ZDZKC!OJ1^^ M<&Q675"%<6(]./$I^P3R#<8-[,S8171@OUA6>%<6!+RYOW*M51VSCCKAQO]79[2H$58PUZ@;9G 8 M57U0A7%B/3AQ*0.!9:X>8Z:J AXPQV#LJ*">40G48!V#\:)BYJE*X$6-T()9 M1MU0@UD&LPS&B]68I2J!$C7"".86=<,*#J"J%[HP7JP'+_XE\5 _!2LO;L6L M@UE',U"$?>"L;#!NS#F8=C!L:B"J,$^O! MB4//$^J'&B:Q>ZU$,!JY0Q5&0OJ.<-Q0#>, ?X/_"US$5&R]@07 /;E.(KV( M>PI6$GF8SU28SU0=-5@S8;QXMIZ"[[BG(',-Q@[F&LPU&"^6["FXU^XRQZ@D MQV 46 \*W-=/\._PKQQXZOW?<__+7]2BR\Y#1/%JG\2]!N%KN]C<>LP'"P'H M"'!H$+K/"K\B3R0(E@Z(&[B^0[=M#J)DJ7[B>?//'N1X"?9?0%3^C>XBI4J& MO!0.,J,OGIQ&L$_[TY)[M>2ETP$"0]/MP&T$":QJY/Y0#E$4;[BUD0/*TKJ M+)%;GS>(;X49T)U09("H4LKB2M'$4U$DXK'T061K"\W,!'/=FG-=,]EB;CNS MQ7:GTX7EYKEKQDCO4C<(&]:C84Q"%8J&8$=H: M#%YUA:.M[H-=KR] HY8X($-L]]_\4@T8RML&_Y-$L3NZK0!@/1,4??5)[@GB ML0IOW$C!V+%R6B (*3%((G@(OH7;#NFID5 @E.*_^/T(>&AP ],(8,L &;"U M(,S'!@@W$L/7@;@,I:.^GHO#X5^)JT5E<12$TW9+[/;?BL\2E@4?'5XK/U&B M]S8>BX]>$(0M.JI_!^'W["?DR;W>4R2F=AYM'AT$Q/R>^3WS^QJ"5UWA:*O' M_'Z#^/WZ .L26/G%-/ C9-X1YO%AHK2=18;6&Q@L6%>;.BSV,!BPW.(#:C4)U-Q8J! !78G9!*(?\KPO3!?Z5EDKP)_Q&>I'F M]N>P,!>="B0ED-1@4QYPO3BB&? QCJ#E/3 O"+%%STJ[UT@\YJ,0B'@R^(]5DT+I M1R-X [Z+0W>(NE0DIDD8)=*G)SR@[SM .*=A<.U&]#7086F6)^15B.H:/$L: M6!*A_1B8 .II\#8H7*@RFG5%8LL/8OAFZ"4H3!#=EOYPG#("3$^[&0>X@N%8 M1DI\!?F#9L1'@Q$LU>J!H&7&$K[0BF4T=J)BX(7N*Y+*&O432HQ^WW&V[E"%N)K6U MYV^I)?8ZO^!7,Y>'VC .#AJQ'3]$:[Z,(D %.&"<")BS2/S8]6A@)4//A1'@ MX(,AK!)&_55LR6T1N3\$<.MX#&L>X;7ATPZ"A5G2$/::3":2=&GX#"_-B'Z9 MZV 83 :N3\^T-CL*+ ? ]@#2+3,;^2?4+X#'X0J"*^D[_X_ MJ:$8KQ@N6$[=&*B'^72;1@)@$+T.GBN!H2-O(X)?A&SXJM_9R7V%2W(#!["AU_T\-VH J(50JUST(Q'@(@*UD&Q$ M<&U*TX7[Q[O)+0+0//^^Y_Z5N(YY;J+"*YPSTH#Q Q#?OR(\(D\6;!5HL0SU ML 3]WT A N8+/C5A[# MTT4 '0 PB&^UQ6K++W ;,Y]\V6%Q:D0++NCER@5TX 0E/L#@%+/4.1R;( 8ZIM7./4 M( MP2PV=ENXA,71P&4@_?#7,#+QEA$TNH+VQYCX14%4!0HK4N"?U7C1C@FM!#\=0Q*!/HRFTJC3BP]E%Z'NH:S]/ ?(ZBX>#Z%A^.Z@?$5Z^VBW>( MX]A[_ "G>2-#31]SR&8@#A8R<9%A G0- ,0 <7 %A,2IJ*:OW(V GR3YE66( M:\0>X#]CT,JOD3R3!#0#"D-/)A$<&-&B,L MD.$!>FEA48N*4MR$^)2?6RC]1/0[0,8XP/49(WZDRH77HG;/N@L'4*\E@'IE MH;Z;!;!\; \WQQ4BH[4AG6*;%\=%P\MQ"'\ 3/JLR'E0^ 1/CPXO=RQ#(O4',TZ#RV!J? ']W5\."OE*K][W MWMCEFG6C?=8:9_,7/@5*M#, 'O]]AV3L7Z5W P*W/1%]=<:CH1$?_MN>^=J< M),Q<_%SO#UBEZ]P1Y_Z46UG_95"4_>*KZ,]=Q6]2C$,U^OW53Z!MTNM]B M;:&7)@P0.[>1K(J> ;AI/XY^>RW?SUQ@Z4UN%/(V?Z=+NO$W4]"@LW;0LR;U MTO6N6/Y@^:-.QU97'\F)C_'OKC:J@2Y+O!F5RQ'HW_Y0%6R,PR#2ML59*P09 M0(#%.>3EN-.DFO=]E%A^9K^W/HU9BURQ?M]$WK9@PCCU/P0#N'E)"G;0$EX MTR21&,&X5.S/Q-6%:$@+E=,6)R-MG"7+A-+[N<>2>Q,D'IK3IS 6V:MP%IA0 M3F#Y<01CYHTB9"O0IJ0[S.-.0-:9F-P%BJ;!I2816HLQH,"8)G"@FR#\CH8 M8\[7X7Q!$D?:.:/$)9KKQ.%PB.O!*UVX5CHZ/T ;A_8\C,)@4C*&WC(<'"S( M." 2,CK#N,@AVN+K%"?ZN=OJ=:C >VK,PPG3*YV(LLZG;XD\%UTFCJA_I]TI]-TNC(Y[*4!O5R:).MK@'(8A$ MRYR=9J \%X -AG%#)QWZQO4\/'/\U]B-"!UHJ08A8)?6JR?%C72OR8T):!?% MVMB-(:DP#)'(*-V(' XIJS@PXQA36 %FV/A40Z:P89$3SYSB7=4(T"5WU#!X MSML)!H'GE(A$H-J[SN^O0%.;=(%-?^OTNM_HE[Z11D+URBK_=S[T'A7^R^// MHMMOBZ/C+Y>')Z?BR_&GP\N3L].+?YZ<7XC#TP_ZD^,/XO++X>G%X1%]V:)O M/IQ\.3ZZ//LB3DX_')\?PU^G1\2QP0#=;JN[ MI\T6,Z&((Z.(7UV%"LU*631N&L_Y&TLR",DH4AAQ&TO_RC4ASJYO?]L\F\?F[)09.#-P!MCUY_'X MB0TKGF$+;A0EP#1N9)0WW \P-E48EJCM[]K#DF6MS(R3NG/@%PJTG$[#X(>+ MD?H>"@YIE@*Z6(#24RY$GOD6PUKQR9/S,[&E?MC4GEDG!]5YB)*)CL:'9:5F M?6/03WD=8;K^8![1M73"[O=;>/ ^E,-Y,FIC-15H07TS? MH@\D%U1+[@5)K;7"H9O%^Y]=P\T>>EZ@V>P9N6O:XC#2XD[BQ47!@KQ6[]Z] M2:6$@DQ WW:[G=;;O=F]S#+\DF0ODT#2RJ=W67^B#0K6>008)MNZ/]'$%,O0 MLIN4T5'5I6R:!;JBVF64; O+-* MCF79,I93(_.A:,:G2UG*"Y7\&2T4&/#*D)PI58S/*+-CJM2BLRVK&'%OV9T_EBZ[4S9^X\KP//00*U66YU$0 M\( R/0\?/_=&KGY/M*8"/F7K?=:"/BQY-7>G+'FQY,4 ^]*&[;1Z4C&H#(A] MO]O#U+E97_'"V*?9+#GC#K:OGWMRJ.L& <4<)X1?KZ5')A$4,^(;S,K[N=]Z"@YU>SV- M-3KB[7*N-)V661:>']5?TW8:8^O'%,;(R"RSN9A9MN/S^9^7+*7W4'&'N7]S M=\KSS3=OS81%R:C@'%\4(85Y M]&A5[VN[>N%KXFC];JO7FY4V6C/Y]VE52GH-%OW8%DC,6IJ[4V8MS%H88-?N M?9X$&-";8$E>;/V61,:3:\KW9DH Z%2Z)8WN9NO!8Z@.]-+K;\!YS.U!U_XC M*_MP_O$/62&8.5:EC?38Q1?KDBGQ#_2>4T&D0HIN;L)\93 I0M'<'HQ!3J<&*V]1:#3/3 %=.XLEPY:[1#K7@M3HWEA>>I@BN"9^%B@ M68?#2\]+O1]4[0=>P@'2UTVU=H+H6Y1,M U]K%M.H*:LXR'\'9"M0E3C1ZZ3 MF*KEH0Y.D,,X 578%(S2BGC6CJ.8"98-3%5UQH&/X7DN;9CRVI88'9=I&"N5'6=URN,OO0.'S%S!"BA^FE@MJ$4Z M?I8?4;(+0;U3FDV+]V0\6KJ*UD"-I6?*@0%04B0P"!$QA M-V#R9)@1EFXXTSDH WIC\LE@XS)"+4%V[ M0/7Q9K$I0 BT%+!W("/JV>8)4T3-(!^%C%'5_SF(+NT3D5ZUJ8(?6$3-];O MK=%2TDPI0S'3$[:V7UT8#J$T_4JO:N[.R):*^$UM!89RJJOVN51L+,U)-D]/ MTOX =]_OX#;? J*\Y.""^]X\)7.!$/(R76)9(VND1L8%GKB"45[SU!WJ3FR' M.JY;U/"=LGF/F0D#['I)\HE2T^%1-?2#"?8?*ZZ[92R:YJPF MY%;S"Q$FLU$V^GAZN[8V$9WC3)@K?'+G]R.*.J6<3;T/7:S A&B899NTF-(! MR)E&7=BTRA7)B;)AGQA?&J)Z:BP0:6+/S!@E4PHJA!$-0W=@3<$YJXMIFYAE MG):O#?Y!^Q8EX:9AI290?%!HEZOCH+7>BHI?$B,VI-=GBY_GEG=%O<[HDHR6 MMVB,+1-VKA>U_3@C!*KCQC1. $ROT<7-X(_6N",UE63QU=E8L-XPQ$!:O3IK MR9FDA>;1I :01WJMZ45)9IFV^)B$^$/+ZN_?_>#&4\Z5TG@SA[UVQ%1?=W)K MU:8>LE;9QX:Q+N=]I>@[4XK\2H9.9*TA*^ MSM(2%OP:N],EC0N;*=*MMG=-04+;G)9F;[FEV2:T-/L_3"T?3BWOU"=617UR MBUZ@0I;T='CFH('&WBCSOT7\KP!D&P58=350G.<"64F#30:H=^H.3;E>2:G_ MNU#<>$X!*G9AN@*U*Z8,F=M,'<[58QTK$N$6!OFM!:KE)O:4\K.5"UTI@HHTZ7:?$Z MN2.K7'6?HKN=5SCO4B]MSS.8^U>QY6Y3-@F=,IF(6CG[QPWION20GE49,^7/ M.)I!+J,$%.O!-P[D&."X!=/ /'1:I//K"=)!@QO?=O>2TZD'T@K*&/@FU221 MUT&X5#TM3 1W<2:084+49ZE8B:,^T\,];ESM*^F#>PP(G9G.]"5W>AB\\4TZESIIY""=2!\M7( M'6J3$C62@^$HN@#@+K=PQ)MKZ7KZ"C"V1]@N]@2=QT?B^,,_#K^(D7;P1[=1 MK":IC6. !K>"H2.(2L['6@'AW.E$VILK5+ W99W>E K)&"OWJ#=H/PV0C1[8 M<@QH_SEP*Q!2@O!6G *K9&V+]>=FW6A=43G7/Z:[7]85"6YD^:RZ, BZI/*7]8K$9#:W/GO4=1PV@JHQD#2IB0B'J^=)"^BH*)7_L MK[D3.4RN< &F>&/7*#3IMDHK'>:; RD1YVRM;J'CTTS4NZCUH.%#\VIF0LI M.S/KJADPYM]3W\ M5X<::G30W=,T0F"NI&YC F!V(]UKJEH#:!?%V@V$#@7,?23'7+H1.1PB ".Q MH'%9R3>+R:_P1FO"Y.?TCG)K&)HI>GNVGM6-LLYU="/7?$DU@5(@JV)FKYE&@WO0+>:1Q17HOV+/#FI@6K7=_M_5&KS=? MBPLF]5/J^M%05S)BZ:I??3JE?OZ4<&#])7YSW[Q[J=6P4 +L4IN9--,U/&WN MV%MW;='ZI!JN Z_\-*+$<% M2#)-0@ROT*4JP)[LL9=9F[,W!ISHS5A;J4M,9 T M1.1$07$]]:K8 #+ 9*EU#=T<*75ZE'2\2-G?;$<#)(5E)-!$+&T;,FP<&!^ M>MIVMC;Z2^=CX;BQ&R=:S=3:(0SOJ)%,O%A'T/\+UA^X4 M::NNIC1"YICJD50_V/"0PC(.LN69'A-I!0\IK@,/"*DI=N3ZV:\#Z7\/DVD\ MO!5:^V^9N"P*1 IM&B.I5_DB1!A$1OP3I[W>)OUA& :X0+W#"+Z@SX7R084T MBS%<$(XI2E6/!!XE-G_M;IO8-D_>P W2?LD_YE\#@CBXTP7%>DP-&#)E6%]6 MZ7+)^J&9)?:B=J.AQQ .4SWF>XWYD;K3/?/Y:VBZEU9#_&9?->6 ML6W%,ZC?,A'!:(&/4UTE\%^?Z>WU^_W>MLM5(2RI.W$Q%I;JQ,L/M?VB.RLMDJ8 MW0 (M9Z20#+CFV"&(Z3UOTH5LC@:T6X13L!?OOT 24FJBH2*5:C=5KA0:I3-BNB3&D94QRUU83 M>IIMC+&:XZ;64IHI2]C/7X*^27HU^S.<+ ,,W3?MO;T%1[_\W>KD\?G[7 9X M\L\_>,8UT_Q[VFZG-&@L038,PI!,*?3FS[M R75I'T?\W)D5TK- SM*^3AM& M8!H:'E@_8>BI]>X?%GWW0:>GRH*(=%LB-U$\Q[A#>,/6\072J7MYM_K:S6<3K,BM)A-J>L MW#LN*[4:AZ"-V4\SR6@S=]4$3>AAU@WJ5\;)A,W6%S;P1NN*O8=4/.Z^ M[0C778J"V'J..&LIIY+5A"Z+O1N'SRMCB) M,:\B@4/_CO%.16^J";;)-1.T ?JTP-G2>+#/.'0'B0URI=<+BT^72E MSLTS]1LG2I&)B1(1=7"2[G1X/T#,' #V^\"(2GU)TLMG0R M\78K3$NAF#;N@%?+\2E M>Z6H-5/:IG=!,Z/2X@[3F4+;IFYI65+]1?V&\=J&K/1E2W1;^^E+&L>[F)Q M$FMI_>?-160FS4V[T;J2YI/R_+UC5+$C4A*/0094GI?&+R/JWP3B,ZQY#'IP M^B2F?9@V="/Q\WZWU>GTB&A13$,:CE L;3-+G#^K$&E]2H1MN#C&-MA0ZC3W M)9M:9PP:"DF] &T)_2!=/U4;^GI^^0&HMJ^[SYFR0[HAV^)L>SM?_J,/2CIX MA*V\RDQYE409':Q@Z1G-UW/_2EP*L)_=[A%V;(=?C\;4T;Z='?;8]"R\,YMJ M)IEJ]D 6)%715=A&!2-3]V$RP4PC-'B8+@3/ER.4[K&8(81K1OA+Q]#"/#"[ M@&Q.='4SO16+1T%\.C<^#:!+[= B3!V>8E)O9L.A$[3OZJ#YQ?E:: O2!Z/C M^^Z!XW9^^:'"5=V]CAG0SF]+F\I,,O+>?":R,2;IM6TVG^7@#P[^8-_RIOLK MOQQ_.KP\_B#.#[]<_EN6. M"JH@XHDINN]N22PEB1CT '730L]5&%S#]_ Y@MC(M%E'$:B0=I&OI8K6#E ] M0A0P,5N)W&JYKVVW:YQ_$,"JJ*^U;OV%TRK'3HSMH>S$NNR I(%U*+9U=I(L MIC>PP6(8$YNFW6C=B4U&9(:!0V91!>K4,#*UB4T]$'2#70>N@U8(H .8X0'2 M?.1J;[DN*C4"W-8VC[0E8MHR7CNBKD#Y5S@_^?+AB!6T1K0A83@IKE*2E$^F];8H4B'(Q%+842@):\M TG-(R"H#N!:2)T-\.0D-;)4>@W9E]NZ9M:U-1.8(!,@[L0TK!8] M<[>4>(^6)#@*7341JV']&+L#-U7<+W:Z](@%D&(=EQE3ONUJLKET@"E[TVZT MKI2]4%$?Z9D$NA+G:*6K"U9A=!0:(D=$BU"FT]3',=18MPI=)#[.A: A13&1 M$\:P2M:WHL2I:XF'$W*GF3:=@7 M+H!,Y%+ )83)!#=JG\RZ3IF^M?E6 X;[S&8IYQ>/!/6>1:(_,)Q?JVW5F]9< M-*MKBS^!_V"+JW0++>/XE;X[P;(RM@ 7OFT+)L)@RYW1W(Z7W2A(!M*+ ONB MR%=:S-@QPDD6UI86N"<[O&UBD#W^7S^]ZW7?ZFJ*]EG[V5\)\%.8V9A3AJARCJS%&)B M09&@:.G4.+ 0M84+,JT;1J;\H*.F.)PIJ)H1&1WF3.2>(E+*I'83B8)3%%\& M306H5H#E^H*T7P>3%"8IC;G1VI(4[.X2$JD NN%.8!'EUH:L6I]I[4EA D$^ M$.N>MDII+RD*[;K5L@@(D6G_&R>S9\YTPFEE(E"0%Y/2>+ 6&26*%HN,EL7Y MKD"ZXN ZV=0RPH13&'5@6F90'O(W@/U'_9.-@6LF$T9)"!@9_TOI!$4<<*/ M)Z=?#DU3G_P@4@>AI"_3QN\/SXNP2GAHDT1L?HM>9"; @I\1X&0-@8RI(P6S0*37$U<'8U2%G=DI.AE0R6EA[K$U=AV M[$IS7VCC:6I2(3$'Y\\!;1I3:H88HS@>)8,(] "5!71@)*6NP$O)4,JE@>_9 MT;T1D**@M<:%LO5+75OY)?BFK8J)G\@E_5HAYO-, M;O2[Q(8:\AXM.8A%]^8GGE=2:'"VRL&KF=(,NAY#&B"SL#K#W$VV.QTL#B%T MC01!Q1WL^X4]S=5UR-=2T+N>*;T O-5Q/)6.W?]EJ8-_3A%C=7"\ 3!:E&Z+ M%5;NOWP8?A-NOKY7O/_F[?X3[W@&P?=W^9ZK=L]?\F*KB3Y&?VB\$XQVIL'P MNXK3^GFIN01$$8P&1_613,A:(:!@8&/.MU(*_7JGA$(&VGDP*Y3*8>FE+N#$ MTDL#:5LC892EEP9S-99>-N.>O]@N[&@+T34)"KU?R>IBXKN6;C >!\:06(A. MA05'<6GR,PDXQMUT=\D7727'M&S7"UW8AMV'96K+,M;OF6_&3L]K;[BU$:<% M(="(&0>/[DP_6^PALJV^,&Y@&IK&7 _J5E\# 8^]7>SMVDAOUUE)O!:9K76$ M%CJP,8"(DF0];)(:H8M'EV;0M,A$8H7+F\DK[^9^ 76/L7XSK[-1R:NK K_Y MG-;-*0"^SP7 N0 XDTGF>DV^3N9Z&U;)H0&:TL,J'YP ]W"=WU\!LDRZ@R3Z MUNGUOM$ONVGEF5>6O]SYT'OD*9?'GT5WMRW.OYR<'IV<'WX2AT='9U]/+P]/ M+\7'X^,+<7CZ05P#$P;L8HW3"0!@Y+ M?^X&Z:J"\7(P6P+MFPO&L#Q8A?_[J]ZKQH+T\H L"E?O!_KB+8OL9AS2PF$7 MZ#^Y6\3 @[54!A.6 _LR""X[@37LZMEPJ6P_=PMQI6_<;TA 07]>K)M];A82 MHP3T@8.<^VN_W9O^>/5^J[M=(B\R\UD29ZN,ATLBW;ULJHEX>'^8-\,\P_S& MP#Q+9RR=L72V(NFLRP(5,Q=F+KF@MD766;V27F>W)7K]=_#7WMYVT?"Y >;. M&L-&2<-S2A68]VPO(G_W0J;++]!NZ\Q:#SCD MG#7X!S>PR%:<>M_PH;D55U( :U14YN/"+W]F5'TTJG;*<+54@,JC Q'*RA#T M^94]0:%Z4"BU/1M&V;5ZLQ9$O^0O8/EY=9[*<^'SFSU,X]8+%BN&HYIX&=W/M/-5G=;_"$CY8C %ZZ/?1<)6@ D@VO7T5T9"]T6 MMY"%]#H']D/ZM7NPW:(>B7A"4T7')$)UY48QM78L:0OIAA,1C.BEHV RE?YM MZZY^C:UL%<, ATA@V#B@-I)*R"@_$#&YMP?1 U=C^S:>#>. 9N[HJ=OBS)_[ M4&_WCT"&#F[C@QO"RH,PHHZ1^)4NW LKFKAP)0.K+L"=WF[ENF;.DA1NI=DT M)L%M?\O+D!.&$YHBF@.JCE04 =@ \M_5SM>2&$T7@&8$"1 )WT^0:+B^](@T(O4&EAQ>5#2XPD>;HA4W;3P,8WMP>[FQ2= ZR&4G(UT!+@;A>&%)> M37&'9=4:RZHKNKQ2/MD,U/U##642*2UEDJ@R3+7P&U"94;!! 8G$FMCUQ+\2 M$**ZNZ2&=ELY@2E[SW$=>@\!VRCO D11*U_!<.HJ0"'1"G$@PWKQF.P)J&7/ MB\<@W:&\&=CWC=W%2L>SZT:A.[4:& %Q8*T/CK4^@)[NY63Q*!E$ZJ\$[0)E M$Y5M="QA9P.E_,)L)4]63BU?&55KJ)"Q)*VN(<+K"RO6"2>70[I?X_+90K*P\X U,;O.W($L_PJ MO1MY&QT46F_NZ O1]P'_;<]\;4X29BY^KO='+3OO$G&?<"OKOPQR^BV^BO[< M5?PFQ3A4H]]?_10'PV^=3O=;'$I')0#'?R4NZ&A8?@$/ &CO$4R+ZO9OK^7[ MF0N\]R8W@Q"QT-CXFVN416-5D*:!9A"^K@;\E 4#SD>]U\V6]I*V F 3KO/[ M*\"?27>01-\ZO?ZWJ00V<_W*\H^R[]XCJSC\?Q9=/?:XOA__WGRQ\GE MA3@\_2 ^GIP>GAZ=''X2%Y>'\,3QZ:6X./KG\8>OGXXO*D<+JRQPL:C,A&#Y MV#"Y+3ZF'N*+U$/\:_.O; ,,9+G=^HGGS9_(G"GDU8S]1AMM4NUMH0EG[B;; MG4Z7@J=MT@%F'9CW"WN:,_[D#2YZU[.QYQ/7<3RUU&D_)Y8^5WV!1@+F7=D( M]]\X#-_8ZZ[KO6YUMTLO%0:',?S?7_5>,4K7_(XOT9U8%D 6JK\2-]3Q: -E M NC@5]<7\=B-Q*&._/M"L648=_XQ"">P_)W_IKBS_/,G,*9XA^['4+E^>QZF M2FK4;#Q ,8]@'E&#>]WJ,8]H^AU3-$HRG7K$&I!-#,?*23Q8>19H$E! "6"S MBQ'+.J$EBU,!AJ%<*DE59"0+F(\)-?>#F"+'@6\ %](?WN;"F@V'PEAL\YF$ M50)$@7ZS:C9CU)PW96FPS0!/YCCE',?#1':(3M4 MGF>$TM]?=5[1[V8&^KT0<%_TMY;Y:\MM7)1B1">6=TK+-)NJ_"+]',.8@=%LBDGZTHY,''AH( M-?=T?K_+8XN>?(U"DU6,3H.[,[J>;SL;A-_W8/.,GFDUQQE\TG_:>SCR$IBU M*LS1UW8OWBQ3Q+^1B+0PJ*W\5M^]:P29+ O]WI0;_Z"B8>A.D40QZ:P"Z2QQ MTSQ)*'EITKDDXJJI M;8%?9-N9Z5_WTI>^)$U^2'UGR^D?RO]LNODXCJ>_OGY].C.7K[KO=W=WNV]>=3J>[]W;OW=M>KP<_[W=[K\-AI]/_ MIG[T=KKM<3Q)+09P",,=V&\HA_&O)E7GU?M>NZO3UI^'.-<##E[HSG-9@,^A M7?#)5P[;?L-HN(5,II'JP8/#S*Y"I8LD8_'*://*KQ284LX5!Q31KHP MFZTKW4\+.0]T@5 Y"4R5XB]40SF4?@Q @Q4\OIZ;P<1%,A G_K"M2Y0>PU/* M\Z3XPPVF8PDJA].>%>#RLO:R7QTL2DJBI675&W"MK$"J6.*H(L@V>]P7.5LAG# M)\,GJ_&KX_M/$/*[G=TW>_N];F>_O[?7>1U/>MU>;Z_[QNF"J-]?@:C/KH/' MZ 9]-%;,B;X;:*W(6PXVT6; J-TTU#Z,0]5+,-;B@J(S9ST MC?WE@_+D#9:'*8RI=?1^-:P&TD]P"WMZ36PW8+M!XP1?MALP>-8)/-ENP/!9 M(?A\$.]_;E6AK$W,(],.G\G!M]M[\V:?''S=SMO]?7+P[;Z$&E%_8'^HSK#[ M%$?]6I7<)T'I8]3\^NR.<;#6.'@Q54,X$E]\A1$*"OERVNZNUG8S??\T:(M] MJP#;N'JJZYKV$TD5X8N=[NO#)SG05^D_7X= ]KS\B^02/O2@HGD^:GD696W%G&K;",RXH[0QHK[@QJC0(U5MP?I#2\ MZ;WIOM-*0^_-VX[3)Z6ASXK[.A3W/BONK+@_'P[6'Z76I[C_*4.LD/8HG;W/ M.GMU08AU=A9O&R3>LL[.D,8Z.X-:HT"-=?8GEVWBB-(UZ>R[K+.SSOY\.%A_ ME'IVG=VJZFF9]-(Z:"TQ4/&- M4^GT^-J=/_H[WSES!(-,**ZI\^';6PH/J- M&1B.W8^7S8C>?6)&-!5>?T@5-2;AK."S+-Q869@5?(8T5O 9U!H%:ANHX&/5 MIG>D%.RQ4O#\2L%N>X\%Y&<5D-G 49O=,0UZ$1J4:Z"-!=>TZU^%H/AG^CYK MGRRH55A08^V3(8VU3P:U1H':!FJ?JW9M=3OL7UZ'[M7M<-FPYNA?E<3"^B/5 MLRMRG^CYS,$<+? P9SVVK7_9]M<^'/Z5N/H0Q<4T\*,@U&YF>B"9BI/3HS;Y M?H< K]*%Z](JXJVPE$XLK#]2/;M)X,2'&XHI=_NS].&, MZ,?+,(EB4/:'L*;% >GWQ*/_Z7H36$,,"C:-UQ*GE"XN/7$81<'0M2W#(A'C M]TH]P!K08VM O<@]6P-8<*ZPX,S6 (8TM@8PJ#4*U-@:L H]A(O&K<<:P%7C MV!KPG%A8?Z1Z=FM H:K;%P2(Z-YT]+E@@=9"W_\#]/L^Z_?U(N"LW[,H7&%1 MF/5[AC36[QG4&@5JK-^O0K/89?U^+?H]5YAC_?XYL;#^2/7L^OUYZ%YC!?AS M#S@,>?HOQC*$"8*]4>H9[="D>4F&(D3WU$3'^-#'MOR0,&><20WCH3CAFH8!Z%N/:!^J&$2 M RC UR-WB(4GEC8Z[:W;Z,3&$M8K*JA7L+&$(8V-)0QJC0*UAAI+UBPGOV'K MR5IB)MZPUL]:/VO]E:=F]4>H9]?ZC#5S[%GRR77?+P\I.HE+N^ V<' M?\$\F74@&!7,"$M;!=ZP58"M E7#VBKH:FP58$ACJP"#6IU!C:T"#Y*C>WOO M]G9)CMY[]_8=AU2LURCPEI79.BFSC'-UQ[F<'G>1#+)F>#GE->^A7LIF5_]3 M?':+@5'1V02Z&B@FNPC#YFI@\UZ+%$/M:J!66P4_JD&8R/!6='O:2L9PO!HX M?F!4U"'LRB'#[6G0%OO6)%JH&W01PU#TC#6-7NQT7Q\^R3C*ME$V(]3 C,"V M488TMHTRJ#4*U-@VN@([#0=,K<LR&T(H;0-U4RA#):<;TRMKTTUO;"!F6&-#8H,Z@U M"M0>Q%SGKJX (-W>C'C[_+8M/>7#(;*,A:_$_-7KO.MW^F_0_-7K==]U]JW] MJ[M^^]?=EU-3%'F$&7K_\6;HQ@#\(PW53=H_(W?CD/L\#% G#\);T/QC54A; M[>V1=MYK"7@BT5:$LD#!HR"M7G&[@9B]TJU^<>U..NQ\EXM)L[29WVD3U;> M&3SK!)ZLO#-\5@@^67E?C?*^]W;OW5L0Z>'G_6[O=3CL=/KLIGMIM;W+:CNK M[8S7C<)K6V-GKFZTI,K.%VH:J\E A:+?T6HOJMZ8W+.XD#3I[RUQ',6A\CPI M_G"#Z5B&$]D2)_X0OB&56\]+DRPV N!$0P!XZ>*]!\/OX\!SU'UO5<'/?S:, M SHV-A:PL:"ATBX;"Q@\ZP2>;"Q@^*P0?+*Q8*7&@C[\W.GU4:GHLE+QXL:" M'AL+V%C >-THO,Z2](W>?.+#_<7TR6?IPQG0CY=A$N4Z41F#P@NZ'=[^Z00[+)"\-**?I\5?5;T&:\;A=?' M/V+EDX9;B.(WJFXW5>"7#.1?% I0*06^M\L:/&OP#15!68-G\*P3>+(&S_!9 M(?AD#?ZY-7A.V'TY#7Z7-7C6X!FO&X77-JY_)?K[/P;-.X,E:/<-GA>"S<5K],C#U M_$K^*CIFH73XIJ'ZZ&-NJ<'JZ6..XV!.WWEYD"WSG'Z6,+&IY?5 M^F#ZY<_ MHS95V,8V]^A^=@[/[)Q[=#.DU0?2N$E[$^77Z#?WIOWNRC M_ 8?O=TW\MON2W@AZ@_M#W8E/B$>>*U*R).@]#%J6'UV5VDDZ#=IBW^J37]25&\%%Z?#=&(:B9ZQ>>;'3 M?7WXI,Y8.JRXF[KHF! _C1!ODJMS=2;/H@36,/?:XVR.2QQ)C5TZJSJ3QKD1 M5A$B7.1O"M"L4T":-$ZI*Y7Q(/SK7;ESO=72ITV]USX,W>#&=F!O,L$[,2%DEI%R@$W]T?>D/8<2UZ<1M5HI9*:X+EE5!ZV"E MF,&SPN#)2C'#9X7@DY7BNY3B'OND7DHI[K&CF)5B1LI*(65!*8Z6]11WWXFO M[8OV4;NHL8*>O-=93KG=[[QAY9:5V\V3SEBY9?"L$WBR56T;**B'E\LHMNFV7<0?/*;Y",ZIE%%^Q-IUW'<(75[]Y>7RH M@G[ U6\8TKCZ#8-:G4&-J]\\N?+&_CY7OUF'2+N_GSE1^2R?I8 %UQ&JS>Z8 MFM4; P\3QXUUK1YX48$*+D,88,F"0D@+JU10B%5VEFXK*-VRRLZ0QBH[@UJC M0(U5]E4(N2_@F*H_M#]"97^":[@^RABKFHR%U<5"T-^FRH^DZ8'R:(VSQQIG M51@C"V<5%R?W+][P,9L=^=5?A:0#6K\,SY MFPR>K,(S?+(*_])0RBK\2ZOP'XX_L@K/A+*BA))5>":%+ZK"?U CFH@U^)=G MY$Q968.O,'%E\*POXV?X9/AD#;ZJC)]!]"X-_M/A'ZS!,Z&L**%D#9Y)X8MJ M\)_D0'FLO+\T#V>BRLI[A>DJ@V=]>3[#)\,G*^]59?P,HGHA5+YF ,UE G(VVX< M"9+08WD5"1DJH28#Y3BF"5,Z!JY5/^C<+:&_CN7 4R6 NI,>@3 ?#((X#B;F M6(@3N[Y#UX*?E,HJLR"Y% 3J?PD.]8\E:%JR)+%HW:$&8OKH3K V %VVM^?; MR3(K6@W@SNWA1L\Z"#QG_NF3WZ1PG=]? &DV_D> M):],&[F?[GR(.GM='G_6D-%]TQ8?S[Y\ANWO_+>X^/KY\^&7?Q>!L[F@LX#C MKQ H: &.&@:Z<9M]]BFP,O=EF5+2])NK*]*?PE!MOIX57L]&"S\:AIK/X^\B MU#6D F7.5A+\BAI2M]/YY6 0A Z,#?-Z$3:Y#2G8!7.9>9$6OH# MJUGD)0_36TX?#(Y4_ 2/BDXJ9_8Q5I\9;>L2M"V]A?[N+P>9BD>*4;]KEWN/ MX(O"^LX@5/+[CAS!++]*[T;>1O9$-" :'5#?!_RW/?.U.4F8N?BYWE\4>*Y3 M#GU/OI7U7X:G1O$=5]&?NXJT\?!/<3#\UNETO\6A=%0")8G=T:SY,+ZW=ZZ-9]Y$0P.2_V3=:5PP^3\(HD7X, MSY"-.50@L84*N46$XMJ%&B+\&"-?7P2AZ.YM.=OX'3Y__&,XEOZ5$H?#&#_K M[O=W6V:D*S<".1#&)B.W Y^Z$7P\#4*:;@ ",5P/?!'X9 $?J+'T1F)P2^_# M3E6H'Z !0Y7X\):3>+=")O$8V-;_4\X&&$$V0&G-[=9//&_^1.;4DU3;5!7<+=IG 4&6ICW"WN:4\CRYT-WE/="3F-]$#-J%!Y,.M<; MG&J)FWA.2K,ZP-X H"UU1L/X,(S_^ZO>JY5!QFZ#(:.N(/ P6??RR^&'XZ_G MXO#H_WX]N3BY/#D[%4=G7\[;)8+2HM O)C!,8%8)#0P,# P6&-"@SM!0:VAX M',< B;?_=@^7NSFN;W\9#5_Q9AL.QZ.ZVS*)% M$ZY!]#J]_A.I]9)HV22L; 8._G'[:R48M2CXI=&P@> DR#,M!AXL@\%BC6#Q M.GHM_N5*'Y1$\C;T$ 'CHKB MJ*CJ1$7A9Q> MZ$;N[";14%06;C36&)XD_)MQ-- ><&-C70:!1[\!@L34Q5& M@1]A0)0)AC*3Y8*ID'J8A."AQ W1$O#30'_JR!@^@/L$YA!SA%3]H(\CI.Q< MO;W'&3^[TQ]L^:Q%G R:1!:%Q#S4@;)W+S@U5RAN) E\5A5I[Y&.E'! M0N^+0\.*& Q#"),+!H9GEU<9&BH+#2\I8'),:J5 Y+Z8U&<(6&=N4A?@6 DW M60XH:B.$;A!M6!R/(K;.0]B;(:>L3']A(8.%C*89S1D:V$#.P, & M_AUQ&!AI\<$-U3 .2HJ$,,%@@O'<(%$;Z?39HBR:##FU"FF87W/#KH;C'#9: M#GANE8%Y?S/(!%NL&1K88LW P.$/# VU,U'YM GF_,V@#VS&9FA@,S8# YNQ&1HX)H+!HH)$@CD& M P,+DPP-3!H8&%B8;#0T<#T(-E_.U8.(XL 7ES?N%9=^8!K"$1!,&6 /)[ZC MIHH\K%SG@:D#UWG@< 8.9^!P!K9!-YKKKU 78#[?#(+ )F>&!C8Y,S"PR9FA MH78F9P:+RH(%''Z17 M^%:/7_9-"%1$QN7?R3B6P_&$=EWV?0#'YBZ8<>BYT]PW*P'IIL13U)6D<.#$ M)DL4C2L]3^$EBH)Z<1G);]:1[DVIU.%Z_% M$K!.YY?T_<)F7LVJ4ZP[50>5ULPG64+BFV=-B:^>D9YOGG6@YEU]B?%\21C@ M:)XZP@%&\U!K:?$IN-N2_B!7+!.!.ES^P^G_)EYZ76_WH1$Y?->,X/6_= ZJ M:89YE(-JJAY4LSJ]X,6)Q@9)!8\3]C?K;C=>"N#KYNOFZ^;KYNNNS75S\,JJ M;H06X*AA$$JM:SU..1"+XCSX+IJK[*X(=@S0#,+7]L="R(]VMU' SN)XGS1J M9XX?% !P!O1:^@.K.=.C-_KF_"")(Q4_P/NBZ7P&WT M%OJ[OQSDN1,LNM^SRRTC;#G@FP+4[ Q");_OR!',\JOT;N1M=%#P,>WH6]*7 M!/]MSWQM3A)F+GZN]T>^J7(L>/*MK/\R*'IL\57TYZ[B-RG&H1K]_NJG.!A^ MZW2ZW^)0.BH!*/XK<0$Y,0<##R 8B2.8%LXG^NVU?#]S@:4W^7_^7D^26%-F ME%_T*B0._/OO?(7,PQYBQWT2X&6\\,7A[M$NAOM@L:XZR=P>#),:!)Y3DK?W MY?##\==S<7CT?[^>7)QGA MZ=')X2=Q<7EX>?SY^/3RHH+7_>PO7^[W_[^]_^AL(^_/.WTDPS*S64,>J*"PXY3>&'"1OHORT- M'-#7D][*N[(0T5?ZC!Z%^T9#6C,)*.$+*R8"#]C72QH?Z>)0NVLVE+N^_G,? ME%<9LI<#XQ($8,@FR(9Y8#C_]U>]5XV%\N4A6Q3@P \T%%C>V\U8;\:?$75, MO/? @^54"CL>+^F7'<1CA?T*X$;I?N81YAS G1G!T]"EZO"_)+#?RS*:"/]W M,PRR==\G_^MU]3J[+='KOX._]O:VBZ+UAHC3>5<#8'00QL'(S:+7R?4P\SF\ M@LRXLD+)0^6/+[2]PIX>.D3TVVM\_3VZ8_*Q_U_4E1O!2,H1Y\G YOQXFCAL'X2E\\ HPTD=2 M\P4O^QSN%?[?Z_1ZET&W]ZVO?]:!M ^HG>7#&JERXK3O!("4) Y^Q'^P4TLTE)3_SL^-+?J14+XNH^X4W;&=13]GJ3Z M/)&95Y5K+RD9?MSI/8FC:M*Z(S[N]%/Z6A4R6R[_5XZ(S-.'9569.5JSD(@L M+^+++3A]N@+S5V=CQ7RV(SX22#9(+&(862^,5(]\KU8&9'AZ1GA:6N MW!&5V1O?4-VUNK("ZR MO97MK76P?50<1MC>6DT8J1[Y9GMK;>")[:UL;V5[*PO0;&]E>^L+VEOWBH8" M&=7$4'"OO55&8_'1"VXXBI6MJM6A_&Q5K;-5M:[$US:W;619?]Y4S7] *9,=NPI22(IZLQ)7R;*\HWD22VO) M.[6?7"#8E#"& X 6M+^^N=V-T""!$B") !V@V=VD]@4A9?N<^^Y[ZTF1M13 MWXBJ:H,G1%415454%08THJJ(JM82527X/+5[HU"7FJLL M@C[S]Z O&)_B-W&-2715'>]?>30AGHIX*N*I#5&3)0513Q%$5<$&7!A$_8G^ M:_5<]OZGN?]+KX/M,BL02_W(G_]E_$RQ>I>WH=^)_[#>&BI@^&1EIG@\HQQ; M6#Q[G]F^'%&TKH&3?NA-S&MCRLK&QNZ.QU\6$"5^2H)C6JO]])M08>,=%/J_ MW2*[I.<'?;H#O99K#4-:V^1/_'E(_Q'WO!<*,45"4VB>P?%8O0L(GXNO/DL, M>'[P1$LH<<*O-/T)WUD!G!1R8[MCAL?N_>&Y?(7#[B_G*4^W'"YW_1_;V=^'"\EW7KZ M<_F"H>\Z_1GQ6:A_%@:'XG]OL)7U[Z @Y_G[=YC9OXF9&/FVL! S(_COQ0+P MNAZZK?1"K?::'Z:2L7R%#)E)K=A.ZF5+2XW.SU MIP#0\]W^[!53"-Q[_X6VS^G_OE?T$-O5#[VEK;ZZO?ER;]Q\,JX_?[RZO:)_ M?;XWOES]U_7=_=67JX_&[=7ES=?/]]??_XOX]/UES^SDK3)9L[N MR((%6K)_%07^IEYWB@I6?^?L[^0;%CF&>G'+1ZJ;K!F169_SS%,O6>&5GZ&B M+;GWC>B1I5N^0\/R^L8'WPKZ7)]]= )F1WX@BA:7(!4[L,X.<"KY>FM^5FZ>8VH9"D8#Q_FQK&]9G@=REW3QX?S,D MSX5 3O_/54]^"'\Q+V+EUUKY+*"WL+B;*Y/Z MU"G@$8\C, 4_S9!%K288.,-WQ+^ R;3NO\4NZ+^%O[ M_*UA"8OF([/94X\%QF';-#JM3L<4VQ@PU^);&D[U;/CCR>/TD"F+*9F2TV<# MQW8B84#9O+]CP/L[Z,T#<=%79@4&=R3Z>;?EOY2^M4A"&*LIE;2 O^&N-IEN MS@_FOM)5!RP(.$A]_N:I=1F,]>_D99-%.C#D%:])6X\">G^AN>42Y?T>9^J0 M_F ,+"=P7TT^3D(A"$(3SW;Q1.]O6P<++&@].*U\,2]LZ6W9J"M!?RUV M;>,DEOIN_-4+_=VSR"E\-6ZMP'J@E7T4ZJ3=/C?^R^=BE*W1. >A M4=*LY0YLV45K4!1BUG;-I7=A[O88\_A^#RUN3UAA.'KBOQ ]6M$4=S\[Q/S$ MI$2;(\:9W#(>A&ZPI6XX,"Y"X\D/R X8<1+ML] .G)YD45[A9;2YM3+/UC#3 M-XLML% G"[LW"ND/(1E-I$T-)S3&8>;$->;;05>-[2++&/\&_:!'2R)^DEA" MLRLA[![^PV<_^"Z6W1HZ$2WA')O*H.WD1J<1C@;;7OHD+DLC= >H[>, M3;%!X#^)=W (3,)CZM,N)[;@>/,/=-I=$JB0[Z#7=Z0]&E@.?1".>@1ACR=N MC;X_ZI&ST/-'4X+S-Y*4GN-RXU.L_P(!^I-H^$&(P]_DYHCYG0%[X,%;*3MT M3[*^(Q'7I0VVW-#/D[0#XWZ>3=_W!2S(['5'?;H"-\O[7&?*'PNY?^(F2FR, M3[:37HS@$V\D(6#$'SNR'"]Z/9BJ3ZDFW+%VH$._@%%ME=K;7L>FV- ?K-"1 MRC,.AZJTR+ ==R3+4BGWY9()YZ X;C/D]D!,=--A'R*SIS&S'1@WHV#V^XZH M_F7'S8>^M M,-'XC0/V[Y$S,8Y250?R?G'H+#&)DWOR"!O=-N@+NVG\9%\/[@Z, >OS !7M MMCT*I+GF6L_AV&2TAD-Z?&&U!2,>T>(_H/<JX]Y8LAM_3[)_UB4I'R0L>V' MZ9_&PB^-Z6-Z+33Q;WP0-Q:NA//CXQ^(Y@? MJ.<:9Q P89N/H_-B7D/I-+%#^.WXF'\^*WB^+W#JWL\2\8- M\U?-*CJ3>0M5>T M42)X,+0"\9N3;7AF&5T:+Q;=B:! 2IFO.=?0_(Y%[T:>=R3>,,D@#$?!D.\@ M720F(?ZM+ ^QP4"F8(3;GF&Y55Y7H(O^R-,J?#5C[O-\\BG)P8YOO"C#L -" M#]VKQ#94I'MO4NI6!"/&^E%FYGR;]4>![ PEC)0#XXY+;.K+X]=A+[3*'EW*Y!K$,G@?&K=6 M'7H4]L.A';-9'-^1,5?2=T_>^>W(P/6< 5F0M(KTH,Z32'<^67UF]%Y3)KS)@U?/S!6QQYE; M<(W'4\1QYMA*9X'SG_V?/ 3M.NQ'3)<3[4\KRMZY:C4%'A M2F6;K4(L3]OFZUGM]PZ2I?+N*"!92?$XW>6'**/)+>(0?@UY+J'#';].J],V MWHAPCRB0B*SOPM'C[J[TU&*O;5*R39Y4G',7'K&LE/T4.*Q/;VJ0\'%/+99R M_K=QP,JXXQ6MHD(D+A!YNUI6U6B 6"N7-FY,0KXDD6S4R(8E8,@L=)%I#8N= M@'9K/ 0/Z[]LO%(YZ[_R8I=3'%7DX5./O7*IE?/RCI[C\TCT.1B>]<0'1S#G MW84DL#]\6T3V]D2F@Y[E"V^QOVVUO]'_3PX M:(J5^0<+0O;ZVZ]3]YFN\%*0]8NL.N^#YP3\:+073MWHRM<47'RX3N7Y]I3_ MO%9_!1\5/%79,.%=G?W3P>P?S/[)G_T#;0AMJ'K06#D?N- 4(2SC2LLH5S#] M&-[(=7/L5_7?)6?*Y;PQTK,S*">^WA1*+GC-".'!\L+]&!0Y0ROS)F"N!Q7= M(L2_.4\/AN5&O^_M&6%@_[X7V*WVZ3?ZM-4^^-?P839A?WC[^;NS2LCA^\47.F\*];.'K4)H*1/6_5#,'$'M33>R\G*>$ M.8N5K-XQT)X$JYU@F3.PDI>H3@VV] <-MC'4&4^I_5(VRURK<9&ULPE*F$6I MY$8 [8HMPP-A1;9$7'NHRKFLL9[C*^G*HC7F+;08Q\F%A2.S7N M17M1@K[25U]A5 M&M90SJF5,-14,;&FP7$-YZJL\,6L%LU:JG[6"\BP,6DF= M)"]^_UV<_9^:K2)GJCS3=?QG?D6C?2"/AA>/UFT=I$=OC"=OR'^*#=Y8$XIY MN%H#G@5GZ2H?MC*N!1P@8+6<*U*4%MC M>:Y"!, !\"8 ?-UI)3#](0W-DX92IQU\2\CC#W?XIRBDH"O]P1XL]\J+G.CU MXL4)]][S-_Q?/_AN&I__=]$4!.QO25//'HW.F9Q[!!6FK0I+.F" \(P&F]NR MU\EKV3ON3+7L=?G?)BU[:/XHMX-U[E3JN0W[,="GQ66M"^S4:([#@J,Y9N8\ MM\=#GOFFMULGIG%ZS/_ADYE2 SP,/M(#XS:4&;>1[JWZBQ".N=WJ[;FI0/LI MGV-R!VU/K?0E_48O<-9IOEPXX4JG9YV?8IWWK&L\5LYTDYFQ=\.EXTU65N"I MBV5OEIDBLCWWW-[YA77YWU^O[Z[OKV\^&Y.X:U<8^\]^F'$(J]G:9EYEM^>WDT50QL MTK^.CMX61$/]FS^[3HO1N545L4/)^P+PO1!'K2U760F990\6;CAL@;M*<+?< M,-\0<9E#(C; (+]K;1B<"6'/CDJ6[U(WL0*\ZX$W>Q![OI^Q,J1%V'0=3'-K MLW:]FO_6V?=9' ^=JQ%*6E.]U,3\)5VL.TK+?\Q_UF7[L3O*9(,$3@W@U\0J M*\IV@/%NPA@Z'.#7"ORP"F$50J- HZRK4P5)8PS.H9EWU4A?P M#C10*DH%VW2VTA W!I2ARZ'+&R4 L!)A)4*S0+.H$4->KZ2@4+7ZF>C%K@CT MB'_4%C^VPL=M%Q8#;[N#-U4+BXMUZ%1*]"7R.L!;7X?17[4I*5F,\5I\A,(N M 2"]14C'8ZD_!98M3G:2^3\L%P^._$BNK2" M@!\5_S^6.V(S$ZLOPAMO,JEZSQC16XF?\*-.OWV]^[AG])E-.^.&"9P# :UJ M;L+6ZM$5:'5&1AV A5X&S.$+P!< I-7V!=KE^0(GI^;I\6G&&3# .F"=1HMH M23FD9,Q1R85&B.XW!9[+D7A+3V\Y_$3T(?-"%JZA>M,#MX!$(%&1/%,NZ@K- M']37'$#W0G-07M3I+(+HZHO7X)WN&M8K\4YC<^1*6B-QJV0]F:EVVSSN')61 MF5HZ@;3RFD<%J B>J9;BN;855B+HD;4"?%7.6NVB9P%UWG!Y@+L!=Z.! E"R MNU%>\JM]>&*VCX]+27[!X0!#Z2J@VK935Q7P MUPC\H;T*V:P= "]**.$UZF.4+O8:Y1%/M2:GCCIFMW."MBEXA[LEB&B;0@(* M@(5>AE[6%>8P_&'XZX/KD@S_\M)$Q^UCLW7818\4*&;'1!%GM22PF5VKNL=" MCHDM,. 'M.J$=,\ Q QPSP#$#7/WC-32Q_Y2@ M24!9:2A#ET, M!( 6(FP$J%9H%EJ/BEFX6PE76M7D%RIJT;WVOO!PH@_8&@\ M,K=/]S/N@U$8&1>V38\153'R"[ $++?<]]#PAGPT1S0'X97WWJ.0"CA7KY#J M[V2-7'O"%OGL>W:=_11GYO%)VSP\V>*\+U1804;5K+"J"_":^ 0PHQH$W8T MVW"7 FJ\X;( /P-^1L/ 7XF?4>(1-T=F^_3$[':RI]S T0!#[8B0EI4(:Q]T MCH8KS9?4Q,58_#SGXH-G>=N>[_9SU"#@7>.TL(N<*6&KJO%=PC+ J%P*;=K$ M[Y!-$1E]?]1S60F3?&%4 .AZG=Q:J3C \07\M^+XUI5+.^DM3FDN;F(; M898U*$DGF=PLH582ZC5Q$Y!5:Q!^MV)60:5#).!EP,L _-7U,DK-I)VV#LWN M,=P,<-)N"Z6*1^9L?^0 AO#4"MYMC9P"/ %/G>"I;R\ZIJ'M*-*5&-F-&1=- MU"F8;[&3&J7VPUFV;^\I08V L;(PA@X'^+4"/ZQ"6(70*- H-4T]*[WD9?LF M(;H\5,!Q@03+'X[5_8T] ,K>#6N_CURHE?3L+R^<1?Y]O='VB46 MA/_Y\VFG?7)N?&0#QW9FYJEM'E)L&.2!6>6:0:I.=2M@8F!<6G, C#G,ZGDC M#5,7\$@T4"I*!?ATMM(0JP:4H2$+52@_!BAW!Y0JEQ]CTM;. UB%Z8^5%YI@JB-@7<94 MQ]B^N)7FQ877OY#&1:HMZK+.PYH/.V=F^_@X,_?1T*@.$AP$855D*/<6C'Q, MD@=HH9^AGYL(=?@(\!$:".M:?(3RQL,?FJU6JXS)\" @$)!>DJIBXP)"_TT! MY7+\_=,/OM-O&K8U=/CIR*YO>:&Q;P3,M2+6)Z %G ZVW MYWB35>>;&L0R<"6U%%&%FUZ09P)@50$L]#)@KBC,2W4)8/\#Q.6!>!_V,_1T MLR&.]B#$OK<=/OPX8O1]PYK*O[RB'P@H5#.(O9/]0,C"- ? J.V#)Z:7F;JX MMH\,B'M_B^F7HU9N+1^Z?>!!-E\TT>V#+ Q "_T,_:P[U$MW"^ # ,@:96.@ MKZ&OMP]S%9MC:@][XU2%K841KSW;?V)&9+TDX]JVW0<#].T.^E3M@U%@+"LR M,,T!KQ)],(HX6OE A^>ECDFZ=+("GZ,@[89[ZZ7NY$O;;)_4/VI-7V)900CA M*"HLE0JWOJB18X$9#\!"+P/FRL)\1[V #*97/<,E]?2K'9*Q]WX?Z@?'P#1( M2=5\#(S1.CCB]]]&D0[J[-6'8P%Z) _=LQ^=<-,4@_P'< 0DH)-KH4P2?T7:=O/!.5^L^<0G6N-$!FHCDH+^J3%$'T>E4V:" !UNL4/&FDVRN;8*5"'KTD@"^*J?XY+%MM]@ A+L#0E5;;!2@=22RF@->)8KKX#/N&H0K:;%9 M[8S2$C-49NODT&P=GVG;7J, J!LR5ACD\ '@ M^N"Z3 ^@Q+S185EY([ ,6$8?:53U7)SZ+?T"3?25MO>-F]AV$\";-OC5?V@. M( J(;@^B^O9;EYA\ MIU0KLRQ_%H. I"AUG0"N@6S'+82^-6PPA6D5>JJU/W(!BP(6%^,^4I:'4H\ MU1T(! +1Z+ F9-#HT!SPHLP)94[Z%%8L.D M@YHGU#SMEFBBXP$=#P L]#+TLJXP+]45@-T/$&MT>COT-""NII[6Z(P51+XU M@.<*N1>Z(PN> X)S$/Z-[_AW%M$EC0%;:^;4ML]< 3P; 4^OESD!,#Y6O*/ODSL4X^D7%2UWRKHZ.6>=1JX0P6^*X[+:LX@P69H%V$ M+\Y@@3K?:7F [P'?HX$"4)7O4=YD+?@>("O(:EUY,UW+SA8_S[GXX%G>MN>[ M_1Q%"&37>+3+'_..="DSR=8@+ .,6B38,HAKN->+Y%IS$%ZY@XL>*N!<">0<0P9QY!Q]<_OT,3^4X(F 66EH0Q=#@'02@!@ M)<)*A&:!9M'Y*)KMFX9H[5 !PP42,)?^TY,3\0<,#C;: YXE3C61B<'8W'Q3HK$+KS^%(6MWB7P$CKO/,?]?2\* M1HSN/%N>4[&OTR"-!3]' [VF5 A15P,1D7# &#H<.KPQX(>!JH*!FE]M#@,5 MR@W*K>9 O,YU&JA";*!5UU-G^ M4X(F 66EH0Q=#@'02@!@)<)*A&:!9E$C@EWA4,6S@\.C3#QD/_D4(]>51F?! M(G'?HY7V[>]&..K]B]D17<"@Q0B=GLN,@/79TY"OBVFD-V6)7$PKJAQ)6997 MO:>[^H$5O%[]>^1$KW>/5L#"FU$41I;'96)A]=\W^5IW_*WNY$O=^U_&;_(G M>^JQ8!3R&]U%5L3X!EVZ5AC>#,3O7+PXX6R"-A1/L-Y$L+-VR^QTLD?F2%4@ MJO-U6=NV:FO;-;N'+;.52$=_HA^6.F.$/ MC+^NM/RW5G 3B*7J_P^_PBT+Q([4CO"O=Q^_#5GP+;[[9#,ZQ4??M0XZ1]FQ M=P+@5:]))<@L:4UR3LNBJTIH&E;(0?.1V>(!C<,VT3AML5@U_EXF*>%P2&_C M_&#NZ[9[=N:8#?L3UHD_2$:'2N&"I:"YI:!J_XY:>$QNQE\@[:&ANZ<1T%:B M>!)SD7<-PI7,19XQN2ZM('BEFU\\T5-'%U$4.+U19)$/>.^3.4:O7L^Q+&?F M8>?8[':/Y]CSRE>_8F0RY%6G RUP @L JQ5@H9'E)L_!JF MK"D/Q *QCMN #5@0L+XYTLF54V_IYR==C&*'@ED_\?Z*^W))F//JGK(S"9L M\I!MWJ8UIU5K=@.2,6WCIUQG(Z[#<%39)NR'S.;O^.P'_9!YZ^S!\N?;8/U+ M>+ZB Q9U>,@R5]+SER-X^0<>,QP! #':S9^\A@H-,K!'=L<>4;GG18'N6"0/ MFP/@T@L4,8(!F*UK!,.T]2,>/35MJT1N@#%!&XR5-Q5ZR0FANGQZT\PY5 M:^%0-0W0NAR8Z4/5EN;Z4X<6J9(TK_2!JZA,*#_+GSY*2LT4_YI/6&I^7QZ\ M5E6"/_.&E6;/-U[_2FL/-GZZZC/[=3UBR14JW?:9>5($P,4AGI_D-]ZP%]L= MB3^N<-HCSLU-0A7$O1.V5%KUK"L9=IW.S@A!#'QW1)$A6<@H,0%@%4%L-#+ M@+FB,(?A#\-?'UR79_B7=T(@#'\0S,X)(L9<('"_[>CF!6&)O[3E$JX<6AS/ ML*VA$UDN&IR!1#7C[&AP1J)(:P"C'0(.HL)VZ6('<6(QW)+!<.U=2G,!30,T#8#M-#/@+JB4(=5#ZM>82"7;M6CT1FT 6FK-K=CM Z.^%/4 M7=.%F+H&T"R0W;'MT=/(Y>;F&]I7_ (@ HC+)G0SB>G[0IR=,VGC: M!)W0=YV^\4PTZ3]S>M39"D#VISD(+^HG%D$T2@KA6RI@[;Y9[%Q^89%%7^Q? M68%'=PU39DE\$G=I[44A@>+WO?TEY88=DWN&IYV3,HH.T^81R@_AHFXDM*M. MEEBGX[\DP")_U"SH*1 =J;; N^$^ M1PPV4!C@,:F=*XX6_P\Y^*#9WG;GN_V.6BKN$.+9)>S4%YY;[KTK(O^*_ M>MW^:]HTD>.,MY+H.CX]VIZ_BGI,^*S:);MT-O)A$ZG'$]MKF&JXCP!UW'!Y M@., QZ&! E"JXU!9HJM]5LI8/C@.8"K5'(=5DUWM@XXXZK%1M7'(="G!(44S M77\X5L]QZ49\]<;G9!F2($QQ)E0%R;!=03Z@JUPF;-JH[Y %$1E]?\3/2-NL MF VF T!>N8W_U^K\VQ)% >XMH%_SL)&4'7/A]2M,DBT^J=0\Z1R:IZVLB[O. MB)(I4PG5G& I741U;?NL+,1KXC$@K=8@[-9N94&50QS@<,#A /1UT3>QJ'9/8;' 9K:85E=.!OQU\@BBIG:(-ME5B!0^,A1]C+&$G^(O>0217]A M!B!S+K&!>W%)4.L%CFF$EA?N"YAD5R6U$S%6SO.>:Y&\%<=M_ Q3VS4,V/ZL MEDA0NP869G?Y/'VS\;W&>Y]ZKU5SN7GHF=V]XMYB6C?8M/(L*+*;V27+;-XT M4,13+-G/51=B/1TV]PW640#9=\Q)73XRP[)M_VEH>:]T$;I=1 ]F!?2Q1_HG M8@^!.'TLB Q_8$2/+&3&P/$LSR;%1"]H18QKN/"@^)ZW5][S-<6ZF!1#N^P8 M,Q;5AEED;*0->\&O !O !K USV[:9-MR>%,8V=/^9;O5^N4\COK0B[C6,*37 M3?[$+R.KY3+NZ=1ZSJSDV&>22YDN*(LQ(+>'7VGZ$[YA8K]2;!V3]8Q[>N\/ MS^4K''9_.4\5[G&+Z]-^-WG>)5[&=,"++(BX@/SGEO@?[7? K._[UH >X=V0 ME,LRX"TTV"K>I/KW1CC6\W?F,+,SOUG&8\"#*C]'OOVMU6I_BP*KST:$ZG^/ M'%+29#J*!2"C\))'9\@$_.U7Z_W,=B[=5VBD2CVY#&S_\M-O9?),^L\_E7OI M%(7%5_YIIYW([,VRP9RJ2H(K=DN+E-A^N?AX]?76N+C\[Z_7=]?WUS>?C>0%^$/D#ONQ#)M:>J.OPVR1*X0_\(=M+ MJ*WH]]]S9KN_N+_Z\^KS_9UQ\\FXN;WZ*R?YT=369NGW7*[%OLC4&>\,:Q3YXP^YX4*?M7*_M/?^ MI__XZ3_^@UM5])__6&4RVJ(\BKA6$1MEO5#5FDF,60B59K44S. H8\B([>%& MYY_:T89^;L\]T=_HU[_>]SMZ,6RCN%@>3Y"=Q@&D2TYGM0(YR.I +%%[, M 9.1J,3V+\H"JU ^[]K>?V0V>^JQP#ALFP9O=,A!P(IVR2K\TB!.T1X*.9:* MUILS'<-KS)M &B&-&F[.CD@C?#F8=0IHC\27NZ4'\/NPZG=L^P>!_V3\P_)& M?%#+L3#LV_#M=@T%;QS/9D->=O:6E %=_^$1(-@U$,PZ^&TX^' IFB'[#74I MFO,F*;TB"N56SVEKIU>0Y5R!5+"[C=G=G+A'LR,5FBP=#WB06QB4W M,"Z\_M7+D'DA"V'QJ=MIGBP=#KDP[]4R%!!=! M6"O+B]<(^7+C&" ?X'F[>(8*!^3A3L"= +Q5=">.Q7#YE#M1WJ#Y]LFI>;;D MZ&80$8BHT9):27(K*;S.Q7WN@>7(*.P\8'/27('EV8].R(S(>C%83!(;J.=T M4P"P"6PJF.W*16"A1MMLVVX5!D5]YD.!$VI@^FLB ^6VE)?A%^?*&7QC",BV M?.-AU'\W-GCNK9?8)ZXWP]9IM>^-Y4$A&MJIHX4;!5#AE 'E](*.6 M%=ZK(G N.I6V8#'KM6?[3XP;&Z7G[$("X^][^TO;XXZ.S\RCS@DJ6IONOZZJ MI]^B60SJN!GJ&,UBC=1H@'R9D(>5#;6N%\9+L;(WRQ,5L[([W3.SW3V&C=UT M1BK-QBXW98(6E:6W7#J"7%=-J\2HTQ+Z60!7P%4CN"*+ N1KC/RL,UA\[\1V M38%JKDU?4=5A\KXK2+9*K[=$7VCX=DUZEU)W"G*FR^ZAB TU/W672MQ$CRR@ M7^?AJW&96BX3@%Q:2JQ&\V6CG)K:EMDFHJ_9FS7E/9KC]4"N MJO-V:AZ4UCX=UIEG!%771=4?G1\.65)]@UF!Q_J&[]&U?K PXD]C/#*W3W\W M[H-1&!D7MDVWC/0:\0?D-A2YF/$'1PLR@(D7J&:$@)0Y__Z_+,?C%8PWWO78 M$*KY**WCHZ[9.FECT-^.%35":#'H#Y0$=&/0'[@ TH)!?W![(#6JN3U5'OEE M=CO9Z>9JF'S@.4BL8CR'.DFT 36L&0+5E(!JLZ&*C"!0KS'J44^F>CV9\F_6 ME/= G>9.[1KFA*#,;6OST7MLX $X&=WX*?"?+FDS'&]$=YN_?F MU0]"LP'V&L >MCO4NWXX5\IVKV>.^XEYTBZU&! ,IRK#*3K+'65&*+C8>L$% M*N( U69#%?D=H%YCU*-R1_7*'>7?K"GO@8JXG=HU/287-LZ8WLTF!#:;B4V,)MQAMPLR@!D=2/1!0*I+]-U;+U=S&G TFZR@KL,*H/*EI9%;W]4CN%+'ZH1DC+;HWJ@\T/ M$:ES+E]QD[^\R7P#YX7U]_^/!?[>^WT8^F SB"H&\BF6:D!UB\(U78 JH*H) M5)$' ^HU1CW*I%0ODU+^S9KR'B@_W*E=6[?\L'W0V=4:KW/QP;-\CI[O]G." M40@OU%(>\YE%!F_837/]^B&U'<8T0-F,NL4.CPH;?7_4L* M.'9OM5K?T)&=BD2'+J2;5 MU5[.6!(@4,\()=WP>D9X MM7CQ 8> +P!" SBG@"FHX@ =5A^J".$7M4 MERA<4P6H JJ:0!7E?T"]QJA'F9+J94K*OUE3W@/E?SNU:RC_0ZG4%DNE/EBA M8QN6US?ZCCN*6-^0997T!XL 0VM@A(]60&OKCZ(PHB_294U:O:^Q.6%\W$^.K4('AMTMAH-UQ M^^Q.FF?W_FULG'T9VV9_,GZO4N'ZK,.';-U>&@>GYRLYH?" X7% ML4N*LY)YJ8LSFRA&!5K72=][+#+>N,0L;^FJXFC!(0MD#E^=M#W #7!O+V6? M0=\Z\0\./,1 ( 9;LDAJ:=Z=8+SD$,A&E:$(?T!F:D_A+VG\O;("CZX3WK) M1 G4R%!_O?OXC:R_;^*1T@&"SNIMQ:N]?QPT:M0*M [:Q^JFZVOI"(-9 A6[ M4,5N8;Q4!;XD# >@>FL9>GBGH '=!0;>*;Q3R(PJ!>9%G=-ZT];%7+-:?%+M M7KQU< )7%#8(]*E:.7MT(P.Q];7=T^,'3F\46=Q@CGSC/K#Z[.NM<6'_>^3( MU3(N_6!X@ Y\8%X!S"O?@<^QCBY\B()*HK!QD&2,:70Q(%"BMIQL/5!20?_Y M+?VJ%^7&":[(3(M>+_VG(>VB%X5*]#AL-G5@BV_;-KOM,_.DU5(W+H)^!L1& MU%"AZ*B'A0!X*]917ZW["4Z T"C250^?%(S3,.%1UR?-R6TWV"=5ZVW;9OOD MS#SLY!W&!9\4]@=4*'KLD;=4"ZU%>^QYB_W, VROE[Z^:H-RN^4['77#'FA1@'FQ?56);GD8 ,U# M-;KE00,0&'B9\#(A,\WV,LO/-JOG9:K]CNV#(WB9,"^@*M?Q,N.<^D_T7YZH M?/_3U/_2>V:[S H$.!_/C2?K98PN_AA[R:57^:49E*Q[F?-R+K/H:0KYP%,8 MOB1I[ 6.:826%^X+G.;(SF37WZ6=C_1#3$MRDA=5];DV8.0IE[$7_)K[DJ7L M8$F@S*Q:H>B(3==E09%=*6,3,L^XFY;Y"KHY=HN.P[9A_S_I$9 MEFV3S6%YKW01NEU$#T;&A6%YI$LC]A!8+O%Y$!G^P(@>6-9GDU*EEXP MMEW"@QP[08]=U^E9RS$%XJ>88L!AP/8SUIBFS+^&L,Q*QGEZ<<9KDZ"E!4GHKUQJ&M+3)G_CSD.OT&[E1PI=* M!1"FP# #@[$#*W$@OBK'/KV+O72)+7ZEZ4_XQ@JPI6 ?HWXF@'#O#\_E*QQV M?SE/E4-S&'_:/TJ>-WYP[@$F[E]Z<:>CS>UA9(2^Z_2-GUOB?P2"@%G?]ZT! M/<*[(8$UUQ%+77"A<9G]8<80VV23ZM\;$8>9OS.'F9WYS3(> QXA^SGR[6^M M5OM;Q$N&1P1N63%,9JY8 #)@+WF(CLS5WWZUWL]L9^Z^_A0#_2]"U;XOYC@N MCR&MZ4TN TH-ZG4#AZ2PNBI)4>7D4K%_H$?8]#6%/;(WRXC(%%?T?+>O22 E M^R+9R,J7BX]7O&WE\K^_7M]=WU_??#8N;[[<3@=*L%SSK1;(4*-!D7W,.[+D MG/[O>T0I?A#Y [[L0R;6GLRZ[K=)M-$?V(_67F+V%?W^>V[UW5_<7_UY]?G^ MSKCY9%S^_>+S?UW=&=>?C;O[F\O_]_>;/SY>?;G[SY]/.^V3<^/CU:?KR^O[ MU;'97HC-F;4X^64M:!8R)@H;+.W\]$4)M#NFQ[((=HE!-R[S$1>-/YL ,?72 MIYL::?D7*'71IE]6.G(V<]W8!Q+I?O[W^+HR_3^=CV^ERIER7+WD1U-/EEV$ M\W@E10&1\GI:*%R*WC*+PZQ2V:RI8KSU1:7K67^]IK MV":;(W&'-F A9K%,A98)H@W15G #(-H0;8AV(S< HEVY:._40D&@548JE@E< MK91H7]"J\LRNY4*\(=X0[X:)-Y@;H@W1WOJ252':]WX$TMX0L@N&'SE-9TIT>'M),L:I"K=T&;,""@'$L^O9W*#B8+G6; M+A#_[8G_96K:.V0?L@^WI6$"?FLY_7W'@VQ#MB';#9/M"]L>/8U<*V)]R#?D M&_+=,/F^XU;Y(_V(!>'?(.$(/2+T6$]+ 6(/M:@W<2(I]!HL%S4L%TA]+4[+ MDS_R(D@]I!Y2K^9J@NM5AC.6"5*OB]2#ZR'UD'J55[.2F@)KZ*!6$F(/L5=V M-:L0^X]LX-@.V!YB#[%7=#4A]MO>@372D_'HN,[AU%ENR3N5?#CR]A=S\<"V M H#\8+F69S/#"OF0\7]8WL@*7HUC6HI6IVV\<>AG0]Z"N\FAU8U<]R*4M.%Z M;'!N8+$5XH]2K9BG#P3,>9_UV3Y>VM,R#Y$N:773!]A6MKJYKYD]+G?9>: R MTGP=AJ/,4:<7X8W'CP(]BH__3%I?1)W-VL> AN*&Z?,_6^GS/]/'?@Z<%];? M_S\6^'OO]^><[KFRY&T #[W%<3Y@%LOHAIIN^^)8BTVSL2(#4DM ZE_!&75P M1JK04JK\6ICCZ]U'T(9&P@C: &TT#JG@CKK\#=EK"V<#L@C6 &LHB%0X&RHZ M&V70!CP-O201G '.T .IX P5.6,R9IC/_[CVXI(\\,>.2"7X _RA!U+!'RKR MQQ<66?1*_2LK\&C-0Q#'CH@CB /$H0=201P*$@?4O]Y"54]YLO6&5EDL=?RO M5ND,<,9_4%VI["?^1B02ALS'&8Y(_QF1;T2/S+@C@RCT@S(K:?5?LO*KBW/7 M1&_)5;["N$H<:L>+,NG_<1302M[23?R^+ :@QQ$_"F>XDO/DL>#)>[_=^7;8 MWM$ZY 8*KO(>5PT$TF"O"XBMO[@,5+.0:O['^;;:/6F:KU0(/Z2+5X"'PD%Z(!0^I M[@'564R=Y:#V$=A'%UD&^X!]]$(LV$=U]ME667:&B3I=\_049*2-:(.,0$9Z M(1:9'Z689]<*NB&V(!H0S2X@%EZ/XMQ3GM-RA/R-LI*IU0#KRJO#@P%SHE' M^ 3JVFO%]5X\3*'6O48II5+*KL3^WM3CO>QPT3=$.1;EM^ ;\(WJ( 7? M*,LW*[@UNU?<#0$&RX!E= $I6*8)++/S1=R09Y .2$<7D"([HUMV1K%:;0.R MJJ"L@E7 *GH@%:Z,JJZ,]I79$,?YG@A&=A<=V>T0]AW+I8>=S+K'[&[,[FY: M7?;.M]4.H_X[3G0A!G>C$TH79PU=M4"L7DX;>&8^SV!J-R06' .. 6(QN4%U M]V:'J[P"8N'PJ,P\VE>#0RP+B"7F=$_*FN\(SGQ"]W#4 MW?7MS92[-NJ%3M^Q@E>N:6X&XK+<5=N]RO&&B;CR#AY: M?(%4/1P[D-$*9+3"%(FZN4B3\G*(-X@(1-14I&+6A!Z.TCIE?849K[[ -[M)%$X"[P%UZ(1;,]N=MGEV? 8ZTT4Y@,Y 9WHA M%EDO-;EK+>K9N<)]2#UX"CRU"XB%V]5LZBK5:^I@YKVRLHV9]Y,R]:^TAL%S M0$L4]""+E/[<\FUWZ851ME;^F[F##I%MY5Q!] MW$"J'BX@> @\!!Y26;K!0^ A/9 *'M*7A]8I9P0)[8QH@X1 0GH@%20$$@() M-5*T04(@(3V0BLF*:_#2&W6):=."^55(*J1%^7UO?TDUQ^GI,08T;E4=O 5G M@;-4!RD\)3-14I,)[:I3W!.>G>=*P(1[0)BX3WI[CW!^6FJ&%=>QZ[WG/&;Z)$%AC\8T*?>@\%>ALP+RRU? MUWN!,(A=][)UM"X7:PX3J@#U@(T76.6=./0B ZEZ.&^@%E +!!;4 FH!4D$M MJE/+#E7N05K!*^"5IB(5O )> :_H(JW@%?"*'DC%6+[MC.5;@6O4J_(^.NV8 M9R==<)%*)0Z@(="06B"%>Z.K>[-K==L06?@X()>F(A4^CNH^#ER4Y@DHIHDO M+33^Y <#YD2C@!G^@.2$QY3I^7S[N]%[-1R2!,=RY0>/OMMG 6:,8\9XXXJU MT9<;]=]-5,'-()5<^O!Z+;7 74H)W/%#/.H=XQK&MU3?E6N@!"OOSJ$%%XC5 MRZT#YZS(.?]CN2.&3@HF:( M-P@)A*078I$=4I-]%"LMQZE^J@HP* >4HQ=B03E*4@X*"YHKA9CK/:F&_L)L MUPI#9T!/+"1KMJ8\'/7^Q>S(B'PC8'WV-.3?PMCOZJK)&]8+HGPE^4YW G," M39'FG13V>__6)YW0<]F7L$0;4S0 __H E+PC^K\HU\!>/<0K /6 M >L I&"='6 =]::'=P_-H_:QV3DZ!A&!B$!$ *EJ1-1(UJF3=!0K\H;$*BBQ MX!9PBQY(A9.CN)-3F8]R?'8&,E')1\$$\>F:Y0O7]2?5WOY@0#_U'DAFPBCD M==[UUG_KOYZ8*-Z$.O"=;Z9:X9 .P<+783AB??YOR[/9)=<>J.#;"5E6WM5# M*R\0JY?+!_8!^T"6U9%EL _81R_$@GUT8)^JZ_DPQ$A_20;W@'OT0BRX!]P# M[FF")(-[P#UZ(19#Q#6E(V5&BG?,L^-CLW5Z!)[21NK!4^ IO1 +'TD'4E*L M"!T$I*HX@X! 0'HA%HZ2GIP$/V=7A!:#R5-%ZK8=L/%$WC%= MBRX_PT3RZJK1&]9;HGPE^DZW%L>L>D_2[0=6\"I]K;$VN/=G>KTF](ORO\:+ MKO*>'7J,@50]/#J0#$@&H@N2 GLFNO MF\[HZI.C4_.XK=GQ$-#4T-30U-#4]6GJTO1MUSP^/#(/3W75N&L6VQJM@Z/A M2V-G&7]FD>'Z8;C6'LI_&KT^-\Z?>.9U+;_S/&N M.S,I589;9+G1F;F KDAO7'NV_\3^(.6Q*T52:7V'5IBZDPTEKCZ\HTU6;P?( M2BDW"F0%L@)9J2W+("N05:,!#K)2EZQT+]L"58&J0%6@*E 5J I4!4D&555, M5=M \:R^;1V<' VC6.7V7+KA#@-]EK*J!WH%V]%PZMI6E7*%-'9X B(#D6E, M9/"Y% 'X=GPNU ZN2V:UU&^']!*_[^TO&U/:/3%/VJN&ZH?JA^J' MZM^6ZH<"KZ!*O(%M.>1!+WB><_'!L[QMSW?[YWTG'+K6ZSO'XT]$O_[!4[H]24- QRJ:QCAB0BFEI=:=Z!!<\ M$N^P()3:OQ82P3#GQDHDN /NV@BN2B98;JFBL(*6@&MZ(%4T,K6O90Z"ZFSS-+M@%.TD%1P"CA%#Z0BS%4O@32I MG!FR"18!BP"I\$RJJ#%;E5D4JBUNFZW6L7EXV-4KL8(QT=#%T,70Q1OKXJHT M:OLL&P!26@8K*O#5?\#Q>- X+]*UK2!XI=R00JY># ](!Z4"$ MMR["(!V0CEZ(!>DH3#JZC[>$ (-R0#E +"@'E /*:8P @W) .7HA%I2C,.7L M:NDPA!GT _K9!<263C\H7ZN6DFJI.5X\!?/HT#P\/=,O]5-5L3$T-S0W-#! M?+BISSAD%Y4IKU^*GYT#K\$98'67,*^^2^7W@)6]46JQW693]1M9;I;6EVB, MV\II8)NM_*[Z5K5JRV837=TN&H@.1 >B:ZRD@^A =#L,?Q"=SD2G>V$=: XT M!YH#S8'F0'.@.= <: XT!YH#S>TFS36I9AV4!\H#Y8'R&DMYQ6LNF\V"2VHR MUZ!!A69SGYT=F^U629.YZZ?$5=X_(GHUS]8KN79S+!"/I7\ M([.%E6(&+7]-4\AD5VN'R9_3]4<]EQC.QB?_,!4KW,(-2 MT\L+KCBF8I1P?G=IE8XK'.%=5;%CHO#0?KJ5@&%)RZ\1"=77.UVZ2MQ5D/\5 M3*4:4ZUTUE-C*O-!5B"KAI(5?"MU!X)4:D@T>7!(6>Y6&86(*_A:.2<;=MMG MYDFK56:5!L@,9-90,H/GM1N>%WAL'6>LSK+Z+)5UL\?S@L1 8B QD-ANDA@8 M:REC-:Y"'K0%V@)M >0:T]:N^%Y+*A97I3*%JMP[)M_,T\Z)UAFRE8O=H?RA M_*'\H?SK5_Y5J?#CTZ-FJ/"X9/TG^J]%X'S_T\S_TC"R768%XB*/'$(O8Z 0 M?+@#*M]_SJ^)WTK]DBC^GA;,J:O,PV^[N#YOMTY^F4'O)2U$+W!,([2\<%\@ M-+W"?-4]EO]ND&J>^P9KX##G';./>?_(#,NVR:*VO%>Z M"-TNH@>S OK8(QA%["&P7%*&0<3[.J)'%C)CX'B69Q.^Z 5CRSP\6+;K&UAW M2X6WE2N\A11$^@HK[],4%0P#MC]+!B6JD?/TS<;WFGZC3=1*5G:Q?_U],B<> M6+*+J<^'?B@BKRE5F_JI?*B\GP1LR*PH_V=6%%GVXY-XV[R?^V1].7/N:+O. M,/63*O&6H9^-R*P7_#J!F[!NIFVQ=JOURWELJ--;N=8PI*5-_L2?ATPCLN#> M"ULI9"Y?X;#[ MRWFJFY!3S:?]X^1YXP?G%EYBWDUQ^Y2/,FEZ_;DE_D<@")CU?=\:T".\&Q)8 METG-0J;*_C"CU3?9I/KW1EC8\W?F,+,SOUG&8\ ]D9_)A_G6:K6_18'59R," M-SDR)/3$F6(!B TON4M#W/?;K];[F>W,W5VR"SE;) MSN\>;)+Z;!(%P99YKIUSI[,WRZQE@8$%2CKHV1?)>NQ?+CY>?;TU+B[_^^OU MW?7]]\(^/5Z?^^1PK=#R)_P)=]R,3:DR5[]&T2 MK?$'MA7N)99NT>^_YX;N_<7]U9]7G^_OC)M/QN7%W=^-3W_<_/,.Z-MU])4< MWT[_.Y^0E853VD^VF>O&+J;(7_&_Q\LB\UG3B2?N2!OS/>GD1U,+FS43SN5* MR+E=QCO#&D7^^$/N$M-GK=PO95SU^,%.NO..,7Y9D, JR7Q:,YNY"255E?.+9<%GN<"[LK=Y[2W>EKWN_[W7V\O:Y6%E$FS93QAS3-1'SIO0E MBJS]R[+U7TE;UUP"E'[P0D/]*J/Q^4^>"ZDL\I8P>[&WR[S,)S_@R< J[3UL MN5I;_K_,"HPKLC+ZBW==W4W.O"1V?>FN+YSDN)HID?L$A>P+;16)]MN_./ZN MU;Y,O8JN^FIZ/R!WD#OE]Z6Y<@?WJL&V=CF!T\W<*^.6GLA?8F]CYQNU\X'_ M9/S#\D96\&H<"Y.[C?W?G?U_XW@V&_(RCK>D >@I'AZQ_;OK;N?)/LS^*LW^ MK4K_#IC]>(FMOL2D*+EXGG?CP\[4RA5N?-9-=2IGAVH["VC#2RM\-#ZY_G-H M#+A9?#-D@17Q+K4+.W)^T+U9^&XY0:YV<$Z#4 U85@++Y<44&R)NA1;QI1BL M=(Y#?A7&6DUP83\#"C&HMQ,":<.-$A-K#__ MI=Z*KIS]V!UE4EYM817@U\0J*\IV@/%NPA@Z'.#7"ORP"F$50J- HZRK473ER/V9:/RK[+1OQ#KJB75\9I'A^F%87J@.N /NZ@\0;SI'M#'3?P'@ M,@"\9FW"7ZMV#S:>J*SK-&7 >HNP7C+*^C;P!T[T!UD1,R.L6^UO+3F^^MZO ME *A% BE0"@%4K.R%@7B@'$#8 P=#O!K!7Y8 MA; *H5&@41I=(-X^1:1.>206&;?E_'!(<_0-9@4>ZQL^/_/Z!Y,Q9^.1N2*@ M?!^,PLBXL&UZL$B;8G)@M!D8134Y(LH[ F 4(*$ J5$%2-=C8^+:L_TG=LT' M -(GI=>2+ZQ".C[JFJV3MG952"@A1PFYXO*/$G(4\P'J,.-@QFF-[?+,N,VJ MRA>:<6VSV]&OE%R3BF%$RW00[P(1739@0<#Z1F2]&.QER+R0:5'["P V X H M_D6H=@? JT29!^S[78/PFO;]8O,^L1FD<7]OO5Q)N^$#\]C J3E8VSDSNR>= MC)EO:%)XJ #-(+ZDI8PJ7":.V#\ JPI@H9MGN,Z)4]D 3:!3=31 M(SD# *M6@(4^W$K4!7IQT8NKW6B+]:TT3&D!E-6',G0Y!$ K 8"5""L1F@6: M18V)+2BM1@!D20#DEI[>/LAY]:AZ6M>W: M ;-"]I')_UY[L041U_=OZ43/=N?(/.JV4.*/$J4=$U>4^*/$'X"%7H9>UA7F M< _@'NB#ZZ5C?5;V#ZH<[W-X8K:/C^L>\ /V@93F2.FJI\2^U;3Q .%Y'?3_ M928 M&+?2PKCP^A?2OOACTM58[ZRHP\YQKLM8=2:I830$OU%+^56\:P49)8!6)=!" M/P/JBD*]=-\!C@* K)VC4#"W]!(Z[SS'_7TOHDO2P\T:_Y6/N@*[@%VV+Y3H M1D)L?ZNA43DM7)PS$N>DC !9Z&7I95YCCS!$X XJ"&&>. M0$\W'.(E)6&,UL$1?XIM5& A'JX#/I=#\5-@>?:C$VZ:D9'_ (_ HUKYF5S8 M]?R@3T\IT4:7(OR$ONOTC6>B3?^9TZ7.5@$2.5%'K0BBURM+0L8'6*\K MXS.,^IETS]A"N;=>MI+F.3DTSTX.2TGSI*TD5 [":=5)9->VS$H$/5) @*_* M*:!=]#:@SALN#W!!X((T4 !*=T$J'')WTC+;1]TR9MS! P%EZ2JQ=:3-*JPZ MZYS4G*)(+Z;XX%G>MN>[_1Q]"&C7$OO]S"+#ML)'8Q2R/MW,\(LWH)>/=R3ZY M)//D-O!_.'W6__#Z->2M5C>)E7(Q-E*V=1"4V>H>FJ?=T^WYPYN4D+ZM]\F0 M,H&B4#EELFO&(6)/#9<%6(RP&!L&_BHMQLVR)L4LQL/VL=D^TM1>!'\U5H0; M<%I0_8["K PLD9#2,3\,V'Y&U#4%X!H<,HO*\_3BC->FID8.0!0051RB:S)] M_<2>@66):0R@72>T*W,F4?W^: :MA1W4Z>55>GJT KJE1"^B4MV2LR?0+"7R M:!W](-NW_Y2@24!9:2A#ET, M!( 6(FP$J%9H%DVU2S;/'ED^Z8ARO95P'"! M'"C/S]8**KV)^G-=VN7[3>EK[YZ; M#Q?2>EA_+,M+Z+SS'/?W/;)&&#W,;+]LY4?S-8PXT"NKI1 J7L^.83T K4J@ MA7X&U!6%NC(UZG @.V-1NULZ@%4>#A!]\ALGQZ;K5:KC $[H"/0D9:C=;8U M=1TQ> W88+GB_Z<3/?8#Z[FB_- VSP4 0AN!4!P+@#02$(XAK_ \U<9Y^:FG MQ#:Y&4S\SK^385)6WFD=K_/PV&SS8_$ZV6/QZCN9&W-=(;6ZQ$)QO 0,JV9 M%\=+0(WOK"S4[WG S0#2RT/Z6C5DL,ZAUG4$>QTG5E=<2-8^Q:G5C8?WQJ?\&+U7XTU\A/7;.&-5UQG638,\,*M%PBH7=@WW)Y&T:@[**W<=43() MK"N3N%I\..%X?&>%QUFKG[]" 26\Y.T+<,TY+'1> ;Y*P'=CT#;<]X Z;[@\ MP"&!0]) 5CON/1B'DD=QZ67V] %SP14IGEK5ZF5$MN? XT#>FNED6T=1PUX M IXZP5/?8<$X*7U'D8X!Y!A C@'DT"AJGN>AB;VG!#4"QLK"&#H/(LA.&(\NSQ?GIX:,5T!K3GR[]IR??,^XBW_Y.%S>B1V;< M#7TO](-M%U(#JKL#555KHQ7H?$*F@\8GJ#>(.= SJZ4D*ESKCOD] *PJ@(5>!LP5A;D2 M]>NP_(%K)2S_"D].[QQMX]1T4!%$5DTJVG;C T+V30'F<@Q^8=$H\'@.:3@W MSU1+=@EP!5SU[F90P!! EJDY "Z]3@W^)C!;B[\I;8J;0;[?V;!,4\,8!*ZD MEM*H>"L+,DX K4J@A7X&U!6%NC+M*? $@.V-SGDHS15H7.H)G 1.VK[<*G8@ M!,+X3<%C-3U-\2/1]M 'C[[;9T%87B( F 5FT=R$M-/.@Q?-37 T%358%Y\G MN-3%U#C)U""N@+.HI>RAG0G))0 6>AEZ65>8HYT)MKX^N"[?UF]<%@GD R%5 MDWS0P 1@;B>5%)*^%LU,HY[KV$*_AT;T2,_S\)A\Z \&M+#> WJ7@%0U8_#H M74(226L HW<)SJ7"=NN"@L7/+)IR+N73W0K+X28V'#1.)#6,,^ W:BE_Z%9" M0@F@A7Z&?M8=ZNA6@NVO%[;+M_TK3"QUN^9AJX46)1#1;@HKSEY"R%[!Y%+@ M_+ B9M!W;<:?/NY:0C<2D*E>+![=2$@D:0M>="/!D534-EVG0O%66@ZWB>&@ M<2:I080!YU!+ 41+$C)( "ST,O2RKC!'2Q(,?GUP79'!7V'ZZ-!L=SIH30() M[9ZPHC4),?IMASEOK5>1'?('I-#[+'@.",I!^#>#OFG38T3H0 (@U8R[HP,) MB2.M 8P.)/B2"INGBT[KE5;#S>!KRF;X&%L,&B>,&D86\ NU%#RT'B%Q!-!" M/T,_ZPYUM![!Z-<+VXL.2EK5ZJ\P:W1Z>HR.(_"/0C*Z6!QQLA%"[,I$*%,Y MGV3.'-TIC- A5Z&7M85YF@)@IFO#Z[G9736L_,KS.D1204&7R.V_K]Y =? MV' 4V(]6R&X&7XA:V)/5<]EGW^,V<."[=,&':[*& Q9NT.*P5HO\L=EN=\RS M[N%"V]A V5.=9O*:!N):'+U]/MEB\'<;*[:+X-Z*J=/\\!>L'U@_V[)^ZC)^ MRHL*#IP7UM__/Q;X>^_W8>ZHQ@@H44:*6)_@1S#"&0< JHJ5H"AC1AFSMN!%&3/J&Q2M;R@^\O2+-!-NR4IX M_+.9I-E$TBNJR@%.-:/QJ.%'.DEK *-C M KZDPJ;J8E]R;$2$O%:NK)32UB?C-(PNX"5J*7HX^P"I(X 6^AGZ67>HHU4( M9K]>V%[2*[RBW=^\'!(8" PT1TJ5F9:#CHWF@*KNUJ)G/_@NSD*PADYDN8;K M6Q[ZBX!6/6+JZ"]"0DA;\*+6$(ZB/H[BHC/R4H6&R2S5F\$_I65Q*0V+/[A= M<>^G?$@R*NH=*=4].S6/AQ0YPV7A^VX(? Y@/8M)YA@K4.]ZPKX.M)-%59KM4]K#NFG%U-\ M\"QOV_/=_N(CTP#MTF*EF1/_LBO_F46&;86/QB9'BKX9A:Q/S_XV+27#P/_A M].GSWJLQ<#S+X]+#GAY/M7BHS.]8D.8(@:)$:RT"NX4XJTF+-07CE_B@: MHX#S>JWU)1,TR.BY))OG-K90/KQ^)?OEVON46"D78R.E],Q82"#Y?6]_V6"- M(_/HN&L>=@^WF"9#C2?$>,N9[334\-C7U!P&B@*CB$%W34JC?,,C LL0T'-"N$]J5 M&6I?OR.;06MASW9Z>94>2ZZ ;BG1"ZE4M^3L"31+B3Q:1XO1]NT_)6@24%8: MRM#E$ "M! !6(JQ$:!9HEDTUB_)'XE2J2]#=H@*&"R1@>"_+Y:/E/3"ZDW$I MNEK6;3)I/H8!0CT[2_3-:Z-II#G@Q4$Y**O2IS1C23\(-Q7X/U?_'CD_+)/WI#U+?O*5=\?O7GATP*V0?F?PO_=T=<>FX>K&%2?+% MBMC58,#LO#-:Z^@IZ9*\M8Y+J=#:;EU6*37_J/2')E*I2$QQF4,M)&"^W2)^ M&)(P)+>/:\7MR"IK_$].S=/C4_W-1U 91!YE_:B9U@[ 2M5, Z* J.(0U;>H M F7].XIV%&RA8 L%6RC84K\66A/[3PF:!)25AC)T.01 *P& E0@K$9H%FJ7F MLOYMS=Q'<7_CD5P@#2/*^:W(Z#%Z#H\?)>$/C%=F!5J>(X%B_T: X5ASQ;0*I@ZCJE%5G*M7U3A3I'@1WG@U%B?BL!34*>Z*$*]M M%^/X$T!74^CB^!.H\9V5A?H=$7@=0+JN7@=OCSJ:[W6\A,X[SW%_WXN"$>,G MS\UX$OMP)=H^$\=EF_K'#[3@2RQDK NWC6F'G])%^\_DPX M\<\N81J@5"Z#.6W,=\BVB(R^/^JY;+D]7V:-&HR+G0?ZFL;%7ZOS;4L6!^3: M '_-O=[U!LHMSK6US--6I[Q46V)0;:?6&CP&0=Y&OJTDU&OB6R#IUB#\;L46 M@TJ'2, U@6L"^#?.-5%R1B%<$_"8MH*LXCE.VY\%@NE8M8)W6[/@ $_ 4R=X MZCLD F,*=Q3I2LSLQ_"9)NH4#)[928U2^^E,V[?WE*!&P%A9&$.' _Q:@1]6 M(:Q":!1HE)K&$99>)K-]DQ!M)2K@N$""Y6XT'+J,/Z#E&A^=T';]16P+C 0+SF !BC MT=7S0QJF+N"+:*!4E KMZ6RE(4H-*$.70Y+=YB M9GE]_F$PHI^SER'SPMGH8HPB0EP1RW?N),/T+::Q_X=Q;Q_-J 590L SZ!3W439AA>"$-A^X:",FYN5%L7PAQD ?29#N)7QSD 97>3)%0VX= N@SPU\:MJ# I MUC:/CEKFT5838^ K\-7V!18-9D@\*)!X^,)LUPI#9T"H$,3A#^A.3T_TIS#R M[>]&..K]B]D17=0@#F%/0_XMM)4!K#N4)4,I#4 .[Q9M9<#Y%MW8RT?+>V#7 MWO]8[HC=#"Z%D7+';90[::+<^[<^63($XR]C0Z4923/P#^1236\5/65(EC46 MN^@I@RIOGCBHZTH@20;HZ^Y=5)@[ZQZ:1^UC\_CL#%UEX*^=%6)TE2$?H4@^ MXL)U_4G:S)^>U1CYVTJD ;P K[K)-)3?P(K8OA6AC!>,EC-@?7MN[\2"N1E, MC56Y]_-ZT9!@VTG\HAL-*KV9(J&V>X%$&^#?!(^CPF1; MQSP[/C9;IT=H5 .5[;0LHU$-Z0H%TA5\EB\;=ZA90?#*4VT_>+G&=$I-?H8. M-:!TAY)J*,L!R.'QHJP4T%?'VPWW'RQK^.Z>[!(_L(+7JW^/G.AU;,>D?5M1 M=7K1_]=PRX:W*#*FR<. M\$3@B>PH].OP1*KL<#./#X_(%SE&@QOX:V>%>&'"[=>(#VV=VB#;958@4/C( M4?8RQA)_B+WD$D5_808@2E\BO9;MXNY0NW7RRXR$71+^>X%C&J'EA?L"NVDT MQ'@]SWNJ>:*2>\G,$V?NL0[2YF(H]6QK7F$*A;/K+Y=[;!V)2\:?Y29-3O/? M.+.J4RK)IH]9,%^[SKEHFN2IG T"+DL50BL7R8643OH**^-IBJ>& =N?-8]* ME*GS],W&]ZI78>W8[NV0R544;5ED;(2V7O!KRU\GD2=>%PM C'W)O7OBY]]^M=[/;&?^OHH%_,M/Z]DO.9[A M'.9?8E/&'P0IAV&:OCNYRC@1VX5FG59OHO<[*/'T>1;E^F]4V;L4N7\Y3D_F M'6+=U?/=?HZ+\.7BX]776^/B\K^_7M]=WU_??#8N;[[<%K'X==YHO)'Z;Y1Z MESE6\F[(Z&J1;0$)LF"\D.<.WAFCX9 %MD5&F;+K_>GZ\\7GR^N+/XR[^XO[JS^O/M_? M-5P=8OLGW_YX=7GUYX>K+\9AVY1F&J_7:S8 ILQ1F;S[/'JBA[1GDI"?K6@4 ML)O!#6VC: ,,"U8[LM"VABP>&R)^Q?%&K'\1_;YW3[]\QUPF,9H&__Y\VFGW3DW;H('RW/^3X[6L[R^\6$4TA?#T!C# M1CEQ*F6W"\>9='U7/'V9:IN7:3B#UQU7-?<\O,5=T#B^Q97&I1\,#XPWT2,3 M2J73.K^462SQM_;Y6\,)#%LA=;S*0VZ1E"%AG6Y.W,^"MT M/?I.2%\)F)]6F72_T*%]M *CEVA.>KT>F?'BY\].]&@LFH;M>WUQIT]^\&G$ M"3M1P)>3JQ"_]UAP,TA^Q,(_'<]Y&CVMU;YP36Y'D:JA_9#9O'+HV0_Z(?/V MWA..LJT+M !//FU8;_QL4U@8TTGJ=1)@3.\B+:\1"M."]O$CLQE_9S+L.#"< MB';8X4]IO#)::N;U#Q0BI'(5139!5R0#UZ05:(*JO BY\DGA6&BNCK"QN HS MA9Z:@+_/,_YBCC'S;*X.Z5-_;+D?&)\2S4;OYY.B"_RG6:UHO"&%RD1QX5OZ M+KW3PV/V":9N+,S D_.0:TD_("E[M'Z0+#/FT5(].5P4(]](:SP202[Z/TAI M\?J$T'AFKBN4]^33@+1X_*O\7M2G)+!+C#?U6GPUHO?IT2]=_ MGM$(SPY=F:_* _/X0K#THM#O!^P'(\FAHYQ[C^]+N-B?W)?3UA.C_XC?YQJ3WX8PZ_1),8D=Y@4; 5TT M^:[8+K%]@6\SUNJ3%N-X[<5Z/=3:S&F^23,S-' M"9,M%8Z>GJ3J6B"1).P++#IN8X7783AB_8\C_OU;H;'O'LFL#6GGQ(\RH9B3 M;^VSN-Q[\N=OU[*$LR9>*&ZV M;FEXJ]7B_V1M/7Z3:?,N7AKQSLE&",WZU\4%\G(UY"K=!H[-:)'$9S/K M>*GUN/G! C[62E3,WPBF6VM]OMY]_$;J_%M\R\DR=0HO4[MUD+=$=%4CM2AF MPB$<-R1JQ$%C!B 8+5FEV_BKGX@C^%I91.\Q*.4]$DA6BZ;UNPQ:\['T_.C8 MC]PU[+/0#IP>XZ1I\.B4U/#=B;1VVFEI)6W%@N> ;),@%/60M!KT)?;" ML) M8]'U"2BDE&.DD,TPCF\EGER_"AGNM">K'O^Y-,QN)-.'A25:/J&4Z.0S6GC_ M@=&7 NG/\J^G)5]N3/SE*5W 58%%D"<)+X#W%;5"V2MQF6N'2M<+P M9O!/*P@L>M_@"Z?T)$1PQVP"++?"+PG^K/_A-?Y>&']Q%K45K>5F#'0X1VL< M&%<6:0U^!\'6#C_^A1\(XS%#W%&,K$J=!6,N7]60O MMW V1#Z&NH5?GT.HUQ+% M?L_R9:;V)G[!R;8PCN/G1Y^^'__,((%S(I>K!/Z+]*.^=&<#Q@O^_3%S%=G. M*4U:R69*_9_ IJ0]W2P4.=8 :4D0#.2-S8/"7)3[%E?Q500Y380F4:WMA:JB MUK4M@\O:!T=SN$RLM R82$/AF5#*BXW[\7*/';C"U#]9@L8Q_P:4+V2:15.. M0#$'H$I3='V'8#ZUBW":'UDNP8K7H,3K($]X<_@?/$^6'4QLT'D..N<\_G,G M]IG$!Z$E"[&G#%SKR1]Y<:ART1ZD'DF,4"Y'T$M;UT.SU3XSNR?=S+*:B9T4 M!RX6O>37Q+.B[WYB6?]F,\8H[65/3X_S$42O-TJ]@C%@O#5@T1OGY-KHQ17; MW+9Y=-0RC^:\<5YLVZ"7,-XD0>/8K39.XO"QD(9%JW+#C8ZIB>&*KTYL*_8R=)+<\F!^O,!<9&E]\H,!QH5-$G#[Y L/R5]++^D4F5^T P97Z0]E$Y[W#E/(S>R/.:/0O=U M8J78KA_&[+O :%FU*Y#.V5$^SP#L19BQ8;C%1.06[BHX]6, M\_RS2;V!5/5D@_G!.,,7IGC1Y.EQ=]1GQKWLFS2N/U\>C,WWV>N%0Y(*/S"- MO#*T._E#XX\_+LUT(5E2QN Z5L]QG>AU7'V6?K?XMU-A,P+6@TQ22,E,KK\T M?U!EE'8C;'V+7V$]HZ)4T3Z<8\'/DUL!B2F,:+P-$KW#:\_>_DX7G M,V\&LZM8(3^5OO:;G'ITE!\(,1>D1HVC>5G1988#;UR/R[>JL2'RXDU;MR': M)V9G)3TS-MH2=9]1/!5:#ALM6Q70KK)&(K,#8I]5)=[-MD89XFT?FB?'^O*N M6@*RR48T_!D#<7$Z;+[*690BN+5>Q;3!3WYP[?U@#2"A^OO7O2!]&% M;?/46C&M4G]EXI'9GI=&&E?D>RR:4K-I>SH:I[[Y8HY_9=FJBEXU$6/IR[A+ MQ-=*3'X+,>++!DQ?S7^Z;A/!)6(-D=\W30^)TT:%V'H MVT[ C8@VBI$!G0(K9LOF,@2J5J*FNN9+O?5%.4N,$[EF!V M=Q:4(KR5S2T]'OGCHBNAR']"?Q+U;^/"SP>>%_.D>3ZVV6(L"E\I[H%Y8I87 M:[2[.$G?>6.]?=,^?CO1DHT.Z,1,VDKR7E6C[P3TV41(.:6?0YT0X].5%#+ M(3I5Z38?7@W>9T2XC!)Z<2:O%*_]6(G)9PGY=^AW1D*%RQ+!WNMD*\:-K*2H M:'^)N)EHT(T[8\=^?T$3Y;GB2RN[-GE[;D1<;/WG;]Z$JIF8K:^ ,+;Z2 ([[[RY.M:/WR' M)Q?Y?7B%GNBL2^"=6BE[JF=Y#K;G T9JU7E,'F^O?*RX2YGV.N0P?7[TQ93? MD+'O+6GSR"A;.Z3KQA5+'R_+M MI^6->X+BM ]AF9:.!%*\1B"5UVQQD)5.,Q@_>.2,8^&)S2_DG+1\+$XG+@/*5P,WO+B;(0 MM9V!S[L'Q_(SO0KA;QW]A8NL7@B/ZY375380/3&9]18#^QF_(CRW KV M)($=,^+@BA>LOG[T6?C9CRXE /+:UZNM(QJ.YO'D?FX/JF>*-$L,74FLG%5&J\55,0V9S;FL+ MF>HQT39+\O0O(5M^[#A9SE,X3Z)L>@XG\D5:46B.))(N+RDZFXD[?&EE_$AZ MA1=>,^?M$6M K$'E6,/]BMQK/''QD\0NB(0WTR13/:3QE[;0!/&-V\&$4)%B MFOB3 \L)$AM==JMP&H_H-2RZS:(2VT?2%5S&XMDF%\DE/]$5_Q07E$E9"*U,!B'G*3_G"=\F M4Q7(^!G'2<9.#]?C8OP=?Q0_ON1\9!X8?_>?V0\^L"?-O<)[%3Y9;'2R.2,> M$M*F=X@'&XZ+RN65_&=/.E/"K:'W+ +/-/IN1A&W]_B&_(_/';!)9N-F<"]D MY][_P"[D]?L?7F_I4:9JR<6#W/LZ6D\YS2&_C!5'4E<[62!NAO/_I%T7^:58 MR="O"D_WF;?IC+)ZW+*6>R&-83ZD M@ 7"%TJ[6^/?6QHHX-&*LV[+%)>(O8CIH05YOS8U 2F(_7\N_J- > ]2RR#(]^3+DAR/;IL\&(]=]G398:,>D$F&@;M6H>U732YDIA2K8H;\V%ME9 MP=VALT].%YZ1D5Z4.?O/SSG93Q]\8KG/UFMX/G582GPLI11?^K^W,S^.UYB> M:?IS^>;BE)6RCTZ9^VXX4V7],U72Z_CKU/!D?M0*?1!/.X[MQ_[9TQJ3"J.F8K6) M3Q$PFS.'3/"EOR##-SQR8/-J/F?@R+11E)QNG:3@1L,X%I#- LWM=N+5#S:_ ML7!X1. ICB%P)_&..XU6T.=>35\F8?A%W\1>U<7=Y;@B@MB$+DRZ-G&Y/LIN M9R*+1WZI/^+&#^YPBCH->2;W09+JNQ;>TJ-AB_&^&::5%<8:IY Y MJ/0.#XX(OLBX3CH0MJBX)@Z ?6;1?7P%&>7Z.N01@SCA0+\S&0@\/URP=%K- MFGT#\6"OG#$U @QR15//.G\0)P>8.;N$/!L:3B7QK"'/D5FN*6H%_N4GM0)) M85.!AH'J5PYIU5.&TUFK\;5 M68=37KD3+8ZYBBK^\616/I,U,YDUC@)&O.V)B3->DUH'>NRI;,QT'Y/\[I_R MNY-^IF<19YA"-X]8B$65M43B5NGK3F5,U\B0^@:A,/G]/O].CPUX;$AF9=+/ M(D+0RV(:,[..,DFNL4:8FHV;[(_)WY&'MDDMDB2/AOP!0^=%1"KY!#-_JMKN M4#2M"1C+_'<@7T'DZ7AA0U*"Q1^JYY.JDC-@>86('\SFDXPWXDKBUF)6':U+ M*#0'C_8&C"!)-B\+XK@4U[&3=[U*OCV)&GU-%&YZP^)H?TI2_#3(SO) -G!< MOJFS.REV.XG8KK?]*1-11IE%X\8F7PB4;[SLO^H],G0^2=_(]P&8ZZG;WW MM..__,F%6X]B Y/T:YBCG,!O'C "A]- M3M^TJ,D6SY8$TH>B"B5.V.9G)&0#IYR*'$=II],#R]+,'%&B]BDG)S'=5[HD M12'*&^@5<_.X,AGR1A232=%?2,#62TS U_%+W?NWUBL9%N3IC_BWKU[(QPN5 M'9$RI[5,2FF\3?%J]2=BB+N(5Q[4!](HIJYA4)CV($ [7>I85<7'MQ7))'XR+NX62G[RZ.5N_D&CF M>=4& >/EO>)*4^46GC0$LC1CQMOW0YKIR5NSR9U)YL2H.6[=SNO33M4MQ@F/ M2?>T]3Q;GC0IF!@77(PKS./DBJQ8&P]CF5[=).>1N!_>E%,2[[N_8 NE*4Y@ M&Z:6=O:=DH:B!)#B;F+N"^,ZA&B8JX(9JW-@.6Z8(9]524?:CDGSN_%&EOZE M84LNS^.X;(^O'R\"'(_WDS-98V6Y:,154O3Z)'0+>3O#3*KL+FF9'Z/>YTFS M!%43>T4D\D5\5EC(7"9B#S25OAUW1\8+9O*''E>YCLVZU[@L@/]>7U8(TD\M M+I_T4R?(V>_9+>6[,3TIQES1WUOI M79:7^N67-TIC7I1CS-IOFQ<\OKD0V_C$W?'7S8H=^9REY_32S=D=E#.65,ZX MJ+(MM[RQ3XN0G$=2S*-=6-W(*QD_O,T5N^7<:')*7T)+ :+;YF7-TZ96=QZ\82 MZC0G#EA<$F2[R" G3I43G)H-U2X+5BV.*EU[W)SBQ^)$\JG3KQ'KRFQM\^PS M\-"L-_$"QX7NMC4*Y?OG13=E>8TPJX2[N\C!*G3JV;CB*A,(W7:,\V!1T%@L ME?1H4Y'C;%'_XCV86-3R**4Y1QB)JKXP(FD@L/&PJ45&I 2RQP6?!1Y7/[EH M:6@5[X)\W0:3OAM=^-SDE%@R/H0G96*/1*@T)QI3(1\-YLYZQ])C&L>@1,@V M$D07.\#$2A;]R"&7G#=#R/ 4O?D/^/;,XVG ^G;R/"S.)2 M]"W!I\(\F2Z[EBHD&S;G[T0O;8]"'BT3WELG]EE&Y>'XCH2.&.G)2":L[V4;-A-JVEXXZD9Q0DEQ]7&4O:F-EFZF@27,Z^L-)>VQ%Q&$" MB2E.'3V9A.T'UK,WCJ3RJ"D/9SAA:G[>^%@^'M=YS;4%YXD(CW.P%V:/A)$C M;?$@Z?,3;CQ=>F*5\RP@SQ(+F\*?$SR.P_96.'/S2>ENMAN">-A+V6531PHM MF27C9389[4QZDGF92'RZ;1/_V ^:+ /=Y+:;H)!24/+9!+ M%2^4& DF>EBEL37RF$? MIDL\8^?;&K)31FPS5N&1#..]U/4 H@ABTY*'\:: M+]ZD"0P&27XLO<%R[6%:P+1HN&F1?@=OY+K9]\S^3L&I/EQ.DV5*P:&[./Y/4%XY;7JB1.]MA.H@ZUGPB*L6;SOV0I]07=0@E95&R MP$@8+#+.F$Q,(7LT/4VQ6"!1NH5BGMK%E(&4'*H9CUJK9(#BH7E$:W>2T[0V MX[^*N>UCHY=SPU0*^$8BSLN/P].X[!Z![1KLO>#^ @W8I?['ON MV'AG.;JJ0%@O,E$:TW6T:U7.O)^FB8V5F8QF5TT/[+7BIW\E"T>GK_X>H%-Y M%?C@=OJ-4QJ[1KC<4[&]+,N:?@7\94=AHCC1X@LZTG'GK1;Y^UNTQ+VEBM]UBZG_Y2::/KMS$%LK,6UV]I[+O;[IP<=DY; M1H6<+ZN<6E#MZ*82SU60%K!Y5 M1>)DHQ"E*]764PN9/@WJ*(N'H2Y^M+Z$P0C[)<()35.2,-<=V*RNLL(DIBNR M?@:E:"VE::U? QM;2*;!.JV#2 @YH.GL->48]+BE0F-K>8];1<=CW(4P"LA\ #,L2,B9E/49L/!:7OR0KP"L9A>#7D;4P1XE7MQZCH(I=VV,Q4IIV0)3*%@Q/0]2:1'I M%$56=*V'(I(%X*!4EPTUM.P1M3S)/6;EN; F@N:CJ\DSP=&2G<(,G<;$2OGE M>?"4(B[*'" JW5AO)-7FT= >X['EXN)MH03/IGGA$]?,0[;JG#8#ES MW.393DGI_&8>AVXL2(W"BK!'[C&TQWN=1*&S=A#DRI9+7S >6S"C^:C7=M0O M]UA^6(:^.)M'RKR9N.+6VZ1G7?O] M(P1F3'.20#&@&VQ@"A%$,'C$,&Z4M?@6X/)7HR'XB:S7 QWV,XE" 4V6] M=X/QT ;?IS5[#69G@?YR]L@\[HUO-$00A@,F&F"!:C$XJLN-=<^< E)!P*7Q MV*,OR:;/;)0%0:8@=*J,UN)@%&RM@O^5!YO?:Z&YXLBDJX*#/?<-5T$7O_S) ME*>1F\BERU)(".I94UB=O1Q.F^XUHT\J6!LX\?2:W4AEV]/6MV?*5J@?@*K] M92RF$%2OH--BZ$F^/USI2DRW)MEIR&:<05KDZ/ M;FO)@2FYL+5?@/?L4^@M0B@JJZ?U5E\D%))+2WX<\2"\8$Q9YP^="]) 5Q^Z MW<-T#N_EU[N/OUW? C6\.7GW?W\Y.VT?7[RS[@[[0@*^ .5C#CL#.;-QU3(Q MJ9+E-+,X3C5<9 \$-N\.;<\3_KV:XSL&0J>\(SVIYP4!0L#X*7@*#,IA$ M,<*;!K+:"46AZOU[D)(M7> [T^B@N+RCO:$.5CH[>:];JOS,#WR?-JB;2%8 M!H($QG(@.!:ME@X"P"__7?@@R3PP7S(K_E?[44L*ZNR4!<_2W*^

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end